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Abstract 
Compliance with medication regimes is a widely researched topic within the field of 
healthcare. Older people are considered to be a greater risk of non-compliance due to 
multiple morbidities. Multi-compartment compliance aids are frequently issued to older 
people in an attempt to improve their medicines management. 
This thesis aims to determine whether the attitudes and beliefs of both the older people 
who use MCAs and the healthcare professionals who request their use, influence the use 
of such devices by older people living in the community. 
A preliminary study which investigated the use of MCAs in primary care is described. 
The findings suggested that over 100,00 people in the UK may be issued with a MCA 
despite little evidence for their efficacy. 
The literature review undertaken for this thesis concludes that very few studies have 
been undertaken in this area and those which have are mainly of poor quality. The 
results from these studies failed to conclusively support the use of these devices and 
further rigorous conducted studies are needed. 
The main study comprises qualitative, in-depth semi-structured interviews with older 
people, who are using a MCA and healthcare professionals. The interviews were 
analysed using a grounded theory approach. 
The study revealed that older people find MCAs easy to use and convenient although a 
minority of the participants did experience difficulties using the device. Maintaining 
independence and remaining in control was important for all the older people and this 
influenced their attitudes towards using their MCA. 
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The healthcare professionals concurred with the observation that MCAs were 
convenient to use and despite a minority stating that MCAs assisted older people to 
remember to take their medication, the majority acknowledged that this was not the 
case. The healthcare professionals agreed that the decision to issue a MCA could be 
seen as paternalistic however there remained a belief that the issue of a MCA would 
assist the older person take their medication correctly. 
The thesis concludes by providing details of a proposed method for undertaking a 
holistic, patient-centred, multi-disciplinary assessment of older people's medicines 
management abilities 
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Chapter 1: Introduction 
1.1 Background to the thesis 
This thesis describes research undertaken to investigate whether the attitudes and beliefs 
held by older people and healthcare professionals influence the use of multi-
compartment compliance aids (MCAs) by older people living in their own homes. 
Multi-compartment Compliance Aid is the term I have used to describe containers 
designed to hold all of a patient's solid medicines in individual compartments. These 
compartments are usually labelled with the day of the week and a time of day. Further 
description of these devices will follow later in the chapter. My interest in the use of 
multi-compartment compliance aids first developed during a research project, 
undertaken in 1997 (Raynor et al. 2000). In this project we investigated the ability of 
community pharmacists to provide compliance support to older people, who were living 
in their own homes. Although the number of participants in this study, who were issued 
with multi-compartment compliance aids, was small the question of the suitability of 
these devices was raised. In 1998 I was successful in obtaining a Galen Award from the 
Royal Pharmaceutical Society of Great Britain and this allowed me to carry out a 
preliminary study, which I describe in Chapter 2. The preliminary study indicated that a 
large number of patients were being issued with multi-compartment compliance aids, 
despite the evidence for their use being unclear. This conclusion led me to ask why 
healthcare professionals recommend the use of MCAs for older people living 
independently in the community. When considering the answer to this question 
I hypothesised that the attitudes and beliefs held by the healthcare professionals 
concerning older people and their medicines may contribute to the appropriate issue of 
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these devices. Equally important, older people who are recipients of these devices may 
also have attitudes and beliefs which may influence their use of them. 
1.2 The Aim of the Study 
The aim of the study was to discover how the attitudes and beliefs of older people and 
healthcare professionals affect the use of multi-compartment compliance aids (MCAs) 
by older people living in the community. 
There follows in this introductory chapter brief consideration of a number of key issues, 
which are of relevance to the work which was undertaken to take forward this study. In 
some cases this will be an introduction to a topic which is thought necessary to make 
prior to the description of the preliminary study in Chapter 2. 
1.2.1 Attitudes and beliefs 
In order to discuss the findings of the study, it is necessary to determine what is meant 
by both "attitudes" and "beliefs". Attitudes are defined in the Shorter Oxford English 
Dictionary as: 
Settled behaviour or manner of acting, as representative of feeling or opinion. 
Attitude of mind: habitual mode of regarding anything. 
Beliefs are defined in the Shorter Oxford English Dictionary as: 
Mental assent to or acceptance of a proposition, statement, or fact, as true, on the 
ground of authority or evidence. 
There is a difference therefore between attitude and belief as defined above. Attitudes 
can be based on a person's individual opinion and continue through habit whereas 
beliefs are based on evidence. 
Attitudes and beliefs have been further explored by Ajzen (1988) who states that a 
person's attitude towards something may be influenced by their underlying belief. 
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Therefore if a person believes that medication is dangerous, then they will have a 
negative attitude to medication compliance. In contrast a favourable attitude to 
medicines might be implied by the belief that pharmaceutical research has led to many 
new and effective treatments. 
1.3 What are Multi-compartment Compliance Aids? 
A brief definition of MCAs has already been given at the beginning of this chapter. 
MCAs usually hold seven days supply of a patient's medication and comprise two 
distinct types: 
Re-usable aids (e.g. Dosett® ,Medidos®). These are made of rigid plastic with 
separate compartments for days of the week and times of the day. Patients access their 
medication by sliding open or lifting a cover. The aid is not tamper proof-sealed when 
it leaves the pharmacy. Re-usable aids can also be purchased in pharmacies or obtained 
by mail-order from a number of outlets. They can be filled by the patient or carer 
themselves or in the pharmacy. 
Disposable aids (e.g. Nomad® and Venalink®) sometimes known as a monitored 
dosage system (MDS). These are made of much less robust materials but have similar 
divisions for days of the week and times of day. They are sealed by transparent film or 
a foil backing sheet, making them tamper proof when they leave the pharmacy. The 
patient accesses the medication either by piercing the film or the foil backing. 
When the preliminary research was undertaken, approximately one third of MCAs 
issued from pharmacies were of the re-usable type (see Section 2.4.2 for further 
discussion). Currently the majority of devices issued are of the disposable type, which 
leave the pharmacy sealed and are therefore tamper evident. 
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1.3.1 What is the evidence for the use of MCAs? 
Prior to undertaking the preliminary study, I had undertaken a brief review of the 
literature relating to the effectiveness ofMCAs. This literature review indicated that the 
evidence for using these devices was inconclusive. I therefore decided as part of this 
current research to undertake a thorough review of all the available literature relating to 
MCAs and older people. The method and results of this review are contained in 
Chapter 3 of the thesis. 
1.4 What is meant by the term compliance? 
The Shorter Oxford Dictionary defmes compliance as 
acting in accordance with a desire, condition etc. 
At a basic level compliance with medication could be defined as taking the correct drug, 
in the correct quantity, at the correct intervals. However the most frequently cited 
definition is that provided by Haynes (1979) who defined it as 
" the extent to which a person's behaviour (in terms of taking medications, 
following diets, or executing lifestyle changes) coincides with medical or health 
advice" p.l. 
The earliest reference to compliance with medication is often stated to have been made 
by Hippocrates and in the early twentieth century, Franz Kafka wrote in his short story 
'A Country Doctor.' Published in 1919 
"To write prescriptions is easy, but to come to an understanding with people is 
hard. " 
Perhaps this is an early reference to shared decision making or concordance? 
The literature on compliance with medication really starts in earnest in the 1950s, when 
new powerful drugs such as antibiotics were first developed. A journal article in the 
early 1970s, (Stimson 1974), reviewed a number of studies of compliance with medical 
instructions and concluded that these studies had all used an ideal image of the patient 
as a passive and obedient recipient of medicines. Those patients who failed to take their 
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medication as instructed were seen as 'defaulters'. Stimson noted that the studies were 
all undertaken from a medical perspective and aimed to discover what made a patient a 
defaulter. Ahead of his time, he argued that this problem should be considered from the 
patient's perspective and went on to carry out a study in which patients were 
interviewed about their consultations with their doctor. His conclusions were that we 
must consider the social context in which our patients live, fall ill and use medication. 
MCAs may be issued because the recipient is seen as a 'defaulter'. How does the older 
person view the issue of a MCA? Do the healthcare professionals, who request the 
issue of a MCA for an older person in their care, consider the older person's 
perspective? These are all questions which I wish to try to answer in my research study. 
1.4.1 Adherence. 
More recently, researchers and health care professionals have used the term adherence 
instead of compliance, this is because the term compliance is seen to suggest that the 
patient is in a passive role simply obeying the instructions of the health professional. 
The term adherence was substituted for compliance with the implication that the patient 
had a more active role and was more involved in the process. Throughout this thesis, I 
will use the term compliance , both terms refer to the same thing, and much of the 
literature referred to uses this term. 
1.4.2 Intentional and Unintentional Non-compliance. 
The distinction between intentional and unintentional non-compliance was described in 
research undertaken in the early 1980s, (Cooper, Love and Raffoul 1982). Later 
studies, (Lowe and Raynor 2000b; Raynor 1992) also distinguished between intentional 
or deliberate non-compliance and unintentional non-compliance. 
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Intentional non-compliance 
Intentional non-compliance is said to occur when a patient makes their own decision not 
to take their medication exactly as instructed. The reasons why patients consult a 
healthcare professional and then decide not to take their medication according to 
instructions are complex. Patients may be unhappy with the medical advice they have 
been given and are therefore reluctant to take the medication. The side effects of drugs 
may prove too severe or reduce the patient's quality of life to such an extent that the 
patient decides to stop taking the medication. Patients may worry about becoming 
dependent on medication and take 'drug holidays'. Sociologists suggest that patients 
may be stigmatised by taking medication (Conrad 1985). Patients' health beliefs have 
also been identified as significant when considering compliance (Home and Weinman 
1999). This intentional non-compliance requires considerable understanding on the part 
of the healthcare professional when trying to assist patients to take their medication as 
directed. 
Unintentional non-compliance 
In unintentional non-compliance, patients wish to take their medication correctly but are 
unable to do so because of reasons beyond their control. The reasons why patients are 
unable to comply include the following categories: 
Inability to understand instructions 
• Lack of knowledge about their medication 
• Difficulty in accessing the medication 
• Poor memory 
• Inability to swallow or administer the medication themselves. 
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Therefore strategies to improve unintentional non-compliance can be targeted at the 
patient's individual problem. These strategies could include better education about the 
medication, clearer information on how to take the medication and easy-to-open 
containers. Reminder charts and other memory aides may also be beneficial (Raynor, 
Booth and Blenkinsop 1993). 
1.4.3 The prevalence of non-compliance. 
There is a large amount of literature on the topic of compliance with medication. A 
meta-analysis of empirical articles, published in English language journals over a fifty 
year period, found that the average non-compliance rate was 24.8%, (DiMatteo 2004). 
This study undertook the meta-analysis on 569 studies, which gives an indication of the 
amount of literature devoted to this particular topic. 
Individual studies have quoted figures of between 25% and 60%, (Blackwell 1972; 
Stewart and Cluff 1972). A more recent study, (Degli Esposti et al. 2002) investigated 
16,783 patients with hypertension whose average age was 56 years. Of these patients 
65% discontinued their anti-hypertensive treatment during the period of the study. 
It is important to consider what is meant by these figures for it seems unlikely that 50% 
of patients take their medication exactly as directed 100% of the time, while the other 
50% fail to take their medication as directed. In a journal editorial (Kravitz and 
Melnikow 2004) the authors question the assumption that 75% compliance means that 
patients disregard a quarter of all recommendations received or that 25% of patients 
never adhere. The authors state that beyond quibbling over the mathematical statements, 
important issues are raised concerning the conceptual and mathematical models used to 
link compliance and outcomes. 
Evidence obtained by electronic monitoring of medicine taking, has suggested the 
following patterns of behaviour. Approximately one sixth of patients take their 
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medication as close as is possible to perfectly, one sixth take almost all the doses but 
with some errors in timing, one sixth miss the occasional day's doses and have some 
timing errors: one sixth take drug holidays three or four times per year, with occasional 
omissions of doses; one sixth take frequent drug holidays and omit doses on a regular 
basis, and one sixth take few or no doses whilst giving the impression of good 
compliance. This pattern of behaviour was described as the 'rule of sixes', (Urquhart 
2002). It is not clear whether this behaviour is generalisable to all patients, however it 
does indicate the variety of compliance behaviour which may occur. 
Another problem which arises is due to the difficulty of measuring the level of non-
compliance. This is frequently carried out by self-report and/or pill count. Both of 
these methods may not give the true result. Studies which use a clinical outcome 
measure, for example improvement in blood pressure control, are often seen as being 
more robust; however in their review of measurement, correlates and health outcome of 
medication compliance Vik and colleagues (2004) state that many factors apart from 
compliance may influence clinical outcomes and therefore these should not be used 
alone to provide a measure of compliance. 
1.4.4 Predictors of non-compliance. 
The ability to predict which patients may be at risk of poor compliance with their 
medication regime could be very useful to a healthcare professional. Identifying 
particular groups of patients as more prone to non-compliance would mean that 
strategies could be targeted at particular groups of patients. Various studies have 
investigated risk factors which might influence non-compliance. A literature review 
article (Balkrishnan 1998) identified 14 studies which investigated the relationship 
between elderly patient's non-compliance with medication and various demographic, 
social, behavioural, economic and medication related variables. Age is often suggested 
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as a predictor of non-compliance with those over 65 being seen as at greater risk, 
however Balkrishnan (1998) stated that this was not an important predictor in most 
published studies. In fact many research studies indicate that older age is an indicator of 
better compliance, (Degli Esposti et al. 2002; Park et al. 1992). A study of elderly 
people with hypertension in the USA (Monane et al. 1996) found that not only was age 
not a risk factor but also that the 'oldest old' that is those aged 85 years or older were 
most likely to achieve compliance of 80% or over. Conversely Park et al (1992) 
identified the 'old-old' as less compliant that the 'young-old'. A postal survey of 
community based men and women aged over 60 years in Australia (Cohen et al. 1998) 
found significant positive associations between non-compliance and being male, taking 
more than two drugs daily, not having had an explanation about the drug and taking the 
drug more than twice daily. Although many factors have been investigated, it remains 
impossible to identify with any certainty which patients generally are more at risk of 
poor medication compliance. 
1.4.5 Strategies to overcome non-compliance. 
Much of the research on non-compliance with medication is directed to developing 
strategies to overcome it. Having discovered that the prevalence of non-compliance 
with medication is high, then developing strategies to overcome this problem are seen 
as a priority. Ten years after his original work on compliance, Haynes published a 
critical review of interventions to improve compliance with prescribed medication 
(Haynes, Wang and Da Mota Gomes 1987). Haynes concluded that although 
considerable knowledge had been gained, none of the methods aimed at improving 
compliance were fully effective. This review of the interventions to improve 
compliance with medication has been updated at regular intervals and will be discussed 
again in later chapters. Research to identify strategies has continued but no single 
method can be said to be completely effective. 
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1.5 Concordance. 
Focusing on compliance with medication is now seen as paternalistic in nature. I will 
be discussing paternalism in more detail in later chapters. In an attempt to move away 
from paternalism, a number of new approaches have been suggested. A 'patient-
centred' approach was first discussed at the end of the 1960s (Balint 1969). A review of 
the literature on 'patient-centeredness' (Mead and Bower 2000), attempted to develop a 
model of the doctor-patient relationship, which is defined by this term. Another concept 
which has come to the fore recently, is that of 'shared decision making', (Charles, Gafni 
and Whelan 1997). Charles and her colleagues aimed to define the key characteristics 
of shared decision making. At the same time, the Royal Pharmaceutical Society was 
producing a report 'From Compliance to Concordance: Achieving Shared Goals in 
Medicine Taking.' (1997). This report suggested that a better terminology was 
'concordance'; which emphasised a partnership between the patient and the health 
professional. In the report, concordance is expressed as follows: 
"The clinical encounter is concerned with two sets of contrasted but equally 
cogent health beliefs - that of the patient and that of the doctor. The task of the 
patient is to convey her or his health beliefs to the doctor, to enable this to 
happen. The task of the doctor or other prescriber is to convey his or her 
(professionally informed) health beliefs to the patient; and the patient, to 
entertain these. The intention to assist the patient to make as informed a choice 
as possible about the diagnosis and treatment, about benefit and risk and to take 
full part in a therapeutic alliance. Although reciprocal, this is an alliance in 
which the most important determinations are agreed to be those made by the 
patient. "p. 12 
Within the profession of pharmacy, the term 'concordance' has become the preferred 
terminology, whereas, in other parts of the world, 'shared decision making' has been the 
expression of choice. Later in this thesis, I intend to discuss concordance in relation to 
the use ofMCAs and also to consider the health professionals' views on this. 
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1.6 Why investigate the use of MCAs by the older population? 
Although the incidence of non-compliance with medication occurs across all ages of the 
population, anecdotal evidence suggests the decision to issue a MCA is generally taken 
for older people only. Non-compliance is well documented in patients with other 
conditions, for example, patients with HIV whose medication regime is complex and 
who suffer from a high risk of side effects. For example MCAs have been issued to 
patients with HIV; however, more use is made of other strategies, for example, 
electronic reminder systems, telephone reminders and education sessions (Bartlett 2002; 
McPherson-Baker et al. 2000). The preliminary study, which I discuss in Chapter 2, 
indicated that the majority of patients issued with an MCA by the community 
pharmacists were aged over 65. Therefore I wished to investigate if the MCAs were 
being issued because the patient was older, rather than because they were having 
problems with their medication and the MCA was deemed to be the most appropriate 
solution. 
1.6.1 The Ageing Population 
The 200 I census shows that in the previous 50 years the population of the United 
Kingdom has aged considerably, both in terms of actual numbers and as a proportion 
(Office for National Statistics 2001). In particular, the ageing population can be seen 
from the increase in people aged 85 and over. In 1951, there were 0.2 million, (0.4% of 
the population), while the 2001 census shows that this has grown to over 1.1 million, 
(l.9% of the population). The ageing population reflects longer life expectancy, largely 
because of improved living standards and health care. 
1.6.2 Level of medication usage in older people. 
The dispensing statistics produced by the Department of Health (2007b) reveal that 
elderly people, i.e. those aged 65 and over, receive 58.6% of all prescription items 
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dispensed in the community at a total cost of £4,401.8 million. The number of 
prescribed items of medication per head of population received by the elderly was 21.2 
in 1996 rising to 40.8 in 2006. Therefore the level of medication usage in the over 65 
age group is rising steadily, allied to this is the fact that the population is also aging. 
Medication costs for elderly people represent a significant burden on the NHS and that a 
significant proportion of this medication is not taken, is a cause for concern. This may 
explain why so many research studies look at ways to improve compliance with 
medication. 
1. 7 A brief description of the study 
The study undertaken in order to address the aim set out in section 1.2 of this chapter 
consists of the following parts: 
A preliminary study which aimed to assess the scale of dispensing of medicines in 
MCAs in a health authority area; the level of service provided by community 
pharmacists, and the needs of the patients receiving their medication in MCAs. 
A review of the literature relating to the use ofMCAs in older people. This review aims 
not only to investigate the evidence base for the use of MCAs, but also to identify other 
literature pertaining to the use of these devices. 
In-depth semi-structured interviews with older people (aged 65 and over) who are using 
MCAs with the aim of investigating the interviewees' attitudes and beliefs concerning 
the use of MCAs. 
In-depth semi-structured interviews with healthcare professionals who may recommend 
the use of MCAs for older people in their care. The aim of these interviews is to 
examine the attitudes and beliefs which the healthcare professionals hold concerning the 
use ofMCAs and the older people who are issued with these devices. 
13 
1.8 A brief description of the layout of the thesis. 
This chapter has set the scene of current thinking concerning compliance with 
medication, concordance and the use of MCAs. I have indicated the rising level of 
medication usage among the elderly population and discussed the increase in the 
numbers of people aged over 65 years in the population of the United Kingdom. 
Chapter 2 describes the preliminary study of MCA use in one health authority area. It 
relates how the findings from this study provided the background for the main study. 
Chapter 3. describes a structured review of the literature on MCAs. This includes a 
critical analysis of the investigative studies on MCAs and discusses the implications of 
their findings. Also described and discussed are other journals articles and reports 
which aim to support the appropriate and effective use of these devices. 
Chapter 4. describes the underlying methodological theory which was used in the main 
study. Notably this covers the choice of qualitative research and grounded theory. 
Chapter 5 describes the methods used in all parts of the study and details how the 
analysis of the data was undertaken. 
Chapter 6 describes the findings of the older peoples' interviews and then discusses 
them. 
Chapter 7 describes the findings from the healthcare professionals' interviews and 
discusses them, comparing them across the groups of different healthcare professionals. 
Finally in Chapter 8 I compare the findings across all the groups interviewed and 
discuss them. This is followed by a discussion of the implications for practice and 
future research. 
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Chapter Two: 
Multi-compartment compliance aids in Primary Care: 
A preliminary study 
2.1 Introduction 
This chapter describes a preliminary study which was undertaken in the local health 
authority area, and which provided the impetus to the main study described in the thesis. 
The aims and objectives of the research are stated, followed by a discussion and 
justification of the methodology for this study. The study consists of three distinct 
parts: a self-administered pharmacy questionnaire, an administered pharmacist's 
questionnaire and an administered MCA users' questionnaire. These three parts of the 
study are described and discussed in later sections of this chapter. The conclusions 
drawn from the results of the study are then discussed. Finally I describe how the 
findings of this preliminary study influenced the procedures followed in the main study. 
2.2 The aims and objectives of the study 
The aims of the study were to: 
Ascertain the current scale of dispensing of medication in MCAs to patients living in 
their own homes in the local health authority area. 
Investigate how local pharmacists provide this service. 
Assess patients already receiving medicines in MCAs with regard to their ability to use 
the aid correctly and their need for the MCA. 
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The objectives were to: 
Detennine the number of patients living independently in the community in the local 
health authority area, who receive their medication in MCAs. 
Explore the methods by which a random sample of community phannacists undertook 
the dispensing of medication in MCAs. 
Identify from where the requests for the dispensing of medicines in MCAs for patients 
living in their own homes, originate. 
Assess a sample of patients who already receive their medication in MCAs for their: 
Ability to use the MCA. 
Understanding of their medication regime. 
Satisfaction with the MCA. 
Need for such an aid. 
2.3 Method 
This study was intended to provide a snapshot of the situation regarding the supply and 
use of MCAs within a particular health authority area at a particular point in time. 
The study consisted of three distinct phases: 
A self-completed questionnaire, which was sent to every registered phannacy in the 
local health authority area. The questionnaire was to be completed by the phannacist 
A structured questionnaire administered by the research phannacist, to a randomly 
selected group of phannacists who had already completed the first questionnaire. 
A structured questionnaire administered by the research phannacist to those patients of 
the phannacists above, who used MCAs. 
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2.3.1 Research method used 
The methods used to undertake this preliminary study fell within the quantitative 
research paradigm. Quantitative research as the name implies is concerned with 
quantities and involves the collection and analysis of data (Bowling 2002). Quantitative 
research is understood to be experimental in nature, with the experiment designed to test 
a theory. The data is usually numerical, reliable and statistically defmed. The 
researcher in quantitative research stands aside from his experiment and is independent 
of it. The results obtained should provide proof or otherwise of the hypothesis and are 
considered generalisable and reproducible. This contrasts with qualitative research 
when the researcher acknowledges their position in the social world and their influence 
on both data collection and interpretation (Temple 1997). Quantitative research aims to 
produce data which is reliable, replicable and generalisable. Quantitative research is 
considered to lie within the positivist framework of sociological theory. Positivism 
aims to discover laws using quantitative methods based on observations and verifiable 
facts (Bowling 2002). In another definition, research within the positivist paradigm is 
seen as linear, progressing logically from previously established to new knowledge 
(May 1994) In Section 4.2. I discuss in more detail the differences between the two 
research paradigms. 
Quantitative research methodology can be experimental, for example randomised 
controlled trials, or it can be descriptive, for example, cross-sectional surveys. Surveys 
are widely used within pharmacy practice research and can comprise a quick and 
relatively easy way of obtaining information about pharmacy related issues. 
The majority of surveys gather descriptive data which may aim to give details of 
services provided, or describe particular populations. 
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The method chosen for this preliminary study was determined by the questions asked. I 
wished to discover how many MCAs were in use in a designated area. Who was most 
likely to have requested the issue of a MCA to a patient? How the community 
pharmacists responded to such requests and what procedures they had in place for 
dispensing medication in MCAs. Finally, I wished to determine if the patients who had 
their medication issued in a MCA could use it and what knowledge they had concerning 
their medication. All these questions are best answered by survey methods. 
Surveys can be defined as a method of collecting information from a sample of a 
population which the researcher wishes to investigate, by means of personal interviews. 
Surveys can be either descriptive or analytical. Descriptive surveys are usually 
designed to obtain information at one moment in time and are therefore also cross-
sectional in nature. Analytical surveys, on the other hand, are designed to obtain 
evidence concerning cause and effect and are usually longitudinal in design. In this 
preliminary study the survey was designed to obtain a snap-shot of what was happening 
in a specific area at one moment in time and was therefore descriptive and cross-
sectional. 
2.3.2 Data collection methods. 
Questionnaires are the usual method of data collection when undertaking survey 
research and can be either structured or semi-structured. Structured questionnaires have 
the advantage of being quick and easy to administer. However the questions need to be 
easily understood by the respondents and the structured nature does not allow for the 
respondent to elaborate on hislher answer. Semi-structured interviews allow the 
interviewer to be more flexible in their approach, for example asking the questions in a 
different order. Respondents can have the opportunity to elaborate on their answers and 
to raise other relevant issues. 
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The reliability and validity of the questionnaire used is very important. Reliability 
refers to whether another researcher could reproduce the work and obtain similar 
results. Validity is concerned with the accuracy of the data obtained. In survey work 
the validity refers to the ability of the questions asked to provide answers which are 
relevant to the study objectives (Smith 2002). In order to validate a survey instrument it 
is necessary to test either all or part of it. The same population must be used to validate 
the instrument as will be used in the research study. The questionnaire used in part 1 of 
the preliminary study was based on one previously used by the health authority for a 
similar survey. 
In this preliminary study two types of questionnaire were used. Part 1 of the study used 
a self-administered structured questionnaire which was posted out to the respondents. 
The advantages of postal questionnaires are that they can investigate a wider population 
quickly and cheaply, and because the questionnaire is self-administered there is no 
interviewer bias. However the questionnaire must be clear and easy to understand and 
the data obtained is not considered as reliable as that obtained by face-face interviews 
(Bowling 2002). 
Parts 2 and 3 of the study used structured, administered questionnaires. Administered 
questionnaires give the researcher the opportunity to clarify a reply or to follow up 
responses, although the structured nature of the questionnaire precludes any further 
exploration of the replies given. 
2.3.3 Research Ethics Approval 
Approval was obtained from the both local research ethics committees in the area where 
the research was undertaken 
When the preliminary study was undertaken, Research Ethics approval was only 
required for the patient interviews. The patients were required to giYe informed 
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consent, that is, they had to be able to read, understand and sign the consent form. 
Therefore consent could not be obtained from those patients who had some cognitive 
impairment. 
2.4 Part 1: The postal pharmacy questionnaire 
2.4.1 Method 
A short questionnaire was designed which aimed to answer the following questions: 
Did the pharmacy dispense in MCAs for patients living independently in the 
community? 
If the answer to question 1 was yes, how many patients were receiving their medication 
in MCAs? 
Which device(s) did they use? 
If the answer to question 1 was no, what was the reason for this? 
The pharmacists were also asked if they were willing to contribute further to this 
research. A copy of the questionnaire can be found in Appendix 1. The questionnaires 
were posted to all 152 contracted pharmacies in the local health authority area using a 
list provided by the health authority. A letter accompanied the questionnaire, which 
gave details of the research and a stamped addressed envelope was provided. 
2.4.2 Results 
The initial response rate was 53%, which increased to 80% after a repeat mailing. 
The results from the 123 completed questionnaires received were entered onto an 
Excel® spreadsheet. 
95 (77%) of the pharmacies reported dispensing medicines in MCAs to patients living 
in their own homes. 
The total number of patients receiving their medicines in MCAs was 1328. 
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The average number of patients per pharmacy was 11 (range 1 to 70). (see Table1). 
Nomad®, Dosett® and Medidos® were the most frequently used MCAs. (see Table 2). 
819 (62%) of the patients were using a sealed device rather than a refillable one. 
Table 1: Number of patients receiving medication in a MCA per pharmacy 
dispensing in MCAs. 
No. of patients No. of pharmacies 
dispensing in MCAs 
(n=95) 
1 - 10 53 
11 - 20 22 
21 - 30 13 
31 - 40 3 
41 - 50 2 
51 - 70 2 
Table 2: Number of patients using each type of MCA 
TypeofMCA No. of patients (%) 
(n=1328) 
Nomad® 694 (52%) 
Dosett® 363 (27%) 
Medidos® 116 (9%) 
Venalink® 85 (6%) 
Manrex 40 (3%) 
Other 30 (2%) 
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There were 28 pharmacies (23%) which did not dispense in MCAs to patients living 
independently in the community. The pharmacists were asked to state a reason and 
these are listed in Table 3. 
Table 3: Reasons for not dispensing in MCAs 
Reason No. of pharmacies (n=28) 
No demand 11 
No remuneration 6 
Would dispense if given 7 day scripts 1 
Pharmacy not suitable (insufficient space) 1 
No reason given 9 
2.4.3 Discussion 
The brief literature review which had been undertaken prior to the commencement of 
this study had not identified any articles reporting surveys of this nature. Therefore the 
prevalence of the use of MCAs by people living independently in the community was 
previously difficult to determine. The health authority in whose area the study was 
undertaken had commissioned a survey themselves approximately three years 
previously. The results of this study had not been published, but the paperwork was still 
on file and available for investigation. The figure for the number of MCAs in use at the 
time of the health authority survey was 320, with an average of four patients issued with 
MCAs per pharmacy. The health authority survey had been carried out in a similar way 
to the study discussed in this chapter and the response rate had been 62%. Therefore the 
results detailed above show a sharp increase in the number of MCAs in use, with the 
average number of patients using an MCA per pharmacy almost tripling. This was 
much higher than anticipated, however it was not possible to identify a reason for this 
from the answers to the pham1acy questionnaire. 
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The figure from the RPSGB for registered pharmacy premises was 11,901 at the time of 
the study. Therefore it was possible to suggest that there might be 100,000 patients in 
the country receiving their medication in a MCA, assuming that the mixed inner city, 
suburban and semi-rural nature of this northern city was comparable with the rest of the 
UK. 
These figures raise the question of why are so many MCAs in use when the evidence 
for their effectiveness appears to be very limited. The questionnaire was not designed 
to seek out reasons for the willingness on the part of the pharmacists to dispense in 
MCAs and therefore it was not possible to answer this question at this point. 
The respondents were asked about the devices which they provided for patients. The 
sealed, disposable Nomad® device was the most frequently issued, with the refillable 
Dosett® the next most popular. The questionnaire did not ask for reasons for these 
choices and therefore it is not possible to state why these devices were chosen. 
However those pharmacies who also provided services to nursing and residential 
homes, where the sealed monitored dosage systems e.g. Nomad® are mostly used, may 
use the same device for their community patients. 
Twenty three percent of the respondents stated that they did not dispense medication in 
MCAs and they were asked to give their reasons (see Table 3.). Lack of demand was 
the most frequently cited reason, however it is not possible to know if these pharmacies 
actively advertised this service or simply waited for someone to ask. Those pharmacies 
which provided the service may advertise the fact to other healthcare professionals, 
leading to more requests. 
Lack of remuneration was the second most common reason given for not providing the 
service. At the time the study was undertaken, there was no NHS funding provided and 
although some pilot schemes had been initiated in other parts of the country (Anon. 
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1996) there were none in this area. The pharmacists usually asked the GP to provide 7-
day prescriptions for the patient; this was allowable under the NHS contract in place at 
that time because the medication would be dispensed weekly and delivered to the 
patient. However this procedure was unpopular with GPs because it was time 
consuming and there is also a suspicion held by some GPs that the pharmacist is 
profiteering. This had led to a breakdown in relationships between some GPs and 
pharmacists. 
2.5 Part 2: Administered pharmacists' questionnaire 
2.5.1 Methods 
The results obtained from the self-completed questionnaire suggested that it would be 
valuable to obtain more information from community pharmacists regarding the issue of 
MCAs. A structured questionnaire administered face-to-face was chosen as the method 
of data collection. 
A structured questionnaire was designed which aimed to answer the following 
questions: 
Who most frequently requested the dispensing of medicines in MCAs for patients living 
in their own homes? 
What method of assessment of the patient did the pharmacist use? 
What verbal advice and information ('counselling') did the patient receive? 
What procedures were in place in the pharmacy for dispensing in MCAs; and was there 
a written protocol? 
Did the pharmacists have any concerns about dispensing in MCAs? 
The questionnaire was piloted with one community pharmacist and as a result minor 
changes to the questionnaire design were made. 
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2.5.2 Selection of the pharmacists. 
The pharmacists who completed the first questionnaire were asked if they were willing 
to be involved in further research. Those pharmacists who had expressed a willingness 
to be involved were listed in a database, along with details of the number of patients 
receiving medication in a MCA supplied by their pharmacy. 
Because the results from the self-administered questionnaire revealed that the number of 
patients who were receiving their medication in MCAs from individual community 
pharmacies varied widely (see Table1) and it was decided that the selection of 
pharmacists would be stratified to reflect the number of patients in their practice who 
used MCAs. Stratifying the sample ensures that sufficient numbers of pharmacies in 
each group will be selected in order that comparisons can be made. 
The groups chosen were 1-10, 11-20,21-30 and over 30 patients being given a MCA at 
that pharmacy. Four pharmacists were randomly selected from the first group, three 
from the second, two from the third and one from the fourth. This distribution reflected 
the number of pharmacies within each group. The randomisation was carried out 
independently of the researcher using a computer programme designed for this purpose. 
The selected pharmacies were contacted in the first instance by letter and then 
telephoned to arrange an appointment. Two pharmacists refused to take part, in both 
cases a change of pharmacy manager had occurred between part one and part two of the 
study. These two pharmacies were replaced by two more randomly selected pharmacies 
from the same group. 
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2.5.3 Administration of the questionnaire 
The questionnaire was administered in the pharmacy at a date and time which were 
convenient for the pharmacist concerned. It was not always possible to undertake this 
task in a separate room away from the dispensary, which was a disadvantage, however 
some meetings were held during the lunch hour while the premises were closed. 
The questionnaire consisted of a mix of open and closed questions (see Appendix 1), 
designed to ascertain the procedure which the pharmacist would follow when requested 
to dispense a patient's medication in a MeA and the dispensing and delivery procedure 
operating in that pharmacy. There were also opportunities for each pharmacist to 
express his or her own opinions on the use of these devices. 
The questionnaire took between 30 and 45 minutes to administer and the pharmacists' 
answers were recorded manually on the questionnaire at the time of the interview. The 
answers were then transferred onto a database as soon as possible after the interview. 
2.5.4 Results from the administered pharmacists' questionnaire. 
The ten randomly selected pharmacists represented all types of community pharmacy. 
The demographic details of these pharmacies are detailed in Table 4 . 
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Table 4: Demographic details of selected pharmacies. 
Pharmacy ID Type of Pharmacist location Number of 
pharmacy details patients with 
MeA 
A Independent Owner Small town on 2 
One shop HA border 
B Independent Owner Inner city 5 
One shop 
C Independent Owner Small village 4 
One shop on HA border 
D Independent Owner Inner city 28 
One shop 
E Independent Employee Outer suburbs 12 
3 shops manager 
F Independent Employee Inner city 13 
5 shops manager 
G Independent Owner Outer suburbs 12 
2 shops 
H Independent Owner Outer suburb 6 
2 shops 
I Large national Employee Outer suburb 30 
multiple manager 
J Large national Employee Inner city 50 
multiple 
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Who requests the issue of a MeA? 
The first question asked the pharmacists to identify which health care professional was, 
in their experience, the most likely to request the issue of a MCA 
The pharmacists were given a card with the names of healthcare professionals or 
organisations and asked to rank the answers from 1 - 7, with 1 being the most frequent 
and 7 the least. The results in Table 5 and show that the patient's own doctor was 
perceived to be the healthcare professional who most frequently requested the 
dispensing of medication in MCAs for patients living in their own homes. The doctor 
was closely followed by hospital staff, carers and social services. The pharmacists rated 
themselves as being the least likely to initiate use of an MCA. 
Table 5: The health care professionals most likely to request dispensing in MCAs 
Ratings from 1 (most frequent) to 7 (the least) 
Pharmacist ID 
A B C D E F G H I J 
Doctor 3 2 1 6 1 2 7 5 1 1 
Hospital staff 6 3 2 7 2 1 3 2 3 2 
Carer 2 7 5 3 3 6 1 4 2 3 
Social services 5 1 4 4 7 3 6 1 5 5 
District nurse 1 7 3 5 5 7 5 7 4 4 
Patient 4 7 6 1 6 5 2 6 6 6 
The pharmacist 7 7 7 2 4 4 4 3 7 7 
themselves 
Mean 
2.9 
3.1 
3.6 
4.1 
4.8 
4.9 
5.2 
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The pharmacists were asked if they had ever been pressurised to dispense a patient's 
medication in a MeA when they felt that it was inappropriate to do so. Four 
pharmacists stated that they had been pressurised by other healthcare professionals; 
however this was not a frequent occurrence. The four pharmacists stated that, in this 
situation, they would comply with the request and then review the situation at a later 
date. The remaining six pharmacists stated that this situation had never occurred. 
Four pharmacists said that they had been pressurised to issue a MeA by a patient's 
family. In such cases two pharmacists stated they would ask the relative to purchase a 
MeA and fill it themselves, one pharmacist would agree to provide the MeA but state 
their reservations and one pharmacist would refuse. 
What procedure is followed once a request is received? 
The pharmacists were asked to describe the procedure that they followed when a request 
to dispense a patient's medication in a MeA was received. 
The questionnaire contained a number of subsidiary questions, asked if the pharmacist 
did not provide the information without prompting. These questions concerned trying 
an alternative strategy, e.g. regime simplification; assessment and counselling of the 
patient and concerns regarding the stability of drugs in a MeA. The pharmacists were 
also asked if they had a written protocol or procedure in place. 
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The data obtained from these questions is detailed in table 6 below 
Table 6: Procedures followed by pharmacist when request received. 
Pharmacy 7-day Assess Counsel Simplify Stability Written 
ID prescriptions patient patient regIme protocol 
A no yes yes yes yes no 
B yes yes yes no no no 
C yes yes yes yes yes no 
D yes no yes yes no no 
E yes yes yes yes yes no 
F no yes yes yes yes no 
G yes yes yes yes yes yes 
H no yes yes yes no no 
I yes no no no yes no 
J yes no no no yes yes 
The dispensing procedure 
The pharmacists were asked questions concerning the filling of the MCAs, and any 
concerns they might have regarding the procedure. Details of any delivery service were 
also sought and the pharmacist was asked if they had a preferred MCA. 
30 
Details of the results are given in Table 7 below. 
Table 7: Details of the community pharmacists' answers concerning dispensing in 
MCAs 
Pharmacy Who fills Who Concerns Collection Preferred 
ID MCA checks about and delivery MeA 
checking 
A Pharmacist N/A yes Pharmacist Manrex 
Sun & 
Moon® 
B Pharmacist Pharmacist no Pharmacist Medidos® 
Qualified 
dispenser 
C Pharmacist Pharmacist yes Pharmacist Venalink® 
or Qualified 
dispenser 
D Unqualified Pharmacist yes Pharmacy Nomad® 
dispenser assistant 
E Unqualified Pharmacist yes Pharmacist or Nomad® 
dispenser driver 
F Pharmacist Pharmacist some Driver none 
or dispenser 
G Pharmacist N/A N/A Pharmacist or Manrex 
driver Sun & 
Moon® 
H Pharmacist Pharmacist some Pharmacist Venalink® 
or Qualified 
dispenser 
I Pharmacist Pharmacist yes Driver none 
or 
Unqualified 
dispenser 
J Qualified Pharmacist no Driver Dosett® 
dispenser 
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Time taken to dispense medication into a MCA. 
The pharmacists were asked to estimate how long it took to dispense a patient's 
medication in a MCA: 
on the first occasion. 
on subsequent occasions. 
Table 8 below lists the estimates given by the pharmacists. 
Table 8: Estimated time taken for dispensing in MCAs 
Pharmacist ID Time taken for first Time taken for subsequent 
dispensing dispensing 
A Unable to estimate -
B 10 minutes 5 minutes 
C 15 minutes 5 minutes 
D 10 - 15 minutes 5 minutes 
E 12 minutes 4 minutes 
F 10 - 20 minutes 5 minutes 
G 15 minutes 5 minutes 
H* 30 minutes 20 minutes 
1# 20 - 30 minutes 10 minutes 
J 30 minutes 7 minutes 
*Pharmacist H dispensed 28 days supply at a time and this explains the variation in time 
taken to dispense. 
# Pharmacist I had a very comprehensive record system which had to be set up for each 
new patient and this explains the length of time taken to dispense on the first occasion. 
What procedure do you follow if the MCA is returned with tablets still in it? 
Receiving a MCA back in the pharmacy which contained medication might indicate 
problems with compliance. The pharmacists were asked what procedure they would 
follow if this occurred. 
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Most of the pharmacists would not take any action on the first occaSIOn, but 3 
pharmacists would talk to the patient to see if there was a reason why the tablets had not 
been taken. All the pharmacists said they would contact the GP if the MCA was 
returned with doses not taken on subsequent occasions. However those pharmacists 
using MCAs with disposable inner sections stated that they often did not see any unused 
tablets because only the outer re-usable parts of the MCAs were returned. 
Choice of MCA 
Eight pharmacists would decide which MCA to use without reference to the patient, one 
pharmacist would vary the choice depending on the medication and one pharmacist 
would choose the MCA which seemed most suitable for that particular patient. The 
pharmacists were asked if they had a preferred MCA and eight stated that they did, 
details are given in Table 8 above. 
Finally the pharmacists were asked if there was anything they would like to add 
concerning the use of MCAs. All of the pharmacists expressed their personal views on 
MCAs. Seven pharmacists highlighted the problems regarding remuneration as being 
their prime concern. Two pharmacists felt that MCAs were not the answer to patients' 
medication problems. In contrast two pharmacists thought that filling MCAs was a 
useful service. 
2.5.5 Discussion. 
The pharmacies selected by the stratified randomisation method represented a good 
cross-section of the pharmacies in the area under investigation. Similarly the 
pharmacists taking part comprised both employees and independent contractors. 
Therefore this random sample, although small, could be considered to be a fair 
representation of community pharmacy across the country at the time the study was 
undertaken. 
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The pharmacists questioned identified doctors as being the healthcare professional most 
likely to request the issue of a MCA, followed by hospital staff. The subject of who 
requests the issue of a MCA to a patient has not been investigated in the literature and 
therefore it is difficult to say whether this finding is in line with procedures in other 
areas. Certainly in more recent times there is anecdotal evidence that hospital staff are 
most likely to make the request, and this is supported by the interviews in the main part 
of the study. It may be of course that the doctor was simply the conduit for the request, 
which had in fact been made initially by another healthcare professional or the patient. 
Once the request had been received, the majority of the pharmacists would request the 
GP to provide 7 -day prescriptions. This method of funding has been a matter of 
contention between pharmacists and GPs for some time. The results of a survey 
undertaken in Northern Ireland (McElnay and Thompson 1992) showed that 92% of the 
respondents felt that the NHS should pay for the provision of a compliance aid service 
to older people. When my preliminary study was undertaken the Disabilities 
Discrimination Act (1995) had not been fully implemented and therefore NHS funding 
for the provision of MCAs to any patients was not available. The issue of funding 
MCA provision has caused considerable debate; when a multi-national pharmacy chain 
introduced charges for the initial supply of a MCA, an article appeared in the medical 
press suggesting that this would mean an extra charge for prescriptions (MacDonald 
2002). A response to the article accused pharmacists of 'profiteering' (Morrison 2002). 
This highlights the misunderstanding and suspicion that has arisen concerning the 
supply of MCAs. 
Having decided to issue a MCA for a particular patient, the pharmacists were asked if 
they would try an alternative strategy first. Seventy percent stated that they would try to 
simplify the regime. Research studies have shown that non-compliance with 
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medication is often linked to polypharmacy (Cohen et al. 1998; Eagleton, Walker and 
Barber 1993; Col, Fanale and Kronholm 1991). Simplifying the regime would appear 
to be an action which should be taken prior to issuing a MCA. Although some 
interviewees stated that they would simplify the regime, further probing revealed that 
this was often in order to fit the medication into the MCA. 
The pharmacists were asked about assessing the patients, 70% stated that they would 
assess the patient in some way, although only 50% would visit the patient to carry out 
this assessment. Research has looked at the ability of people to use MCAs (Griffiths et 
al. 2004; Nikolaus et al. 1996; Atkin et al. 1994), however all of these studies only 
investigated Dosett® boxes. Other studies have investigated patient preference (Walker 
1990, 1991) and give an insight into which devices patients prefer. Research has been 
carried out into the ability of older people to manage different types of medication 
packaging (Beckman et al. 2005; Griffiths et al. 2004; Forbes, Rees and Ross 1990; 
Keram and Williams 1988). All of these studies investigated a number of different 
types of packaging including blister packs but not MCAs. Forbes at al (1990) found 
that the study subjects experienced problems accessing their medication from blister 
packs, 28% of the study subjects aged 60 years or over reported that it was too hard to 
push the contents out. Twenty five percent in the same age group stated that they had 
difficulty holding on to the contents after opening. The other two studies reported fewer 
difficulties with blister packs, but Beckman et al (2005) found that the ability to open 
blister packs lessened with declining cognitive function. Although these studies refer to 
blister packs, similar problems could be expected with the sealed disposable type of 
MCA and therefore it is particularly necessary for a pharmacist to check if the patient 
can use these devices successfully. 
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The pharmacists were asked if they would counsel the patients themselves on how to 
use the device. This is essential, as patients may be unfamiliar with MCAs. Eighty 
percent stated that they would counsel the patients with the two who would not being 
the pharmacists with the largest number of patients. 
The remaining questions all related to the dispensing of medication into a MeA. Firstly 
the interviewees were asked about stability of medication in a MCA, 70% stated that 
they would check the stability of the drugs, however as the majority of pharmacies filled 
the MCAs weekly this was not considered a major problem. A study had been carried 
out investigating the stability of medication in MCAs (Walker 1992a), which concluded 
that, although the majority of solid oral dosage forms could be safely transferred to a 
compliance device for a seven day period, there were important exceptions to the rule. 
In addition the author stated that there was a lack of information on short term stability 
of medications in an easily accessible format. This issue of stability of medication in 
MCAs will be discussed further in Section 7.7.4. 
Only two of the interviewees had a written protocol in place for the dispensing of 
medication in MCAs. In fact several of the respondents appeared surprised by the 
question. The Royal Pharmaceutical Society of Great Britain approved the introduction 
of standard operating procedures (SOPs) covering the dispensing process in February 
1999. Guidance on developing and implementing these SOPs was published in 
December 2001 (RSPGB. Practice Division 2001) and dispensing in monitored dosage 
systems was listed under 'other issues' the pharmacist might wish to consider writing 
SOPs for. However at the time the preliminary study was undertaken a pharmacy was 
not required to have SOPs in place. 
Accuracy checking during the dispensing of medication in MCAs was a cause for 
concern for all of the pharmacists interviewed. Two pharmacists preferred to fill the 
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MCA themselves rather than check the dispensing carried out by others; however they 
did not get their own dispensing checked. In two other pharmacies the dispensing was 
always double checked irrespective of whether the filling was carried out by a 
pharmacist or a technician. Seven of the ten pharmacists reported some concerns with 
the checking process and those pharmacists who always filled the devices themselves 
stated that they did this in order to remove the need to check. Accuracy in filling MCAs 
is extremely important and is discussed in more detail in Chapters 6 and 7. 
The pharmacists were also asked if they provided a delivery service; five pharmacies 
employed a driver and in the remainder the delivery was undertaken by a member of 
staff or the pharmacist themselves. Patients may be disadvantaged by having their 
medication delivered by a driver because they have no opportunity to ask questions 
about their medication and receive no counselling or advice when new medication is 
delivered. 
The pharmacists were asked to estimate the length of time taken to dispense a patient's 
medication in a MCA both on the first occasion and subsequently. This was intended to 
be a guide only and the pharmacists were not asked to time themselves, but just to use 
their judgement and give an estimate. The mode length of time for subsequent 
dispensing was 5 minutes. A research paper (McElnay and Thompson 1992) 
investigated the length of time taken to dispense into compliance packs. The six MCAs 
used in the investigation included a Dosett® and Medidos® both of which were used by 
some of the pharmacies in this study. McElnay and Thompson (loc. cit) found that the 
mean dispensing time into a Dosett® box was lmin 45 sec (range 1.01 - 3.25) and for 
the Medidos® the mean was 2mim 52 sec (range 1.19 - 3.50). Another research article, 
published after this preliminary study was carried out, investigated the difference in the 
time taken to dispense into a MCA from either loose tablets or a patient pack (Green. 
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Johnson and Wells 2000). Green and colleagues concluded that it took longer to 
dispense into a MCA from a patient pack than using loose tablets. The figures given by 
the pharmacists in the preliminary study were only estimates and included the time to 
complete any paper work. 
Returning medication in the MCA can indicate that a patient is not complying correctly 
with their medication regime. The pharmacists were asked to state what they would do 
if this situation occurred. The majority of the pharmacists would take no action on the 
first occasion; however three pharmacists said that they would talk to the patient to try 
to ascertain the reason. Subsequently, if this recurred, the pharmacists stated they 
would contact the GP. However as those pharmacists who used disposable MCAs 
observed, they may not be aware of the issue because the patient would not return the 
device to the pharmacy. The return of unused medication was investigated by Ryan-
Woolley (2005). Ryan-Woolley found that in the pre-study period, the "wastage" in the 
intervention group was 18.1 %. This figure declined after a MCA was issued to reach a 
level of 1 % after 12 months. However it is not possible to state whether the decline in 
wastage levels were due to increased compliance or simply due to the research subjects 
disposing of any unused medication. 
2.6 Part 3: Administered patient questionnaire 
The third part of the study comprised administration of a structured questionnaire to the 
older people who were receiving their medication in a MCA provided by those 
pharmacists who participated in part 2 of the study in part two of the study. 
2.6.1 Method. 
The pharmacists assisted in recruiting the patients to the study by sending out letters and 
information leaflets (and in some cases visiting the patients themselves) to explain the 
study. Once a signed consent form had been obtained, the patient was contacted and a 
,-EEDS UNIVE:RSm' UBRARY 
38 
time for the interview arranged. The patients were interviewed in their own homes and 
were infonned that they could have a third party present if they wished. All the 
interviews took place in the daytime and lasted between twenty and thirty minutes. 
The administered questionnaire 
The structured questionnaire was based on one previously validated in an earlier study 
(Raynor et al. 2000). The questionnaire was piloted on 5 patients who were selected by 
the phannacist who had piloted the phannacist questionnaire. As a result of the pilot 
minor changes were made to the questionnaire. 
The questionnaire was designed to answer the following questions: -
Did the patient know the names of, and indications for, their medicines? 
Could the patient manage to use the MCA correctly? 
Did the patient receive any assistance to use the aid? 
How did the patient obtain repeat prescriptions from the GP and further supplies of 
medicines? 
How did the patient feel they would be able to manage if they did not have the 
medicines in a MCA? 
How did the patient feel the MCA compared with medicines in ordinary bottles and 
packs? 
2.6.2 Results 
Patient recruitment 
A total of 169 patients were receiving their medicines in MCAs from the ten phannacies 
who participated in part 2 of the study, from these, 61 (36%) signed consent fonns were 
received by the research phannacist. Reasons given for not giving consent included: 
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Not wanting a stranger to visit them at home. 
Suspicion of the reason behind the study (was the MeA going to be taken away from 
them?) 
The carer felt that patient was too old or too confused to answer questions 
The patient was unable to read or understand the recruitment leaflet 
Of the patients who consented, two people were admitted to hospital before they could 
be visited, two changed their minds and one forgot the appointment and was unable to 
arrange another. 
Patient demographics 
The age, sex, housing, and support arrangements for the patients are shown in Table 9. 
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Table 9: Patient demographic details (n=56) 
Sex Female 38 
Male 18 
Age in years Mean (range) 78.5 (46-93) 
Type of Housing Own home 43 
Sheltered 11 
Warden controlled 2 
Living Alone 40 
arrangements With partner 12 
With son/daughter 3 
With relative/friend 1 
Support services Home care 40 
District nurse 8 
Relative/friend who visits 4 
No help 9 
MeA Dosett® 20 
Nomad® 19 
Medidos® 6 
Venalink® 7 
Manrex Sun & Moon® 4 
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The patients were asked if they knew how long the MCA had been in use. Few could 
recall this infonnation and despite making enquiries with the dispensing phannacist the 
details for over 50% of patients were not available. For those patients where this 
infonnation was available, the range of time was from 4 months to 8 years. 
The patients were asked if they knew who had suggested that they had their medication 
dispensed in a MCA and the answers given by the patients are detailed in Table 10 
below. 
Table 10: Who suggested that patient had an MeA? 
Who made the suggestion Number of patients Percentage 
(n=56) 
Hospital staff 22 39% 
GP / doctor 9 16% 
Nurse 6 11% 
Pharmacist 6 11% 
Home care/warden 3 5.5% 
Day centre 2 3% 
Patient 1 2% 
No information 7 12.5% 
Patient Medication Details 
Prior to the home visits, the phannacists were asked to supply the patient medication 
details for those patients who agreed to take part in the research. The phannacists either 
provided a computer printout or filled in a sheet provided by the research phannacist. 
The patients were asked by the research phannacist for the names of all the medication 
they were taking and what they were taking the medication for. The answers were 
written on a chart within the patient questionnaire. 
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Figure 1 below provides details of the number of patients receiving different numbers of 
medication in their MeA. 
Figure 1: Number of patients receiving different numbers of drugs in MeA 
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No of Drugs in MeA 
The mean number of drugs dispensed in the MeA was 5.75 (range 1 - 12) and the mean 
number of daily dosage times (i.e. the number of times during the day the patient had to 
remove drugs from the MeA and take them) was 2.5 (range 1 - 4). 
Figure 2: Number of daily doses taken by patients. 
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There were 29 (52%) patients who had medication which was not in the MeA (usually 
liquid preparations or inhalers) . Patients also had "pm" medications which were 
dispensed separately and two patients had regular medicines which they preferred not to 
have di spensed in the MeA. When questioned 38 (68%) patients did not kno the 
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names of any medication in the MeA, 4 (7%) patients knew some of the names and 14 
(25%) patients knew all of the names. 
There were 36 (64%) patients who had some knowledge of why they were taking the 
medicine, e.g. "heart problems", "indigestion" or "bowels". Asking the patient what 
they were taking the medication for often triggered the name of the medication in those 
people who claimed not to know the names. 
Twenty-nine (52%) patients had seen a doctor in the previous month (GP or hospital 
doctor). Of these, 7 (12.5%) patients had had changes made to their medication, and 
no-one had experienced any problems with the changes, although some patients were 
waiting to have the new medication dispensed in their MeA. 
Help received with medicines 
There were 42 (75%) patients who stated that they received no help to take their 
medicines, leaving 14 (25%) who stated that they did receive help. Patients received 
help from a relative, home care staff, a warden or a nurse. The patients were asked to 
describe the help they received which included removing the medication from the 
MeA, handing the medication to the patient or simply reminding or checking the 
medication had been taken. No carers were said to fill the MeA. 
Patients were asked about the collection or delivery of the MeA. 48 (86%) patients had 
their medicine delivered by the pharmacy, the remaining 8 (14%) either had the 
medicines collected by third party or collected their medicines themselves. 
Patient's abilities to use the MeA 
When patients were asked if they had any problems using the MeA, 10 (18%) said that 
they did. These problems were usually that they found the MeA difficult to open or the 
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tablets difficult to remove. However, the problems were not sufficient to prevent any 
of the patients taking their medication. 
Patients were then asked by the research pharmacist to demonstrate opening the MeA 
and removing a tablet. Only 4 (7%) patients were unable to demonstrate this 
satisfactorily. In these four cases this inability to use the MeA was due to either a sight 
problem, confusion or because the MeA was too stiff to open. Only one of these 
patients was not receiving help to use the MeA (the problems of this patient were 
referred back to the pharmacy and a different system was to be tried.) 
Patients were asked to read the days of the week and times to ensure that they could use 
the MeA correctly. Five (9%) had difficulty reading the text, three of these patients had 
help to take their medicines but two patients did not. When asked how they managed if 
they found the text difficult to read, both patients replied that it did not matter because 
each day's dose was the same. The patients just started at one end of the MeA 
irrespective of what day of the week this was and worked across until all the doses were 
taken. 
Patients were asked what they did about taking their medication if they had to go out 
during the day or if they went on holiday. Almost a third responded that they did not go 
out and therefore did not have a problem. The majority of those who did either go out 
during the day or go away on holiday, took the MeA with them. The remainder used 
other strategies as detailed below. 
Adjusted time of dose or outing. These patients either timed their trips to fit in with 
their medication schedule or, more usually, altered the time they took their medication 
in order to fit in with their trip. 
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Takes medication out of MeA. The patient removed one or more doses from the MeA, 
usually placing the medication in another container but sometimes wrapping in a tissue 
and placing in the pocket. Two patients also took a bottle of water as well. 
Misses dose. Two patients admitted that they would simply miss a dose out. As this 
happened infrequently they did not think it was a problem. 
No problem. These patients usually had only one dose time in the MeA usually at 
breakfast time but occasionally at night. These patients had no problem with short trips 
out because they could take the medication before they went or when they came back. 
This group of patients did not go away for longer periods. 
Patient compliance 
The patients were asked if they used a strategy to remind themselves to take their 
medication. Approximately one third stated that they did not have a strategy and simply 
relied on the MeA. The majority of the interview subjects did have a personal system 
and these are described below. 
Time Eleven (20%) patients relied on noticing the time either on the clock or by the 
radio or television. 
Place Five (9%) kept the MeA in a particular place e.g. beside the kettle or near the 
cornflakes packet. 
Own system Two (3%) patients had an elaborate system of their own device, which 
involved removing the medication from the MeA each day and placing in another 
receptacle. 
Does forget One patient admitted that he/she forgot despite having the medication in the 
MeA. 
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Patients were asked if the phannacy had given them a choice of which MeA to have. 
Only one patient said they had had a choice, the remainder had simply accepted the 
MeA sent by the phannacy. Some patients did know that there were other types of 
MeA, but did not seem concerned by the lack of opportunity to choose. The research 
phannacist noted that, although some of the phannacists had a preferred MeA, patients 
from that phannacy did not always have their medication in the preferred MeA. This 
appeared to be due mainly to problems regarding the number of different medications 
being taken (some devices are of larger capacity than others). 
Patients who had medication that was not in the MeA were asked if this presented any 
problem. Of the 27 patients who had medication which was not in the MeA, 24 (83%) 
said that this presented no problem. One patient stated that there might possibly be a 
problem and 2 patients said that this was a problem. 
Patients were asked how having their medication in an MeA compared with having 
their medication in ordinary bottles. The results are summarised in Table 11. 
Table 11: Comparison ofMCA with tablet bottles 
How does MeA compare with Number of patients (n=56) 
tablet bottles 
Much better 52 
A little better 2 
No different 2 
A little worse 0 
Much worse 0 
Patients were asked if there was anything else they would like to say about having their 
medication dispensed in an MeA. There were 9 (16%) patients who said they had no 
further comments. The remaining 47 (84%) had a wide variety of comments, ranging 
from enthusiasm with the system, to issues relating to the phannacy. Twelve (25.5° ~ of 
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those who commented) said that the best thing about having their medication in an 
MCA was that they could look at the MCA and tell if they had forgotten to take their 
medication. Eight patients (17% of those who commented) said that the MCA was 
much easier or much better to use. 
2.6.3 Discussion 
The low consent rate from patients using MCAs limits the generalisability of these 
findings. The Research Ethical approval obtained allowed only informed consent 
(rather than assent) and this will have eliminated those patients who were too confused 
to read and understand the patient leaflet. There was evidence, both in telephone calls 
and in writing, of relatives refusing to allow their elderly relatives to take part. A study 
in the USA investigated the opinions of family members about elderly relatives taking 
part in research (Williams 1992). The author stated that family members are frequently 
involved in the decisions of whether an elderly person should participate in research. In 
particular Williams noted that family members often advise elderly relatives not to sign 
any papers or agree to anything before getting their approval. The reasons why older 
people declined to take part in a research study was discussed by Petty and colleagues 
(Petty et al. 200 I). The researchers identified ten broad categories of response when 
they followed up those who had declined to participate in a randomised controlled trial. 
Not all of these categories were applicable to the preliminary study but there was some 
commonality, for example, unable to read or understand the information sheet, feeling 
unwell, and mistrust of study objectives. The subjects questioned in the preliminary 
study may not be truly representative of those receiving their medication in MCAs, as 
those who were cognitively impaired were excluded and also those whose relatives 
sought to protect them were unable to take part. It is possible therefore that the subjects 
questioned were more self-reliant and mentally alert. 
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When asked who had suggested that the patient received their medication in a MeA, 
hospital staff were the most frequently suggested. This differs from the pharmacists 
who stated that most requests came from the GP. The patients' statement that it was 
hospital staff who instigated the request, is supported by an observation made by the 
research pharmacist. At the time of the study, the hospital NHS Trust issued Dosett® 
boxes to those patients who were deemed to need a MeA on discharge. The patients in 
the study exhibited their Dosett® box for the researcher to see, explaining that this was 
the device they had received on discharge from hospital. 
The patients questioned in this preliminary study were prescribed between one and 
twelve medications that were dispensed in a MeA. This range of medications gives rise 
to a number of questions. Dispensing one medication in a MeA is neither cost-effective 
nor of benefit to the patient and on the other hand those receiving more than six 
medications might benefit from a medication review and simplification of the regime. 
Over half the patients questioned could not name the medication they were taking. 
Research studies have linked knowledge of medication and medication compliance. A 
study of 24 older people who were living independently in the community found that 
the majority of the participants needed some form of education about the name, 
scheduling or function of their medication (Griffiths et al. 2004). In their study 
Griffiths and colleagues measured knowledge of medication by the simple approach of 
asking patients to identify all their current medications and describe function, dose and 
scheduling. This method mirrors that used by myself in this preliminary study. 
A minority of those questioned stated that they found the MeA difficult to use, although 
only four were unable to demonstrate their ability to use the device satisfactorily. 
Similarly, a small minority had difficulty reading the printing on the MeA. It is 
interesting to note that the two interviewees with sight impairment who did not rcceiyc 
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help, did not see a problem. Instead they ignored the printed days of the week and 
started at one end of the device and worked through. Those interviewees were correct 
in pointing out that as each day's medication was the same it mattered little whether 
they took the medication marked for Monday on a Sunday. A problem could arise, 
however, if a third party tried to check the patient's medication compliance. 
A majority of those questioned relied on personal strategies to aid their compliance with 
the medication regime in addition to the MeA. The use of both internal and external 
strategies to assist in remembering to undertake particular actions is well documented in 
the literature on memory and medicine taking (Branin 2001). 
The patients were asked how they took their medication if they went out for the day or 
on holiday. Those who were not housebound described a number of strategies that they 
used to ensure that they took their medication as near to time as possible. A small 
minority did miss the dose out, perhaps feeling that having an opportunity to take part in 
social activities out weighed the need to take the medication. For others the MeA made 
going on holiday easier as they could be sure that they had all the required medication 
with them. For some, however, there were concerns about taking the MeA out of the 
house. These concerns centred on the fact that the MeA had a label on it which stated 
that it was the property of the pharmacy. Also there were uncertainties regarding 
obtaining extra medication to last the duration of the holiday. All these queries should 
have been addressed when the MeA was first issued either by a face-face counselling 
session or by an information leaflet. 
The majority of the patients questioned m the preliminary study stated that they 
preferred to receive their medication in a MeA rather than in conventional packaging: 
the main reason for this appeared to be because they could tell if they had forgotten to 
take a dose. This statement that they could tell if they had missed a dose did lead to 
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another question 'what to do if they had missed a dose?' and many of those questioned 
were uncertain. This suggests that careful counselling of the patient should be 
undertaken when the device is first issued. In a survey of hospital in-patients about 
their information needs (Howard et al. 1999) almost 90% of those questioned stated that 
they regarded information on missed doses as important. A survey carried out in the 
USA (Lyons, Rumore and Merola 1996) discovered that less than 50% of those who 
responded had received any information on the consequences of missing a dose. 
Furthermore just over 50% did not know what action to take if they had missed a dose. 
Knowing what to do if the patient discovers two or three hours later that they have 
failed to take their medication is very specific to that patient. The action to take is 
determined by the particular medication being taken and therefore this information 
needs to be tailored to each individual patient. An Australian paper (Gilbert, Roughead 
and Sanson 2002) suggested that problems often arise because health professionals do 
not provide patients with sufficient information regarding missed doses. 
The study subjects also had other questions concerning their medication, often 
producing a list when I first arrived. This quest for information could be indicative of a 
lack of opportunities to seek advice. The structured questionnaire allowed for little 
development of themes and ideas although some patients were eager to discuss specific 
problems outside the scope of the research study. The preliminary study therefore 
provided a snapshot of what was happening in the health authority area at one particular 
period of time. The study gave an indication of the prevalence of the use of MCAs and 
raised a number of issues concerning the appropriate use of these devices. 
2.7 Conclusions. 
This preliminary study provided a picture of the supply and use of MCAs in a particular 
area and at a particular time. The study highlighted several areas for concern: 
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The large numbers of MCAs issued despite the lack of evidence for the effectiveness of 
these devices. 
The lack of assessment of the patients. 
The failure to provide counselling and assistance to patients when a MCA is first issued. 
The concerns expressed by the pharmacists regarding the lack of remuneration for 
supplying and filling MCAs. 
2.8 How this preliminary study informed the subsequent research. 
This preliminary study highlighted the increase in use of MCAs within Primary Care. 
This increased use was despite the fact that there was at that time (as now) little 
evidence to support the use of these devices to improve compliance with medication 
regImes. 
In Chapter 3 a review of the available literature on MCAs and older people is described 
and the evidence for the use of these devices is discussed. The lack of evidence 
concerning the effectiveness of these devices raises the question, 'why are these devices 
issued so frequently?' The pharmacists interviewed were happy to dispense medication 
in these devices provided that surrogate funding could be obtained, however they 
appeared to give little thought to the suitability for a particular patient. 
The structured questionnaire in the preliminary study gave little opportunity for the 
pharmacists to express their attitudes and beliefs concerning the use of these devices. 
The majority of the pharmacists simply responded to a request from another healthcare 
professional to issue a MCA. Interviewing other healthcare professionals to elicit their 
attitudes and beliefs about the use of MCAs would therefore seem to be an important 
next step. 
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The structured patient questionnaire similarly did not allow the patients to express their 
own opinions about the use of these devices. I was interested to discover what their 
feelings were, when a MCA was issued. This study provided information on the ability 
of those questioned to use the MCA, but did not explore their beliefs about taking their 
medication. 
As a result of undertaking this preliminary study I identified four areas of interest which 
I wished to explore further. Theses areas of interest were: 
Trigger for use. I was keen to explore what triggered the issue of the MCA in the first 
instance. 
Use of MCA. How did the recipient of the MCA manage the device what did they and 
healthcare professionals see as the advantages and disadvantages of these devices? 
Health beliefs. Did the health beliefs of both those using the devices and health care 
professionals affect the appropriate issue and use of the device? 
Age. Were older people more likely to be issued these devices and was the issue of a 
MCA ageist? 
A qualitative study using semi-structured interviews would give the opportunity to 
explore those issues which the participants saw as important. Such a study is described 
in Chapters 5, 6, and 7. 
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Chapter 3: 
Review of Literature relating to the use of 
Multi-compartment Compliance Aids by older people 
3.1 Introduction. 
This chapter details the findings of a review of the literature concerning MCAs. Prior 
to undertaking the preliminary study, which is described in Chapter 2, a limited review 
of the literature relating to the use of MCAs was undertaken. This review suggested 
that a more structured search of the literature was needed in order to determine the 
evidence for the use of these devices. Section 3.2 explains the scope of the search and 
the search parameters. The search strategy is then explained and the methods of 
searching the data bases are described. The results of the literature search are detailed 
in Section 3.4. The following section details a critical analysis of the studies identified 
by the structured review. Section 3.6 contains the conclusions obtained as a result of 
undertaking this review. The final section contains a brief summary of the chapter. 
3.2 Scope of the review 
The review of the literature was designed to identify all the available published 
literature relevant to MCA use by older people. In order to ensure the breadth of the 
review, all eligible articles were included irrespective of research method or any 
methodological deficiencies. Inclusion criteria were set in line with the main focus of 
the study, i.e. the use of Multi-compartment Compliance Aids by older people living 
independently in the community. 
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3.2.1 Inclusion criteria. 
All experimental studies which had as a main focus the use of MCAs by older people to 
aid compliance with a medication regimen. 
All descriptive studies which described the use of MCAs to aid compliance, or the 
dispensing of drugs in MCAs. 
Studies which looked at the use of MCAs by people aged 65 and over who were living 
independently in the community. 
Systematic reviews of the literature referring to MCA use. 
Papers published from 1982 onwards. 
English language papers. 
3.3 Search Strategy 
The search parameters were designed in order to cover a wide range of the literature 
available. Searches were undertaken in the following databases: 
• MEDLINE 
• EMBASE 
• CINHAL 
• PsychINFO 
• Pharmline 
• International Pharmaceutical Abstracts (lP A) 
• Cochrane Database of Systematic Reviews. 
The search terms used were: patient compliance, reminder systems. and drug 
packaging, which are MeSH terms, and compliance aids which was a keyword search. 
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All the search terms were used in each database and the results recorded. Not all the 
search terms produced results in every database and it was necessary to try different 
combinations of search terms. Having identified a number of articles with the initial 
search, the titles were viewed and any with no connection to compliance with 
medication were rejected. Next the abstracts of the identified articles were obtained and 
those articles which did not have Multi-compartment Compliance Aids as the main 
focus of the research were rejected. The remaining references were recorded on a 
database. All the journal articles were obtained and read. A small number were 
discarded at this point because a more in depth review revealed that the article did not 
fit the inclusion criteria. Searches were also made of all the bibliographies of the 
journal articles obtained and searches were made of colleagues' personal reference 
collections. Details of the search strategy undertaken can be found in Appendix 2. 
3.4 Results 
A total of 36 references were identified by the above search methods. Details of the 
type of study or article are detailed in Table 12 below 
Table 12: Numbers of different types of study identified. 
Type of study Number 
Randomised Controlled trial 11 
Non-randomised controlled trials 1 
Cross-over trial 1 
Longitudinal studies. 4 
Cross-sectional studies 4 
Systematic review 4 
Descriptive studies 11 
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3.4.1 Randomised Controlled Trials 
The aim of this literature review is to determine the evidence base for the use of MCAs. 
Randomised controlled trials (RCTs) are considered the gold standard of investigative 
studies and therefore would provide the highest level of evidence. Eleven RCTs were 
identified and are listed in Table 13. 
Table 13: Details of randomised controlled trials. 
Ascione et al 1984 
Becker at al 1986 
Crome et al 1982 
Huang et al TRACE 
study 2000 
Huang et al VITAL 
study 2000 
Lee et al 2006 
Murray et al 1993 
Park et al 1992 
ASCIONE F.l, L.A. SHIMP. 1984. The effectiveness of four 
education strategies in the elderly. Drug Intelligence and 
Clinical Pharmacy, 8 pp.926 -31 
BECKER L.A, K. GlANZ , E. SOBEL, 1. MOSSEY, S.L. 
ZINN, K.A. KNOTT. 1986. A Randomized Trial of Special 
Packaging of Antihypertensive Medications. The Journal of 
Family Practice, 22, (4) pp.357-361. 
CROME P, B. CURL, M. BOSWELL, D. CORLESS, R.R. 
LEWIS, 1982. Assessment of a new calendar pack - the 'C-
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3.4.2 Controlled trials without randomisation. 
One article was identified that detailed a controlled trial without randomisation. A 
control group was present in this study, however allocation to either intervention or 
control group was not made by means of randomisation. 
Ware et a11991. 
3.4.3 Cross-over trials 
WARE, GJ. N.H.G.HOLFORD, J.G.DA VISON, R.G. HARRIS 
1991, Unit dose calendar packaging and elderly patient 
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One study was identified as a cross-over trial. The patients in this trial acted as their 
own controls i.e. for half of the study duration the participants received either the 
intervention or acted as controls, and for the second half of the study, the groups 
swapped over intervention group becoming controls and vice versa. 
Wong et al1987 WONG, B.S.M. D.C.NORMAN, 1987, Evaluation of a Novel 
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3.4.4 Longitudinal studies 
Four longitudinal studies were identified; in these studies the participants were 
interviewed at intervals regarding the use of the MCA. None of these studies included a 
control group. Details of the longitudinal studies can be found in Table 14. 
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Table 14: Details of longitudinal studies 
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3.4.5. Cross-sectional studies. 
The four studies which were cross-sectional in design looked at either the acceptability 
of particular MCAs or at the ability of the study subjects to either fill or use the MCA 
correctly. Details of the cross-sectional studies identified can be found in Table 15 
below 
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3.4.6. Descriptive studies. 
Eleven other journal articles were identified all of which were descriptive in nature, and 
the use of MCAs was the main focus of the article. 
Table 16: Details of descriptive studies 
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3.5 Description of studies and critical discussion. 
In this section each trial is described in a standard fonnat followed by a discussion 
relating to the 11 trials. 
3.5.1 Randomised controlled trials 
Study 
Participants 
Country 
Interventions 
MCA 
Randomisation 
Outcome measures 
Conclusion 
Notes 
Ascione et al1984 
158 elderly patients aged 60 - 89 years, living in their own 
home and taking one or more cardiovascular drug for at least 
one month. 
USA 
The participants were divided into seven groups as follows: 
No pre-test interview. - intervention oral instructions 
No pre-test interview. - oral instruction + reminder calendar 
Pre-test interview - oral instructions 
Pre-test interview - oral instructions + reminder calendar 
Pre-test interview - oral instructions + reminder package 
Pre-test interview - oral instructions + written instructions 
Pre-test interview - no intervention control 
The medication reminder package was described as a 
'commercially available, seven-day compartment plastic 
package known as the Seven Day Pill Reminder.' All the 
medication for each day was placed in one compartment. 
Not disclosed. The study design was stated to be single-blind 
with physicians and interviewers unaware of which intervention 
the patient received. 
Improvement in drug knowledge and compliance behaviour. 
Compliance behaviour measured by self-report. 
Oral instructions plus reminder package improved self-reported 
compliance compared with control. Fifty five percent of the 
patients in this intervention group who had admitted previous 
non-compliance became compliant after the intervention 
compared with ten percent of the control group (p<0.03) 
The minimum length of time to follow-up was one week 
Study 
Participants 
Country 
Intervention 
MCA 
Randomisation 
Outcome measures 
Conclusion 
Notes 
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Becker et al 1986 
180 patients aged between 20 and 80 who were already taking 
medication for previously diagnosed hypertension. All patients 
had demonstrated poor BP control on at least 1 visit in the 
previous 2 years 
USA 
All patients in the experimental group received their medication 
in a special packaging format consisting of 28 foil backed 
blisters marked with day of week and time of day. The control 
group received their medication In traditional pill vials. 
Medication was provided free of charge to both groups. 
A commercially available system which comprised 28 foil-
backed blisters. Each blister contained all the medication to be 
taken at one time. The foil backing was printed with the day of 
the week and the time. 
Method not disclosed. 
Self-reported compliance. Patients were asked a non-
threatening, non-judgemental question about their compliance 
behaviour. Pill counts. Patients were asked to bring in all 
remaining medication to each follow-up visit. Blood pressure 
control. Blood pressure was taken three times at each visit. 
The first measure was discarded and the average of the second 
and third was used as the blood pressure measurement for that 
visit. Blood pressure control was defined as a diastolic blood 
pressure of less than 90 mm Hg. 
No significant improvement in blood pressure control or in the 
two other compliance measures were found in the intervention 
group. 
Missing pre-enrolment and baseline data. Participants received 
free medication to ensure they stayed in the study. Participants 
in the intervention group considered the special packaging more 
difficult and less convenient to use. 
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Study Crome et al 1982 
Participants 78 elderly patients, age range 68 - 98 years, recruited from a 
hospital geriatric department. 
Country UK 
Intervention Patients in the intervention group received their medication in 
the 'C-Pak' (an individually prepared blister pack which 
allowed the presentation of a number of different drugs in each 
pack). 
MCA A disposable, calendar type pack. Each tablet is enclosed in an 
individual blister. The blisters are arranged on a card according 
to the day of the week and the time of day. Medication to be 
taken at the same dosage time is not all contained in one blister. 
Randomisation Method not disclosed 
Outcome measures Tablet count. 
Conclusion No difference between intervention and control group. 
Notes This study took place in a hospital setting with participants self-
administering. 
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Study Huang et al2000 (TRACE study) 
Participants The 184 participants were recruited by means of advertisements 
and word of mouth. The age range was 44 - 72. Participants 
were only non-smokers, non-vegetarians and those not having 
taken anti -oxidant vitamin supplements III the prevIOUS 2 
months. Approximately 50% had a history of disease and, a 
similar proportion, were taking medication. No further details 
were gIVen. 
Country USA 
Intervention Participants were randomised to pill orgamzer or no pill 
organizer and one of four vitamin supplementation groups. 
Participants attended follow-up appointments one and two 
months after randomisation. 
MCA A refillable seven-day organiser with a single compartment for 
each day of the week. 
Randomisation Randomisation to use of an organizer was by means of computer 
generated random numbers. Randomisation of supplementation 
group was determined by a fixed randomisation scheme. The 
allocation was concealed by using opaque envelopes. Both 
participants and personnel were masked to the assignment of 
supplementation groups. 
Outcome measures Adherence to pill taking was assessed by pill count, serum 
vitamin levels and self-report. 
Conclusion The use of pill organizers did not enhance adherence when 
assessed by any of the three trial methods. 
Notes The pill organiser group received the organiser and two bottles 
containing vitamins or placebos. Instructions on the use of the 
organiser were provided. 
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Study Huang et al 2000 (VITAL study) 
Participants 297 retired teachers (age range 57-72) recruited via invitational 
mailings. Thirty percent had high blood pressure, 6% diabetes 
and 8% high cholesterol at baseline. 
Country USA 
Intervention Participants were randomised to receive one of two supplement 
groups either in a pill organiser or in a unit-dose blister pack. 
MCA Pill organizer group received a seven-day refillable organiser 
with one compartment for each day of the week. The 
participants in this group filled the organiser with the vitamin 
pills provided. 
Blister-pack group received monthly blister-packs each with 31 
blisters labelled with dates. Each blister contained the vitamins 
for that day. 
Randomisation Method not disclosed. 
Outcome measures Adherence was assessed by pill counts, serum vitamin levels 
and self-reports. 
Conclusion Adherence was similar in the two groups when measured by 
serum vitamin levels. Adherence was improved in the blister 
pack group when measured by pill count and self report. 
Notes This study compared a pill organiser with a blister pack 
therefore no comparison with standard packaging. 
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Study Lee et al 2006 
Participants 200 elderly (65+) patients living independently III the 
community. Patients had to be taking 4 or more medicines for 
chronic conditions. 
Country USA 
Interventions The study consisted of three phases. In phase 1, patients were 
assessed for baseline adherence, BP and LDL-C. In phase 2, all 
patients received the intervention - education, regular follow-up 
by pharmacist and MCA. In phase 3, participants were 
randomised either to continue pharmacy care or to return to 
usual care. 
MCA Clear plastic blisters with a foil backing. Each blister contained 
all the medication for one dosage time (e.g. morning) and was 
numbered for the day of the month. Separate blister packs were 
provided for each dosage time. 
Randomisation Randomisation was undertaken using a computer-generated 
random number sequence. Allocation was concealed to both 
patients and study personnel. 
Outcome measures At the end of phase 2: change in number of pills taken vs. 
baseline. At the end of phase 3: between group comparison of 
medication persistence. 
Conclusions The pharmacy care programme increased medication adherence, 
medication persistence and lowered BP. 
Notes Interventions included education and follow-up by pharmacist as 
well as MCA. 
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Study Murray et al 1993 
Participants 36 patients aged 60 years or over and taking three or more 
prescribed medicines. 
Country USA 
Intervention Participants were randomised to one of three groups: 
Unit-of-use packaging with twice daily dosing 
Conventional packaging and twice daily dosing 
Conventional packaging and no change in dosing. 
MCA A unit-of-use package consisting of a two ounce plastic cup with 
a snap on lid containing all the medications to be taken at the 
time of dosing. 
Randomisation Not disclosed. 
Outcome measures Medication compliance assessed monthly for 6 months using 
tablet counts. 
Conclusion Unit-of-use packaging and twice daily dosing improved 
compliance with medication. 
Notes Intervention group receiving unit-of-use packaging also receiyed 
a change in medication dosage to twice daily. 
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Study Park et al1992 
Participants 61 elderly adults aged over 60 years taking a minimum of 2 
prescribed medicines and living in the community. Participants 
were further divided into 2 sub-groups: young-old ( aged 70 and 
younger) and old-old (aged 71 and older.) 
Country USA 
Intervention Participants were randomly assigned to receive: no intervention 
(control group), a medication organiser, a medication reminder 
chart or both organiser and chart. 
MCA The medication organiser consisted of 28 compartments. The 
compartments were labelled for four dosage times per day. 
Each set of four compartments was labelled with a day of the 
week. All medications for one dosage time contained in one 
compartment. 
Randomisation Method not disclosed. 
Outcome measures Medication compliance was assessed by means of an electronic 
bar-coding device, which was given to each participant. 
Conclusion The young-old subjects showed a high rate of adherence which 
was not improved by any of the interventions. The old-old 
group had a lower rate of adherence and those who received 
both organiser and chart had the best rate of adherence in this 
group. 
Notes Participants required to use a bar code reader and instructed to 
swipe the reader across the bar code for a particular drug at the 
time they were taking it. This reading provided the data on 
compliance. Participants received payment at the start of the 
study. 
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Study Peterson et al1984 
Participants 53 consecutive attendees at an out patient clinic for people with 
epilepsy. Participants were aged from under 20 to over 60. 
Country Australia 
Interventions Patient counselling leaflet, Dosett® box, seIzure diary and 
reminders for prescription and appointments. 
MCA Commercial Dosett® box. All medication for one dosage time 
contained in one compartment. Medication accessed by sliding 
down the plastic cover for the appropriate day of the week. 
Randomisation Coin toss method. 
Outcome measures Plasma anticonvulsant levels. Appointment keeping and 
prescription refill frequency. 
Conclusion The combination of strategies improved compliance with 
medication and clinical control of the participant's epilepsy. 
Notes Large number of interventions and therefore difficult to state 
which intervention improved compliance. 
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Study Ryan-Woolley et al2005 
Participants 62 elderly residents of a sheltered housing association aged 60 
years and over. Participants were divided into 2 matched 
groups. 
Country UK 
Interventions One member of each matched pair received a medication 
orgamser and the other received medication m standard 
packaging. Questionnaires were administered pre- and post-
study. 
MCA Nomad® tray. All medication for one dosage time contained in 
one compartment. Medication accessed by pIercmg the 
cellophane covering. 
Randomisation Method not disclosed. 
Outcome measures Both groups were asked to return any unused medication to the 
pharmacy at the end of each month. The percentage of 
medication returned was calculated. 
Conclusions The amount of returned medication in the intervention group 
was reduced over the period of the study. 
Notes Failure by control group to return unused medication meant 
there could be no comparison with the intervention group. 
The study was sponsored by Surgichem Ltd. (the manufacturers 
ofNomad® compliance aids). 
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Study Simmons et al 2000 
Participants 68 diabetic patients with poor glucose control. Age range 43 -
66. 
Country New Zealand 
Interventions The intervention group received a special kit which included a 
calendar blister pack and instructions on how to take the 
medication. The control group had medication in the usual 
containers. 
MCA A calendar blister pack, which was labelled for days of the week 
and times of day. All the medication for each dosage time was 
contained in one blister. The medication was accessed by 
pushing the tablets out of the blister. 
Randomisation By means of a random number sheet carried out by a third party. 
Outcome measures Participants answered a brief questionnaire, had their blood 
pressure and HbA1c measured at the start of the study and after 4 
and 8 months. 
Conclusions The intervention group showed a reduction in HbA1c over an 8-
month period compared with the control group. 
Notes All participants received a 'medication box'. The intervention 
group had a calendar blister pack containing their medication 
inside their box. The control group received medication in 
standard packaging inside their box. 
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Discussion of the randomised controlled trials identified. 
Study subjects. 
This research is concerned with the use of MCAs by older people. All the studies 
included investigated MCA use in the older age group; however, in some studies the age 
range was wide. The aim of all the RCTs identified was to test how the intervention 
affected compliance with medication and if the study subjects were all good compliers, 
it would be impossible to detect any improvement. Only three of the studies identified 
enrolled subjects who were thought to have problems with medication compliance, 
(Simmons, Upjohn and Gamble 2000; Becker et al. 1986; Peterson, McLean and 
Millingen 1984). The TRACE study (Huang et al. 2000) recruited by means of 
advertisements and word of mouth; however the inclusion and exclusion criteria did not 
identify ability to take medication correctly. The VITAL study (Huang et al. 2000) 
recruited retired teachers. This provided an older age range; however it did not identify 
any problems with medication compliance. The remaining seven studies all recruited 
via geriatric hospitals, day centres or sheltered housing facilities, and this made 
recruitment easier for the researchers, but little is known about the ability of the subjects 
to manage their medication before the start of the study. The majority of studies were 
undertaken in the USA, with just two taking place in the UK and one each in Australia 
and New Zealand. 
Sample size and power. 
It is important when undertaking a research study to ensure that the size of the sample 
investigated is sufficiently large to ensure that the results obtained are reliable. Haynes, 
III his systematic reVIew stated that: 
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"as a general guide, studies with a single intervention group and control group 
would need to include at least 60 participants per group if they are to have at 
least SO% power to detect absolute difference of 25% in the proportion of 
patients judged to have adequate adherence. " (Haynes et al. 2002 p.lS.) 
The number of participants taking part in these RCTs ranged from 31 - 297. Several of 
the studies divided the participants into more than 2 groups and only one study indicated 
that a power calculation had been carried out, (Simmons, Upjohn and Gamble 2000). 
Randomisation 
Randomly allocating a trial participant to intervention or control group provides a 
safeguard against the introduction of bias into the study. The method of randomisation 
should be clearly stated. Four studies gave details of the method of randomisation, 
(Lee, Grace and Allen 2006; Huang et al. 2000; Simmons, Upjohn and Gamble 2000; 
Peterson, McLean and Millingen 1984,). The method of randomisation was disclosed in 
the TRACE study carried out by Huang et al but not in the VITAL study. The studies 
by Huang, Simmons and Lee all described methods to conceal the allocation. 
Subjects lost to follow up. 
All studies will have participants who either drop out of the study at an early stage or 
who complete the full study but for whom no outcome data is obtainable. Researchers 
should give details of both numbers and characteristics of these subjects as large 
numbers of drop-outs or subjects lost to follow up can cause bias to a study. Nine of the 
RCTs under consideration had subjects who dropped out or who were lost to follow-up. 
All these studies stated reasons for the subjects' failure to complete the study. One 
study, (Lee, Grace and Allen 2006), provided a flow chart detailing the numbers who 
dropped out and reasons given at each stage of the study. The flow chart also provided 
information on how this affected the analysis. The remaining two studies did not lose 
any subjects during the course of the studies. For one study, (Park et al. 1992) the 
length of follow-up was short (two weeks) making it less likely that anyone \\'ould drop 
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out. In the other study (Ryan-Woolley and Rees 2005) all the study subjects lived in 
sheltered housing complexes and were therefore relatively easy to follow up. 
Interventions. 
The interventions for all the studies under consideration are briefly described in the 
tables above. The MCAs used comprised a mixture of refillable types similar to the 
Dosett® or to the devices which are on sale in community pharmacies and disposable 
devices similar to Venalink® or Nomad®. One study (Murray et af. 1993) used 
individual plastic pots for each individual dosage time. These appear unlike any 
commercial MCA in use and, as the participants had to be issued with one pot for each 
dosage time, would be difficult to transport and store. Another study (Crome et af. 
1982) used individual blisters for each drug which were then stapled to cards according 
to the time of the dose. Participants using this type of MCA had to open a blister for 
each medication they were taking at any particular time. Four studies compared special 
medication packaging in the intervention group with standard packaging in the control 
group. The remaining 8 studies used multiple interventions. In two studies, the subjects 
in the intervention group received all the interventions and, in the other six studies, the 
intervention participants were further sub-divided to receive different interventions. 
This use of multiple interventions can make interpreting the impact of the results very 
difficult. 
Outcome measure 
All the studies used some measurement of medication compliance as an outcome 
measure. The majority of the studies used pill counts and self-report. Neither of these 
measures can be seen as reliable. Subjects may over or underestimate their compliance 
when reporting to the researcher; this may not be done deliberately or with any desire to 
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deceive. Pill counts again may not represent a true picture of medication compliance; 
subjects may remove medication from the container but not take the medication. 
A systematic review of the literature investigating interventions made by community 
pharmacists to improve adherence to chronic medication (Van Wijk et al. 2005 p.326) 
discussed the various methods used to measure adherence and the authors stated that: 
"From the results of our review, it is impossible to recommend one of the different types 
of measurement of adherence." 
Researchers in Canada used pill count, self-report and pharmacy claims data to measure 
medication adherence in an elderly population (Grymonpre et al. 1998). They 
discovered that pill counts can underestimate adherence whereas adherence measured 
by self-report or from pharmacy data can often be over estimated. Another study which 
investigated adherence to anti-hypertensive medication (Choo et al. 1999) compared the 
adherence as reported by patient report, automated pharmacy records and pill counts 
with that obtained using a Medication Event Monitoring System (MEMS®). The 
MEMS® system comprises a special cap which fits onto a medication container and 
records on a micro-processor each time the cap is removed. The researchers concluded 
that adherence measured by pill count or pharmacy records was higher than that 
obtained by the MEMS® system. 
Six studies used clinical outcome measures in addition to the compliance measures. 
The clinical measures included blood pressure control and serum levels of the 
medication being taken. In studies which investigated people with diabetes, HbA1c 
levels have been used. HbA1c levels give a reading of mean blood glucose levels over 
the previous 8 weeks and therefore provide a good indication of diabetic control. 
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Including clinical outcome measures has been considered to be more rigorous than 
relying on compliance measures alone. 
Follow-up period. 
The length of time which elapsed before the subjects of the study were followed up 
varied greatly between the different studies. The shortest time to follow-up was one 
week (Ascione and Shimp 1984; Crome et al. 1982), followed by 2 weeks (Park et al. 
1992). In the remainder of the studies, the follow-up time ranged from 1 to 14 months. 
A very short follow-up period could be considered a confounding factor because the 
subjects' behaviour may still be influenced by the original interviews or instructions 
when they were initiated into the trial. Haynes, in the Cochrane Systematic Review 
(Haynes et al. 2005) stated that studies of patients with long-term conditions should be 
followed-up for at least 6 months following positive initial findings. 
Analysis of results. 
All the studies described how the results of the trial were analysed; with nine studies 
giving clear details in a separate section of the paper. The remaining three studies, 
(Murray et al. 1993; Becker et al. 1986; Crome et al. 1982), referred to the statistical 
analysis briefly at the end of the method. 
It is important for researchers to give clear details of the type of analysis and statistical 
methods used in order that the reliability of the results can be ascertained. All of the 
studies under investigation compared the results of the different groups by means of 
hypothesis testing. The researchers gave details of the statistical tests employed and 
therefore it is possible to determine if the tests used were the correct ones for the type of 
data in question, the shape of the distributions and the groups involved. All the studies 
collected data on compliance with medication and these were either collected by pill 
count or by self-report. Pill counts, which are undertaken by the researcher and then 
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expressed usually as a percentage, are metric continuous data. Self-reports of 
compliance are more difficult to deal with as these are usually expressed as an opinion, 
for example, "very good", "good" "moderate" "poor". Data of this type is usually 
considered as ordinal categorical data. F our studies (Huang et al. 2000; Simmons, 
Upjohn and Gamble 2000; Becker et al. 1986; Peterson, McLean and Millingen 1984;) 
use clinical measures (BP, Serum / plasma levels and HbA1c), as outcome measures -
this type of data is metric (continuous) data. 
Three studies (Ryan-Woolley and Rees, 2005; Ascione and Shimp, 1984; Peterson et 
aI., 1984) stated that paired t-tests were carried out; however only the Ryan-Woolley 
study used matched pairs in the study design. For those studies, which combined 
clinical outcomes with measurement of compliance, different statistical tests may be 
needed to deal with the different types of data. All the studies with multiple outcome 
measures described using more than one statistical test. 
Four studies, Lee, Grace and Allen 2006; TRACE & VITAL (Huang et al. 2000) and 
Park et al. 1992, used a form of multi-variable regression analysis. This type of analysis 
allows the researcher to look for causal relationships between one variable and one or 
more other variables. Therefore investigating a casual relationship between changes in 
medication compliance and the medication packaging and / or other interventions would 
appear to be very useful for these studies. Some researchers also wished to explore the 
relationships of medication compliance with other variables e.g. age. 
Finally in this section on statistical analysis, it is important to investigate how the 
researchers dealt with the patients who either dropped out or were lost to follow-up. 
How this data (or lack of data) is handled can make a considerable difference to the 
reliability of the study results. Two studies, (Lee, Grace and Allen 2006; Simmons, 
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Upjohn and Gamble 2000), stated that they used 'intention-to-treat' analysis, which is 
regarded at the best method for dealing with missing data in RCTs. Two studies, 
(Ryan-Woolley and Rees 2005; Park et al. 1992), did not record any patients lost to 
follow up, although Park did state that there was some missing data due to equipment 
failure. The remaining studies all lost some subjects during the course of the study and, 
in these studies the analysis was completed on those subjects who completed the study. 
This may give rise to bias because trial completers are not the same as all subjects. 
Conclusions drawn by the studies. 
Three studies concluded that there was no significant difference in outcomes between 
the intervention and control group. Eight studies reported significant differences in 
outcomes between intervention and control although, in six studies, the interventions 
were complex and it is difficult to decide which part of the overall intervention caused 
the improvement. 
The main difficulties with all of these studies lie with the subjects investigated and the 
outcome measures used. The numbers of subjects in almost all cases are insufficient to 
power the study, especially when the improvement in outcome measures being 
investigated is small. A trial may also be confounded by using subjects whose level of 
compliance prior to the study had not been determined, thereby making it impossible to 
prove that the MCA had improved compliance. All of the studies used outcome 
measures of pill count and self-report. These are open to question because they do not 
give a definitive value for compliance, rather they give, either the subjects' perception 
of their actions or what they chose to say. Pill counts only give a value of pills removed 
from the container not an indication of whether they were actually swallowed. Some of 
these trials did try to improve on the outcome measures by including various clinical 
measurements and this would appear at first glance to be a more rigorous approach. 
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However, it must not be forgotten that there are patients who comply perfectly with 
their medication and yet fail to see an improvement in their condition. This may be due 
to individual pharmacodynamics or pharmacogenetics. 
The quality of the RCTs investigated. 
The discussion in this chapter has indicated that the RCTs investigated have, in the 
main, been of poor quality and inconclusive in their findings. This conclusion has been 
supported by the findings of the systematic reviews detailed in this chapter. My 
analysis of the RCTs has discovered that the poor quality of these RCTs is due to a 
number of factors namely: 
• Insufficient numbers of participants to power the trial 
• Little or no information on the baseline compliance of the subjects of the trial. 
• Outcome measures which are difficult to measure and do not provide an unbiased 
measurement of medication compliance 
• Short length of follow-up time 
• Little information on subjects lost to follow up and incorrect methods of dealing 
with the data from these individuals 
• In some trials very little details given about the statistical analysis undertaken and 
making it difficult to assess if the correct statistical methods have been employed. 
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3.5.2 Controlled Trial without randomisation. 
Study Ware et al1991 
Participants 84 elderly patients (mean age 78 yrs.) admitted to one of two 
hospital wards and then discharged into the community. 
Country New Zealand 
Interventions The intervention group received medication in a calendar blister 
pack and the control group in conventional bottles and packs. 
MCA A foil backed plastic blister pack with 28 compartments. All 
medication for one dosage time was contained in one blister. 
Medication was accessed by pushing through the foil back. 
Outcome measures Home visits were carried out at 10 days, one month and three 
months post discharge. Compliance was checked by oral 
interviews and/or tablet counts. 
Conclusions A significant improvement III patient compliance III the 
intervention group compared with the control group. 
Notes Unequal numbers of participants in intervention and control 
group. Large number of participants lost to follow-up. 
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3.5.3 Cross-over trial 
Study Wong et al1987 
Participants 22 elderly patients attending a geriatric clinic. Age range 66 -
90 years. 
Country USA 
Interventions 11 patients received their medication in a calendar blister pack 
and 11 patients received medication in standard bottles. At the 
end of 3 months the intervention group and control group were 
crossed over. Each patient therefore acted as hislher own 
control. 
MCA A calendar blister pack with 31 large blisters All the medication 
for one dosage time was contained in the blister. Separate cards 
were issued for each dosage time. 
Outcome measures Compliance was measured by means of pill count and a 'non-
compliance index' calculated. 
Conclusion The use of the calendar blister pack significantly improved 
compliance as measured by the 'non-compliance index'. 
Notes Larger number of male participants than is usual in trials in this 
age group. 
Discussion of non-randomised controlled trials 
There were only two trials identified and each used different methodology. Both trials 
employed control groups but the subjects were not randomly assigned to either group. 
The subjects in both studies were patients at geriatric hospitals. 
The Ware study investigated subjects who started as in-patients on two hospital wards 
in the same hospital. For a three month period, the patients who consented to take part 
in the study on one ward were in the intervention group and those from the second ward 
were controls. At the end of the three month period, the role of the wards was reversed. 
82 
The study subjects self-medicated on the wards and continued after discharge. 
Demographic details of the study subjects were given and the two groups were similar. 
The study subjects in the Wong trial were outpatients at a USA Veterans facility. Each 
subject received the intervention for 3 months and acted as a control for three months. 
Half the group received the intervention first and then had it removed; whilst the other 
group received normal packaging first and then received the intervention. This type of 
study design could be open to bias because the study subjects who received the 
intervention first may not revert to pre-intervention behaviour when the intervention is 
removed. Therefore it is difficult to determine the effect of the intervention. 
The numbers recruited by both studies were insufficient to detect a significant 
improvement in medication compliance. 
The Ware study lost a total of 29 subjects to follow-up, 14 in the intervention group and 
15 controls. Five subjects were lost to follow-up in the Wong study reducing the 
number in this study still further. Neither trial indicated how they accounted for the 
missing data caused by subjects withdrawing or being lost to follow-up. 
The interventions in both studies were a calendar blister pack very similar to the sealed 
MCAs available in this country. The control groups received their medication in 
ordinary packaging. 
Pill counts were undertaken in both studies to assess adherence and in addition the Ware 
study included data from oral interviews. 
The intervention groups in both studies were followed up for 3 months however because 
of the study design in the Wong study the subjects participated in the study for a total of 
6 months. 
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No details of any statistical analysis were given in the Ware study and it appeared from 
the report that none was undertaken. Wong et al did give details of the statistical tests 
used. 
Conclusion of studies. 
Both these studies concluded that compliance with medication was improved in the 
intervention group. However, the results can not be considered reliable due to the lack 
of randomisation, the small numbers involved and the lack of statistical information. 
3.5.4 Longitudinal Studies 
Four studies were identified which did not use a control group. However the study 
subjects did receive an intervention and the result of this intervention was recorded over 
a period of time. 
Study Bazire 1984 
Participants 12 non-compliant psychiatric outpatients. Age range 39 - 87. 
Country UK 
Interventions Dosett® box. 
Outcome measures Compliance measured by recording how many tablets remained in 
the Dosett® box at the end of each week over a four week period. 
Conclusion 9 patients demonstrated obvious improvement in compliance. 1 
patient required a prolonged period of training in the use of MCA. 
2 patients were described as failures. 
Notes Useful list of disadvantages which were identified with the 
Dosett® box. 
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Study Walker 1991 
Participants 125 outpatients aged over 55 and taking at least one solid oral 
dosage form. 
Country UK 
Interventions Participants were gIven a MCA to take home and use. 
Participants chose their own device from a selection on offer. 
MCA Dispensatab, Dosett®, Medidos®, Mediwheel, Medsystem, Pill 
Mill and Redidos. All devices held one week's supply of 
medication. 
Outcome measures Participant satisfaction with the device. 
Conclusions 80 participants stated that the MCA had helped them to keep to 
the treatment programme. 
Notes No information on which devices were chosen by the participants. 
Study Maguire 1986 
Participants 54 geriatric patients, living independently in sheltered housing. 
Country Northern Ireland. 
Interventions Three compliances devices were tested. A Dosett® box, a tear-off 
capsule device and a memory card or counselling. 
Outcome measures Pill count. 
Conclusions Compliance aids of the type tested are only of limited value in 
improving compliance and should only be used as an adjunct to 
counselling. 
Notes 
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Study Walker et al 1990 
Participants Subjects recruited via community pharmacies after requesting the 
purchase one of a number of compliance devices advertised in the 
pharmacy. 22 subjects completed the interview. 
Country UK 
Interventions Participants used the chosen device in their own home, filling the 
device with their medication. 
MCA Dispensatab, Dosett®, Medidos®, Mediwheel, Medsystem, Pill 
Mill, Redidos and Daily Pill Minder. 
Outcome measures Structured questionnaire administered 4 - 8 weeks after the initial 
purchase. Participants were asked for the opinion of the device 
they had purchased. 
Conclusions Participants who were interviewed found the compliance device 
useful. 
Notes. The participants received the compliance device free of charge in 
return for agreeing to be interviewed. 
Discussion of longitudinal studies. 
These four studies are of limited value. There are no control groups and the sample size 
in three studies, (Walker, Bellis and Jumani 1990(b); Maguire 1986; Bazire 1984), is 
too small to show evidence of effect. The fourth study (Walker 1991) recruited larger 
numbers; however 36 subjects dropped out of the study before completing the second 
follow-up interview. 
Follow-up period. 
A follow-up period of at least six months is considered to be needed in order to provide 
evidence for the effect of the intervention. In these studies the follow-up periods varied 
from one month, (Walker, Bellis and Jumani 1990(b); Bazire 1984), to six months for 
the other two studies. 
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Interventions. 
The intervention in the Maguire study was complex with subjects receiving one of three 
compliance devices or counselling. The study period of 24 weeks was divided into five 
experimental periods. Baseline compliance was monitored during the first period and 
then subjects were given one of three compliance devices or were counselled. Pill 
counts were taken at the end of each experimental period and subjects who were still 
non-compliant were changed to a different device. 
Interventions in the other three studies consisted of a compliance device. In Bazire's 
study, all subjects received a Dosett® box; in both studies by Walker, the study subjects 
selected their device from the different types on offer. 
The use of complex interventions can make interpreting the results difficult as it is not 
always apparent which intervention or combination of interventions has caused the 
effect. 
Outcome measures 
The outcome measure in both of Walker's studies was patient satisfaction with the 
device. The subjects in the 1990 study were interviewed once, four to eight weeks after 
receiving the device. Those subjects in the 1991 study were interviewed after 6 weeks 
and 6 months using a structured verbal questionnaire; however, no details of the 
questions asked are provided. 
The other two studies employed pill counts as the outcome measure. 
Although patient satisfaction is of importance when considering the use of these 
devices it is a difficult outcome measure to assess. Pill counts can also be considered , 
as less than reliable as it is impossible to determine if the participant has taken the 
medication or simply disposed of it. 
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Statistics 
The only study to include details of statistical analysis was Walker's 1991 study while 
the other three studies simply gave brief numerical details. 
Conclusions 
Two of the studies investigated the role of the MCA in improving compliance with 
medication and the subjects investigated were either known to be non-compliant (Bazire 
1984), or had their compliance assessed at baseline (Maguire 1986). The two studies by 
Walker investigated volunteers, and their ability to take their medication as instructed 
was not considered prior to the start of the study. 
None of these studies could be used to provide evidence of the effectiveness of MCAs 
in improving compliance with medication; however, the Bazire study in particular is 
frequently cited as evidence of the efficacy of a MCA. 
3.5.5 Cross-sectional studies. 
F our studies were cross-sectional studies, that is, each study investigated a group of 
subjects assembled at one moment in time to investigate a particular intervention. No 
control groups were used and the subjects were not followed-up at a later date. 
Although MCAs were the focus of each study, none of the studies investigated 
compliance with medication. However, the findings of each of these studies may 
provide information to inform the use ofMCAs. 
Two studies, (Walker 1990; Wildin and Skellem 1989), investigated the subjects' 
preferred MCA. In both studies, the subjects were outpatients - (52 subjects were 
emolled in the study by Wildin and 222 in the study undertaken by Walker). The 
intervention in both studies comprised showing each participant a number of different 
MCAs and then asking a series of questions about the devices. 
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Wildin et al 1990. In this study the participants were shown a Dosett® and a 
Medidos® and then asked which they preferred. Questions were also asked about 
knowledge of medicines and their medication regime. Subjects were asked if they 
would use a compliance aid if given one and whether they would be prepared to buy 
one. 
Walker et a11990. This study evaluated seven different MCAs. The participants were 
asked to remove a tablet from each of four different devices, the devices had been 
assembled in groups of four and subjects were randomly assigned to test a particular 
group of four. Subjects were scored for their ability to remove the tablet on a scale of 1-
5. Subjects were also asked for their preference. 
The other two studies (Atkin et al. 1994; Park et al. 1991) investigated the patient's 
ability to correctly fill a MCA and the ability of the patient to remove medication from 
the packaging including a MCA. 
Park et al 1991. Park and her colleagues assessed the ability of arthritis patients to 
correctly fill medicine organisers, which could be bought over the counter. Three 
different types of organiser were assessed, with each subject filling one type of 
organiser. The investigation took place in the office of the local rheumatologists where 
details of current medication and understanding of their medication regime were noted. 
Next the subjects were asked to fill the organiser with their medication. Finally they 
completed a questionnaire about health and a test to measure verbal intelligence. 
Analysis was carried out to determine the subjects' knowledge of their medication and 
their ability to load the organiser correctly. Statistical tests were undertaken to look for 
relationships between knowledge of medication and errors in loading; also relationships 
between age and errors in loading. This study provides information on how accurately 
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participants load the orgamsers under test and two of the orgamsers investigated 
appeared to be similar to ones that can be purchased over-the-counter in the UK. 
However, the test was carried out in very artificial circumstances and this is a 
confounding factor. Nevertheless this type of information would be useful when 
deciding whether or not to suggest an older person fills their own MCA. 
Atkin et al 1994. The fourth study in this group investigates the ability of patients to 
manage medication packaging. The study participants were 120 elderly patients of a 
teaching hospital acute geriatric service. The study subjects were assessed for their 
ability to undertake six different tasks relating to medication packaging - one of these 
tasks was to open and remove a tablet from a Dosett® box. This study provides clear 
details of the methods used and the results obtained. The statistical tests used are 
detailed and the relationship between Mini-mental state score and functional ability was 
assessed. The study concluded that the manufactured drug packaging currently 
available significantly impeded the access by older people to their medications. This 
was particularly true of the Dosett® box. 
Discussion 
Although these studies did not attempt to evaluate the effectiveness of MCAs they 
provide an important view of the problems which may occur when such devices are 
issued to older people. The inability of older people to remove the medication from 
MCAs will be discussed later in this thesis. This is obviously an important 
consideration and yet the study by Atkin remains one of only two studies identified 
which investigated this issue. The second study, (Nikolaus et al. 1996) investigated 
elderly patients' problems with medication both in-hospital and post-discharge and does 
include testing the ability of the patients to open and remove tablets from a number of 
different packaging formats. Included in the different types of packaging was a 
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Dosett® box. This assessment took place while the patients were in hospital and the 
study then investigated the patients post-discharge to identify risk factors which might 
be associated with poor medication compliance. The use of the MCA was not the main 
focus of this study and therefore it was not included in the review. The authors however 
state that their findings on the ability of the patients to open a Dosett® are not consistent 
with the findings of Atkin et a1. A higher proportion of patients in the Nicklaus study 
were able to open the Dosett®. Further investigation of this study revealed the fact that 
the term 'dosett' was used generically, that is different types of MCA were tested. The 
authors state that they selected the MCAs most likely to be suitable for their patients. 
3.5.6 Descriptive studies 
Finally, the remaining studies were descriptive in nature and did not involve study 
subjects. The studies were included in the review because MCAs were the main focus 
of the work and, although not investigating improvement in compliance, this group 
includes work on important factors relating to the use ofMCAs. 
Four studies, (Hattaway 1998; Corlett 1996; Rivers 1992;Walker 1992b), are simply 
descriptive, describing the different types of devices available. These studies make no 
attempt to assess the usefulness of each device and, as can be seen from the reference 
details, were written some time ago. The study by Hattaway describes those devices 
available in New Zealand and therefore is of little value for those working in the UK. 
Similar studies have been carried out in the USA and include descriptions of electronic 
devices. The studies by Rivers and Corlett describe not only MCAs but also devices for 
assisting patients to use eye drops, inhalers and insulin syringes. 
Two studies investigated the use of MCAs by district nurses, (Stewart et af. 2001; 
McGraw and Drennan 2000). The study by McGraw and Drennan investigated a 
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number of issues regarding the use of MCAs in primary care in England. In particular. 
they investigated the filling of MCAs by district nurses which is deemed 'unsafe 
practice which carries risk for both practitioner and patient' (United Kingdom Central 
Council for Nursing 1992). The study by Stewart et al took place in Scotland also 
referred to the UKCC advice on nurse filling of medication compliance devices. This 
study investigated the activities of nurses providing community-based services in 
Scotland. Both these studies concluded that significant numbers of community based 
nurses were filling MCAs. However the studies were undertaken shortly after the 
UKCC advice on the filling of MCAs by nurses and perhaps there had not been time for 
a change in practice to occur. 
One study, (Levings, Szep and Helps 1999), looked at the safety of MCAs. This study 
was undertaken in Australia and used data obtained from the Australian Incident 
Monitoring System (AIMS) which is operated by the Australian Patient Safety 
Foundation. Similar studies undertaken in the UK have not been identified, despite 
anecdotal evidence that many errors do occur. This is an important area for 
investigation, as it is as vital to know if the use of MCAs can cause harm, as much as it 
is to know whether MCAs improve medication compliance. In other words, we need to 
investigate both risk and benefit. 
One paper, (Green and McCloskey 2005), gave details of a survey carried out to 
investigate the prevalence of use of MCAs in secondary care. This studied used a postal 
questionnaire to determine how many acute hospitals provided MCAs and medicine 
reminder charts to patients on discharge. The questionnaire also requested information 
on the type of MCAs used and any form of patient assessment was used. The response 
rate to the questionnaire was over 73% and therefore this survey does provide a pictufl.! 
of the provision of Me As within acute hospitals. The conclusion drawn was that, 
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although a majority of acute hospitals provided these devises, only a minority reported 
having an assessment process which would allow them to target the MCAs 
appropriately. This survey, which was published in 2005, provides a clear view of the 
situation in acute hospitals at that time. This appears to be the only published survey of 
this type and therefore provides useful information on the use of MCAs in acute 
hospitals. 
The other paper which described the use of multi-compartment compliance aids in 
primary care and the prevalence of this use (Nunney and Raynor 2001) refers to the 
preliminary study described in Chapter 2. 
Two studies, (Green, Johnson and Wells 2000; McElnay and Thompson 1992) 
investigated the length of time taken to dispense medication in a MCA. The study by 
McElnay and colleagues investigated the length of time taken to dispense the 
medication regime for five fictitious patients into each of six different MCAs. Only two 
MCAs of the six investigated are in regular use today (Medidos® and Dosett®). The 
mean dispensing time into the Dosett® was 1 min 45 sec. and into the Medidos® 3 min 
59 sec. In the second study, Green and colleagues investigated the difference in time 
taken to fill one type of MCA - a Nomad® - with either loose tablets or tablets which 
had first to be removed from a patient blister pack. The majority of oral solid dose 
medications obtained by pharmacies will now be in patient packs and therefore this is of 
relevance to pharmacists who issue MCAs. The task in the study by Green consisted of 
dispensing 28 days supply of medication into four Nomad® trays. Ten sample 
prescriptions were dispensed twice by each of ten dispensers. The study concluded that 
there was a significant difference (P<0.05) between the times taken to dispense from 
loose medication and that taken to dispense from patient packs; with the time taken to 
dispense from patient packs being the longer. 
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These two studies appear to be the only ones which have looked at the time taken to 
dispense into MCAs. Both studies are small however they indicate that dispensing time 
is significantly longer than conventional dispensing. This information would be very 
useful for community pharmacists who may wish to charge for providing medication in 
MCAs. 
Discussion 
Although these studies provide no data on the ability or otherwise of MCAs to improve 
compliance, they do indicate areas where more research is needed. For example more 
up-to-date descriptions of the latest type of MCA available would be useful for 
healthcare professionals who wish to provide such devices. Information on the safety of 
these devices is very important and would provide information to health care 
professionals who need to balance risks and benefits. Further information on the 
prevalence of the use of these devices would assist any health economics evaluation of 
the use of these devices. 
3.6 Systematic Reviews 
Systematic reviews are pieces of research which aim to answer a clear question by 
identifying and reviewing the literature in that particular field of enquiry. Systematic 
reviews must be transparent, replicable and systematic. 
A review by Haynes for the Cochrane Collaboration (Haynes et al. 2005) investigated 
strategies to improve medication compliance. It was first published in 1996 and has 
been revised in 2002 and again in 2005. The interventions investigated by the studies 
were diverse, in fact the authors stated: "No taxonomy of simple labels would do justice 
to the often complex interventions tested" (Haynes et al 2005 p.6.). They then list 15 
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different common themes or groupings one of which IS "special reminder pill 
packaging" . 
Only one trial is included in the special reminder pill packaging section, which is the 
trial by Becker et aI, (1986), already described above. Also included in the review was 
the trial by Peterson et aI, (1984), which again has been detailed above. Three studies 
identified in the current review and discussed above were excluded from the Haynes 
review, (Simmons et al 2000; Murray et al 1993; Wong and Norman, 1987). The 
studies were all excluded for deficiencies in study design (as the Haynes review only 
considered RCTs) and its overall conclusion was that current interventions to improve 
medication compliance in long-term chronic conditions are complex and not very 
effective. This review asks a clearly stated question and follows the procedures laid 
down by the Cochrane Collaboration for undertaking reviews. 
A second Cochrane review has been published recently, (Heneghan, Glasziou and 
Perera 2006), which investigates the role of reminder packaging in improving 
medication adherence in long-term conditions. The focus of this review was on RCTs 
which sought to improve medication compliance by the use of 'reminder packaging 
aids' . The reviewers included participants of any age provided they were self-
administering their medication. The participants had to be taking their medication for 
one month or more. The methodology of all identified trials was assessed according to 
Cochrane Systematic Review guidelines. Eight trials were finally included in the 
review of which three studies (Simmons, Upjohn and Gamble 2000; Becker et al. 1986), 
and the TRACE study (Huang et al. 2000) are included in my literature review. Of the 
five remaining trials identified four did not meet the age requirements and the fifth 
(Winland-Brown and Valiante 2000) investigated the use of a voice activated device 
and a pill box which was not clearly described in the text. However close scrutiny of 
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the picture In the journal article showed evidence of an electronic timing device 
incorporated in the pill box and for that reason this study was not included in my 
review. The reviewers concluded that only one study, (Simmons, Upjohn and Gamble 
2000), was of sufficiently high standard. This is interesting because this trial was 
excluded by the Haynes review, the reason given being "follow-up too short or on less 
than 80% of participants". The reviewers drew the final conclusion that, although 
reminder packaging may provide a simple method for improving patient adherence with 
medication, it may not provide the best answer and errors may occur. 
The third systematic review was commissioned by the World Health Organisation 
(WHO) and looked at trials which investigated fixed-dose combination pills and unit-of-
use packaging, (Connor, Rafter and Rodgers 2004). The review aimed to identify all 
RCTs where participants were adults taking more than one oral self-administered 
medicine. The intervention had to consist of the use of combination pills or unit-of-use 
packaging compared with usual pill containers. Outcome measures had to include one 
of either adherence measure, pharmacological goal of medication or cost of therapy. 
Fifteen trials were identified that met the inclusion criteria of which three trials related 
to combination pills and the remainder to unit-of-use packaging. Three trials, using 
unit-of-use packaging investigated patients with HIV, leprosy and malaria which are not 
conditions normally found in the over 65s in the UK. Two further studies were 
undertaken prior to 1982 which was the start date for this review. Seven of the 
remaining eight studies were included in the review described in this chapter, (Huang et 
al. 2000; Simmons, Upjohn and Gamble 2000; Murray et al. 1993; Ware et al. 1991; 
Wong and Norman 1987; Becker et al. 1986; Crome et al. 1982). The eighth study 
(Binstock and Franklin 1988) investigated four compliance strategies on the blood 
pressure control of 112 patients. However the details of the age of the participants were 
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incomplete. The authors simply stated that almost one-half were aged between 50 and 
65, and there is no information given as to whether the remaining subjects were older or 
younger or a mixture of both. Therefore this was not included in my literature review .. 
The systematic review undertaken for the WHO was well designed with a clear question 
posed. The researchers searched six databases and provided details of the search terms 
used. There was no evidence of hand searching of journals although web sites relating 
to conferences and research institutions were searched. 
The reviewers discussed various limitations in the identified studies. For example, as 
has been mentioned previously, the sample sizes were too small to detect small 
increases in adherence. The length of follow-up was too short in some cases and the 
number of participants lost to follow-up and intention-to treat analysis was only carried 
out in one unit-of-use packaging trial (Simmons, Upjohn and Gamble 2000). Once 
again the trial undertaken by Simmons and his colleagues was identified as 
methodologically rigorous. The review concluded with the comment that the lack of 
reliable evidence about effective strategies for improving adherence is extraordinary 
given the amount of time and money spent on assessing clinical effectiveness and the 
number of individuals taking multiple medicines. 
Finally, a review undertaken by McGraw (2004), followed similar methodology to 
previous reviews although only two databases were searched, (Medline and 
International Pharmaceutical Abstracts). The review considered RCTs which compared 
the effect of MCAs to standard packaging in community-dwelling adults. The 
participants had to be taking one or more prescription medicines for an on-going 
condition and have problems with adherence. The researchers investigated a large 
number of search terms and gave a detailed description of their search strategy. 
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Thirteen studies were initially identified and eleven eventually excluded for not meeting 
the criteria. The two studies which were included were Becker et al (1986) and 
Simmons et al (2000). The reviewers stated that the study by Simmons was designed 
and conducted to a high standard. The study by Becker et al was considered to be of a 
lesser standard. The review concluded that further research needs to be carried out to 
assess the effectiveness of MCAs. This review is limited by only searching two 
electronic databases which may allow some studies to be missed. However the 
methodology used is robust and transparent and the researchers assessed the validity of 
the studies thoroughly. 
3.7 Conclusion 
This review of the literature was carried out between January and April 2003. 
Subsequent updates were undertaken in April 2006 and April 2007. The findings of this 
review have been inconclusive, with the majority of the RCTs being of poor quality. 
Four of the studies were carried out more than twenty years ago and a further three were 
undertaken in the early 1990s. This may explain some of the methodological problems 
encountered with the studies. The remaining five studies were published in the last 
seven years. However even the later studies are not without problems. One of the main 
difficulties with this type of investigation is the type of participant chosen. I have 
previously stated that in order for a RCT of a device to improve medication compliance 
to be conclusive, the participants must be known to be non-compliant, otherwise it is 
impossible to determine if the intervention has worked. Studies are still carried out with 
groups of older people on multiple medications but these facts by themselves do not 
indicate non-compliance. A further difficulty with this type of study is the measurement 
of compliance; pill counts and self-reports are open to abuse as the participants will be 
aware of the nature of the study. Clinical outcome measures may giye greater accuracy 
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although it must always be remembered that patients can be compliant with medication 
and still fail to respond, due to differences in pharmacodynamics and pharmacogenetics. 
However, arguably the biggest problem with this type of research is the fact that the 
researcher is trying to measure changes in behaviour and these may occur for a variety 
of reasons. For example, simply taking part in the study may improve compliance even 
if the participant is in the control group (the Hawthorne Effect) (Mayo 1946). 
How could ReT designs be improved? 
I suggest that by employing the following methods the quality of a RCT investigating 
this question would be improved: 
• Only select participants who have known problems managing their medication. 
• The number of participants must be sufficient to detect a significant difference in 
compliance 
• Care must be taken to ensure that in all respects, except the issue of a MCA, control 
and intervention groups are treated identically. 
• Outcome measures should include where possible a clinical measure, for example 
blood pressure measurement. 
• Follow up should be for at least 6 months. 
• Details of subjects lost to follow up must be meticulously recorded. In particular 
details of subjects who drop out of the study due to inability or reluctance to use the 
MCA must be documented. 
Finally, I conclude that the current evidence does not support the use of these devices to 
improve compliance with medication by older people living in their own homes. This 
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conclusion is supported by the work of other review authors. Studies need to be 
undertaken which are methodologically sound and well constructed. 
Statistical tests used must be suitable for the study design 
3.8 Summary. 
In this chapter I have described my review of the literature on the use of MCAs. I have 
provided details of the databases searched and the search terms used As a result of this 
structured literature review I identified 37 journal articles which investigated the use of 
MCAs, of which 11 were RCTs. I also identified 4 relevant systematic reviews. The 
critical analysis of these studies reveals many deficiencies in the research methods used 
and highlights the difficulties of undertaking research in the field of medication 
compliance. Finally, I conclude that at the present time there is still no reliable 
evidence to support the use of MCAs to improve the medication compliance of older 
people. That is not to say that these devices may provide some support to older people 
who have complex medication regimes and further research may reveal that these 
devices do improve compliance. 
The review of the literature also raised further questions regarding the use of MCAs by 
older people, in particular the reasons which healthcare professionals have for 
recommending the use of these devices. The main study which is described in the 
following chapters will attempt to answer these questions and to provide guidance on 
further research which needs to be undertaken. 
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Chapter 4: 
Research methodology and underpinning theory 
4.1 Introduction to the chapter. 
In this chapter, I discuss the reasons for the choice of a qualitative approach for this part 
of the study. The choice of Grounded Theory as described by Strauss and Corbin 
(1998) is discussed and justified. The chapter commences with a discussion of the 
conflicting views held by various groups of healthcare professionals, about the relative 
merits of qualitative research methods and quantitative research methods (section 4.2.). 
The following section gives a brief description of the historical background to 
qualitative research and the various theoretical concepts which underpin it. In section 
4.4, I discuss the rationale for choosing qualitative methods for this part of the study. 
Grounded Theory is then defined, along with a description of its development and the 
split which occurred between the two original authors. I defend my reasons for 
choosing the Grounded Theory approach in section 4.6. and then discuss its limitations. 
4.2 Qualitative or Quantitative methodology. 
A general definition of quantitative and qualitative research can define quantitative as 
being numeric, and qualitative as mainly descriptive (Gerrett and Stevenson 1995). 
Temple (1997) describes quantitative research as positivist, that is, based on the results 
from external stimuli which can be both observed and measured and this has been 
discussed in Section 2.3.1. Qualitative research has been defined as social 
constructionist, which can be interpreted as identifying reality in terms of social or 
cultural practices. I have previously stated that positivism can be defined as a view of 
the research process in which the researcher is independent of the reality they are 
describing. The researcher's gender, race, age, ethnicity or class are not relevant factors 
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in the research. Social constructionism on the other hand states that no researcher can 
stand outside of their social world (Temple 1997); they have an influence on the 
research as a whole from the selection of topics, through data collection and analysis, to 
interpretation of the findings. Quantitative research, therefore, is related to interpreting 
the results of a research study by the use of numerical and statistical strategies. These 
can be interpreted as hard facts. Qualitative research, on the other hand is the 
interpretation of results using the social and cultural practices of those being studied. 
Historically, research undertaken in the fields of medicine and pharmacy has been 
quantitative in nature. These research studies have been designed to determine the 
efficacy of a particular drug or treatment and, by means of statistical interventions, have 
tried as far as possible to make the results applicable to the wider population. This need 
to provide solid evidence about the intervention being investigated runs deep within the 
minds of those working within these particular fields. Randomised controlled trials are 
seen as the "gold standard" of experimentation and, indeed, it is by the clinical trials 
method that all new drugs are investigated. 
This opinion is supported by the first article in a series on qualitative research published 
in the British Medical Journal (Pope and Mays 1995). The authors discussed how the 
rigid demarcation between quantitative and qualitative research does not encourage 
movement between the two opposing camps. Another article in the British Medical 
Journal describes the difference between the two paradigms (Greenhalgh and Taylor 
1997). Quantitative research is described as starting with an idea, progressing to data 
generation and by deduction ending in a conclusion. Qualitative research, on the other 
hand, begins with an interest in exploring a particular area, proceeds through data 
collection and by inductive reasoning develops ideas and hypotheses. 
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4.2.1 The quantitative versus qualitative debate. 
Within the medical and phannaceutical professions, there has been considerable debate 
concerning the reliability and generalisability of qualitative research. Some 
professionals see qualitative research as unreliable and unable to produce reproducible 
"facts"; whereas quantitative research is seen as having the ability to produce 
hypotheses which can be tested and reproduced by other researchers. In an editorial, 
Black (1994) argues that quantitative research has "acquired a bogus value". He 
continues that if something can be measured or counted it is seen as "scientific", 
whereas this type of credibility is not given to the unmeasureable. 
Malterud (2001) argues that qualitative methods could improve our understanding of 
medicine. He states that qualitative research is still regarded with scepticism by the 
medical community, who point to the subjective nature of the research and the absence 
of facts. This difference of opinion is typified by the reaction in the British Medical 
Journal to two articles which appeared in the same issue in 2000. In the article which 
looked at assessing quality in qualitative research (Mays and Pope 2000), the authors 
discuss whether it is possible to assess both qualitative and quantitative research 
according to the same criteria and continue by detailing how qualitative research may be 
assessed. The second study (Lilford et al. 2000), put the case for randomised controlled 
trials to be allowed to track developments in a particular research area and not be forced 
to wait for new treatments to stabilise. The authors called these proposed trials "tracker 
trials" and the paper discusses in some detail how these trials might be carried out and 
the statistical methods employed. Some time after this issue was published, the journal 
published a strongly worded letter (Isbister 2000) praising the paper on "tracker trials" 
and stating that the paper on qualitative research lacked "clearly discernible logic". The 
author of the letter went on to say that the tenninology used in the qualitati\,c paper was 
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jargon and the tenns used "unscientific". The letter writer continues by saying that he 
believes that all research should "be concerned to develop theory." A spirited 
correspondence followed with all of the respondents supporting the qualitative research 
article and remonstrating with the original letter writer for his lack of education on the 
subject of qualitative methodology. This illustrates the depth of feeling which does 
exist within medical fields regarding qualitative research. I supported the views of 
those respondents who stated that the paper gave a clear description of qualitative 
methods. 
4.2.2 The pharmacy perspective. 
Phannacy research was for many years implanted in the "scientific" tradition and it is 
only in the last twenty years that "phannacy practice" research has come to the fore as a 
respected discipline. The International Journal of Phannacy Practice, for example, was 
first published in 1991. An article published in the Phannaceutical Journal on the 
subject of qualitative research states that phannacy practice research was defined in 
1991 as a "new and rapidly expanding area of research." (Kairuz, Crump and O'Brien 
2007). The late arrival, therefore, of qualitative research into the field of phannacy 
research has resulted in difficulties in the understanding of the paradigm. For 
sociologists, psychologists and those in educational research, this method has been 
understood since the early part of the twentieth century and over that period the 
underpinning knowledge and theory have been rigorously explored. The first in a series 
of articles published in the International Journal of Phannacy Practice aimed to draw 
attention to the failure of phannacy practice researchers to engage with sociological 
theories when undertaking their research (Bissell, Traulsen and Haugbolle 2001). The 
authors state that this failure to incorporate sociological theories into research studies 
hinders the development of phannacy practice research. However, in my opinion it may 
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be the lack of understanding of these sociological approaches that leads pharmacists to 
be hesitant of undertaking qualitative research. 
4.3 Qualitative research: the historical background. 
Qualitative research has its roots within sociology and is often said to have started out in 
the "Chicago school" in the 1920s and '30s. Other sociologists point to the work of 
Max Weber in the 19th century as the start of qualitative research. In their three part 
work "The Landscape of Qualitative Research", Denzin and Lincoln (1998) consider 
five stages in the development of qualitative research. The traditional phase from 1900 
to 1950, the modernist or golden age from 1950 to 1970, the blurred genes phase from 
1970 to 1986, the crisis of representation from 1986 to 1990 and the post-modem or 
present moments from 1990 to present. The different phases saw the development of 
theories and practices in qualitative research. Each phase had its protagonists and 
leading figures in the world of sociology have come to be linked with certain phases. 
As time has passed, the work of these prominent figures has fallen out of favour to be 
replaced by others and then sometimes to be revived at a later period. There are many 
theoretical approaches to the study of sociology and therefore many theories e.g. 
functionalism, Marxism, symbolic interactionism, post-structuralism, post-modernism 
and feminism. These different theories provide methods to interpret our actions and 
behaviours and help us to see how these are influenced by the wider world around us. 
The practice of sociology within the medical field has emerged relatively recently, as 
compared with other disciplines; although it would seem obvious that how people 
behave when they are ill can be influenced by their own beliefs, by their relationships 
with healthcare professionals and by the wider social world. Understanding these 
influences is important for the functioning of an efficient national system of healthcare 
proVISIOn. 
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In the next three sections, I intend to discuss briefly three of the major theoretical 
approaches which have been prominent in the twentieth century and continue to 
influence sociology today. 
4.3.1 Functionalist sociology and the role of Talcott Parsons. 
Talcott Parsons is often seen as one of the founding fathers of sociology (Bissell, 
Traulsen and Haugbolle 2002b). His influence on sociology from the 1930s to his death 
in 1979 was considerable. However, his theories were called into question in the latter 
part of the twentieth century. Talcott Parsons' work falls within the functionalist theory 
of sociology. Functionalism is concerned with describing society as a series of 
interacting and self-regulating elements. Each element has a part to play in maintaining 
the whole therefore ensuring order in the system. Parsons was interested in producing 
"grand theory" or "grand narrative" bringing together the theories of some of the major 
thinkers in sociology such as Max Weber and Emile Durkheim. Parsons believed that 
ill health should be seen as a social phenomenon rather than something appertaining to 
individuals. Therefore too many sick people resulted in a failure in the effective 
performance of social roles and, consequently, the correct functioning of the social 
order. Parsons formulated the "sick role" (Parsons 1951) in which individuals had rights 
and responsibilities both in their relationship with their doctors and with the wider 
world. Parsons described four components of the sick role: 
III people are exempt from their normal social responsibilities such as work or domestic 
labour. This exemption requires some form of legitimisation from doctors or those in 
medical authority. 
III people are not held responsible for their condition and cannot be expected to recover 
by an act of will. 
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III people must want to try to get well- if not they can be accused of malingering. 
III people are obliged to seek and co-operate with medical practitioners to help make 
themselves well again. 
Parsons' ideas can be used to understand the issue of compliance with medication, in 
other words, as Parsons states, it is the duty of the sick person to co-operate with doctors 
and sick people must want to make themselves well again. Therefore patients, who 
deliberately fail to take their medication as directed can be seen as deviant. From 
Parsons' perspective, the doctor-patient relationship is both harmonious and consensual, 
despite being unequal in terms of power. Parsons' theories and grand narratives became 
unpopular in the 1960s and 1970s for a number of reasons. Firstly, his sick role model 
does not appear to allow for chronic illness. Many people with chronic diseases have to 
continue in employment and, therefore, do not fit into the sick role pattern. Secondly, 
Parsons' sick role theory states that the patient cannot be held responsible for their 
illness. This conflicts with, for example, the case of smoking related illnesses. Thirdly, 
Parsons describes a paternalistic doctor- patient relationship; patients today are more 
likely to question their diagnosis and treatment than they were half a century ago. 
In particular, with reference to this research, Parsons' theories conflict with the idea of 
concordance. The concordance has, in the past ten years, superseded the term 
compliance, when referring to medicines management issues. The report produced by 
the Royal Pharmaceutical Society (1997) describes concordance as a negotiation 
between the prescriber and patient as a therapeutic alliance. This is completely at odds 
with Parsons' view of the relationship, in which, he refers to the "institutionalised 
superiority of the professionals' role" (Parsons 1951). My research is aimed at 
discovering if the attitudes and beliefs of the older people and healthcare professionals 
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affects the appropriate use of MCAs by older people living in the community. In later 
chapters of this thesis, I will discuss the attitudes and beliefs of these two groups, 
observed when undertaking research interviews. Some of these attitudes and beliefs can 
be understood by referring to the work of Parsons. 
4.3.2 Symbolic interactionism. 
Symbolic interactionism came into prominence in the 1960s and 1970s and arose from 
work carried out in the sociology department of Chicago University. Symbolic 
interactionism is of interest to many healthcare professionals because it has been in part 
responsible for a number of research techniques commonly used in qualitative 
healthcare studies. The proponents of interactionism do not refer to it as a theory but 
rather as a loose collection of ideas which guide research in sociology. The term 
symbolic interactionism was first used by Herbert Blumer in 1937; Blumer based much 
of his work on the thoughts of George Herbert Mead (1934), whose pupil he was. 
(Blumer 1969). Mead thought that human beings could move beyond their biological 
control and be responsible for their own behaviour as they interact with the world 
around them. Annandale (1998) describes this as self development by means of role-
taking and by seeing ourselves as others see us. 
Symbolic interactionism has found a place in the fields of medicine and health, with one 
of the most influential proponents being Erving Goffman, who studied the behaviour of 
staff and patients in mental hospitals (Goffman 1961). Goffman argued that rather than 
helping the patients, the environment of the mental hospital actually contributed to the 
patients' behaviour. Therefore it was necessary to see the behaviour sympathetically 
from the patients' point of view in order to understand it. Goffman was also interested 
in the rituals and ceremonies which occur during the normal interactions of everyday 
life. This work has been taken forward by researchers who have looked at these 
108 
interactions in the field of medicine and health, in particular the work of Strong (2001) 
who investigated paediatric outpatient clinics. Glaser and Straus, in the 1960s, 
investigated death and dying and produced the term "awareness contexts" to 
conceptualise 
what each interacting person knows of the patient's defined status (as a dying 
person), along with his recognition of the others' awareness of his own 
definition. (Glaser and Strauss 1965 p.1 0) 
They recognised bargaining as central to organisational life as the patient endeavours to 
obtain what he wants and at the same time the staff attempt to strike bargains with the 
patients. This negotiation has been at the heart of the interactionist theory. 
Within pharmacy research, the interactionist paradigm has a great deal of relevance to 
patient compliance, for example, as interactionism would lead us to question whether it 
is right for patients to blindly follow the doctor's orders. In a study of patients 
diagnosed with epilepsy (Conrad 1985), the author proposes that the two dominant 
theories on medication non-compliance (problems with the doctor-patient relationship 
and patients' health beliefs), are joined by a third less developed perspective. This third 
perspective, which Conrad states is rarely mentioned in studies of compliance, is a 
patient-centred one. Patients are seen as active rather than passive agents in their 
treatment. Conrad examined the social meanings of medications from his patients' 
perspectives and concluded that varying their medication was due to four distinct 
reasons: testing, control of dependence, destigmatisation and practical practice. 
Another area of pharmacy practice, which may benefit from interactionist consideration, 
is the area of lay health beliefs. The interactionist would give full backing to the 
patient's own health beliefs because these are forged from the patients' own experience 
of his social world. Health professionals may say that these lay beliefs are the product 
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of ignorance or a lack of understanding and it falls to interactionist writings to help the 
healthcare professional see through this argument. 
In my research, I intend to investigate the beliefs and attitudes of older people and 
healthcare professionals about the use of MCAs and therefore investigating these beliefs 
with reference to interactionist theory would give me a greater understanding of the data 
obtained. 
In their paper on interactionist sociology and its relationship to pharmacy practice 
research, Bissell and colleagues (Bissell, Traulsen and Haugbolle 2002a) state that few 
pharmacy practice researchers engage with the original theories on which qualitative 
research is based. They say that this is particularly true of those researchers who use 
grounded theory as a method of data analysis and who make little reference to the 
theoretical issues which underpin this method. They further state that little work has 
been done to investigate the experience of medicine taking and how it impacts on the 
patients' sense of self. One question they pose is "is the use of medicine stigmatising?" 
and I feel that this question can also be asked about using a MCA. Therefore I see a 
role for interactionist theories in my study on the appropriate use of MCAs. 
Symbolic interactionism has more recently been criticised. The most common criticism 
is that it fails to take note of the issue of power and the way that power can shape 
meamng. 
4.3.3 Michel Foucault and the Post-modernists. 
Annandale (1998) states that there is constant debate between the conflicting 
approaches in sociology and this is seen as a productive feature of sociological 
theorising. However, more recently considerable changes have taken place resulting in 
great debate. The work of Michel Foucault has produced much discussion within the 
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field of social theory; he has produced an innovatory analysis of power and the 
individual subject. Foucault was interested in how knowledge of the human subject is 
gained and then used, particularly in terms of creating power differentials. Foucault's 
work does share some similarities with that of Parsons as they were both interested in 
the role of illness in modem society and viewed it as deviant behaviour. Parsons 
thought this deviance could be legitimised by entering the "sick role", but Foucault saw 
the role of medicine as that of disciplining the population. Foucault is often associated 
with two recent, major theoretical movements in sociology - post-modernism and post-
structuralism, although various authors dispute to which one he belongs or if he belongs 
to either. Foulcadian principles of research use discourse to explore the concepts of 
knowledge, power and surveillance. These methods have been used in health research 
to explore the discourses around HRT treatment (Harding 1997). However as Bissell 
and his co-authors point out little work has been carried out within the area of pharmacy 
practice using Foulcadian principles (Ryan, Bissell and Traulsen 2004). The post-
modem perspective has come to the fore in the later part of the twentieth century and 
this theoretical framework is more difficult than many of the others to define. 
To post-modernists there are no "real things". An editorial in the British Medical 
Journal entitled "Medicine, postmodernism, and the end of certainty" (Hodkin 1996) 
discusses "the death of the House of Belief'. The writer goes on to say that medicine 
alone remains immune to these uncertainties, which he attributes to the medical 
professions' continuing support for the belief that there is "one truth out there" which 
can be known, understood and controlled by any rational and competent human being. 
The reaction to this uncertainty, the editorial continues, is Evidence Based Medicine, 
which promises certainty. 
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4.4 Why choose Qualitative research methods? 
When embarking on a research project, it is important to decide which type of 
methodology would be most appropriate for the topic under investigation. No method 
can necessarily be seen as better than another, just better suited to the topic under 
consideration. Qualitative research is considered more appropriate for answering the 
"how" and "why" questions and for assessing how people interpret events and make 
sense of the world around them. Pope and Mays (1995) state that qualitative methods 
should be used in health and health services research because these methods allow the 
researcher to access areas such as lay and professional health beliefs, which are not 
easily studied by quantitative methods. 
Another article which aims to give an overview of qualitative research (Kairuz, Crump 
and O'Brien 2007) states that issues can be explored from the participants' perspective 
and study the nature and structure of people's attitudes, feelings, ideas and thoughts. 
A number of different methods are available to qualitative researchers for example, 
Phenomenology, Ethnomethodology and Grounded theory. 
The preliminary study in this thesis, (see Chapter 2) suggested that patients who were 
using a MCA had attitudes and beliefs about the devices, their medicines and their 
healthcare professionals, which could be explored in greater depth by qualitative 
methods. The reasons why healthcare professionals promote the use of these devices 
was not explored in the preliminary study and, by using qualitative methodology, I 
hoped to discover if the attitudes and beliefs of the healthcare professionals led to the 
appropriate use of these devices. 
It is also important, when considering a qualitative approach, to decide which 
conceptual framework is best suited to the area under investigation. In the previous 
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section, I have tried to give a historical and methodological perspective to qualitatiye 
research. I have indicated that a method based on the symbolic interactionist 
conceptual framework would seem appropriate for the area I wish to study. Glaser, in 
his 1978 book, argues that grounded theory allows the researcher 'to discover what is 
going on.' A paper that investigates 'method slurring' (Baker, Wuest and Stem 1992) 
states that a researcher's purpose in using grounded theory is to explain a given social 
situation. The authors of this paper continue by describing how identifying core 
categories and sub-categories allows the researcher to understand the underlying 
principle of what is happening in the given situation. I intended in my research to 
interview older people about their use of Multi-compartment Compliance Aids and to 
listen to their narratives concerning managing their medication and how this fitted into 
their daily lives. I also intended to interview healthcare professionals to understand why 
they recommended the use of these devices and listen to their descriptions of the 
medicines management abilities of their older patients. 
This research which asks, "why, how and when?" appeared to me to be eminently 
suitable for investigation using a grounded theory approach. 
4.5 What is Grounded Theory? 
Grounded Theory is a method of qualitative analysis developed in the 1960s (Glaser and 
Strauss 1967). Glaser and Strauss stated that rather than starting with a theory about the 
world and then testing it; the data should be collected first and the theory developed 
from the analysis of this data. The theory is then fmnly grounded in the data which has 
been collected. Charmaz in her chapter on grounded theory states that the power of 
grounded theory lies in its tools for understanding empirical worlds. (Charmaz 2000 
p.510) 
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Glaser's background was in positivistic methodology whereas Strauss worked in the 
symbolic interactionist tradition. They collaborated, in a seemingly unlikely alliance, to 
produce a method of identifying theory which was grounded in data. Glaser and Strauss 
sought to link the rigour of quantitative research with the rich insight of symbolic 
interactionism. They stated that by generating the theory as the data was collected, a 
theory was developed which was best suited to its purpose; as opposed to making a 
priori assumptions and then attempting to get the data to fit them. Glaser and Strauss go 
on to say that theory that is generated in this way, from the data, cannot usually be 
refuted by more data, or replaced by another theory. In the first book on grounded 
theory which they co-authored "The Discovery of Grounded Theory" (1967), they 
describe what they mean by grounded theory, its place in sociological research and its 
differences from other ways of generating theory. They then describe the methods 
which can be used to generate and develop grounded theory, starting with comparative 
analysis continuing through the flexible use of data and concluding with a final section 
on the implications of grounded theory. 
In her study of patients with Alzheimer's disease, Orona (1990) describes how she 
started the study with an interest in how carers of people with Alzheimer's disease made 
the decision to move the patient into nursing care. As the research progressed and she 
coded the data, she realised that the carers were explaining how, by the time the 
decision was taken, the person the carers knew was' gone'. This loss of identity became 
the focus of the study. She goes on to say that, "the beauty and strength of the grounded 
theory approach is that it is not linear. Instead, the approach allows for the emergence 
of concepts out of the data." (Orona 1990 p 1249. ) 
Another paper, Charmaz (1990), also discusses this property of grounded theory which 
can lead the researcher to follow "interests, leads or hunches" that they find in the data. 
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Grounded theory allows the researcher to follow the directions suggested by the data; 
therefore if the data reveals a new area of enquiry this can be pursued. 
Glaser and Strauss eventually went their separate ways. Glaser remained constant to the 
original grounded theory methodology whereas Strauss in conjunction with Corbin 
(Strauss and Corbin 1990) further developed the analytical techniques and provided 
guidance for novice researchers. 
The main difference between the two methods lies within the method of coding the data. 
Glaser's (1978) coding method divides the process into two phases - substantive and 
theoretical, with the substantive coding further sub-divided into open and selective. 
Strauss and Corbin's coding begins with open coding which is followed by axial coding 
and finishes with selective coding. Although Glaser and Strauss and Corbin use similar 
terminology, their definition of the terminology is different. Glaser (1992 p.38) defines 
coding as: "conceptualising data by constant comparison of incident with incident, and 
incident with concept." On the other hand Strauss and Corbin (1990 p.61) define 
coding as: "the process of breaking down, examining, comparing, conceptualising and 
categorising data". 
In 1992 Glaser wrote another book "Basics of Grounded Theory Analysis: Emergence 
vs. Forcing." This book opened with the description of correspondence which had 
taken place between himself and Strauss. These letters are described by Melia (1996) 
who discusses the content of the letters and the questions they raise. Melia describes 
how Glaser accuses Strauss of writing about a different method which he (Strauss) then 
called "grounded theory." Glaser names this other theory "full conceptual description." 
Stem (1994) describes how, in her opinion, two methods have sprung from the original 
work on grounded theory, and she characterises these as Straussian and Glascrian 
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models. This difference of opinion about what now constitutes "grounded theory" is 
taken up by (Kelle 2005). Kelle sees this difference of opinion as arising from an 
attempt by both authors to "explicate, clarify and reconceptualise" some of the basic 
tenets of their original approach. Kelle goes on to say that Glaser accuses Strauss and 
Corbin of "forcing" categories on the data by means of "coding paradigms", and he 
describes Glaser as remaining true to the original methods which has researchers 
approaching the research field without any prior questions or problems. 
4.5.1 How is Grounded Theory research carried out? 
Grounded Theory has become a very popular method of undertaking research within the 
health care field. This may be because the Grounded Theory method is seen by some 
researchers to be inherently positivist in nature and therefore healthcare professionals 
who find the concept of qualitative research difficult may find it easier to take the 
grounded theory approach, which they see, rightly or wrongly, as leaning towards the 
quantitative side. 
The researcher must approach the research without strong or specific hypotheses to be 
tested and then deal with a large amount of data which must be constantly reviewed and 
compared. I have discussed in the previous section (3.5) the split that occurred between 
Glaser and Strauss and how two methods of Grounded Theory can now be identified. 
The method, developed by Strauss and Corbin (1990), has been described as a method 
suitable for the novice researcher (Heath and Cowley 2004) and, as a novice researcher 
after investigating both methods, I decided to follow that of Strauss and Corbin. 
Therefore my description of how to undertake Grounded Theory research is according 
to the later work of Strauss and Corbin (1998). Strauss and Corbin (1998) state that 
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"A researcher does not enter the field of research with a pre-conceived theory in 
mind. Rather, the researcher begins with an area of study and allows the theory 
to emerge from the data. " P.l2 
In my main study I detennined my area of study by reviewing the work I had 
undertaken in the preliminary study. As I have stated in section 2.8 the preliminary 
study gave rise to a number of unanswered questions and I translated these into areas of 
interest which I wished to explore that is I wished to discover what triggered the issue of 
a MCA, the views of the older people and healthcare professionals on the use of MCAs, 
the health beliefs of both groups and was age a factor in the use of these devices. I feel 
that this method of interrogating the data is completely in accordance with Strauss and 
Corbin's methodology as stated above. 
Data Collection. 
The most common method of data collection used is in-depth interviews. These are 
semi-structured interviews which follow a basic topic guide to aid the researcher as the 
interview progresses. Interviews are usually audio-recorded if pennission is given by 
the participant. In addition the interviewer usually writes field notes as soon as possible 
after the interview has been concluded. These field notes consist of the interviewer's 
thoughts and perceptions on what the respondent had said, details of body language and 
any other incidents which may have occurred during the interview. Other methods of 
data collection can be used in grounded theory research, for example, observations and 
field work notes. 
Sampling. 
Sampling, that is, the selection of participants for interview, can be carried out 
purposively or theoretically. Purposive sampling can be defined as "the identification 
and selection of particular individuals who share characteristics relevant to the study" 
(Smith 2002). However when using Grounded Theory, theoretical sampling is 
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considered to be the method of choice. Theoretical sampling is defined by Strauss and 
Corbin as: 
" sampling on the basis of emerging concepts, with the aim being to explore the 
dimensional range or varied conditions along which the properties of concepts 
vary. " (1998 p. 73). 
The sampling, within a grounded theory approach, changes as the study progresses: so 
in the first instance when the research is just starting, the sampling is described as open 
sampling. Strauss and Corbin suggest that one way in which open sampling can be 
carried out is to proceed very systematically down a list going from one person to 
another on the list and recruiting, for example, every third person who comes through 
the door, or everyone on the list who agrees to participate. This, they suggest, is a 
practical method most used by novice researchers. As the research progresses and the 
coding of the data moves from open coding to axial coding, then sampling will still 
proceed on the basis of theoretical concepts but the focus will change. Axial coding 
aims to relate categories to sub-categories and further develop categories in terms of 
their properties and dimensions. Sampling therefore becomes relational and variational 
in order to find incidents which demonstrate the dimension and variation of a concept 
and its relationship amongst other concepts. 
The third type of sampling is known as discriminate sampling when the researcher 
samples specifically to obtain the maximum opportunity for comparative analysis. 
Sampling continues until theoretical saturation occurs, that is when no new data 
emerges regarding a category, the category is well developed in terms of its properties 
and dimensions and the relationships between the properties and the categories are well 
established and validated. Strauss and Corbin (1998) state that theoretical saturation is 
of great importance and unless all the categories become saturated, the data collect~d 
will be unevenly developed. 
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Coding and systematic comparison of the data. 
Analysis of the data must commence as soon as the first data are collected. In the first 
instance the data is subjected to open coding. Strauss and Corbin recommend that, at 
the beginning of a research study, the data is subjected to micro-analysis, which is 
described as detailed line-by line analysis. This level of analysis is necessary in order to 
generate initial categories; however it can be seen as time consuming. Alternatively 
Strauss and Corbin state that open coding can also be carried out by reviewing whole 
sentences or paragraphs and asking the question 'what is the major idea in this sentence 
or paragraph?' A concept can then be named and a more detailed analysis undertaken. 
Open coding. 
Open coding is defined by Strauss and Corbin as "The analytical process through which 
concepts are identified and their properties and dimensions discovered in data." (Strauss 
and Corbin 1998 p. 101) The open coding process breaks down the text into discreet 
sections which can be examined and compared for similarities and differences. 
Axial coding 
Axial coding is the second stage of Strauss and Corbin's three stage coding method. 
Having "opened up" the data using open coding it is now necessary to reassemble the 
data by making links between a category and a sub-category, this is accomplished by 
axial coding. In the second edition of their book, the authors introduced a coding 
paradigm to assist with axial coding. The basic components of this paradigm are: 
Conditions - a conceptual way of answering the questions why, where, how and when. 
Actions/ interactions - which are strategic responses made by individuals or groups to 
issues, problems, happenings or events which arise under those conditions. 
Consequences - which are outcomes of actions / interactions. (Strauss and Corbin 1998) 
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Selective coding. 
Selective coding is the final stage in this three stage approach and is defined by Strauss 
and Corbin as: "the process of integrating and refining the theory. (Strauss and Corbin 
1998 p.143) 
In this final stage, there is a detailed development of categories, a selection of core 
categories and finally integration of the categories. 
Comparison. 
Once sufficient data has been obtained to form a comparison, e.g. two interviews, the 
data should be analysed and the comparisons begun. This procedure is described in 
detail by Boeije (2002). Boeije explains that constant comparison is an important 
element in developing a theory that is grounded in the data but that researchers often fail 
to explain how this comparison took place. In their original book Glaser and Strauss 
(1967) described this constant comparison method as occurring in four stages: 
1. comparing incidents applicable to each category 
2. integrating categories and their properties. 
3. delimiting the theory 
4. writing the theory. (Glaser and Strauss 1967p.1 05) 
After the two authors went their separate ways, Strauss and Corbin retained "theoretical 
comparisons" which they state are different from "constant comparisons". Theoretical 
comparisons allow the researcher to think about properties and dimensions and to 
enable theoretical sampling to take place. 
Figure 3 below illustrates my interpretation of the procedure for carrying out grounded 
theory analysis. 
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Figure 3: Steps in Grounded Theory Analysis 
Memos and diagrams 
Strauss and Corbin state that, as the coding progresses, the researcher should write 
memos which can take several forms, e.g. code notes, theoretical notes and operational 
notes. These memos are said to be important because they provide a record of how the 
analysis progressed and help the researcher to reflect on the analysis. 
Diagrams are visual memos which allow the researcher to explore relationships 
between, for example, categories and subcategories. Diagrams can change as the type 
of coding changes and become more complex as the selective coding stage is reached. 
The place of the Literature review. 
In their original work, Glaser and Strauss (1967) stated that a literature review should 
not be undertaken prior to the start of the research. In other words the researcher should 
commence the research with an open mind. Glaser retained this belief but Strauss in his 
work with Corbin (1990, 1998) states that the researcher will enter the field with a 
degree of prior understanding about the topic under consideration. Strauss and Corbin 
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state that there is no need to review all the literature in the field prior to starting a study 
and to do so would run the risk of constraining the researcher. Other researchers have 
written about the place of a literature review when undertaking a grounded theory study. 
(Heath 2006; Hickey 1997). Heath describes how she decided to begin with a literature 
review, however she limited the reading to abstracts. This limitation prevented her from 
becoming too familiar with the literature. Hickey, in his study of district nurses, 
followed the method advocated by Strauss and Corbin. He goes on to describe, how as 
the themes emerge from the data, literature can be used to develop these themes. 
I have already described in Chapter 3 my structured review of the literature on Multi-
compartment Compliance Aids. The information I obtained from this review simply 
confirmed the information I had obtained in my previous research. This literature 
review informed part of the original topic guide for the older peoples' interviews but the 
review of the general literature on compliance and other related areas was only 
reviewed as themes emerged from the interviews. 
4.6 What are the limitations of the Grounded Theory approach? 
Among researchers in the field of healthcare, there exist two opposing sets of opinions 
about the role and use of the grounded theory method. There are those who dismiss the 
method as being of little use and those who embrace the method and use it frequently. 
A review of published grounded theory research (Becker 1993) discovered that many of 
the studies reviewed were not grounded theory studies but simply descriptive. Becker 
goes on to say that this may be due to using the wrong type of sampling; in grounded 
theory the sampling should be theoretical as opposed to selective. In addition, Becker 
also highlights the problems regarding the lack of understanding that researchers may 
have concerning the underpinning theory which supports the grounded theory 
methodology. In another paper (Wilson and Hutchinson 1996), the authors identify 
122 
methodological mistakes which have occurred in studies which purport to be following 
grounded theory method. The authors go on to state that in their opinion these mistakes 
may cause authentic Grounded Theory approaches to be viewed as less credible. 
The reported high prevalence of poor studies which state that the grounded theory 
method was used may be the reason why some researchers are unimpressed with this 
method. This thought is supported by Charmaz (1990), who reasons that criticisms of 
Grounded Theory may suggest an incomplete understanding of the method. She goes 
on to say that: "Weaknesses in using the method may have become equated with 
weaknesses inherent in the method." (p.1164) 
Another problem with the grounded theory method is that the researcher needs to be 
clear which grounded theory approach they are undertaking. As a number of authors 
have pointed out, after Glaser and Strauss split they each developed their own vision of 
grounded theory. Therefore if a researcher uses the Glaser approach and the work is 
reviewed by someone from the Straussian school, the work may be judged as poor. 
Researchers using the grounded theory method must also be clear from the beginning 
which approach they are taking and avoid the possibility of mixing interpretations. 
In an article discussing qualitative research on chronic illness (Conrad 1990), the author 
discusses the type of data used in grounded theory analysis and describes the procedure 
for data collection and open coding. The author expresses the opinion that, as the data 
is broken down by open coding and then reassembled by axial coding; it loses its 
relationship with the original narrative. Thus the data becomes simply coded extracts 
removed from the original context. Conrad contrasts the grounded theory method with 
that of narrative data analysis which he says "stresses the importance of the story the 
respondent has to tell." Conrad continues that despite misgivings, he is a user of 
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grounded theory methodology; however he states "how much of the narrative life world 
do we sacrifice to create a meaningful sociological world?" This appears to me to be a 
valid point, by breaking the data down in this way and then grouping together ill 
categories and sub-categories there is the risk that some context is lost. 
4.7 Summary 
In this chapter, I have discussed the differences between qualitative and quantitative 
research and highlighted the differing opinions within the fields of medicine and 
pharmacy regarding these two research paradigms. In section 4.3, I have given a brief 
historical and philosophical background to the different theoretical approaches which 
are found in qualitative research. Within this section, I have also attempted to link these 
theoretical approaches to various aspects of pharmacy practice research and to this 
current research in particular. I have defended my decision to choose qualitative 
methods and grounded theory III section 4.4. Section 4.5 defines grounded theory, 
discusses its discovery and the subsequent schism between the original authors. I have 
given a detailed description of the method of undertaking grounded theory analysis 
according to the work of Strauss and Corbin (1998) in section 4.6. Finally in section 4.7 
I discuss the limitations of using grounded theory as a method of qualitative analysis. 
124 
Chapter 5: 
Methods and Analysis of the older persons' 
and healthcare professionals' interviews 
5.1 Introduction. 
In this chapter I will discuss the method used for both the older persons' and healthcare 
professionals' interviews. Firstly I describe the setting for this study. In Section 5.3 the 
procedure for obtaining ethical consent and how this affected the recruitment process is 
discussed. There follows a detailed description of the methods used, and a defence of 
the choice of semi-structured interviews. This is cross-referenced to the grounded 
theory methodology described in Chapter 4. In section 5.5 I provide a detailed 
description of the analysis methods employed and relate this to the grounded theory 
approach of Strauss and Corbin (1998). 
5.2 Setting for the study. 
The study was carried out in a large industrial city located in the North of England. 
When the study was undertaken, the city was divided into five Primary Care Trusts 
(PCTs). These were arranged so that each PCT covered inner-city and outer suburban 
areas. Prior to the commencement of this study, I had considerable contact with the 
pharmacists working in all five PCTs, both through previous research work and my role 
as a tutor for the Centre for Pharmacy Postgraduate Education (CPPE). I contacted the 
Heads of Medicines Management in all five PCTs at the start of the study and all were 
supportive. The Head of Medicines Management in two PCTs indicated that they 
would be willing to assist with recruitment if needed. The decision was therefore made 
undertake the study in these two PCTs. 
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Contact was also made with the pharmacy department at the secondary care trust in the 
same northern city. Senior staff working in the department also indicated that they 
would be willing to assist with recruitment if needed. 
The Local Medical Committee and the Local Pharmaceutical Committee were informed 
of the research and their support obtained. 
5.3 Research ethics approval and consent. 
During the time span of this research, there have been a number of changes within the 
field of research ethics. When I originally registered to undertake a PhD in May 2002, 
each individual Research Ethics Committee arranged its own system of research ethics 
approval. I was able to obtain research ethics approval from both committees of the city 
where the research took place, by sending application forms to one committee, were the 
application was considered for "chairman's actions". When approval had been given I 
was able to receive reciprocal agreement from the other committee. Research Ethics 
approval was obtained in June and August 2003. A change had been made to the rules 
governing research in April of that year and it became necessary to obtain research 
governance approval in addition to research ethics approval. This was obtained from 
the Research and Development Unit which covers NHS research in a number of towns 
and cities in the area. Approval was obtained with the proviso that I obtained an 
honorary NHS contract with all local Primary Care Trusts. An honorary contract was 
applied for and obtained. 
Undertaking research with older people can give rise to some ethical problems. Older 
people may not be sufficiently competent to give informed consent and the Mental 
Capacity Act (2005) includes safeguards for the conduct of research involving such 
people who may be unable to give consent. Normally approval by a Research Ethics 
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Committee would be subject to the participant giving informed consent. Participants 
must be able to read and understand the information leaflet and sign the consent form. 
For the purposes of this study, I wished to be able to undertake an interview with the 
older person and this would require a certain level of understanding; therefore informed 
consent was suitable for my purposes. Many older people who receive their medication 
in MCAs have reduced cognitive function and undertaking research with this group 
would require the identification of a consultee (someone who has a role in caring for the 
person who lacks capacity but is not paid or acting in a professional capacity). 
Approval for this type of research is usually more difficult to obtain. 
When the study was first commenced, I was advised that, because I was not 
interviewing patients within the secondary care trust, only members of staff, it would be 
sufficient to gain the consent of the staff member and permission from their line 
manager. When I was ready to commence the interviews in 2005 this policy had 
changed and it was necessary to obtain Research Ethics approval from the secondary 
care trust's Research and Development department. This was obtained in December 
2005. 
5.4 Research methods. 
The reasons for undertaking a qualitative research study in this case have been fully 
discussed in Chapter 4. The next decision relates to the precise method of data 
collection for this study. The preliminary study, which is described in Chapter 2. used a 
very structured questionnaire consisting of mostly closed questions along with the use 
of observation to assess the older person's ability to accomplish various tasks. It was 
clear that frequently, in this earlier study, the older people wished to discuss their 
concerns in greater detail but this was not acceptable within the framework of that 
study. For this main study, I needed the older people to be able to express their own 
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views about a variety of subjects, for example, MCAs, their medicines, and the health 
professionals with whom they came into contact. 
Within qualitative research, several different methods of data collection can be used to 
obtain data from members of the general population and from healthcare professionals. 
These include, direct observation, interviewing, video recording and collection of 
written evidence provided by the people concerned e.g. letters, self-filled 
questionnaires. 
It is important to choose the method of data collection which is best suited to the data 
source and to the type of data which you wish to collect. Many would argue that direct 
observation is the most suitable means of obtaining data, whereas, in this study it was 
felt that talking directly to both older people and the healthcare professionals would 
provide the type of data required. 
5.4.1 The choice of in-depth semi-structured interviews 
Within qualitative methods, in-depth semi structured or loosely structured interviews 
are the form most frequently used. In this type of interview, the interviewer uses a pre-
prepared 'topic guide' of open-ended questions. I judged that this type of interview 
would allow the older people to discuss their experiences of using a MCA and to 
elaborate on their attitudes and beliefs about medicines. The same type of interview 
was used for the healthcare professionals and again I wished to explore the 
interviewees' attitudes to the use of MCAs and also their beliefs about the ability of 
older people to manage their medication. Using in-depth semi-structured interviews 
allowed me to explore the interviewees' attitudes and beliefs to a greater extent than if 
the interviews had been structured, or if I had chosen focus group methodology. 
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Because of the short time available for each interview, it is necessary for the researcher 
to be able to rapidly build up a positive relationship with the interviewee (DiCicco-
Bloom and Crabtree 2006). When interviewing the older people, I introduced myself as 
'a research pharmacist' from the university. Research has been carried to investigate 
whether the professional role of the interviewer can influence the outcome of qualitative 
interviews (Richards and Emsli 2000). In their study, Richards (a G.P.) and Emsli (a 
sociologist) undertook in-depth interviews with 60 middle-aged men and women of 
varied occupational social class. The interactions that took place during the interviews 
were noted by both researchers. While some interactions were common to both sets of 
interviews, some appeared to be associated with being a doctor or a sociologist (who 
actually introduced herself as a researcher.) The researchers concluded that the 
professional identity of the doctor is so well known that it overshadowed the personal 
characteristics of this researcher. By introducing myself as a pharmacist, I may have 
introduced a level of response from the interviewees which may not have occurred with 
a different interviewer. 
The interviews with the healthcare professionals were undertaken in the same way as 
the older people, using a slightly different topic guide The interviewees were all 
informed before they agreed to take part that the interviews would last approximately 30 
minutes. My previous experience showed that it can be difficult to recruit healthcare 
professionals as the time they have available for such work is very limited. Setting a 
time limit was an attempt to maximise recruitment by addressing the problem of time 
commitment. I also insisted that we had a quiet place to conduct the interview in order 
to be able to record it and not to have interruptions such as telephone calls or staff 
queries. Piloting the topic guide with a community pharmacist, a junior hospital doctor 
and a nurse showed that 30 minutes was sufficient time. 
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Undertaking all the interviews myself, I was concerned that I might influence how the 
interviewees behaved. I have interviewed pharmacists before but never other healthcare 
professionals. Research has been carried out looking at the effect of the interviewer 
interviewing fellow professionals. As part of two qualitative studies employing semi-
structured interviews with GPs, the interviewees were asked their opinions on being 
interviewed by a GP researcher (Chew-Graham, May and Perry 2002). The study 
concluded that the professional identity of the researcher can influence the type of data 
obtained and must be stated both in the results and the discussion. Six pharmacists were 
interviewed for the study and of these four were known to me, mostly through my 
previous role as a CPPE tutor. None of the other healthcare professionals were known 
tome. 
5.4.2 Topic guides. 
When undertaking in-depth semi-structured interviews, the interviewer usually prepares 
an interview guide which consists of the topic headings that the interviewer intends to 
discuss with the interviewee. This interview guide (more commonly called a Topic 
Guide) acts as a pointer to the interviewer showing him or her the way forward. Using 
the topic headings, the interviewer can guide the interviewee in the chosen direction. 
The topic guide can also include prompts and probes which may be used if the 
interviewer wishes to encourage the interviewee to elaborate further. Care must be 
taken both in the ordering of the questions or topics and to avoid the use of closed or 
leading questions. The novice researcher may ask leading questions or fail to note 
whether cues are picked up or ignored (Britten 1995). Barbour and her colleagues in a 
description of a training workshop on semi-structured interviewing (Barbour, 
Featherstone and Members of WoReN 2000) suggested that asking questions in 
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qualitative research can be a difficult art to master for the new researcher in particular 
getting the correct balance between being both precise and also flexible. 
As a novice researcher, I was fortunate in being able to attend a number of training 
sessions on qualitative interviewing and address these problem areas. 
The general questions which I produced for the older peoples' interview guide were 
informed by the results of the preliminary study which I describe in chapter 2. The 
interview schedule for the healthcare professionals was also informed by this study, but 
in addition, I was able to draw on the responses from the older people's interviews. The 
topic guides produced are included in Appendix 3. In accordance with grounded theory 
methods as the interviews were undertaken, when new themes emerged, I reviewed the 
topic guide and made alterations to the topics in order to address these issue. For 
example, the first two interviews with older people introduced the themes of 
independence and control, which had not been in the original topic guide. I therefore 
added these topics to the guide. I was able to pilot the healthcare professional's 
interview schedule with a community pharmacist, a nurse and a junior hospital doctor. 
These interviews were recorded and transcribed but were not included in the findings. 
These three interviews highlighted a number of problems with my original schedule and 
I made significant alterations prior to commencing the main interviews. 
5.4.3 Recruitment of Older People. 
The approval from the local Research Ethics Committee stipulated that I could not 
approach older people directly to recruit them to the study. I therefore asked for help 
from healthcare professionals who regularly came into contact with older people using 
MCAs. The sampling of the older people was purposive - see Section 5.4.4 for a 
further discussion of sampling. 
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A letter was written to all the community pharmacists in two selected Primary Care 
Trusts enclosing details of the study and explaining about the help needed. Community 
pharmacists who were willing to assist with recruitment were asked to return a reply 
slip to me and I then arranged to visit the pharmacy and explain the recruitment protocol 
further. Participant information leaflets and consent forms were left with the pharmacist 
for distribution to prospective participants. Details of the relevant paper work used 
during the recruitment of the older people can be found in Appendix 3. The 
pharmacists were asked to forward details of older people who were willing to take part 
in the study to me and I would then contact the participant directly and arrange an 
interview. I received support from the Head of Medicines Management at both PCTs 
who were eager to see this research progress further. As a result of this support, I was 
able to arrange that a pharmacist working with the Intermediate Care Team would assist 
in recruitment by identifying suitable participants during visits to older people to review 
their medication. This face to face recruitment was much more successful than the 
more distant recruitment offered by the community pharmacist; who usually included 
the information leaflet and consent form in the bag with the dispensed medicines. 
Those community pharmacists who followed up the leaflets with a telephone call were 
more successful at recruiting participants. In addition a pharmacy technician who had 
been recruited by another PCT to undertake medication reviews with older people also 
assisted in recruitment. She regularly attended events organised by the local Elderly 
Action Group and I was able to accompany her during' Ask about Medicines Week' and 
hand out leaflets about the study. 
In order to be included in the study participants had to fulfil the following criteria: 
be over 65 years of age, 
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take four or more regular solid dose oral medications which were contained in a MeA 
and 
live independently in the community. 
The exclusion criteria were: 
Being unable to read or understand the patient information leaflet 
Being unable to undertake the interview in English. 
When recruitment started, it became obvious that not all older people using multi-
compartment compliance aids were having the devices filled by the community 
pharmacists. Some older people had bought a device and were filling it themselves and 
some were having a device filled by an informal carer usually a relative. I therefore 
decided to include all these participants in the study in order to provide a balanced 
picture of MeA use by the older population. 
Ensuring confidentiality. 
The participant information leaflet gave clear information concerning confidentiality. I 
was careful to explain to the prospective participants, when I contacted them to discuss 
the research, that they would not be identified in any part of the research. I have used 
code numbers to identify the participants in this thesis and none of the written 
documentation contains any means of identification. The tape recordings have been 
kept in a locked filing cabinet throughout the study and have only been accessed by 
myself and the authorised transcriber. I was careful when interviewing the participants 
not to use their name. All tapes and transcripts will be destroyed at the end of this 
study. 
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5.4.4 Recruitment of the health care professionals. 
In Chapter 3, I described the sampling strategies which can be used in grounded theory 
research. The two main types of sampling are purposive and theoretical and when 
recruiting the older people I used purposive sampling. However, when recruiting the 
healthcare professionals, the sampling became theoretical because I used the emerging 
themes for the older people's interviews to provide details of the healthcare 
professionals I needed to recruit. This change in the type of sampling used as the 
research progresses is in accordance with the procedures described in Strauss and 
Corbin's 1998 edition. 
Pharmacists, doctors and nurses were identified by the older people recruited as being 
responsible for the institution of their MCA. These healthcare professionals were 
working in secondary, that is within a hospital, or in primary care, providing care to 
older people in their own homes. In addition three older people had received their 
MCA from the pharmacist working with one of the Intermediate Care teams in the area. 
Intermediate Care 
The term Intermediate Care first came into use in the mid-1990s and at first the term 
covered a wide range of services and there appears to have been no official definition. 
However the National Service Framework for Older People (Department of Health 
2001) introduced a detailed definition of 'intermediate care' in Standard Three which 
states that: 
older people will have access to a new range of intermediate care services at 
home or in designated care settings, to promote their independence by providing 
enhanced services from the NHS and councils to prevent unnecessary hospital 
admission and effective rehabilitation services to enable early discharge from 
hospital and to prevent premature or unnecessary admission to long term 
residential care (p 41.) 
l34 
The provision of intermediate care has varied throughout the country with some areas 
focusing on intermediate care wards either within a secondary care hospital or in a 
separate establishment. However in the area were the main study was undertaken the 
main focus of intermediate care was provision of support in the older person's own 
home. 
At the time of the study there were a number of dedicated intermediate care teams 
which were separate from the primary care provision. The function of intermediate care 
is to provide a link between secondary care and the patient's own home. Intermediate 
care can consist of a number of different services brought together under one umbrella 
organisation. 
Therefore I decided to recruit from all three professions and, as far as possible, from 
secondary and primary car and from those working within intermediate care. Letters 
were distributed to all general practitioners in the two PCTS which were supporting this 
research. I had previously contacted the community pharmacists and I recruited from 
those who had already expressed a willingness to assist with the research. Letters were 
sent to the Intermediate Care services and to the district nurses based in each PCT. The 
hospital pharmacy in the secondary care trust was contacted and through this contact I 
was able to recruit hospital pharmacists, doctors and nurses. 
Details of the interviewees can be found in Section 7.2. 
Ensuring confidentiality. 
Confidentiality was ensured III the same way as described above. The healthcare 
professionals are only identified by a code number in this thesis and I have been careful 
to avoid any statements which might identify them. As before, the tapes were kept in a 
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locked filing cabinet. The transcribing was undertaken by myself or a uni\·ersity 
transcriber and all transcripts were also kept in the locked filing cabinet. 
5.4.5 Undertaking the interviews. 
All the older people's interviews took place in the participants' own homes. Most of 
the participants were alone. Although on three occasions a relative was present in the 
house at the time of the interview, the relative was asked to remain silent while the 
interview took place. Interviews took between 20 and 45 minutes and were recorded; 
all the participants were asked to give permission for this and no-one declined. 
Participants were informed that the tape recorder could be switched off at any time 
during the interview if they so wished. In addition to the recorded interview, 
participants were asked to give some brief details about themselves, date of birth, living 
arrangements (i.e. own home, sheltered housing), any help they received (warden, home 
care) and details about the multi-compartment compliance aid they were using. 
The richness of the interviews varied greatly between participants, with some 
participants being very vocal and giving great details of their medicines and how they 
managed, whilst other participants simply gave one word answers and were very 
reluctant to elaborate, making the interview very difficult. The transcribed interviews 
ranged from 1000 to 4200 words. 
The healthcare professionals' interviews were undertaken in their place of work. Each 
participant was asked to arrange a time and venue convenient for themselves, when we 
would be able to have approximately thirty minutes of uninterrupted time. I also 
requested a quiet and private venue where it would be possible to record the interview. 
All participants were asked to give permission for the interview to be recorded, and as 
before, I stated that the tape recorder could be switched off at any time. No participant 
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refused to be recorded and no participant asked for the recorder to be switched off. 
Interviews were recorded early in the morning, before the start of the day's work or 
during a lunch break. One community pharmacist arranged to undertake the interview 
on a day when a second pharmacist was present. Thirty minutes may seem a relatively 
short time to undertake a qualitative interview, however the topic guide was short and I 
knew that the healthcare professionals would be reluctant to give me a longer time. All 
the interviews lasted between 30 and 45 minutes and the word count varied between 
1300 and 5500. 
5.4.6 Theoretical saturation. 
In grounded theory methodology, recruitment usually continues until 'theoretical 
saturation takes place' (Strauss and Corbin 1998), that is until no new themes are 
discovered in the data. Strauss and Corbin, however, state in their 1998 edition that 
sometimes this is not possible and that constraints of time, energy and availability of 
participants may impose limits on the data collected. Within this study, the older 
person's interviews reached theoretical saturation with no new themes emerging from 
the later interviews. The recruitment of the healthcare professionals was limited by the 
availability of participants and time constraints. However analysis of the interviews 
indicates that theoretical saturation was reached. 
5.5 Analysis of interviews. 
The analysis of the interviews began as soon as possible after the first interview was 
undertaken. I decided to undertake the analysis manually rather than use a computer 
programme. Computer aided qualitative data analysis (CAQDAS) has become popular 
in recent years and various software packages are available for the researcher to usc. 
e.g. NVivo@ and NUD*IST®. Although using a computer programme can assist the 
researcher in indexing and retrieving text, I preferred to analyse my data by hand using 
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index cards. In a paper on 'common pitfalls in grounded theory analysis' (Becker 
1993), the author suggests that the use of computer programmes to aid analysis in 
grounded theory studies can result in the lack of creativity required in this method of 
analysis. Although computer programmes are useful for handling and sorting data in 
the grounded theory type of qualitative analysis, the analyst needs to identify the 
conceptual links themselves. 
5.5.1 Tape transcription and review. 
Immediately after each interview I wrote short field notes giving details of the interview 
and my initial thoughts. As soon as possible after this I listened to the tape, firstly to 
check that the recording was clearly audible and secondly to make initial identification 
of themes. The tapes were then transcribed either by myself or by an experienced 
transcriber working for the university. When transcription of each tape was completed 
the transcript was checked very carefully against the original tape and any errors 
corrected. 
It is suggested that returning the transcribed interview to the study subject for 
verification increases the validity of the data. In this study I decided not to do this. The 
older people I interviewed were willing to take part in a single interview but many 
expressed concern that they might be contacted again either by myself or by other 
university researchers. I reassured them that this would not be the case and that their 
names would remain confidential for the duration of the study and then destroyed. To 
have returned the transcripts for comment would have broken this assurance. Other 
researchers have found that returning the transcripts is not always successful (Dearnley 
2005). Having decided not to return the transcripts to the older people it was then not 
possible to return the transcripts to the healthcare professionals as this \\'ould have 
introduced bias. 
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5.5.2 Open coding 
The transcripts were printed out on A4 paper in tabular fonn with a column on the left 
and right hand side and the text in the central column. The lines were numbered and 
line-by-line coding commenced. The first two interview transcripts were analysed 
using the microanalysis method, which is a detailed line-by-line analysis. This micro-
analysis allows initial categories to develop and emerging themes to be identified. Later 
interviews were also analysed line by line or paragraph by paragraph. Details of the 
themes were noted on the side of the transcript and sections of the transcript were 
highlighted. This type of initial analysis is described by Strauss and Corbin (1998) as 
open coding. In this method, the data are broken down into smaller sections and the 
ideas and thoughts held within those sections assigned a meaning or theme. These 
themes are then compared across the data and the data re-examined for re-occurring 
themes. Figure 4. illustrates how the data was broken down into smaller sections 
indicated by the different coloured marker pens. The individual rows were numbered 
for easy reference and notes were written in the margins. These notes and suggested 
themes were then transferred to index cards and to memos. 
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\ '~~ '..< l;.f, 
I ~ '" 
~~~~~~~~~~~---l--~~ 
IN 
OP 
IN 
OP Since I used to take the medicine on me own ? about 3 or 4 month 
IN r..i Right do you know who actually su ested that you had a box 
OP 1-" Now I got to know last time my doctor -
(0 anyway it was me own doctor because I only---. Now then they 
(, switched me I used to take me own I knew all my medication I 
:'l. knew what it was for and everything they started delivering these 
n dosette boxes iKld they started sending them wrong and I went a 
J~ full week without anything in place of warfarin it was when I had 
1-( just come out of hospital and they bad stopped me warfarin and 
) ~ the chemist knew and the doctor knew cause I rung the doctor 
n myself to tell them and they knew that they had put me on thiJ<" 
>i clopidogril anyway I was getting neither clopidogril or the o~ 
)1 one I am going to be in a right hole here I go t on about it and then 
,~ next time what happened one time when he come I'd got me 
'r warfari.n ,to take at night a tablet aqd a clopidogril to take in the 
' momin . , II could have been in serious 
c< trouble there I would have had to have gone in hospital because 
iiI- there would have been too much for me for me blood, well yo.U ' ll 
" understand that. You see because they were both for the same-
" thing 
en she talked me into it again she said ' 
tlJ. 'l...L\;). "'" ~ ~ __ P- are you going to go back onto your dosette box again the doctor 
I, would Like you to go back on it I said I'll go back on it on 
~ condition you don 't make anymore mistakes at 
; r~ .{.J "f) I ' J d if you make anymore mistakes 
.,jl, .... :lv., ' ' .h 
.. /"'~ that's it I'm ringing the doctoLand I'm gomg to complaIn to ~e 
• f"OJ ~~ -v.u~\" v 1) doctor about it all because it isn 't fair is it and that was anothe 
h they stopped me that raloxifen I wrote that on I said to them 
~~~~~ ~~ , J /) what's the matter I only take one a d,ay but thaI 's f~r osteoporosi,s 
" )8 and I must take that one a day for bnttle bones I said why haven I 
1~ you put thal9n? Anyway they finished up they got in touch WIth 
ch , l ,(-'.) ~r ~ ~o the doctor and the doctor has given them all th8t (shows a list) 
)', they've stuck all them QIl (shows labels stuck on medidos) 10 
j! those are actually what I take now. TIHri ' bid 
0....., J J g '~Lr1 
p j~ ~ IQ. .. j .-
Figure 4: Details of open coding on a page of interview transcript. 
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5.5.3 Memo writing 
Strauss and Corbin (1998 p217) state that memos are: "written records of analysis 
which may vary in type and form." 
Writing memos is considered to be an important part of the analysis procedure, however 
the way memos are used can vary between researchers. In her study of people \\'ith 
Alzheimer's disease (Orona 1990), Orona describes in detail how her use of memos 
developed as the research progressed. Firstly she used memos to record whatever 
thoughts came into her head as she read the interviews. Secondly she used memos 
when she felt the analysis had become blocked in order to try and clarify her thoughts. 
Thirdly she used memos to begin to conceptualize the data. 
My memos were written in a separate book, the interviews were identified by code 
number and the line numbers were used to identify each memo, a memo consisted of a 
precis of the original transcript and then my interpretation of that section. 
An example of a memo is shown in Figure 5 below. 
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Figure 5: Example of a memo. 
, 
VV\ M 
Writing the memos allowed me to express my thoughts concerning a particular section 
of the data. Later in the analysis I used the memos to compare themes across the data 
sets. 
5.5.4 Axial coding 
Axial coding has been described in chapter 4 section 4.5.1 . Having carried out open 
coding on transcripts the process moved to the axial coding stage. Details of themes 
had been entered on index cards and by using the index cards I was able to re-assemble 
the data making links between categories and sub-categories. The index cards were 
colour coded to link in with the four ' areas of interest' which I identified as a result of 
undertaking the preliminary study (see section 2.8). 
Figure 6 below shows an example of an index card 
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Figure 6: Index card from MCA area of interest. 
Difficulties in using MeA 
MCAJ9 
~7slz 
F7~}3 -
/173 )4-
~J13 
F]S hi 
The index cards gave details of the theme and theme reference number; the other codes 
refer to the particular interview. 
The four areas of interest which I referred to above are : 
Trigger What triggered the fIrst supply of the medication ill a multi-compartment 
compliance aid. 
MCA How the older person managed using the MeA and how they felt about it. 
Health Beliefs What health beliefs and attitudes to medicines use the older person 
might have. 
Age. If the older people thought that their age might affect how they were treated. 
Each of these areas of interest was assigned a colour and the transcript ere 
highlighted with coloured pens to indicate which area of intere t a particular line or 
paragraph fell into. 
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Themes were entered on to index cards which were colour-coded in line with the areas 
of interest. Using the index cards the themes with similar ideas or meanings were 
grouped within the area of interest into sub-categories and the sub-categories grouped 
into larger categories. 
To aid the analysis of these themes and categories, a database was designed using a 
computer spread sheet to show which themes had been identified by each participant, a 
separate work book was used for each area of interest. 
After sorting of the themes using the index cards and I began to develop categories and 
sub-categories, tables were then produced linking the interviewees own words with the 
themes and categories. An example of such a table can be seen in figure 7. 
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Figure 7: Part of a table of "Trigger themes" from healthcare professionals' 
interviews. 
Category Theme Healthcare professional details 
Question: Do you supply / request the supply of medicines to older people living in 
the community? Followed by can you tell me a little more about this. 
Decision is ours 
Decision of 
professionals 
non 
Pharmacy suggests "you know usually the last two or three 
have probably been identified by 
ourselves" Community pharmacist 5111 
Risk management 
Relatives request 
supply of device or 
purchase 
themselves 
Patients seek help 
themselves 
Patients buy their 
own MCA and fill 
it themselves (self 
fillers) 
"she (patient) made a mistake yesterday 
and that is I'm thinking at what point do I 
say the risks are too great sort of thing." 
Community matron 16.201 
"we have a lot of people purchasing them 
over the counter. It tends to be 'Oh I'll 
get one of those for mother' sometimes 
they buy two or three" Community 
pharmacist 516 
"sometimes the relatives would identify 
it, sometimes relatives buy a box from the 
chemist and they fill them up each week." 
ICTnurse 21188 
"the members of the family ask us 
sometimes" GP 101171 
"patients may be aware that they are not 
quite in control of what they are taking 
and want help to sort it out" Community 
pharmacist 5118 
"yes well some people just buy a Dosett® 
box and fill it themselves on a Sunday 
afternoon and put them out for 
themselves." Community matron 161253 
Decision of other Hospital discharge 
professionals (but 
" you know the hospital put them on 
venalink and often will fax a copy of the 
discharge so we know what they are on" 
Community pharmacist 5180 
not us) 
"we get a discharge note that says please 
put in a venalink" Community pharmacist 
416 
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5.5.5 Selective coding 
The final stage in the grounded theory approach as described by Strauss and Corbin 
(1998) is selective coding. When the researcher reaches this stage of the analysis 
process he or she is ready to develop categories and to deduce a number of core 
categories which will underpin the theory. 
I used the database to assist with this final stage of coding and was able to identify core 
categories in my data. Figure 8 below shows the portion of the Excel® spreadsheet 
which refers to the table shown in Figure 7 above. Therefore the core category became 
'decision making,' which contained four sub-categories and ten themes. 
Figure 8: Portion of spreadsheet showing Trigger for use categories. 
Pharmacy suggests 
Risk management 
Relatives request 
Decision of non-professionals 
patients seek help 
patients buy own MeA 
hospi tal discharge 
anotherHCP 
myth of homecare 
leT request 
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Trustworthiness. 
In order to ensure that the researcher's analysis of the data can be considered 
trustworthy it is advisable to ask friends or colleagues to work with portions of the data 
in order to audit the analysis. I asked my supervisors to review the themes which I 
developed from the analysis and a colleague reviewed a sample of the transcripts and 
the themes which I derived from those transcripts. 
5.5.6 Refining the theory 
Finally Strauss and Corbin (1998) write about 'Refining the Theory'. This consists of 
reviewing the data for consistency and logical development and to identify a core 
concept. In a paper which compared the different approaches to grounded theory of 
Glaser and Strauss (Heath and Cowley 2004 p.149), the authors stated: 
"it is wise to remember that the aim is not to discover the theory, but a theory 
that aids understanding and action in the areas under investigation. " 
In later chapters I will discuss the findings of both sets of interviews and in the final 
chapter of this thesis I will draw together these findings and present a theory based on 
the data obtained. The important question when undertaking a grounded theory study is 
'how useful is the theory generated?' (Baker, Wuest and Stem 1992). I intend to 
discuss the implications of my theory for practice and for research. 
5.6 Summary. 
In this chapter I have described the setting where the research was undertaken. Details 
of the Research Ethics approval obtained are provided and I also discussed the process 
for obtaining approval for projects involving older people. I discussed the various 
methods of data collection used in qualitative research and justified my choice of semi-
structured interviews. The difficulties which occur when recruiting both older people 
and healthcare professionals for this type of research are discussed alongside my 
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methods for overcoming these difficulties. The procedure used when undertaking the 
interviews is described and the difficulties I encountered explained. In the final section 
of the chapter I gave a detailed explanation of how the analysis was undertaken 
including examples of the various analytical processes. 
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Chapter Six: 
Interviews with Older People - Findings and Discussion 
6.1 Introduction 
This chapter details the findings of the analysis of the older people's interviews and 
follows with a discussion of these [mdings. The chapter commences with a description 
of the demographic details of the interviewees and goes on to describe how these 
interviewees were categorised according to who filled the MCA they were using. I 
continue by explaining that the interviews were designed to explore four areas of 
interest namely: 
What triggered the initial supply of the MCA (section 6.3) 
The advantages and disadvantages of using a MCA (section 6.4) 
The health beliefs of the older people. (section 6.5) 
Themes related to age and ageism are identified in section 6.6 
In section 6.7, I discuss the findings and relate these findings to those found in other 
research studies. Finally the chapter concludes with a summary. 
6.2 Demographic Details 
Fifteen older people were recruited to the study by the methods described in Chapter 5 
Section 5.4.3. At the beginning of the interview, the participants were asked for some 
personal details including their age, their living arrangements and their MCA use. 
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The demographic details of the interviewees can be seen in Table 17. 
Table 17: Demographic Details of the older people interviewed for the study 
ID Age Gender Living Accommodation Support 
no. arrangements Services 
OP1 74 Male Alone Own home None 
OP2 86 Female Alone Sheltered Warden 
OP3 76 Female Alone Housing assn. No 
OP4 73 Female Alone Sheltered Warden 
Home care 
OP5 89 Female Alone Sheltered Home care 
OP6 72 Female Alone Own No 
OP7 79 Male With wife Own leT 
OP8 75 Female Alone Own No 
OP9 88 Female Alone Own No 
OP10 79 Female With daughter Own No 
OP11 79 Female Alone Own No 
OP12 91 Female Alone Sheltered House manager 
OP13 92 Female Alone Sheltered Warden 
OP14 85 Female Alone Own No 
OP15 88 Female Alone Sheltered Warden 
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Table 18 gives details of the MCA and medicine usage of the older people and as a 
result of these findings the older people were divided into three groups categorised by 
who filled their MCA. 
Table 18: Details of MeA and medicine use by the older people recruited to the 
study 
IDNo. Type of Length of Nos. Who fills Who requested 
MCA use medicines 
OPI Nomad 18mths 7 Pharmacy patient 
OP2 Medidos 3-4 mths 7 Pharmacy GP 
OP3 Dosett 5mths 8 Self relative 
OP4 Venalink 12 months 13 Pharmacy relative 
OP5 Dosett type unknown 8 Carer relative 
OP6 Type 7 years 5 Self patient 
unknown 
OP7 Type 1 yr 8 Carer IC pharmacist 
unknown 
OP8 Type 2 weeks /2 5 Self IC pharmacist! 
unknown yrs self 
OP9 Nomad unknown 4 Pharmacy unknown 
OPI0 Dosett type 2 weeks 12 Carer ICT pharmacist 
OP11 Venalink 1 yr 11 Pharmacy Hospital I GP 
OP12 Venalink lyr 6 Pharmacy hospital 
OP13 Venalink 2 yrs 8 Pharmacy unknown 
OP14 Venalink 2-3 mths 5 Pharmacy GP/daughter 
OP15 Type 2 mths 4 Carer Relative 
unknown 
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Not all the interviewees had their MCA filled by the pharmacy, as described in Section 
5.4.3. I also recruited older people who were filling a MCA themseh'es and those whose 
MeA was filled by an informal carer. These three distinct groups were named 
"Pharmacy filled", "Carer filled" and "Self filled". Further details are given below. 
Pharmacy filled 
The subjects in this group received their MCA directly from the pharmacy: - the MCA 
usually contained 7 days supply of medication and was either delivered by the 
pharmacy or collected from the pharmacy by a carer or the older person themselves. In 
this group, the pharmacy was usually responsible for ordering and obtaining the older 
person's prescription from the GP surgery. 
Carer filled 
The interviewees in this group had their medication put into a MCA by a relative or 
informal carer. The carer had often purchased the MCA themselves, although not in 
every case, and the medication was dispensed by the pharmacy in ordinary packaging. 
The process for obtaining repeat prescriptions from the GP surgery was either organised 
by the carer or by the pharmacy 
Self-filled. 
The participants III this group had purchased a MCA and then filled the device 
themselves using the medication dispensed by the pharmacy in ordinary packaging. 
These subjects were usually responsible for organising the repeat prescriptions although 
some might use a pharmacy operated repeat prescription service. 
I wished to investigate if there was any difference in the attitudes and beliefs held by the 
interviewees in each group 
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6.3 What were the triggers for use? 
This section looks at what triggered the use of a MeA in the first place. Initially the 
interviewees were asked to think back to the time before they received the MeA and 
discuss how they managed their medication. 
6.3.1 How did the older people manage before? 
All the interviewees were asked if they could think back to a time before they used a 
MeA. The participants were divided in their answers, some admitted to a degree of 
problems with medicine taking:-
"] was taking them at dinnertime and again at teatime and] wasn't supposed to 
take them like that. JJ OP 11 
"it's a hardjob to remember them all. JJ OP3 
However, other participants did not admit to any previous problems. 
"] don't forget, ] do forget (other) things but] don't forget my tablets. JJ OP 14 
"] used to take me own ] knew all my medication ] knew what it was for and 
everything. JJ OP2 
Almost half of the interviewees stated that they had had no problems managing their 
medication prior to receiving an MeA. Such self-reported compliance can be open to 
question; however, my previous work with this age group suggested that they make the 
utmost effort to be honest in their answers (Raynor et al. 2000) 
6.3.2 Did the older people have any system for reminding themselves to take their 
medicines? 
Previous studies have shown that people who take a number of different medicines 
often devise their own routine or method of reminding themselves to take their own 
medication (Branin 2001). I wanted to discover if these older people had previously 
used such a system as this might impact on the way they used their MeA. 
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This prompt resulted in a number of descriptions of places to keep medicines, and 
containers to keep the medicines in. Sometimes the containers were produced for me to 
see. 
ill used to have them all on the side, ] used to sit there and have them all in the 
drawer." OP4 
"] used to have a smaller little box, just for every day and get them ready like 
that. " OP3 
6.3.3 Who suggested that they used an MCA? 
The participants were asked "Who first suggested that you had your medicines in this 
type of box?" Two participants stated that their OP had initiated the supply. 
" ... my doctor said you see, the doctor said he was going to do this" OP 14 
ill said who's put me on this Dosett box and why (participant to pharmacist) -
she said it's your doctor." OP2 
A third of the older people stated that a relative had initiated the supply of the MCA. 
" ... it was my daughter that arranged itfor her Mam." OP4 
ill think it was when my daughter went with me to the doctors. " OP 14 
However, not all of the participants were clear about the reasons and stated that they did 
not know why they had been given the MCA and that it had arrived unannounced and 
with no apparent warning. 
" ... well as far as 1 was concerned there was nothing said about me changing to 
a Dosett box." OP2 
"They (the chemist) didn't tell me it (MCA) just came. " OP9 
6.3.4 What circumstance may have led to receiving a MCA? 
Discharge from hospital after an emergency admission frequently was given as a reason. 
"] went into hospital a week before Christmas and] must have had a brainstorm 
or something. " OP 10 
"] fell] got tripped in the garden and hurt my knee, ] was in hospital three 
weeks. " OP2 
These interviewees described being taken into hospital after an accident or a sudden 
severe illness, and admitted that they were often confused in the hospital setting, finding 
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it difficult to understand what was going on. None of the interviewees talked about any 
medicines assessment they may have had in the hospital setting and so it is difficult to 
know if any was carried out. 
" ... they (hospital staff) gave me some to bring out with a thing similar to that 
(indicates MCA) and ] thought when ] 've finished ] will have to go to the 
doctor's but] haven't at all. " OP 12 
"]t was the hospital in the first place that gave me a little leather sort of a box in 
there and they kept on with that." OP 11 
Hospital discharge also led to confusion with medication, even in those people who had 
managed well previously. 
"They changed all my medication while] was in hospital and so ] wasn't really 
au fait with what] was taking. " OP 10 
"Coming out (of hospital) with a list of medicines you are to take and you had to 
study which hour and what time of day and] was getting confused. " OP 1 
The participants, who were filling their box themselves, had usually made their own 
decision to obtain and fill the MeA. The trigger in this case was the recommendation 
of a friend or relative or seeing an advertisement in a magazine. The fact that the self-
fillers were open to such suggestions may indicate that they had already identified some 
problem with their medicines management although nobody stated this. 
"] enquired at the chemist and they had one there so ] purchased it from there. " 
OP6 
"] saw this box for tablets advertised in a magazine and sent for it, ] found it 
would hold three weeks supply of medication and] worked out a system. " OP8 
A number of the self-fillers referred to their need to be organised. 
"J suppose in a way J'm that kind of person, orderly. Routine that's how J've 
always been." OP8 
"J try to keep them separate, this is for morning that's for afternoon and that's 
for night yer know which, then] know what I'm doing." OP3 
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6.3.5 Overview of themes and categories emerging from 'Trigger for use'. 
The themes which emerged from this analysis were grouped into categories. Two 
categories were identified: Willing to use and Reluctant to use. Figure 7 below shows 
the relationship between the themes and the categories. 
Figure 9: Categories and sub-categories emerging from 'trigger for use' 
Relatives Unaware of 
decision any problem 
Organised 
Healthcare & in control 
professionals' 
decision 
Non- \ compliance 
Hospital \ \ 
discharge \ 
I Willing use I I Reluctant use I 
6.4 Older people's opinions about their MeA 
Previous studies have looked at user preference when issuing a MCA. In one study 222 
people aged over 55 were given the opportunity to try a number of different MCAs and 
to rank the devices in order of preference (Walker et al. 1990(a)). However this study 
took place over 15 years ago and the MCAs in the study do not reflect the devices 
available today. Patients are rarely given the opportunity to choose which device they 
wish to use and there is evidence that patients are not checked for their ability to use the 
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device they are given. (see Section 7.4.2.) Therefore, I wanted to discover how these 
older people were managing their MCAs. 
The first general question was "How do you manage your box?" 
6.4.1 It's easy to use 
A majority of participants stated that it was easy to use, or that it was simple to use or 
very handy. 
"] found it a lot easier to use because it had the date and the time like when to 
take them. " OP 11 
"] find it easy really because] can keep them on hand you see. " OP 14 
6.4.2 Always available 
Another aspect, which was popular with the participants, was the fact that their 
medicines were always available. This was especially important to those people who 
regularly went away on holiday or to stay with relatives. 
"... and at holiday times, ] tell them a fortnight beforehand and they give me 
three lots of those (MeA) that's for three weeks. " OP 1 
Another important factor which was another aspect of 'medicines always available' was 
the fact that they were less likely to run out of their medication. 
"] would mentally stock up and make sure that ] had tablets to refill without 
dashing to the chemist for an emergency supply. " OP8. 
This lady was a self-filler and liked the fact that because she filled the device herself 
she could assess if she needed to obtain further supplies. 
For other participants, the fact that the device was filled and delivered weekly by the 
pharmacy and the ordering of repeat prescriptions was handled by the pharmacy meant 
that they always had sufficient stocks of medication. 
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6.4.3 Acts as a reminder 
None of the participants stated that the MeA helped them comply with their medication 
regime or prevented them from forgetting to take their medication. However, 
approximately one third of the interviewees remarked that the MeA did either act as a 
reminder, or by placing the MeA in a special place it contributed to reminding them. 
"it's the matter of the order they are in these boxes, I can look and see. It's a bit 
awkward this week because I've got double lots in the box and that and I've 
almost three weeks, but I can tell what I've taken and what I haven't." OP 5 
"I keep them (MeA) here (interviewee pointed to place on the hearth) if it's 
facing that way it's the morning. " OP 1 
6.4.4 Still uses own reminder system 
Two of the participants removed medication from the MeA and placed it in another 
receptacle in order to facilitate remembering to take their medication. 
"Yes I've got them (medicines) in a saucer on there (points to sideboard) but 1 
won't take any more until the lady comes to make me my lunch. " OP 13 
"I get them ready at night, I always get them ready at night because I have a 
little pill box and I always put it on the table where I have my brealifast. " OP J 4 
In particular warfarin was a drug which was frequently placed in a separate container. 
"It's (warfarin) separate, it's only to be taken at 6pm, it's separate is warfarin. " 
OP8 
6.4.5 Unhappy with using MeA "it's difficult to use". 
Not all participants thought that the device was useful or helpful, and those interviewees 
who were unhappy with their MeA were usually very quick to tell me about this. 
"I've had a little trouble and all with this Dosett box lately. " OP2 
"I didn't like it when they started with these, I said I wanted my other box back 
but they won't give it me back. " OP 13 
This lady had used a Dosett type box for some time and the community pharmacy had 
changed over to a sealed Venalink type system which she found very difficult to use. 
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Previous research by myself (see Chapter 2) and by others (Atkin et al. 1994) has 
shown that older people can have difficulty removing the medication from a multi-
compartment compliance aid. Therefore, I asked the older people to describe to me how 
they removed their medication from the MCA. A number of participants highlighted 
difficulties that they experienced in using the devices. These ranged from having to 
make sure that all the different medications had been removed from the compartment, to 
serious problems piercing the foil to access the medication from a sealed unit. 
"it's very hard to open, 1 find it difficult and there is nothing wrong with my 
fingers. " OP8 
"yes you cut at the back, you cut through them like that and you put your hand 
in to get the tablets out, but 1 think I'm getting used to it now but 1 still don't like 
it" OP13 
A number of the participants had devised their own methods of coping with the 
problems they encountered using their compliance aid. The methods employed 
indicated a level of improvisation and responsibility. 
" Oh 1 can tell you what 1 use (to remove the medication) eyebrow pluckers! 
Well 1 can't get my fingers in and 1 have an old pair. " OP 14 
6.4.6 Identifying medicines: a question of trust. 
The fact that it can be difficult to identify medicines when dispensed in a MCA was a 
problem for some of the interviewees and there did need to be a level of trust between 
the older person and the dispensing pharmacist. For one interviewee, this trust had 
seriously broken down. 
"if you make any more mistakes that's it I'm ringing the doctor and I'm going to 
complain to the doctor about it all." OP2 
This interviewee was reporting a conversation she had had with the pharmacist - in her 
opinion there had been a number of dispensing errors. 
The ability to identify the medication in the MCA was important to approximately half 
of the participants. Although the MCAs filled by the pharmacies did have labels affixed 
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to some part of the device, it was not easy for the older person to read the label and 
associate the information with a particular tablet or capsule in the MeA. The 
participants recognised the medication by means of colour or shape and if the 
medication in the MeA looked different from what they had received before they 
became unsettled and unsure. 
"] tell you what bothers me, ] mean ] take, this is what ] take today, that is 
supposed to be Nitrazepam 5mg where does it say that it is 5mg Nitrazepam?" 
OP2 
The Nitrazepam tablets which this participant had previously received were marked 
with a '5' and an 'N', the tablets in the MeA had no markings. 
" ] couldn't name them but] can tell what they are you know what] mean, ] can 
tell by the colour and the shape. " OP5 
"] don't know what this blue and pink thing is, ] don't know what that one is. 
You see these are tablets I've never had before." OPIO 
6.4.7 Six 0' clock warfarin. 
Warfarin tablets caused concern among those participants who were prescribed this 
medication. Those participants who had been started on warfarin in hospital were given 
their medication during the 6pm ward drug round and this need to take warfarin at 
precisely 6pm then continued into home life. Some participants removed the warfarin 
from the MeA so as they could remind themselves to take the dose at 6pm. 
"] take warfarin, ] take that at about 6pm in the evening so it is not in my box 
but] still have to remember to take it." OPIO 
6.4.8 Problems caused by change in device. 
A minority of interviewees had experienced a change in the type of MeA issued. The 
change was either because they were discharged from hospital with one type of device 
and then had a different device issued by the community pharmacy or because the 
pharmacy changed the device it was providing. Most of those affected by the change 
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appeared to take it in their stride, although there was little evidence of counselling 
regarding the change. 
"This is only the second week I've had this (sealed type MCA). I don't know 
why they changed it. They just came differently a couple of weeks ago. " OP 12 
However, one lady was very upset about the change and found the new device very 
difficult to manage. 
" I didn't like it when they (pharmacy) started with these, I said I want my other 
box back but they won't give it me back. " op 13 
6.4.9 What are the benefits of a MCA? 
Finally in this part of the interview, I asked the participants if they could describe to me 
the benefits of using the MCA. The fact that the MCA removed the need to think about 
their medicines had been suggested in my previous research and again this was 
discussed. 
" I was surprised and very pleased about it because it stopped me thinking, you 
know sort of going to get my tablets you know because you can forget when you 
get to a certain state. "OP 14 
"the doctor said he was going to do this (arrange an MCA) and I thought 
goodness me I am getting looked after. " OP 14 
Some participants admitted that although the MCA was useful they still had some 
problems and had on some occasions not taken the medication correctly. 
"sometimes I forget, but I can tell I get right woozy, after about 4 or 5 hours and 
it dawns on me I must have forgotten to take my tablets. " OP 1 
6.4.10 Overview of themes and categories emerging from 'Use of MCA' 
The themes which emerged from analysis of the older peoples interviews and which 
were related to the use of MCAs were sorted into sub-categories and categories as 
detailed in figure 10. below 
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Figure 10: Categories and sub-categories emerging from "use of MCA" 
I Easy to use 
I Acts as a reminder 
I 
I Always available 
I Well looked after 
I 
I Six o'clock warfarin 
I Difficult to use 
Problems identifying 
tablets 
I Still make mistakes 
I Positive attitude to MCA Negative attitude to MCA 
6.5 Health Beliefs of the older people. 
Research has shown that compliance with medication can be linked to the health beliefs 
of the patients taking the medication (Home and Weinman 1999). The main aim of this 
study is to determine whether the attitudes and beliefs of older people with regard to 
medication use have an influence on the appropriate use of a Multi-compartment 
Compliance Aid. The participants were asked if they had any personal beliefs about 
taking medicines. 
6.5.1 Medicines are important. 
A majority of the participants felt that medicines were important and that they 
understood the need to keep taking the medicines. 
"1 would be frightened if J didn't take them, J don't want to die just now for the 
want of taking them" OP4 
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"Important they keep you fit. I feel that I am taking them for my own good. " 
OP9 
6.5.2 Medicines are harmful and should only be taken when necessary. 
Conversely a minority of the participants viewed medicines as harmful and were 
concerned particularly about side effects. 
"Then they stopped me taking some because G (daughter) found out that some 
of them which I was taking created some problem and so she or the pharmacist 
rang the doctor. " OP 10 
"Since November they put me on these new tablets and I told the doctor about it, 
I said I've never ever sat in a chair and gone to sleep, I said I could come in 
here now and sit down and the next thing I could be asleep. " OP 11 
These participants also were worried about taking unnecessary medication and felt that 
healthcare professionals should discuss any new medication with them and prove that it 
was necessary. 
"I don't want to be taking unnecessary medication if it isn't necessary because 
they just seem to write a prescription out anytime and they just assume you know 
what you are taking. " OP 10 
Two participants stated that they felt that they were taking too many medicines. 
"I don't think I need all these tablets. " OP 11 
" ... but I've got all this other rubbish here, there's so many. " OP 10 
Changes to medication were also a worry and the arrival of an unrecognised tablet or 
capsule in a MCA could cause problems. 
"Yes well I've suddenly seen this red and blue one and I don't know why that's 
cropped up. " OP 10 
This was a particular problem for those older people who had their MCAs delivered by 
the pharmacy. There was often little contact between the older person and the 
pharmacist and the medicines were delivered by a driver; therefore changes to 
medication were often not discussed and interviewees were left worried and bewildered. 
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6.5.3 Knowledgeable about medicines. 
Some participants were very knowledgeable about their medication and were able to 
name their medication and to state what they were taking the medication for. 
"These are me (sic) morning (ones) what 1 take in the morning at breakfast. 
That one is clopidogril in place of warfarin, that one is for blood pressure, that 
is Losec MUPS now then that isfor brittle bones, raloxifene." OP2 
" ... when 1 take four in the morning that's it, then 1 take one at dinnertime and 
one at night. Is that aspirin? Then that's thyroxine, one of these is for my 
stomach and this one is digoxin. " OP 15 
The interviewees were identifying the individual medicines in the MeA and therefore it 
was important to them that they could identify the medication. Interviewees were also 
relying on their memories as it was not always easy to read the labels attached to the 
MeA. This point was emphasised by some participants who said that taking tablets was 
a routine or a way of life. This was particularly true of those who had taken regular 
medication for a number of years. 
"It doesn't bother me taking them you know, it has got to be a way of life more 
or less. " OP9 
"1 've always taken them, they've sort of grown. They've been added to as 1 've 
gone along you know, different things that 1 need them for. " OP5 
6.5.4 The relationship with healthcare professionals. 
The relationship that the participants had with various healthcare professionals was also 
important when it came to taking their medication. Those participants who trusted their 
doctor or other healthcare professional were more likely to follow the treatment as 
prescribed, often without any further discussion. 
"The experts have provided them, the consultants and they know better than me, 
1 just take anything (they suggest). " OP8 
"There is no point in the doctor trying to help me if 1 don't take the tablets. " 
OP14 
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Following the doctor's orders however does rely on the older person having a good 
relationship with their doctor, and some participants explained that this relationship can 
sometimes be difficult to create. 
" You get used to your doctor you see and the doctor I had before he was 
marvellous when my husband died, he really was. 'You can come and see me 
anytime M' he said if you are worried about anything. I thought how lovely it 
was and then all of a sudden he's going back to Newcastle where he came from 
and I've got to get used to a new doctor, which took a long time." OP 14 
However, if the relationship with the healthcare professional has broken down, and 
there is no trust, then the participant may become suspicious of any treatment provided. 
"I'm talking about my doctors because I'm just about sick of them, when I go 
I'm really poorly sometimes and they put me on gabapentin and say it's my 
nerves. " OP 1 
There had been a real breakdown in communication between this participant and his 
GPs, which was due to a misunderstanding of the use of the word 'nerves'. The 
participant was in considerable pain and had consulted his GP he had been prescribed 
gabapentin but had thought that the reference to nerves meant that the problem was all 
in his mind and that he was imagining the pain. However despite this he was taking the 
gabapentin but was reluctant to consult the doctors again. 
6.5.5 Independence and being in control. 
I had realised after undertaking and analysing the first two interviews that 
"independence" was a word or topic which was important to the participants and 
therefore I added a question about independence to the topic guide. For all the 
participants, maintaining their independence was of prime importance and a number of 
participants thought that using the MeA was contributing to maintaining independence. 
"Independence, I have always strived for (it) since I lost my husband 15 years 
ago." OP8 
"1 \'c always been independent, always. " OP 11 
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Alongside independence was the importance of being in control and making your own 
decisions. 
"] have choices, ] want to make my own decisions. " OP8 
"] like basically to be in control of what I'm taking. " OP 10 
However it was possible that some of the interviewees regarded receiving the MeA as a 
way of losing their independence. 
The underlying threat as seen by many of the participants was having to give up their 
own home and move into residential care and therefore they strived to remain as fit as 
possible and to be seen to be managing, so as to remove any suggestions of residential 
care. 
"] mean how can] ensure that] am staying here (in own home)?" OP8 
"so they said 'would you like to go into a (residential) home.' ] said not likely] 
don't want no home. " OP 13 
The ability to adapt to changing circumstances was apparent in a number of participants 
and they were prepared to accept the limitations that advancing years and illness had 
imposed and were able to make the best of their situation. 
"] 'm quite happy as ] am you know and] can get out for a walk and] can meet 
my friends and go to church. " OP 14 
] 'm not that person sitting in the house and watching that telly don't get me 
wrong only today because your coming. I'm always out, trying to be out as 
much as possible. " OP3 
However for some (and not always the oldest participants I interviewed), getting out 
was not an option, these participants were housebound and did feel isolated. The 
biggest worry was having a serious fall or collapsing and being unable to call for help 
"I'm worried about having a bad do when I'm on my own and I've locked the 
door vou know what] mean and] can't tell anyone. "OP 1 
"] wear this 'charmer' and you just press it and get the paramedic men. How 
the devil they are going to get me down on that chair] don't know because 1 
won't go down on my own. " OP 13 
This lady was in a first floor flat which was provided with a stair lift. 
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Although I did not ask any particular questions in this area, death and bereavement did 
feature in the participant's interviews, only one participant was living with a spouse and 
for some the death of a spouse had left them struggling to manage with their health 
problems and medication when previously this had been taken care of for them. 
"Then Dad (her husband) died whilst we were on holiday about 7 years ago, 
while we were in the Isle of Wight. It was the last day we were there but there is 
nothing you can do about it so you just have to accept these things". OP 10 
"N (husband) took over and started doing the tablets but then when he got to the 
back end and started being poorly then he got really mixed up, so consequently 
when he died last year I had to start again and it's a hard job to remember them 
all." OP3 
Some of the participants felt that they had been near death themselves and, as a result, 
were careful to take their medication. 
" ... there was a nurse at the side of me and she said 'you have been very poorly, 
all you were saying was 'let me die, let me die' and she said the doctor said Oh 
no we don't let anybody die. And that was some years ago and that's why I take 
these little blue heart tablets although I don't have any trouble with my heart. " 
OP13 
"they found a clot around me (sic) heart so they gave me this drug and I had a 
heart attack when they were doing it, it were really awful, I thought I were going 
to die. " OP 3 
Finally, in this part of the interview, I asked those participants who were filling their 
own devices if they were aware that some phannacies filled MCAs for patients. I made 
it clear that I was not offering this service to them but hypothetically asked if they 
would accept the service if offered. All four of the self-fillers made it clear that all 
though they were aware of the service they did not feel that they needed it yet. 
''yes but I don't think I'm in that category as yet thank goodness. I've got my 
independence and I'm capable of doing it so therefore everything I can do on my 
own I'm pleased to be able to do." OPI6 
"I don't need it yet but there are a lot who do. " OP8 
It was clear that the self-fillers, although using a MeA, saw the devices provided by the 
phannacy in a different category and those people who required this service to be in a 
different state of health to themselves. I tried to discover what sort of person would 
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require the service and it became clear that they thought it was people with cognitive 
problems. 
"well I would assume dementia or somebody living on their own and they might 
forget." OPI8 
6.5.6 Overview of the themes and categories emerging from health beliefs 
The themes which emerged from the health beliefs area of interest were grouped into 
categories and subcategories and details are given in Figure 11 below. 
Figure 11: Categories and sub-categories emerging from health beliefs. 
Medicines are important Medicines are harmful 
Knowledgeable about 
medicines Take too many medicines 
Independence and in Changes to medication 
control 
Medicines are a way of 
life 
Lack of trust in healthcare 
Trusts health care 
professional 
professional 
I Positive health belief themes J I Negative health beliefs themes I 
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6.6 Themes related to Age and Ageism 
Multi-compartment compliance Aids are often recommended for use by older people. 
This may be because there is a perception that people in the older age groups are less 
likely to take their medication as directed or that older people are more forgetful. I 
wished to discover if the older people I interviewed thought that they had been given an 
MeA because of their age and if so, what their feelings were about this. The first 
interviewee raised the question of ageism without prompting, he was very vocal on the 
subject and said that he felt that many people, not just healthcare professionals, treated 
him like a child. 
6.6.1 Lack of respect: treated like a child 
"They treat you like a kid you know like an old age pensioner which] am but] 
don't like to be told that. ] want to manage on my own, ] think they talk down to 
you when you get to a certain age that's the feeling] get. ] don't want them 
here." OP1 
One other participant was very concerned about the way she was treated in hospital and 
had complained to the staff. 
"] just tell them straight] said 'look lets face it I'm 75 and I'm not a kid at 2 
year old that you are talking to. ,,, OP 11 
Some participants felt they were treated with a lack of respect by the healthcare 
professionals and they attributed this lack of respect to their age. 
"] wasn't asked if she (member of staff) could be in on my private conversations, 
she wasn't a professional and their attitude wasn't professional either. If] had 
been 50 would] have been treated like that?" OP8 
This comment refers to an incident which happened when the interviewee was in 
hospital, she felt that she had not been treated with respect and had in fact been seen as 
confused and incapable. 
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6.6.2 Lack of communication and consultation 
Another concern, for some participants, was that they felt marginal is ed, that decisions 
about their care and their medication in particular were taken by healthcare 
professionals without discussion; sometimes a relative was involved in the decision 
making which gave rise to feelings of resentment. 
" ... both the pharmacist and G (daughter) know more about what I'm taking 
from the doctor than I do myself now. Now that is something that I wouldn't say 
irritates me but I think, I should be knowing that. " OP 10 
6.6.3 Fear of losing mental faculties. 
Another concern for the participants was the thought that they might be losing their 
mental faculties. The interviewee who did not want to use the MeA and had already 
sent it back on one occasion, found out from the pharmacist that it is the GP who has 
requested that her medicines are dispensed in this way and this worries her. 
"I was a bit upset I thought Oh God do they think I am going bonkers or 
something, you know." OP2 
This worry that mental confusion was waiting around the comer was expressed by other 
participants. 
"In fact I go and help at the luncheon club down at church because I think how 
long will I be on this side and not the other." OP6 
"And I'm all there, I know what's going off. That's it isn't it because some 
people have dementia and all sorts. " OP 15 
6.6.4 Proud of their age 
Not all the participants saw their age as a problem, a number were proud of their age 
and especially the fact that they were told that they did not look their age. 
"] find that people say 'you are not as old as that M are you? ' you know] go 
'well yes' and I give them the date that I'm bom and you can't get ayvay from 
that can you?" OP 14 
"No I'm proud to brag about it (age). I mean there is a lady at (flat number) 
~H'ho is coy about her age, now] can't imagine people being like that who don 'f 
want people to know. " OP 12 
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This group had maintained a quality of life and although they may have had to adapt to 
their changing circumstances they still enjoyed life. 
" I'm quite happy as I am you know and I can get out for a walk and I can meet 
friends and I go to church. I do everything really and I do try to keep it up but I 
am tired in the morning and I can't get used to that but I forget about it. " OP 14 
"as long as I am able to look after myself and cook and clean that's all I'm 
happy." OP9 
6.6.5 Overview of the themes and categories emerging from age and ageism 
The themes which emerged from this area of analysis were grouped into categories and 
subcategories. Details of the categories and subcategories are given in figure 12 below. 
Figure 12: Themes which emerged from the Age and Ageism analysis 
I Proud of age l I Treated like a child 
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6.7 The older people's interviews: Discussion 
6.7.1 Trigger for use 
The themes which emerged from the interviews in this area of interest could be divided 
into those which led to the older people willingly using the device and those which led 
to reluctant use. Some themes could be defmed as falling into both categories. 
I 
I 
I 
171 
A majority of the interviews produced themes which came within the willing use 
category. Interviewees were willing to accept and use a MeA if the use had been 
suggested by a family member. 
The three interviewees who acknowledged problems in taking their medication prior to 
receiving the MeA, were also happy with the device. These interviewees accepted that 
they had problems managing their medication and were grateful for the assistance the 
MeA gave. However, one interviewee did state that he still forgot, occasionally, to take 
his medication. 
The themes which were grouped in the decision of a healthcare professional sub-
category led to both willing and reluctant use of the MeA. For two of the interviewees, 
the decision was made by their GP. The decision was welcomed by one interviewee, 
possibly because the decision was supported by a family member, but not by the other. 
The interviewee who was reluctant to use the MeA had, in fact, returned the device on a 
previous occasion and was considering returning the current device. This lady was 
suspicious of the motives of both the GP and the pharmacist and felt that she had 
managed her medication perfectly well prior to her accident and hospitalisation. 
Approximately half of the interviewees stated that the issuing of the MeA had been a 
decision made by a healthcare professional and, for the majority of these older people, 
this was connected to a hospital stay. This mirrors the findings of the preliminary study 
where 39% of the patients interviewed had, had their MeA instigated by hospital staff. 
The hospital admission, for those interviewees in the main study, appears to have been 
an unplanned one, resulting from a fall, an unexpected collapse or worsening of a 
known medical condition. One interviewee, OPI5, indicated that the fall she had was 
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caused by the medication she was taking, although it was unclear whether it was a case 
of overdosing or being prescribed a medicine she did not require. 
Research studies have looked at the incidence of drug related factors in admission of 
older people to hospital. Polypharmacy, (defined as taking five or more regular 
medicines), and taking drugs with a narrow therapeutic index were concluded to be risk 
factors amongst sheltered housing residents (Johnson et al. 2006). The older people 
therefore often arrived in hospital confused, anxious and disorientated and may appear 
to the hospital staff to be unable to manage their medication on discharge, leading to the 
issue of a MeA. A paper published recently (Young and Inouye 2007) suggested that 
older patients may be diagnosed as demented when in fact they are suffering from 
delirium. The problems of waking up in a hospital bed and trying to make sense of 
what had happened were discussed by two of the interviewees. While some 
interviewees were happy to receive a MeA on discharge others were not and the 
inclusion of unfamiliar drugs within the MeA could lead to further distress. The most 
common complaint was that 'nobody told me'. This lack of communication on hospital 
discharge can lead to inappropriate medication compliance. A study of 103 elderly 
patients, discharged from a general hospital, looked at the impact of counselling by a 
clinical pharmacist prior to discharge (Sweeney, Dixon and Sutcliffe 1989). The 
patients in the counselled group showed a reduction in medication errors compared with 
the control group. Studies have looked at the provision of particular strategies to 
improve medication compliance after discharge, however these have not always been 
conclusive. Four different educational strategies were investigated in 42 patients aged 
65 or over who were being discharged from hospital (Esposito 1995). The interventions 
included educational material, a medication schedule and 30 minutes verbal instruction 
and the four groups each received different combinations of the interventions. The 
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groups which received the medication schedule (similar to a reminder chart) had the 
highest compliance rates. 
The older people in this study, who received the MeA as a result of a hospital stay, 
were divided in their willingness to use the device. If the decision was made by the 
healthcare professional without reference to the older person then this was likely to lead 
to a degree of dissatisfaction. However, if the older person believed that they had made 
or contributed to the choice themselves, they were much more willing to use the device. 
It could therefore be conjectured that making one's own decision or agreeing with the 
decision might be an indicator in how happy a person is with their MeA. The 
interviewees who were self-fillers all discussed taking control or responsibility oneself. 
Liking to be organised and working out one's own system were also themes which 
came out of these interviews. These themes did not emerge from those older people 
receiving a MeA via the pharmacy or having one filled by a carer. 
The question of choice in healthcare is one which has been given a great deal of 
publicity in recent years. The Department of Health has set mechanisms in place to 
allow patients to make choices about their healthcare.(Department of Health 2007a). 
For some interviewees, the reason they had received a MeA was a mystery. As far as 
they were concerned, they had been managing their medication well and could identify 
no problems. There may be an element of self denial in this and, while the older person 
thinks they had been managing well, others (such as relatives, healthcare professionals) 
may have detected problems. A quarter of the interviewees stated that they had a 
particular method of reminding themselves to take their medication and these strategies 
used as an aid to remembering can be very important (see Section 7.7.4.). 
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The consequences of issuing a MeA to older people who are already using their own 
reminder methods can be counter-productive. Older people may try to continue using 
their own method by removing the medication from the MeA and using their home 
made reminder system. This can cause confusion both for the older person and for 
healthcare professionals who may wish to monitor medication compliance. 
6.7.2 Use of the MeA. 
The themes for MeA use were divided into seven sub-categories which were then 
grouped into two categories. The categories were 'Positive attitude towards MeA use' 
and 'Negative attitude towards MeA. Firstly I will discuss the positive attitudes. 
A majority of the patients cited ease of use, simplicity or 'handiness' as advantages and 
this sub-category was found right across the three groups. Only two participants (both 
'pharmacy filled') did not see these advantages. Provided that the user could manage to 
use the device successfully, removing the necessity to open separate boxes and bottles 
was an important consideration to these interviewees. 
Another reason given for having a positive attitude to the MeA was that there was 'no 
need to think about medicines'. The medicines were in the MeA which was filled by a 
carer or the pharmacy and the older person simply took what was in a particular 
compartment without any thought, more medicine arrived as required and for some 
people this situation was ideal. People, who are happy to take their medication in this 
way, have been described as 'Passive Users'(Dowell and Hudson 1997). This view of 
patients as passive recipients of medication was also discussed by Stimson (1974). 
Stimson thought that this view of "ideal" patients as passive recipients of care was the 
view of the majority of healthcare professionals at this time and he sought to question 
this perception. For those older people in this study who could be defined as "passiyc 
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users", the fact that the pharmacy organised the repeat prescriptions and often delivered 
was also seen as a positive point. 
The self-fillers took control of their medication, they were willing to spend up to thirty 
minutes on one day each week filling the device in order to make taking the daily doses 
easier. Therefore, despite some misgivings about the particular device, the self-fillers 
could see a benefit. 
Only three participants, one from each group, stated that the MeA reminded them to 
take their medication. Some interviewees stated that they kept the MeA in a special 
place, others were reminded by events during the day and others removed the medicines 
from the MeA and put them elsewhere. Remembering to take one's medication as 
directed is often considered to be a prospective task. That is, the patient has to 
remember to undertake a task in the future (Einstein and McDaniel 1990). However 
researchers have argued that medication adherence is a much more complex task than 
this, involving working memory, long-term memory and social factors (Park and Kidder 
1996). Research has been undertaken, to investigate the ability of young and older 
people to perform various memory tasks (Maylor 1996). Despite the opinions to the 
contrary, older adults have demonstrated a superior ability in many of these memory 
experiments. Research into memory and adherence among older people has suggested 
that older people are more likely to use memory strategies to aid memory (Branin 
2001). These memory strategies can be internal e.g. relating medicine taking to one's 
own routine, or external e.g. using a MeA or writing notes. Research has shown that 
older adults use more internal strategies than external when adhering to their medication 
regimen.(Branin 2001; Gould, McDonald-Miszczak and King 1997). 
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Those interviewees, who trusted their healthcare professionals, were most likely to have 
a positive attitude to using the MeA. Interviewees described excellent service from 
community pharmacists both in terms of delivery and in managing changes to the 
medication regime. Having a good relationship with the GP was also likely to lead to 
positive MeA use. 
Negative attitudes were also identified In over half the interviewees and these are 
discussed below. 
Some interviewees found the MeA difficult to use despite thinking that the device was 
'handy' or that the medicines were always available. A study by Atkin et al (1994 
p.IIS) found that 24% of the study group could not open a Dosett® box, in fact the 
researchers go on to say 
"it is likely therefore that patients most in need of such containers are the least 
likely to be able to manage them. Perhaps the true value of such devices is to 
aid carers in the management of patient medication. " 
Another study found that 16.8% of the study group could not open a 'Dosett' (Nikolaus 
et al. 1996). The researchers in this last study examined the difference between their 
findings and those of Atkin et al and stated that this was likely to be due to the fact that 
they had tested different' dosetts' and chosen the most appropriate for the needs of their 
patients. This suggests that careful selection of a MeA and trial with the older person 
may result in easier use. I have been unable to discover any recent research studies 
which have looked at the ability of older people to remove medication from the sealed 
disposable type of MeA e.g. Venalink® or Nomad® and yet my own personal 
experience from previous research and the comments made by interviewees in this study 
suggest that older people can experience considerable difficulty in removing medicines 
from these devices. In Section 7.7.4. I discuss the health care professionals' opinion 
about this. 
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A number of interviewees had had the type of MCA changed. This may happen after 
hospital discharge when the hospital provides one design and the community pharmacv 
provides a different one. On other occasions the community pharmacy changed the type 
of MCA they supplied. For some older people this was a problem and often the change 
was made with little consultation or communication leaving the older person upset and 
confused. Neither the hospital nor the community pharmacies appeared to base their 
decision regarding which MCA to issue, on the ability of an older person to use the 
device. Green and McCloskey (2005) surveyed 217 hospitals about their use of MCAs. 
The 168 respondents used a range of different MCAs and the researchers stated that the 
reasons for choosing to use a particular MCA were unclear. However the study showed 
that choice was unlikely to be made based on patient assessment. Those participants 
who were self-fillers or who had the device filled by a carer were less likely to 
experience this problem, although having purchased a device which then proved 
unsatisfactory might make the purchaser reluctant to discard it. 
The problem of identifying medicines in the MCA was noted by 50% of the participants 
including two whose MCA was carer filled. Older people, who had been in control of 
their medication previously, still felt the need to check that the correct medication had 
been supplied and the arrival of an unfamiliar medicine in the MCA caused concern. 
The possible confusion caused by the change in appearance or packaging of dispensed 
medication was investigated among patients attending community pharmacies in 
Merseyside (Goulbourne and Rubinstein 1989). Three quarters of the patients 
interviewed had experienced unexplained visual changes to their dispensed medication 
and 69% expressed a wish that the appearance of their medication should remain the 
same on each prescription. This highlights a problem caused by the lack of 
communication between the older person and the community pharmacist. Those older 
178 
people who received pharmacy filled MCAs usually had their medication delivered by 
the pharmacy. The delivery services were provided by a driver. The older people 
therefore missed out on the counselling and advice which those people attending a 
pharmacy to have their prescriptions dispensed would receive. 
6.7.3 What were the health beliefs and attitudes of the older people? 
The older people interviewed held very definite attitudes and beliefs about many aspects 
of their lives. Their health and medication use was not necessarily the most important 
consideration, although these issues did form part of the wider picture. 
From the very first interview, the importance of maintaining their independence 
emerged as a theme. This was not a theme which I had originally considered and 
therefore the topic guide was modified to include a question on independence. However 
it was seldom necessary to ask this question as interviewees were keen to tell me of 
their desire to remain independent or in control. Independence and control are 
considered to be attributes of autonomy (Jacelon 2004). In her study of older adults 
admitted to hospital in USA, lacelon investigates the concept of autonomy. She defines 
autonomy as "the freedom and ability of older adults to act on their own behalf."(p.30). 
Although lacelon's study investigated hospital in-patients there appears to be a great 
deal of relevance to the older people in my study. 
As would be expected, all the 'self-fillers' gave strong indications about their 
independence and the importance of making their own decisions and being in control. 
When asked the hypothetical question about having a MCA filled by the pharmacy, two 
stated that they did not need that service yet, indicating that they felt that MCAs v,"ere 
filled by the pharmacy for people who were confused or unable to manage their 
medication. As one interviewee stated 
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"I've got my independence and I'm capable of doing it so therefore everything J 
can do on my own I'm pleased that I'm able to do so and until the time comes 
(when) 1 may have to revert to the chemist doing it and 1 will accept it if I'm 
unable to do it on my own. " OP6 
The interviewees, who had the MeA filled by a carer, were less likely to discuss 
independence; three of the four people in this group relied heavily on family support 
and might not manage without it. 
A majority of those using a pharmacy filled MeA also discussed the importance of 
maintaining their independence and especially remaining in their own home. So it may 
be that these participants accepted the MeA as a means to maintaining their 
independence. 
Irrespective of whether the MeA was filled by the pharmacy, a carer or themselves, the 
majority of the interviews produced themes which fell into the 'medicines are 
important' sub-category. This finding agrees with other research that has shown that, 
rather than being non-compliant with their medication, many older people are concerned 
about their health and realise that taking their medication as instructed is important 
(Britten 1994). A number of the interviewees were very knowledgeable about their 
medication and implied that they would discuss this knowledge with the healthcare 
professional if the need arose. 
Some of the participants regarded their health problems as serious and therefore viewed 
medicines used to treat these illnesses as important. This finding supports the Health 
Belief Model (HBM) (Becker and Maiman 1975). The Health Belief Model, as 
described by Becker and Maiman, proposes that the likelihood of a person adhering to a 
medication regime is determined by five variables: 
The perceived susceptibility to the disease process. 
The perceived severity of the disease. 
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The perceived benefits of the action weighed against. 
The perceived cost of taking action. 
The degrees to which internal or external cues to action are present to activate the other 
variables. 
In this study, those participants who viewed their medical condition as serious were 
meticulous about taking their medication, usually this was medication to treat a 
cardiovascular problem and warfarin was singled out as being extremely important and 
not to be missed. On the other hand, the same participants often missed doses of other 
medication, for example analgesics, which they viewed as less important, although they 
realised that without the analgesics the pain would return. 
The relationship the interviewee had with healthcare professionals could have a positive 
effect on their beliefs about their illness and their medication or it could cause the 
opposite effect. Some participants trusted their doctors and were happy to 'follow 
doctors' orders' seeing the doctor as the expert. This was particularly true of hospital 
consultants whose views the interviewees rated highly. Research has confirmed this 
trust that many older people have in their doctors. A study of 170 French adults aged 
18 - 93 rated their likelihood of taking a medication intended to relieve physical 
suffering in 27 scenarios (Herve, Mullet and Sorum 2004). In younger adults, high trust 
in the physician was not sufficient a reason to accept a new medicine whereas in very 
elderly adults high trust led to high acceptance. 
This issue of trust in the healthcare professionals was found across all three groups. 
Not all the themes which emerged from the interviews could be considered to fall into 
the positive category. A third of the interviewees viewed medicines as harmful and to 
be avoided if at all possible. There was a feeling among this group that too many 
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medicines were prescribed and the interviewees wanted to be convinced that any new 
medicine was necessary. This attitude has been discussed in other research studies 
(Britten 1994; Donovan and Blake 1992) In the study by Britten one respondent used 
the word "carcinogenic" to describe medicines while others saw medication as 
unnatural and harmful. Donovan and Blake found that patients stopped taking 
medication because of fears of side effects or publicity about withdrawn drugs. In a 
qualitative study which investigated patients decisions regarding their antihypertensive 
drugs (Benson and Britten 2002) similar findings were discussed. Patients' reservations 
about taking their antihypertensive medication were related to opinions that drugs were 
unnatural or unsafe and best avoided. There appeared to be a lack of information and 
counselling given to the older person about any new medication and this often left them 
confused and unsure. A study of patients with chronic conditions who were prescribed 
new medication found that about one third did not take the new medication as 
prescribed (Barber et al. 2004). The researchers found that many of the patients 
expressed a need for further information. 
Some interviewees stated that their medications were changed when they were 
discharged from hospital. These interviewees felt that they weren't fully consulted 
about these changes, although on some occasions their relatives were informed and this 
led to resentment. Various studies have looked at the problems which occur with 
medication management after hospital discharge and various strategies have been tested. 
Special counselling by a pharmacist, pharmaceutical care plans and reminder cards were 
found to improve compliance with medication after discharge (AI-Rashed et at. 2002; 
Smith et al. 1997). 
Other negative beliefs that the interviewees discussed fell into the sub-category of the 
consequences of old age. All the participants apart from two lived alone and four found 
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it almost impossible to get out of the house even with help, while others had to rely on 
assistance from relatives or friends. Consequently some participants found themselves 
isolated and worried about a worsening of their condition and being unable to call for 
help. A few interviewees discussed problems which had occurred as a result of the 
death of a partner and how in some cases their illness had worsened. The fear of death 
also made some interviewees very detennined to keep taking their medication in case 
non-compliance with their medication might lead to very serious consequences. 
6.7.4 Have I got this because of my age? 
Age can be represented by our chronological age (Bytheway 1997), however this is not 
always a useful discriminator. Old age at this present time appears to start when a 
person receives their state pension, at the time of writing this thesis that is 60 years for 
women and 65 years for men in the UK. However many women work until they are at 
least 65 and men beyond their 65 years pension date. For this research study, I set the 
minimum age for interview as 65 years, although in reality the youngest I interviewed 
was 72 and the oldest 92. When looked at in terms of health and quality of life there 
was no relation between these factors and chronological age, the interviewee who 
appeared to be in the poorest health was 73 and one of the fittest and mentally most alert 
interviewees was 91. 
I have previously stated in section 6.3 that research studies have not identified a link 
between medication non-compliance and age. Researchers in the USA who investigated 
compliance with anti-hypertensive medication by elderly Medicaid enrolees (Monane et 
al. 1996) found that old age was associated with better compliance. The study 
investigated 4068 elderly patients aged over 65 and found that those patients aged 85 or 
over were most likely to be compliant followed by the 75 - 84 age group with the 
patients in the 65 - 74 age group least compliant. The researchers hypothesised that 
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those patients who were in the older cohort might represent a 'survivor cohort' who had 
attained their age by taking their medication as directed. A study in the UK compared 
compliance with two difference medication regimens in young and old adults (Lorenc 
and Branthwaite 1993). The results of the study suggested that age alone was not a 
reason for poor compliance. Based on the different research studies, old age cannot be 
seen as a reliable predictor of non-compliance and I was therefore interested to discover 
if the MCAs had been issued to the participants solely because of their age. 
The first interviewee, OP 1, left me in no doubt about his thoughts on ageism and several 
other interviewees also introduced the subject of age. Ageism has been described as a 
set of social relations that discriminate against older people and stereotype them in an 
oversimplified and generalised way (Minichiello, Browne and Kendig 2000). Research 
into ageism has usually centred on identifying ageist practices, rationing of services 
according to age or discriminatory treatment. Fewer studies have looked at ageism from 
the older person's perspective. Minichiello (loc.cit.) interviewed older people in order 
to discover their views on ageism and his respondents spoke freely of the negative 
experiences of "being seen as old" and "being treated as old". 
Some participants interviewed in my study stated that they felt they were treated like 
children and in particular were "talked down to," with healthcare professionals 
assuming that they couldn't understand. This type of behaviour results from 
stereotyping older people and has been observed by other researchers (Koch and Webb 
1996). Lack of respect was another theme which emerged, with some interviewees 
thinking that healthcare professionals did not show them respect or treat them 
respectfully. The interviewees related this type of treatment to their age. This is 
supported by the research undertaken by Koch (1996) who undertook interviews with 
patients on a Care of the Elderly ward in a large UK hospital. The interviewees in the 
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Koch study felt that they were treated like objects and that little thought was given to 
treating them as individuals. 
Positive views on age were held by less than half of the interviewees in my study, 
adapting their way of life to suit their situation was mentioned by about a quarter of the 
participants and about an equal number expressed pride in having achieved the age they 
had. These older people accepted their stage in life adapted to changes in circumstances 
and in some cases looked forward to the coming years. 
Leading on from this, there was resentment that relatives or carers seemed better 
informed about their condition than they were. The four participants who had their 
MCA filled by an informal carer, in each case a relative, had differing views on this 
arrangement. The interviewee OP7 who had the MCA filled by his wife was very 
accepting of the situation and had probably been looked after by his wife all their 
married life. One interviewee OP5 was very accepting of her daughter's help and the 
interview revealed that the daughter who filled the MCA was acknowledged to be the 
'bossy one' in the family who arranged everything. This was all described with good 
humour. The third interviewee (OP 10) was grateful for the arrangement at first but as 
she regained her strength and independence was showing signs of resentment. The 
fourth interviewee (OPI5) was happy to receive help fro her family. 
Studies have looked at the role of informal carers in managing medicines for older 
people (Francis et al. 2002; Boyle and Chambers 2000). These studies identified a 
paternalistic attitude among some of the carers interviewed which may also be the 
problem for the two participants of this study detailed above. 
Regarding the issue of MCAs, two negative themes emerged in this section. Some 
interviewees felt that people, (not necessarily themselves), might be insulted if given a 
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MeA, i.e. it implied that they couldn't cope and were being treated like child. Another 
worry mentioned by people, who had received a MCA, was that the healthcare 
professional thought that they (the older person) were losing their mental faculties. 
6.8 Summary of chapter. 
In summary, this chapter has found that: 
The Trigger for use most frequently identified by the participants was admission and 
subsequent discharge from hospital. 
Use of MCAs was linked to positive themes in many of the participants but there were 
difficulties for some people in using the device. Making medicine management easier 
was the most frequent positive theme and very few participants stated that using the 
MCA helped them to remember to take their medication. 
The Health Beliefs of the older people were an important indicator of the participants' 
compliance with their medication. 
Age and ageism. Some participants identified themes linked to ageism while others did 
not. There was some suggestion that MCAs might be issued to people because of their 
age. 
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Chapter 7: 
Interviews with healthcare professionals: 
Findings and Discussion 
7.1 Introduction. 
This chapter details the findings of the analysis of the healthcare professional interviews 
and follows with a discussion of these findings. The chapter commences with the 
demographic details of the healthcare professionals recruited to the study. The triggers 
which can lead to the issue of a MCA to an older person and the characteristics of the 
recipients are discussed in section 7.3. The following section details the advantages and 
disadvantages of the MCAs as perceived by the healthcare professionals. The health 
beliefs and attitudes of the healthcare professionals are explored in section 7.5 and the 
attitudes of the interviewees towards age and ageism are discussed in section 7.6. A 
discussion of the findings is contained in section 7.7. and Section 7.8 summarises the 
chapter. 
7.2 Demographic Details. 
Seventeen health care professionals were recruited by the methods described in Chapter 
5. At the beginning of each interview, the participants were asked brief details about 
themselves including their job title and the number of years since they registered with 
their professional body. 
Table 19 shows details of the healthcare professionals who consented to take part in the 
study. 
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Table 19: Healthcare professionals' demographic details 
IDno. gender Profession Sector Years smce 
registration 
HCPI Female Pharmacist Intermediate Care 9 
HCP4 Male Pharmacist Primary Care 5 
HCP5 Female Pharmacist Primary Care 19 
HCP6 Male Pharmacist Secondary Care 27 
HCP7 Female Pharmacist Secondary Care 1 
HCPll Female Pharmacist Secondary Care 29 
HCP9 Male Doctor Primary Care 13 
HCPI0 Male Doctor Primary Care 19 
HCP13 Female Doctor Secondary Care 23 
HCP15 Female Doctor Secondary Care 3 
HCP8 Female Nurse Secondary Care 30 
HCP14 Female Nurse Secondary Care 2 
HCP12 Female Nurse Intermediate Care 23 
HCP2 Female Nurse Intermediate Care 6 
HCP3 Female Nurse Intermediate Care 7 
HCP16 Female Nurse Primary Care 20 
HCP17 Female Nurse Primary Care 2 
7.3 What triggers the issue of a MeA? 
The research study was first briefly described to each healthcare professional and I 
explained that 15 older people, aged over 65, who were taking four or more regular 
solid dose oral medicines contained in a MCA, had been interviewed. I followed this 
explanation with a simple closed question: 
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"Do you recommend the use of multi-compartment compliance aids for older people in 
your care?" 
This question did have to be modified slightly for the community pharmacists as they 
are more likely to respond to a request than initiate the use themselves. At this point 
only one person said that they did not recommend the use of these devices and then 
went on to explain why not: 
"To be honest I don't actually recommend the use of compliance aids 'cause J 
think that people who are going to forget to take their medications you know just 
using ordinary boxes, medicine boxes, I don't think the Dosett boxes help 
remind them to be honest that's my opinion really. " HCP 14 
This young Staff Nurse did have some very definite ideas about the use of MCAs but 
although this answer might seem like the end of the interview almost before it had 
begun, she did go on to develop her own theories further. The other participants did 
recommend the use or in the case of the community pharmacists did dispense in MCAs. 
This question was then followed up by: "Can you tell me a little more about this?" 
This probe led to further clarification concerning who would request the issue or use of 
an MCA and what the characteristics were of the older person. 
7.3.1 Who would request use? 
This question brought forth a good deal of discussion about who would request the use 
of an MCA for a patient Two interviewees suggested that they might request the supply 
themselves. Surprisingly from my perspective one of these was a community 
pharmacist. 
.. You know usually the last two or three have probably been identified by 
ourselves. " HCP5 
Interviewee HCP 16 also indicated that she would make the decision herself if she felt 
concerned about a particular patient. 
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The majority of the healthcare professionals interviewed stated that the request was 
made by other healthcare professionals rather than themselves. Hospital discharge was 
seen as a driver for MCA issue, by those working within the primary care. 
"you know the hospital put them on Venalink and often will fax a copy of the 
discharge so we know what they are on "HCP5 
"we get a discharge note that says 'please put in a Venalink '. " HCP4 
"The myth of home care" 
The most frequently stated reason given by the healthcare professionals was "the myth 
of home care", the phrase used by one of the hospital pharmacists interviewed. It is 
used here as an "in vivo code", as described by Glaser and Strauss (1967) where the 
name assigned to the theme or code is one used by an interviewee themselves. 
"They (the patients) are going home and they are going to have home care and 
there is still this myth that perpetuates that home care can't assist medication 
unless it is in a compliance aid. " HCP 11 
This idea that home care staff were unable to prompt a patient to take medication unless 
the medication was dispensed in a MCA was discussed by a number of participants. 
" we only request it, compliance aids, if we know that they're going to have 
home care prompt medication, in which case it's a legal requirement because 
home care aren't able to get them (medicines) out of separate boxes. " HCP 12 
"sometimes it's somebody else that is going to prompt them and also home care 
will only prompt people even though we keep hearing that they have this 
fantastic new scheme where they are training all the healthcare assistants so 
that they will be able to prompt people not from dosetts but they won't at the 
moment." HCP 13. 
"mainly if they were having home care, then they would need it, if they weren't 
able to do their own medicines then if home care were going to prompt or give 
medication they have to be in a compliance aid. " HCP 2 
Some healthcare professionals stated that the Intermediate Care Team also preferred 
that patients who were being discharged into their care had the medication in a MeA. 
"if they (nursing staff) have arranged for lCT to supervise the tablets. " HCP7 
"Intermediate Care team like them so that they can supen'ise the patient taking 
them (medicines). " HCP6 
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Relatives request the supply of a MCA 
Relatives were also cited as requesting a MCA or the healthcare professional felt that 
the relative would purchase a device themselves. 
"sometimes the relatives would identifY it, sometimes relatives buy a box from 
the chemist and they fill them up each week." HCP2 
"the members of the family ask us sometimes. " HCP 10 
Self-fillers 
Finally, the healthcare professionals identified those patients who bought and filled their 
own MCAs as described in Section 6.2 and categorised as "self-fillers". 
'yes well some people just buy a Dosett box and fill it themselves on a Sunday 
afternoon and put them out for themselves. " HCP 16 
7.3.2 What were the characteristics of the older people? 
The interviewees were asked if they could describe the type of older person who would 
be likely to receive their medication in a MCA. 
Memory problems 
A number of the interviewees stated that memory problems were a reason for initiating 
a MCA. 
"they've (patients) got a problem with memory, a Venalink or Dosett box is 
better for them because it prompts them to take just the tablets that day. " HCP8 
"most commonly it would be patients who are a little cognitively impaired and 
who are struggling to manage their medication when it is presented to them as 
separate boxes or bottles. " HCP 13 
"Elderly patients, some of them with say with difficulty remembering to take 
their medicines at specific times of the day or take their medication in the 
appropriate kind of prescribed way." HCP 10 
Expert patient. 
The healthcare professionals also identified different levels of expertise with medication 
amongst the older people. A number of interviewees stated that many of the older 
people they saw could be considered "expert patients" in regard to their medicine 
management skills. 
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"1 would say most people we see like to be meticulous about the tablets and thev 
take it very seriously because they want to maintain their health." Hep 12 -
"you know some of these people come in and they are 99 and they are on 
polypharmacy and they still remember every iota that they are taking all the 
doses all the times." Hep 15 
Less knowledgeable patient 
However some older people were identified as being "inexpert" with little knowledge of 
what they were taking or why and who seemed happy to simply follow instructions. 
"they (the patients) just like them in a box because they weren't interested, they 
trusted their doctor they just took what they were told, when they were told and 
they liked the aids." Hep2 
"you ask people who are still on tablets what tablets they are taking , some 
people say 'I've no idea'." Hep3 
Physical disabilities 
Aside from memory problems, the interviewees saw physical disabilities as a reason for 
initiating a MeA; arthritic hands and visual impairment were given as reasons for 
initiating use. 
"Sometimes people with physical arthritis, arthritic hands things like that." 
Hep12 
Polypharmacy 
Problems due to having a large number of different medicines were also mentioned as a 
reason for using a MeA. 
"1 can see the advantages particularly with the polypharmacy patients, these are 
not young people and they are on all sorts of tablets. " Hep 15 
"patients who are taking a lot of medication. " Hep 16 
7.3.3 Assessment of the older people. 
The issue of assessing older people, before initiating a MeA, was brought up by many 
of the healthcare professionals. The healthcare professionals, who were most likely to 
initiate use, were those who discussed their assessment in some detail. 
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"the pharmacy needs assessment is very much about what is the patient's usual 
routine, who orders the medicines, where do you keep them and things like 
that. " HCP 1 
" when a nurse initially assesses a patient one of the nurse's roles is to look at 
the medication and we have an assessment tool which we use and we identify 
lots of things about whether the patient knows what medication they are taking, 
why they are taking it, when they are taking it do they have any difficulty 
opening boxes do they use any compliance aids. " HCP 12 
Healthcare professionals, who were not so closely involved in the original setting up, 
were often likely to criticise their colleagues, suggesting that the older person had not 
been properly assessed. 
"and sometimes they (patients) are sent home with these Venalink and they have 
no idea, they've never seen them before and sometimes their tablets have been 
changed whilst in hospital and they don't know exactly which ones. " HCP3 
Two healthcare professionals raised the point that knowing when and where to assess 
the patient could be very important. One of these healthcare professionals was a 
community pharmacist who recently had a short stay in hospital and her comments were 
based on personal experience. 
"1 presume they use a proper assessment tool in the hospital ----they send a lot 
of them (older people) out on Venalink or what ever but I mean J've just been 
this last week, I've been in for a tooth operation and I had a general anaesthetic, 
I was very disorientated for a couple of days and it does make me think do they 
(older people) appear a lot worse in the hospital situation, they're not in their 
own homes.---- may be they are alright at home but deemed to be worse (in 
hospital) I don't know. " HCP5 
The other healthcare professional to highlight this possible problem was a consultant in 
Care of the Elderly. 
"Ideally in my view, and it is only my idea, ideally you wouldn't ever do this 
(assessment) from a situation in which the patient's in a sort of unstable 
condition, so if someone 's not been well and been in hospital you wouldn't 
choose that as the right time to assess whether they can from now on in 
perpetuity manage their own medication or not. " HCP 13 
7.3.4 Try other strategies first. 
Finally in this section on 'Triggers', I asked if the healthcare professionals \\'ould try 
something else before resorting to a MeA. A number of alternatiyes were mentioned, 
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the most popular being medication charts and reviewing the medication to try and 
reduce the number of medicines. 
"the first thing we go for is a medication card which is a list of all the tablets, 
their name, the brand name, what they look like, what they are for briefly like 
for your heart or for blood that sort of thing. Then there is four rows and we put 
how many they should take of each tablet at the four times of the day. " HCP 11 
" we do ask GPs for a medication review or we try to condense them 
(medicines) down to once or twice a day. " HCP 12 
7.3.5. Overview of themes emerging from Trigger for use. 
The themes emerging from the trigger for use analysis were arranged into sub-
categories and finally the sub-categories were placed within two main categories. The 
two categories which were identified were decision making factors and patient 
problems. All the themes which emerged from the initial analysis of the interviews 
could be placed within one of these categories. Figure 13 depicts the sub-categories and 
categories identified. 
194 
Figure 13: Sub-categories and categories emerging from Trigger for use. 
Decision making factors I Patient problems 
Hospital discharge I Poor memory 
Request from another healthcare 
professional I 'Inexpert' patients 
The 'myth' of home care I Physical disabilities 
Relatives make request 
I Polyphannacy 
Self-fillers purchase their own 
Lack of assessment 
7.4 Advantages and disadvantages of Multi-compartment Compliance 
aids 
All the health care professionals were asked "what advantages do you see in the use of 
multi-compartment compliance aids by older people living in their own homes?" 
7.4.1 Advantages 
The majority of the interviewees were able to discuss advantages of MCAs, both for the 
older people themselves, or for the healthcare professional. 
I 
I 
I 
I 
I 
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Ease of use and convenience. 
A majority of the interviewees cited ease of use and convenience as the main advantage 
of these devices. 
"I can't get away from the fact that you ask a patient to open six different bottles 
of medicine and read the labels and get it right and follow a chart it is obviollsh" 
much easier to open one little slot in a compliance aid." HCP 1 . 
'for the patient, I think, sometimes it can be simple because it is all just in 
compartments so they don't have to worry about the timings and the quantities 
and all that stuff and sometimes it's easier for them. " HCP 16 
Memory aid 
A number of healthcare professionals stated that the MeA acted as a memory aid and 
that this was a main advantage. 
"they've (patient) got a problem with memory then a Venalink® or Dosett® box 
or Nomad® is better for them because it prompts them to take just the tablets 
that day. " HCP8 
"the fact that they are set out for them (patients) it is a prompt to remind them to 
take the tablets." HCP 17 
Independence. 
Another advantage which was discussed by some of the healthcare professionals was 
independence. Independence had been a main theme which emerged from the older 
people's interviews and it was interesting that the healthcare professionals also brought 
this out. 
"Yes if it helps the patient to stay independent at home but you have to make 
sure the patient can use it (MCA) ... yes certainly there are certain patients who 
it (MCA) helps their independence. " HCP 11 
"I think they do enable people to stay in their own homes whereas they might be 
admitted to a semi-residential home or something like that. " HCP 14 
To benefit others 
Other advantages, which were discussed, were clearly not for the patient's benefit but 
rather for the benefit of a healthcare professional or a carer. 
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"] think the advantages tend to be that people can see what doses they have 
taken so it's good for carers and such like to be able to see what people 
(patients) are taking or they believe they are taking. " HCP4 
"it can be an advantage also for you as a professional to monitor because if)'ou 
are going in every day you can check whether the stuff has gone out of (MCA). " 
HCP16 
Continuous supply 
The fact that those older people who had their MeA filled by the community pharmacy 
usually had the device delivered as well was seen as an advantage by two of the 
healthcare professionals. In addition to delivery, the community pharmacy would often 
arrange the repeat prescription thus ensuring that the older person did not run out of 
medication. 
"they (MCAs) get delivered to the house. " HCP 17 
Although most healthcare professionals quickly named a number of advantages some 
interviewees struggled to answer and it became obvious that this was something that 
they had never given any serious consideration. 
7.4.2 What are the disadvantages? 
I followed up the question about advantages with one about disadvantages although 
some participants were eager to discuss the disadvantages right from the start. 
"] don't see that much advantage in MDS. ]t tends to cause more problems than 
it cures." HCP4 
"]t's really that ] am not aware of what the overwhelming advantages are, if 
there are no advantages then we have to way this up against any disadvantages 
there might be. "HCP 1 0 
The number of disadvantages discussed far outweighed the advantages that had been 
cited and interestingly what had been seen as an advantage to some participants was 
then given as a disadvantage sometimes by the same participants. 
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No use for those with cognitive impairment. 
Memory prompting and use in those with some cognitive dysfunction was cited as an 
advantage, however more participants gave these two themes as disadvantages. 
"They don't as you know always work as well as they should because a lot of 
times the patient, depending on the level of functioning reall}" the cognitive 
functioning, they (patient) may take them (medicines) all at once or they may tip 
them up and empty them on the floor. " HCP9 
"In terms of practicalities obviously if you don't know what day it is and you 
don't know what time it is having a box which says Monday breakfast doesn't 
necessarily help. " HCP 13 
Not a memory prompt 
Despite a minority of participants having stated an advantage of using a MCA was that 
it would be a memory aid, the majority of the healthcare professionals interviewed 
stated that MCAs did not act as a memory aid. 
"if they (patients) forget to take the tablets, if they forget to look at the boxes 
(original packs) in my opinion they're not going to remember to look at the 
Dosett box either 'cos it's not like it actually tells you to take your tablets, you 
still have to remember to look at it. " HCP7 
"and the other thing is that even if you've got the thing (MCA) you still have to 
remember to take it (medicine) haven't you?" HCP 16 
Having established that the MCA does not really remind or prompt the patient to take 
their medication, the healthcare professionals then went on to discuss other 
disadvantages. 
Unable to use the MCA 
The physical problems which older people might have in accessing the medication from 
the MCA were discussed by a number of participants. 
"I see a lot of people coming out of hospital with Venalink and they can't 
actually get into them and I see a lot of people struggling to use the aids they 
have been given which always really frustrates me because if they have come out 
of hospital they have been in a controlled environment and someone should have 
asked if they could actual~l' use it. " HCP 1 
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"well J certainly have come across patients who are unable to get tablets out of 
the compliance aid. J've come across patients who can't read the instructions so 
they've taken them out in a haphazard fashion, so they don't take out Monday, 
Tuesday, Wednesday, they take them out randomly." HCP6 
This issue of older people being unable to use the MeA was discussed in some detail by 
most of the healthcare professionals and amongst some there was the feeling that those 
healthcare professionals who had issued the MeA had failed in their duty of care to the 
patient because they had not checked that the patient could use the device. 
Change of device. 
The interviews with the older people had shown that if the MeA had been issued by the 
hospital on discharge there was a likelihood that when the community pharmacy took 
over the supply the device would change. The older person, who has been instructed 
how to use one device may then be issued with a completely different device and 
possibly no further instructions. 
"do we completely confuse them (patients) by giving them a weeks (supply) in a 
Venalink and then changing it when they get home, which J think is a bit of an 
issue. " HCP7 
"J can certainly see that (changing MCA post discharge) will be a problem and 
it's difficult to know how we should manage that really. " HCP6 
A problem, which could be associated with changing a MeA, was identified by one of 
the more recently qualified interviewees. 
"we have actually had a few problems with them we had a patient who ... you 
know how they (MCAs) usually go down on the days of the week and they 
usually go across don't they with the times we've had patients take them 
(medicines) Monday, Tuesday Wednesday all down in one. " HCP 14 
Here, the interviewee is describing a problem caused by the different styles of various 
brands of MeA. The patient may be used to the days of the week running horizontally 
across the device with the times of day running vertically down, if the device is changed 
to another brand, the style may be different. To give an example, in a DoscttF box the 
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days run horizontally and the times vertically; however, in a Venalink® the days run 
vertically and the times horizontally. A patient having the device changed without 
further instruction could use the device incorrectly. 
The community pharmacists were divided on whether this was a problem. One had 
obviously never considered the matter and the other, although aware of the problem, 
thought that with the use of sealed devices becoming the norm then the differences were 
negligible. 
"It (changing MCA post discharge) hasn't been a problem, no it hasn't been a 
problem, I mean it hasn't happened that many times but it seems fine. I mean 
I've never looked into it, I'm sure we could go to some lengths to get a specific 
thing if (required). " HCP5 
Yes I know it's a common thing that people will just think of MDS as being just 
one type of device and yes. Less of a problem now because I think we all tend to 
use quite similar sealed devices whereas before some people had the plastic 
Medidos boxes and things like that, but now for clinical governance not many 
people use them so people are quite used to a push out blister type of device. " 
HCP4 
Prefers own system. 
Another disadvantage which was mentioned by the healthcare professionals is 
connected to the expert patient theme which emerged from the 'trigger' area of interest. 
These expert patients often wished to follow their own routines and systems which they 
may have developed over a period of time and trying to persuade them to use an MeA 
can be difficult. 
"you do occasionally get patients who can't adjust to them (MCA) and they 
would prefer to use their own system worked out beforehand, which has usually 
been working adequately. " HCP 12 
Older person's choice 
Another issue which fits into the 'expert patient' theme is the removal of choice from 
the older person, which a number of healthcare professionals saw as a disadvantage. 
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"And so they (patients) find it hard when we put them (medicines) in an MDS to 
maintain that level of choice about what they want to take. We have people 
perhaps who don't want to take their pain killers now and then or thel' don't 
want to take their sleeping tablets one night out of seven, or maybe th~y don't 
want to take their Frusemide tablet one morning and it limits people's ability to 
decide what they want to take and what they don't want to take. " HCP4 
IdentifYing medication in the MCA 
The difficulty of identifying tablets when they are in a MCA was also discussed by the 
healthcare professionals and is connected with the older person's choice. If the older 
person does not want to take a particular medication, then it is vital that they can 
identify that medication from the three or more others contained in the same 
compartment. Some older people also feel the need to check as far as possible that the 
correct medicines have been dispensed and again this relies on being able to identify the 
medicines in the MCA. Identifying medicines, however, can be fraught with difficulty, 
because all the tablets may be white and look very similar or the colour of the generic 
medicines dispensed may change from month to month. 
'yes it's a problem (identifying medicines) and it's also a problem for things 
like soluble tablets. I know some places still put soluble aspirin in compliance 
aids and it's mixed in with other tablets so they have to fish out the soluble one 
and that can be a problem, or some of the chewable ones, they have to fish out 
their calcichew. " HCP 11. 
"it's very difficult when things change brands or something like that and even 
for me to tell is that really the correct one because they might have changed and 
1 'm not aware of it. So I can see patients would be very nervous about taking 
something that's a different colour or shape. " HCP6 
"Actually there was a lady yesterday who was trying to dissolve her 
prednisolone 'cause she thought it was her aspirin, because it was in a Dosett~ 
box that's a another problem because they both looked identical. " HCP 16 
The problem caused by being unable to identify individual medicines within a MeA can 
therefore lead to older people not taking their medication or to a loss of trust in the 
pharmacist providing the medicines. 
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Stability of medicines in a MCA. 
The question of the stability of medicines in a MCA was discussed, not only by the 
pharmacists, but also by other professionals. The fact that not all medication can be 
dispensed in a MCA, usually for reasons of stability, was clearly seen to present a 
problem for the older person. 
'for one thing you can't put all medication in it, some medication has to be kept 
in the dark or airtight and all that sort of stuff." HCP 16 
"if you are giving someone a compliance aid and you believe they need it, then 
what is to be gained by then giving somebody also a separate box of Vicorel and 
a box of Lansoprazole capsule separately. Where's the logic in it? .. HCP4 
Both community pharmacists interviewed had serious concerns about the information 
available on stability of drugs when dispensed in a MCA. Notably this was not 
mentioned in this way by other healthcare professionals although there was awareness 
that some drugs could not be dispensed in MCAs. The community pharmacist concerns 
were about finding out the relevant information and this represented a serious ethical 
dilemma for the pharmacist; without the information should they dispense a drug in a 
MCA. 
"The lack of evidence behind medication being in there, limited stability 
medications, there's lots of formulations that we have no evidence if when they 
remove packaging are stable and we find ourselves putting things in that we 
know are not stable when they go in MDS and as a professional that's very hard 
for us. " HCP4 
"apart from literally ringing every single manufacturer (about stability) and 
ask what they suggest and often they say 'well this is what we say'. It's not that 
they have done any research you see, you don't always get a proper answer. " 
HCP5 
Inflexible dispensing. 
Leading on from this theme of drugs which cannot be dispensed in a MCA, there is also 
the problem that MCAs provide a very inflexible form of dispensing. Provided the drug 
which the older person is taking is to be taken every day and between one and four 
times each day with no other special instructions, then e\'crything will be fine. 
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However, there are a number of drugs which are taken, particularly by older people, 
with very specific instructions. For example a drug used to treat osteoporosis 
(alendronate) is usually taken once weekly and must be taken on an empty stomach at 
least 30 minutes before breakfast (and any other oral medications). The tablet must be 
swallowed whole with a full glass of water and the patient must stand or sit upright for 
at least 30 minutes. In order to comply with these instructions, the older person must 
either have the alendronate packed separately or be able to identify it from the 
compartment which may contain other drugs. This particular problem was discussed by 
a number of the healthcare professionals. 
"so for example, things like alendronate once a week doesn't fit into a 
compliance aid very well when you've got other things that you've got to pick up 
four times daily. So you can't put everything in so then you start losing the 
benefits of having it. " HCP6 
Another problem caused by the inflexibility of the MeA was drugs which have doses of 
more than four times daily, most notably these would be drugs used to treat Parkinson's 
disease. 
"because you know the way the compartments (in MCA) are there are only four 
compartments for example if someone has Parkinson's Disease you know and 
they are trying to take the Sinemet more frequently you can't do that sort of 
thing. " HCP 16 
Drugs which are taken when required were also seen to be a problem. Are these drugs 
to be put into the MeA to encourage older person to take the dose regularly or simply to 
miss out the doses which they feel they don't want or don't need? 
"other medication is PRN medication that's a problem because either they 
(patient) have either got to have it (paracetamol) four times daily or not have it 
so a lot of people end up taking paracetamol four times daily whereas they 
'would have normally just taken it a couple of times a day. " Hep 16 
Practicalities of supply 
Another group of disadvantages highlighted by the healthcare professionals were linked 
to the category of 'practicalities of supply' (of the MeA). A number of healthcare 
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professionals mentioned that the MCAs were costly and difficult to provide and fill, 
surprisingly it was not only the pharmacists who highlighted this problem. 
"it's a dispensing practice and it can be very time consuming for us from a 
dispensing point of view if you've got one or two Dosett® boxes to do eve,y day 
because we are very busy up there with general prescriptions so we pass it on to 
the chemist who will look after their dispensingfrom then on. " HCP9 
"if they (community pharmacists) are asked to jill all these Dosett® boxes it 
takes them loads longer so clearly they are going to recoup that cost from 
somewhere. " HCP 13 
The problems regarding the supply and filling of MCAs led to difficulties in finding a 
community pharmacist to fill one for an older person. 
This problem was particularly highlighted by those working in secondary care, who 
would like to discharge a patient with a MCA, but needed to find a community 
pharmacy to continue the service. 
"In fact I've got a patient on the ward who wasn't on a compliance aid before 
they came in, has now gone to the Intermediate Care Team who have requested 
that they have a compliance aid jilled so that they can help supervise medicines 
for the patient and I have to jind a chemist who will jill that for them. It's ok for 
me to do it for a week but I've got to jind somebody else and I asked the patient 
which community pharmacy they used and they weren't sure so I am now having 
to ring round community pharmacists to jind out if a) whether they know this 
patient or b) whether they would be willing to jill the compliance aid. So that's 
a lot of work. " HCP6 
"not every chemist that are local to the patients will do Dosett boxes, nomads 
or Venalink. " HCP8 
Having identified a community pharmacy to provide this service for the older person, it 
may be necessary to arrange delivery if the older person cannot get to the pharmacy. 
Not all community pharmacies provide this service so this may cause problems. 
"we do prescription collections from surgeries but we don't as a rule do 
deliveries." HCP5 
The community matron noted that, although the pharmacy may deliver, it is unlikely to 
be the pharmacist who does the delivery and therefore the older person may not be able 
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to get assistance or advice if required. One of the community pharmacists interviewed 
had trained the delivery driver to provide advice to the patients. 
"we have a driver who I've trained up and he's got a SOP to be able to offer 
advice to people on how to use them (MCA)". HCP4 
One of the General Practitioners noted that the older people may not get sufficient 
instruction in the use of the MCA. 
"] sometimes think that they (patients) may not be given sufficient guidance from 
there (pharmacy) ----------can be possibly that they are not receiving sufficient 
training or guidance or follow-up even in using the Dosett box or compliance 
aid." HCP9 
However other healthcare professionals felt that they themselves did provide the older 
person with adequate instructions. 
"We usually do it (demonstrate how to use) ifwe are involved. Ifwe're visiting 
the patient and we've requested (MCA) we feel it's our responsibility to follow it 
through and part of our ongoing assessment to make sure they can use it." 
HCP12 
"Show them how to use it (MCA) Oh yes. If it's not them then it's the carer or 
somebody else in the family." HCP5 
Problems caused by medication changes. 
The healthcare professionals also noted that problems can occur when the older person 
has their medication changed. MCAs are usually delivered weekly, and so if a dose 
change occurs or a new drug is prescribed mid-week then either the new drug has to be 
dispensed separately or the MCA has to be returned to the pharmacy for re-dispensing. 
"the pharmacist has probably taken the medicines for the week on the Friday, 
the antibiotics are prescribed on a Saturday so they have to decide "whether to 
put them in (MCA) or quite often people keep them separately and take them 
separately. " HCP 16 
"the big thing that we always get involved in is that if they have a blister pack 
(MCA) and suddenly we need them on a new tablet we then have to get the 
blister packs back to the pharmacy to be filled up again l-t'ith the new tablet in 
them. " HCP 17 
Changes in dose of an existing drug can cause almost bigger problems as this can mean 
considerable delay in the change of dose being actioned. 
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"from my perspective when I've worked in the anti-coagulant clinic, tl):ing to 
then co-ordinate a changing dose for somebody with a compliance aid is \'ery 
difficult and you do worry whether you actually get it done in time. " 
HCP6 
"having to get a phone call on a Wednesday, like this person's dose has been 
changed and you've delivered one (MCA) on Tuesday, as I say it is becoming 
more and more of a problem that we try and sort out. " HCP4 
The wrong medicine or the wrong box. 
Dispensing errors were something that concerned the older people whom I interviewed 
and the healthcare professionals also had deep concerns which were based on serious 
occurrences. 
"and the other big issue I'm very much aware of is mistakes so clearly if a 
pharmacist is dispensing a whole bottle full of pink pills and a blue one gets in 
there it is apparent immediately whereas if you are putting a lot of coloured 
tablets in a lot of different slots it seems to me that the possibility of error is 
high. " HCP 13 
"and we've had patients who have actually had the pharmacist dispense the 
wrong Dosett box to the wrong patient and they took the medication and didn't 
realise because cause they didn't think to check the box and they were actually 
taking someone else's medication. " HCP 14 
"there is the other possibility for error which I have encountered on two 
separate occasions which have had extremely serious consequences have been 
when people have had the wrong Dosett box delivered to their house by the 
chemist and have taken someone else's medication. " HCP 13 
Finally, in the disadvantage section, two healthcare professionals pointed out that 
having an accident with the MeA could cause serious problems. 
"The only trouble is if they drop the damm thing because I mean she (patient) 
once brought it in, she said I've dropped it and there were tablets -----some 
actually managed to skip into others so she brought it back in. I mean she had 
the sense to bring it in." HCP5 
"in fact if they (patients) lost the blinking thing well then you would be 
absolutely in a bit of trouble then wouldn't you, cause you would have no 
medications at all. " HCP 15 
7.4.3 Overview of the themes emerging from Use of MeA 
The themes identified concerning the use of multi-compartment compliance aids were 
grouped into sub-categories and categories. The two categories were advantages and 
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disadvantages and the subcategories which were linked to these categories are detailed 
in Figure 14 below. 
Figure 14: Categories and sub-categories emerging from "Use of MCA" area of 
interest. 
Advantages Disadvantages 
Ease of use & convenience Not a memory aid 
Not for the cognitively impaired 
I Memory aid 
Unable to use 
I Independence Change of device 
Medication change 
I Continuous supply 
Prefers own system 
I For the benefit of others Older peoples choice 
Identifying medication 
Stability of medicines 
Inflexible dispensing 
Practicalities of supply 
Medication I dispensing errors 
7.5 Beliefs and attitudes concerning MeA use. 
I was interested in finding out how the health beliefs and the attitudes of healthcare 
professionals and older people might influence the use of MCAs. The interviews with 
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the older people had identified a number of themes and these themes were used to 
inform the topic guide for the healthcare professionals. 
7.5.1 Independence 
Independence was seen by a number of the older people as extremely important to them 
and something which must be maintained at all costs. I tried to discover what impact 
the provision of a MeA might have on the older person and then asked the healthcare 
professionals if they had experience of these attitudes in older people. Some healthcare 
professionals thought that the MeA helped an older person maintain their 
independence. 
"so I think they (MCAs) do help to maintain some independence." HCP8 
However, other healthcare professionals were of the opinion that older people might 
regard the issue of a MeA as loss of independence. 
"and in a way the Dosett® boxes do maintain their (the patient's) independence 
because it allows them to remain at home but on the other hand some 
independence has been taken away from them because they are not in control of 
their own medication anymore, someone else is putting it in front of them. " 
HCP17 
"it (MCA) does kind of take the responsibility away from some of the patients, 
who may be functioning perfectly adequately mentally, in that their medicine is 
drawn up, their tablets are drawn up and prepared by somebody else and 
delivered to them so they may over a period of time become a little less familiar 
with why and what they are taking. " HCP9 
The healthcare professionals also noticed that many older people like to remain in 
control as much as possible. 
"those who are independent, yes, I can see that they would, they like to be in 
control of their lives as much as they can. " HCP6 
Healthcare professionals were also aware that older people very often had their own 
routines which often seemed complicated or peculiar to the healthcare professional but 
very reasonable to the older person. 
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"some of them are very good and they have good systems and it's worth talking 
to them about how their system works because you get a feel for whether they 
have confidence in their system and know what they're doing. You do get a 
general impression of how compliant they are with their prescribed regimen. " 
HCP6 
"I do try and make quite strenuous efforts to understand because people have 
these really weird methods of working it out which often does to them make 
sense and it's scary looking in on it. " HCP 16 
Despite at times finding the older person's routine less than satisfactory, many of the 
healthcare professionals realised that older people often preferred their own systems and 
would simply revert back to their old ways. 
"we do occasionally meet people that can't adjust to them (MCA) and would 
prefer packets and bottles and it's usually because they have their own little 
system worked out beforehand which is usually working adequately probably, 
our team have stuck our nose in a bit too far and assumed that a compliance aid 
would be beneficial to them but it's not always. It usually is but not always. " 
HCP12 
" yes people have reverted back to complementary resources and in fact we 
have found drivers go in and say "Mrs so and so's popped them all out into a 
little eggcup again that's sat by the side of the table". It really isfrustratingfor 
us to go to the effort of filling them and then to find that out but that's one of the 
things that goes on. " HCP4 
I wanted to discover if healthcare professionals had particular attitudes and beliefs 
concerning older people and their medication. I decided that to ask directly what these 
attitudes or beliefs were might not result in a useful answer. Therefore, I decided to ask 
the healthcare professionals if they saw evidence of intentional non-compliance among 
their older patients, i.e. older people making a decision not to take their medication as 
opposed to simply forgetting to take their medication or being unable to access it. I 
wanted to discover if the healthcare professionals had any particular views on this topic 
and also any strategies to deal with it. 
7.5.2 Intentional non-compliance. 
Only one healthcare professional said that they saw little evidence of intentional non-
compliance 
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"my personal experience of when 1 have been working with patients is that the 
majority of non-compliance 1 see is unintentional, they (patients) are confused, 
they have dementia, they are forgetful, they are blind and they can't see but that 
might be the picture they are giving to me, do you see what 1 mean?" HCP 1 
All of the other interviewees stated that they were aware of older people in their care 
who had decided not to take their medication. This might be on a permanent basis or 
just occasionally. 
Side effects. 
The reasons for intentional non-compliance which the healthcare professionals saw 
were varied but the main cause appeared to be side effects. 
"they come in and they're on a multitude of tablets or they might say this tablet 
makes me go too often or it makes me wet myself or it's given me diarrhoea -----
--------they've a lot of tablets to take and especially if they have been put on 
something new they say it's given me an upset stomach I'm not taking that. " 
HCP8 
'yes there's been quite a few, I'd say quite a few, several instances of people 
saying 'well nobody ever tells me what these tablets are for, therefore I'm not 
taking them' or they've perceived that they are not doing any good or they've 
perceived they're doing harm. " HCP7 
Poor knowledge about medication. 
Another reason, quoted by the healthcare professionals, was poor knowledge of the 
medication. 
"there was a lady, and she has never admitted it before, she said "1 only take my 
anti-depressant when 1 feel a bit low" and obviously she hadn't understood the 
method of its working. So in that situation it is a matter of education really. " 
HCP16 
Lack of communication. 
Approximately fifty percent of the healthcare professionals felt that there was a lack of 
communication with the older person and that this was often the cause of the problem. 
"1 think we don't do enough in the hospital of talking to patients about the 
change that we \'e made to their medicines, to get them on board, for them to 
become concordant with that, when we change something we ought to be saying 
to them 'is this OK?' but equally 1 think some things get changed around by GPs 
without communication either so it (works both ways). " HCP6 
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Taking too may medicines. 
One third of the healthcare professionals also stated that this intentional non-compliance 
was often due to the health beliefs of the patient. Many older people are taking large 
numbers of medicines and this can become a burden, some of the healthcare 
professionals felt that in these circumstances the older people might decide to stop 
taking one or more of the medicines. 
"Yes usually when they have a lot of tablets just that there are too many and 
they are quite selective and they will stop taking some or all of them for a couple 
of days. " HCP 11 
"nobody wants to be on more tablets and we are told that frequently, but we 
might not really be aware of how deep seated the belief is amongst everybody, 
almost everybody, there's very few people want to be on tablets. " HCP9 
The healthcare professionals' attitude to intentional non- compliance. 
I then asked the healthcare professionals how they felt when they became aware that 
older people were deciding for themselves not to take their medication. For some 
healthcare professionals, this was not a problem, they respected the older person's 
decision, although, they might feel it necessary to convey this infonnation to the 
prescriber. 
"1 respect their decision, you know, if it's someone who 1 've got no concerns 
about the mental health, ] respect their decision and we do usually tell the GP 
about it if they stop like a particular drug we will report it back to the GP, but 
we don't try we explain the advantages of taking the drug and if they don't if 
they choose not to take it that's up to them. " HCP 12 
For other healthcare professionals, there was an undercurrent of censure, although they 
went to great lengths to say that they respected the older person's decision. 
"you do get some patients that are not honest and you can see them "J'll take 
them in a few minutes" and then they'll put them in their handbag. You see a 
collection in their handbag of ones they don't want to take and others are more 
honest and say"] don't want to take that. "RCP 2 
211 
The healthcare professionals also felt that they saw the consequences of the older 
people's intentional non-compliance and, although, they said they would not be 
judgemental there was a feeling that this was a problem. 
"what's brought them into hospital is because they've not been taking their 
water tablets so their heart failure has got worse or whatever and especially 
someone who's been bouncing back for the same reason you think you're 
fighting a losing battle. " HCP8 
What are the solutions? 
When asked about solutions to this problem, there were many different suggestions. A 
number of solutions focused on counselling about their medication, what it was for, why 
they ( older people) needed to take it. 
"Generally it's just been because they don't know what they're taking but] will 
sit down and go through what they are taking, why] think they are taking it, if 
it's not obvious, it's not always clear from the notes, in several cases they've 
turned round and said that's fine now] know why] am taking it, ] 'm quite happy 
to take it, but they've been on it for years and nobody has ever said anything or 
they didn't feel like it had been reviewed." HCP7 
"] think the big thing is communication. You've got to communicate with the 
patients, try and be honest, see if you can work with them and get the best plan 
that is going to work. " HCP2 
Try to reduce side effects. 
Alongside counselling and communication, the healthcare professionals did talk about 
some practical solutions. For example, if side effects were the cause of the intentional 
non-compliance than perhaps it would be possible to change to a different medication. 
"if the side effects are that bad we might be able to think of something similar 
that they could take you know a similar medication that they could take 
instead. " HCP 14 
Simplifo the regime. 
Simplifying the medication regimen was also mentioned as a possible solution. 
"] am quite keen on tll'ing to look at reducing the burden of medication on 
people at medication r~l'iews which we do fairly frequentZ1' in the practice. " 
HCP10 
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Encourage or coerce. 
However some healthcare professionals saw their role as encouraging or coercing the 
older person to take their medication. 
"] 've got my agenda when] go to visit a patient which is '] must get them to take 
all these pills. ' Full stop." HCP 1 
"we usually just try to persuade them, you know try to explain why they need to 
take their medication and usually with a little bit of gentle persuasion we 
encourage them to take them, but] mean sometimes it is really difficult." 
HCP14 
Negotiation 
Negotiation was also seen as a method of overcoming the problem. 
"] mean myself] like to address the problem in an open way and I'd like the 
patient to be honest so we can work with the patient, the doctor the nurses and 
try to find a compromise. " HCP2 
"Some times it's a matter of negotiating like some people don't like taking their 
water tablets when they are going to the day centre so you have to assess the 
risks of that sort of thing, is it going to matter for one day or are they really in 
quite bad heart failure and it is going to tip the balance. " HCP 16 
7.5.3 What other health professionals think and do. 
The healthcare professionals frequently suggested that it was the attitudes and behaviour 
of other healthcare professionals which could be called into question. For example, one 
of the community pharmacists felt that many of the older people who received a MCA 
were started in hospital and that the hospital staff saw the issue of the MCA as a 'quick 
fix' which would speed up discharge. 
"] think lots of elderly people are started (on a MCA ) in hospital because 
they're elderly and because there isn't time or the staff to explain to them how to 
take their regimen and they believe - there's this perception with doctors and 
nurses this is the easiest way out. " HCP4 
A hospital pharmacist also stated that 'other people' see MCAs as the best thing that can 
be used to help a patient with medication. 
"a lot of people do see compliance aids as the overall thing that will help 
patients and they don't realise that there are other things that can be used first 
and the difficulties that can be encountered. " HCP 11 
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This idea was endorsed by the pharmacist working with the Intermediate Care team. 
"] would say then that they (healthcare professionals) generally think that a 
compliance aid is going to solve all problems and] think a lot of people think oh 
I'll put a compliance aid in and I've done my bit. " HCP 1 
7.5.4 What are the older person's beliefs concerning their health and treatment? 
Healthcare professionals also expressed their own opinions about the older people's 
beliefs concerning their health, their treatment and how this might affect their life. 
Loss of independence. 
The healthcare professionals acknowledged that for some older people the worry of 
losing their independence and having to go into nursing or residential care loomed large. 
"Right yes, it is a horrendous thing when you think about it that old people live 
in this kind of fear that somebody is going to come along and put them in a 
home. " HCP 13 
Some of the healthcare professionals suggested that by agreeing to use a MCA the older 
person could be trying to retain their independence. 
"They want to keep their independence and they want to get back home as soon 
as possible, back to their own home, back to their own routine to do what they 
want to do and not be bound by hospital rules and things. " HCP8 
However other healthcare professionals felt that older people felt disempowered when 
given a MCA. The healthcare professionals said that they could understand this attitude. 
"certainly some people feel very resentful when somebody tells them, switches 
their medication to a Dosett box they feel very disempowered and some people 
feel that they actually managed their medication better before. " HCP 13 
"1 would be wary of someone else filling a compliance aid for me because 
you've lost your independence, somebody's taken this over, this part of your life 
over filling this compliance aid for you and you've got no control over what it is 
and you can't tell whether they've done it right or not so you are having to trust 
somebody else and that is quite difficult] suspect." HCP6 
Having trust in the healthcare professionals. 
The healthcare professionals also stated that it was often very important to older people 
to be able to trust their healthcare professionals. This was seen as a generational 
attribute, in that older people belong to a generation who admire doctors and nurses, 
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perceiving them as trustworthy. Visiting the same community phannacy and trusting 
the staff may also come into this category. This attitude was seen by the healthcare 
professional as sometimes helping and sometimes hindering the older person's 
medicines management skills. 
For example, being admitted to hospital and having your medicine changed by an 
unfamiliar doctor with little or no explanation, was likely to lead to non-compliance. 
'yes if that patient's been on that tablet for years and suddenly the doctor in 
there (hospital), not their own GP, because they have more trust with their own 
GP, the doctor on the ward has stopped it and it might be the first thing that they 
said 'Oh the doctor stopped that tablet, I don't know why though." HCP3 
The healthcare professionals were also aware that older people needed to trust their 
phannacist, and this could give rise to problems when the older person's usual 
phannacy would not dispense in a MCA after discharge from hospital. 
"in other cases it becomes difficult when the chemist that the patient usually 
uses has said that they haven't time to do it or won't do it, then we have to start 
looking for another chemist because it is a sort of trust issue in a lot of cases the 
patients are used to one pharmacy, they don't want to go somewhere 
else. "HCP7 
7.5.5 Six o'clock warfarin. 
Finally I asked the healthcare professionals if they had any concerns or issues about the 
dispensing of warfarin in a ·MCA. This question was not in my original topic guide but 
this theme had emerged from the older people's interviews. A number of older people 
had stated that they never forgot to take their warfarin and that they took it every day at 
exactly 6 pm. In order to carry this out the older people had in some cases gone to 
extreme lengths, for example, returning early from a day out or purchasing a separate 
container to put the warfarin in. The older people explained that "warfarin's different" 
and "it (warfarin) has to be taken at 6 pm." I was therefore interested to ask the 
healthcare professionals if they encountered this behaviour and if they could give 
reasons for the older people's actions. 
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The answers given by the interviewees revealed that among health care professionals 
there were some misconceptions about the timing of warfarin doses. 
"it is interesting the six 0 'clock thing because we have at the moment a patient 
who is on warfarin and she had just started medicines, she had never had 
medicines before and she kind of had it in her head that she could remember to 
take medicines in the morning but there was no way she could remember at 
teatime, so we switched it to the morning and the amount of people who have 
said 'oh you can't give warfarin in the morning '. Why can't you give warfarin in 
the morning? As long as the people who are testing know you are taking it in 
the morning and when it's a steady state I can't understand. " HCP 1 
Some healthcare professionals noted that older people could get very stressed if they did 
not receive their warfarin dose exactly at 6pm. 
"you know like if they do the INR during the day, it's not always back in time for 
the doctor who's on the ward to write it up and then of course you have to get 
the on call doctor to write it up and he's busy and he can't get here and 1 can 
see the fright in their eyes as they lay on their beds waiting for their warfarin 
because I know (laughs) perhaps I shouldn't laugh but you think 'what do you 
think is going to happen if you don't get your warfarin at 6 0 'clock?" HCP8 
One community pharmacist felt the problem had become more serious and prevalent 
with the increase in the number of patients who were prescribed warfarin. This 
pharmacist also thought that the involvement of more pharmacists in anti-coagulant 
clinics gave rise to much more explicit counselling about how to take warfarin and this 
was the reason for the 6 pm dose. 
"Like warfarin is a major issue. ----------it's become more acute because of the 
new guidelines, the guidelines on AF and because suddenly more people have 
been diagnosed with AF, everyone and his dog tends to go on warfarin, so 
before you had a couple of patients, who were elderly who were on warfarin 
and it was all well and good, now every second person is on warfarin, so it's 
become more of a problem. Pharmacists are getting more involved in anti-
coagulant clinics and pharmacists are far more aware that people should be 
taking the warfarin dose at the same time every day and there are certain times 
of the day that are easier for people to take it and it might interact with some 
medication. So you find them (pharmacists) being very religious on the fact like 
telling these people you must take warfarin at 6 0 'clock, it must be the same time 
every day. " HCP4 
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7.5.6 Overview of the themes emerging from health beliefs and attitudes 
The themes for health beliefs and attitudes were grouped into sub-categories and 
categories and details of which are given in Figure 15 below. 
Figure 15: Categories and sub-categories emerging from Health Belief area of 
interest 
Independence 
Maintain independence Lose independence 
R<main in control ( 
Communication 
Education & counselling ~"" Poor medication knowledge 
Negotiation ·~~L _______ ----.J I Lack of communication 
,-------------------------, 
Paternalistic beliefs 
Important for older people _/~_/ 
to trust healthcare v/ 
professionals 
7.6 Age and Ageism 
Patients must take their 
medication as directed 
Themes which were concerned with age and ageIsm had emerged from the older 
people's interviews, in fact some participants had very definite views on the subject. I 
therefore put this point to the healthcare professionals. 
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" Some of the older people I interviewed felt they were treated differently because of 
their age, have you seen any examples of this attitude in your area of practice?" 
There was a spread of opinions about this particular theme, most participants said they 
could understand what the older people were talking about but that they hadn't seen any 
evidence of this in their area of practice. However, some healthcare professionals stated 
that they could imagine that sometimes their actions could be construed as ageist. 
"yes situations where they've for years and years had their own routine and 
then their memory problems have deteriorated and then we have gone in and 
treated them like a child. " HCP3 
"] haven't been told that directly but] can see where they (patients) are coming 
from actually and ] know the aids and that they probably do, they look very 
childlike really the aids themselves. " HCP9 
7.6.1 Providing a MeA could be seen as patronising 
Healthcare professionals themselves stated that giving an older person a MCA could be 
seen as being patronising. 
"it is a bit patronising isn't it especially for people who are borderline you are 
saying you can't manage we are doing it this way because we know you can't do 
it." HCP16 
Some of the healthcare professionals thought that older people were started on a MCA 
simply because of their age and an assumption that if you were older then you would be 
unable to manage your medication. 
"So yes] think lots ofpeople are started (on MCA) because of their age because 
people have this misconception that they won't be able to retain the information 
of how to take the medication especially if they are on multiple medications. " 
HCP4 
"] don't know if it's (they are) too old to understand, ] think on the wards 
sometimes they don't take the time and possibly they haven't got the time but 
they still should take the time and they don't take the time to explain exactly 
what the patient's got. " HCP 11 
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7.6.2 Blame others. 
The healthcare professionals often laid the blame at the door of other healthcare 
professionals and then went on to state that in their particular field they were well 
trained to avoid this type of behaviour. 
"] mean the problem is outside of elderly medicine there is a different opinion 
held elsewhere. ---------it's the ageist argument it keeps coming up all the time. " 
HCP15 
"but our team we're highly skilled in assessing older people and we know how 
to, you know how to use the right approach, we've done it for so long assessing 
them, so ] can't think of anyone I have worked with in recent years who would 
treat an old person like a child. " HCP 12 
7.6.3 It does happen but it is not intentional. 
Some healthcare professionals admitted that this type of behaviour might happen on 
occasions but that it was never intentional. 
"] suspect this does happen and I suspect some of us do it unconsciously without 
realising it. The NSF did have a section on this for elderly people. ]t talks 
about having policies which are discriminatory in making elderly people special 
whereas in fact they should be treated the same as everybody else. ] don't know 
whether I've come across specific examples but I'm sure it does happen. " HCP6 
7.6.4 Misunderstandings. 
Other interviewees suggested that the older people might be misinterpreting the 
healthcare professionals' motives. Therefore, although the healthcare professional did 
not explain matters relating to their medication, this was not because of age. 
"] think perhaps not necessarily an age thing more of a medical condition that 
we sort of say "well they're not going to understand, there's no point. " HCP7 
"] don't mean to sound ageist by saying this but some of them are confused and 
things and a lot of them don't realise that they are. So] think just to keep them 
safe we do need to keep an eye on how they are going with their medications and 
that probably does sound ageist but] don't mean it to sound that way. If you 
know what] mean. " HCP 14 
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7.6.5 Older person in denial. 
The healthcare professionals also pointed out that I was asking this question because of 
statements made by the older people themselves; the healthcare professionals thought 
that older people were often in denial about their condition. 
"but a lot of them are in denial about how forgetful they are so you will get a 
picture from the patient which is 'don't treat me like I'm stupid' and you speak 
to the family, relatives and they say 'she hasn't a clue she is really forgetful. " 
HCPl 
"but obviously they are probably in a bit of denial not knowing, thinking that my 
memory is fine something like that so it's probably a part of them understanding 
that their memory isn't as good as it was five years ago. " HCP 3 
7.6.6 The healthy aged. 
The converse of this was that many of the healthcare professionals had examples of 
older people who retained all their faculties well into their eighties or nineties. 
"you do get the very healthy active eighty five, ninety year olds coming in and 
they feel almost victimised that they are in the same ward as some of these other 
patients that may be very demented or have devastating strokes or whatever and 
just this spectrum of severity is so wide that they are almost completely out of 
place and they almost feel as if you are not appreciating that they have all their 
marbles. " HCP 15 
7.6.7 The relatives' involvement. 
Healthcare professionals also pointed out that relatives can be involved in the supply of 
MCAs and that it is often relatives who indicate that their elderly relative is not 
managing their medicines. This can sometimes give rise to conflict between the older 
person and their relatives and the healthcare professional can find themselves caught 
between the two. 
"1 had a patient in (place name) recently who was just discharged -------nothing 
wrong with her mentally, fantastic memory, plans her own life------so she came 
out with a Dosett box and she was really cross about it and the ward and her 
niece had set it up between them without consulting her and she l-vas rea/~I', 
really cross about it and she made no bones about it. " HCP 12 
Some healthcare professionals felt that involving the relatives of the older person with 
their medication could be beneficial. 
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"] will always first of all try family to fill the box and 1 have trained quite a few 
different families - relatives to fill boxes. --- --------- ] always say to them]'d 
much rather you (relative ) did it because it enables someone younger and 
compos mentis to be championing their (the patient's) medicines. " HCP 1 
However, this could also cause problems if the family member goes away. 
"if you are relying on a relative to fill it (MCA) up that could cause problems if 
they are away. " HCP 17 
7.6.8 It's an ethical dilemma. 
Finally, one healthcare professional highlighted what might be considered to be an 
ethical dilemma. Does the healthcare professional follow their own professional opinion 
or does he or she follow the older person's own wishes? 
"You certainly see that where this very difficult judgement has to be made 
sometimes by the healthcare professionals. The patient may want to go home 
alone and you do that and they come bouncing back a week or so later and you 
try and do it again and this time you say 'well we can give you more support' 
and they don't want more support. Then it's a difficult fine line as to how much 
you cajole or persuade them to have support which they probably need but 
against their free will and it's a very difficult fine line] suspect sometimes. " 
HCP6 
7.6.9 Overview of the themes emerging from age and ageism 
The figure, below, gives details of the classification of the themes relating to 'Age and 
Ageism' identified during the analysis of the healthcare professional interviews. The 
themes were grouped into sub-categories and then into categories, which are detailed 
below. 
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Figure 16: Categories and sub-categories emerging from Age and Ageism area of 
interest. 
No Ageism 
It's not done intentionally 
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I Older person in denial 
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7.7 Discussion about the Healthcare Professional interviews 
7.7.1 What triggers the decision to provide an older person with an MCA? 
With the exception of interviewee HCPI4, all the other professionals stated that they 
did at some time recommend the use of MCAs for older people living in the community 
or, in the case of the pharmacists, dispensed medicines in these devices. One other 
healthcare professional stated that he had considerable reservations and this was HCPI0 
(a OP), who had very strong views about the use of MCAs, coupled with the 
pharmacists' requests for 7 -day prescriptions. This had led him to believe that the 
community pharmacists were profiting from the dispensing of MCAs and promoting the 
use of the devices. This practice of requesting the OP to provide 7-day prescriptions for 
those patients who had their medicines dispensed in a MCA was discussed in the 
chapter detailing the preliminary study (Section 2.4.3). 
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Those interviewees who stated that they did recommend the use of MCAs then 
discussed their reasons. The majority of themes in this area were concerned with either 
the characteristics of older people or with problems concerning the medication. 
"Problems with memory" was the theme most frequently discussed by the healthcare 
professionals in this section of the study. Almost half of the interviewees stated that 
problems with memory would be an indication that an older person might require help 
managing their medication. There is a general perception that the older a person gets 
the more forgetful they become. However, as discussed in Chapter 6 section 6.3, 
research into memory has not shown a link between age and failing memory (Lorenc 
and Branthwaite 1993; Park et al. 1992). The relationship between memory and 
medication adherence will be discussed in greater detail in section 7.7.4. 
A minority of healthcare professionals described older people as being either expert or 
inexpert with regard to medicine management. Both opposing characteristics were 
given as reasons for an older person to receive a MCA. Expert older people were 
described by the interviewees as those who knew their medication, the names, the doses 
and what they were taking it for. These 'experts' wanted to stay in control and to retain 
some degree of choice in their medicine taking. The older people who were self-fillers 
came into this category; they wanted to retain control of their medication and chose to 
use a MCA to make things easier for themselves. The term 'expert patient' has been 
used by the Department of Health in the 'Expert Patient Programme' (2001). The aim 
of the Department of Health programme is to enhance the self-management skills of 
patients living with long-term conditions. The interviewees, in this study, were not 
using the term 'expert patient' in exactly the same way as defined in the report. They 
were identifying older people who were knowledgeable about their medication and their 
illnesses and wished to remain informed and in control of their treatment. The 
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healthcare professionals also suggested that the expert older person might welcome a 
MeA if they had identified a diminishment of their medicines management skills. The 
MeA could be seen as a way of maintaining independence and retaining some control 
of the medication. The theme of 'expert patient' was identified by nurses and one 
pharmacist. 
Those older people who were classed as 'inexpert' were seen to be uninterested in their 
medication in addition to showing little knowledge or understanding of their medicine 
regimen. These people were happy to accept a MeA and in some respects welcomed 
the fact that using a MeA required little thought on their part. These characteristics 
were only discussed by nurses. I have previously discussed in Section 6.7.2 research 
which described some patients as 'passive users' (Dowell and Hudson 1997) 
Some healthcare professionals identified older people who had a degree of physical 
disability as suitable candidates for a MeA. Having problems with your hands, 
resulting in a lack of dexterity, was an example given. The healthcare professionals 
suggested that it might be easier to remove the medication from a MeA rather than 
several blister packs. Visual impairment was also given as a reason for suggesting a 
MeA. The Disabilities Discrimination Act (1995) requires service providers to make 
reasonable adjustments to their service so that people with disabilities are able to use it. 
Not only does the pharmacist have to ensure that people with disabilities are able to 
access the premises but also make full use of the services provided. Pharmacists have 
therefore to make sure that people with disabilities are able to take their medication and 
if they are not able then provide suitable support. The support required has been 
interpreted as providing a compliance aid however, having considered the comments of 
the oldcr people interviewed, it is easy to see that a MeA is not suitable for evcryone 
and in fact could make the medication less rather than more accessible. The 
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introduction of the new contract for community pharmacy in 2005 required community 
pharmacists to assess patients and determine if they fell within the remit of the Act. For 
patients who are assessed as requiring assistance under the terms of the Act phannacists 
are able to provide two levels of service: 
Level 1 includes making adjustments to labelling and packaging and providing reminder 
charts. 
Level 2 is providing a MCA. 
The introduction of this support within the Pharmacy Contract does mean that 
community pharmacists are paid for providing the service. However this is not a 
separate payment but a small amount added to the payment for each item. There 
remains no payment for those people who may be seen as needing a MCA but are not 
considered "disabled" under the terms of the Act. 
Polypharmacy was the medicine problem mentioned by a number of interviewees as a 
reason for issuing a MCA. The healthcare professionals defined polypharmacy as 
having a large number of medicines to take by mouth each day along with a 
complicated dosage regime. Polypharmacy has been defined as the concomitant use of 
five or more drugs (Viktil et al. 2006). This study, which took place in Norway, studied 
patients admitted to six internal medicine and two rheumatology departments in five 
hospitals. Comparisons were made between those patients taking five or more 
medicines with those taking less than five medicines. The drug-related problems 
experienced by each group were compared. The study found that the number of drug-
related problems increased approximately linearly with increase in the number of 
medicines taken. Another study which investigated medication use in a community-
based sample of elderly men and women (Cohen et al. 1998) concluded that non-
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compliance was significantly increased if the number of drugs taken exceeded two 
daily. This suggests that the healthcare professionals I interviewed were right to 
consider polypharmacy as a trigger for non-compliance. 
Several of the healthcare professionals stated that they didn't make the decision to issue 
a MeA themselves. The decision was either taken by someone else or was 
implemented because another healthcare professional or professional group demanded 
this action. Throughout the interviews with the healthcare professionals, this 'pass the 
buck' attitude was prevalent. Approximately one third of the interviewees stated that if 
the older person was having help from home care then a MeA was essential. This 
attitude was described by one of the hospital pharmacists as 'the myth of home care'. A 
third of interviewees stated that if home care staff were involved with the patient's 
medication it must be in a MCA. One or two interviewees stated that this was a legal 
requirement. However, in other parts of the UK, home care staff are trained to prompt 
or administer medicines from ordinary packaging (Asghar, Gray and Woolfrey 2001; 
Taylor, Harris and Sandford 1999). Some interviewees also stated that the Intermediate 
Care Team required that patients discharged to their care must have a MCA. However, 
when I queried this with the ICT nurses, this was denied. 
Hospital discharge was given as the most common reason for issuing a MCA, the 
community pharmacists stated that this was the main way they received requests. The 
secondary care staff also stated that older people were often considered for a MeA on 
discharge, this was linked to concerns that if the older person failed to take their 
medication correctly they would 'bounce back' into hospital. Research in the USA 
supports this point of view, finding that 22% of medicine related re-admissions were 
due to patient non-compliance.(Bero, Lipton and Bird 1991). Studies have looked at 
interventions to improve patients' medication management post discharge. A self-
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medication programme was found to result III higher levels of compliance post 
discharge (Lowe et al. 1995). Counselling by a clinical pharmacist prior to discharge 
led to reduction in medication errors post discharge (Sweeney, Dixon and Sutcliffe 
1989) and discharge plans followed by domiciliary visits by community pharmacists 
produced no significant difference (Nazareth et al. 2001). It would appear that simply 
issuing a MCA on discharge would not necessarily lead to reduced re-admission rates. 
The assessment of the older people prior to issuing a MCA was discussed by a majority 
of the interviewees. The hospital pharmacists and healthcare professionals from the 
ICT stated that they would assess the older person prior to issuing a MCA. The 
healthcare professionals working in Intermediate Care employed assessment procedures 
which looked at medicines management alongside nursing and daily living 
requirements. In particular, the nurses working in Intermediate Care explained that their 
assessment procedures would take place over a period of days or even weeks and would 
involve observing the older person and providing assistance if needed. The Single 
Assessment Process (SAP) was introduced in Standard 2 of the National Service 
Framework for Older People (Department of Health 2001). This Standard aims to 
ensure that the NHS and Social Care treat older people as individuals and enable them 
to make choices about their own care. The assessment undertaken on hospital discharge 
and when entering Intermediate Care would fall into SAP and this was why those 
working in Intermediate Care felt that this type of assessment would identify any 
problems. The hospital pharmacists also stated that they would assess the older person 
and would be prepared to refuse to supply a MCA if, in their opinion, it was not the best 
option for the older person. Examples of medication packaging, including a MeA, 
could be brought to the ward for the older person to try. However, the issue of whether 
the ward setting was the most appropriate place and time to undertake this assessment 
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was discussed by a number of the healthcare professionals. Older people, who have 
been admitted to hospital in an emergency situation, are often confused and 
disorientated and hospital wards are noisy and busy, this was discussed in Section 6.7.1. 
Studies have shown that older people find it difficult to remember what advice was 
given to them on discharge and assessing their ability to manage their medication at this 
time may not be the best solution. A study in Germany looked at elderly patients who 
had managed their medication themselves prior to an emergency hospital admission 
(Nikolaus et al. 1996). The patients were assessed for their ability to perform activities 
of daily living and for their cognition and affect. In addition, the patients were tested 
for manual dexterity and cognitive capacity. Finally, the patients were assessed for their 
ability to open and remove tablets from four types of pharmaceutical packaging 
including a Dossett® box and were also tested for visual acuity. Patients were visited 
after three days and three months post-discharge. The researchers made some simple 
recommendations as a result of the research, which included assessing the patient's 
ability to use the medication container prior to discharge, and supervising and training 
the patient about their medication within the first few days after discharge. 
A minority of the healthcare professionals stated that they would try other solutions 
first, the most popular being the medication chart. Various studies have assessed charts 
(Raynor 1997; Grymonpre, Sabiston and Johns 1991) and found them to be useful in 
aiding compliance. 
7.7.2 The advantages and disadvantages of MCAs 
All the healthcare professionals were asked what advantages and disadvantages they 
saw in the use of these devices. 
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More than half the healthcare professionals, spread across all three professions, stated 
that ease of use and convenience was a big advantage. The fact that the older person 
could access all the medication for one dosage time by opening one section of the MeA 
meant that medication errors were less likely and could save the older person time. The 
fact that 'patients like them' was also given as an advantage. While it may be true that 
removing the medication from a MCA may be easier and take less time than removing 
five or six different tablets or capsules from their individual blister packs, this does not 
seem to be a sufficient reason for issuing an older person with a MCA. 
Continuous supply was also seen as an advantage, the fact that the pharmacy filled 
devices were usually delivered to the older person's door without the need for a repeat 
prescription to be collected from the surgery, meant that running out of medication was 
unlikely to happen. The healthcare professionals saw this as an advantage. 
The issue of independence had been discussed by the older people in their interviews 
and it was obvious that, to some interviewees, this was an important issue. I asked the 
healthcare professionals if they thought independence was important to the older people 
in their care and many agreed that it was. A minority of the healthcare professionals 
thought that providing a MCA would maintain the older person's independence 
allowing the older person to remain in their own home. 
The issue of independence will be discussed further in Section 7.7.5. 
Approximately one third of the healthcare professionals saw advantages either to 
themselves or to other healthcare professionals in the use of MCAs. The suggestion 
was made that the healthcare professional could use the device to monitor what the 
older person was taking, although observing that a day's supply of medication had 
disappeared from the MCA does not confirm that the medication has been taken. A 
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number of healthcare professionals were aware that older people might dispose of their 
medication in an attempt to deceive them. 
A significant minority of the health professionals stated that using a MCA was an 
advantage to those older people who had memory problems. An equal number of the 
healthcare professionals stated that one of the disadvantages was that the MCA did not 
remind the older person to take their medication. The MCA was not considered a 
suitable device for use by those older people who have any degree of cognitive 
dysfunction. 
Looking in more detail at the issue of memory, MCAs are often recommended by 
healthcare professionals and others for use by older people because there is an 
assumption that, as we age, our memory deteriorates. Memory is a very complex 
function and consists of: 
Retrospective memory, which is a memory for past events, for example remembering 
events in earlier times or the plot of a film or book. 
Prospective memory which is memory for things to be undertaken in the future, for 
example going to a meeting or putting a meal in the oven. 
Compliance with medication has been cited as a prospective memory task (Einstein and 
McDaniel 1990). However, work by Park and colleagues (Park et al 1996), has 
suggested that a number of factors, prospective memory, working memory, long term 
memory and social factors, are involved. 
In order to take medication correctly a person must remember the instructions that have 
previously been given by using retrospective memory. They then use prospective 
memory to take the medication at the correct time (Einstein and McDaniel 1990). Park 
and Kidder (Park and Kidder 1996) stated that retrospective memory is of importance in 
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complying with a medication regime and that this can be a difficult task because of the 
complexity of the information associated with each medication. 
The affect of ageing on the memory function has been the subject of many research 
studies. There appears to be a clear link between age and deficits in retrospective 
memory; (Gould, McDonald-Miszczak and King 1997) however, research into 
prospective memory has suggested that older adults do better on these tasks than 
younger adults (Park et al. 1999). The better performance of the older adults in 
prospective memory studies appears to be due to the use of memory aids or strategies 
(Branin 2001). The memory aids or strategies in use can be either internal or external. 
Internal strategies involve mental activities which are aimed to improve the quality of 
the encoding of the material to be remembered or to improve the retrieval of already 
encoded material. Older people are often encouraged to 'use it or lose it' meaning that 
they should undertake mental activities such as crosswords or quizzes in order to 
increase or maintain mental capacity. External strategies involve using physical 
changes to the environment, for example, writing and leaving notes in view. These 
strategies could include using a MeA or a medicine chart or placing the medication by 
the kettle or on the bedside table. Research studies have been carried out to determine 
which type of strategies older people used when taking their medication. A study of 
190 older adults living independently in the community in the USA looked at the 
strategies they employed to remember to take their medication (Branin 2001). The 
participants in this study used more internal memory strategies than external strategies, 
with relating taking medication to their daily routine being the most frequently used 
strategy. Another study of 51 older adults, which looked at the use of memory 
strategies for taking medication, (Gould, McDonald-Miszczak and King 1997), also 
found that the older adults used more internal than external strategies. 
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In chapter 6, I looked at the reminder systems that the older people had indicated to me 
that they used, external strategies such as placing the MCA or original packaging in a 
special place, and removing the tablets from the MCA and placing elsewhere were 
frequently mentioned. The internal strategies of linking the taking of the medication to 
the daily routine were also commonly used and a number of the older people mentioned 
that taking their medication had become a 'way of life' . 
During the interviews with the healthcare professionals a number of interviewees 
discussed the reminder systems which the older people had put in place. Some 
interviewees stated that they found it difficult to accept these memory strategies 
especially when the older person had been given a MCA and had then reverted back to 
their old reminder system. The research studies discussed above indicate that older 
adults will decide to use whatever system suits them best and, whether, their system 
relies on internal or external cues will depend on how that particular person uses their 
memory. 
Clearly a MCA will help someone who has a complex medication regimen which they 
find hard to cope with as the MCA will remove the need to retrospectively remember 
which drugs to take and how many of each. When it comes to remembering to take all 
the medication at the correct time, the MCA can be seen as an external cue but the older 
person will have to remember what it is they have to remember and the MCA may not 
help at all. 
Healthcare professionals also stated that a MCA would be no use for those older people 
with a more severe cognitive impairment than mild memory loss. Using a MeA 
correctly does depend on the user having an understanding of days of the week and 
times of day. A study comparing the abilities of cognitively intact older people with a 
232 
group with Alzheimer's disease found that the patients with Alzheimer's disease were 
50% less likely to process the instructions on a drug label correctly than the cognitively 
intact group (Park et al. 1994). Healthcare professionals have reported instances of 
older people taking all the medication in a MCA on one day and older people with a 
degree of cognitive impairment would be most likely to be unable to use a MeA 
correctly. 
Almost 50% of the healthcare professionals stated that not all older people can use a 
MCA and individual brands were highlighted as being more difficult to use. There was 
a degree of anger among some of the healthcare professionals who stated that they had 
found older people with a device which they could not use. Blame was laid at the door 
of other healthcare professionals for failing to check that the older people could manage 
the device they were given. A number of studies have looked at the ability of older 
people to use various types of medicine container (Nikolaus et al. 1996; Atkin et al. 
1994). Another factor which added to the difficulty of using the device was the fact 
that, if the secondary care trust discharged the older person with one type of device, 
then this might change when the community pharmacy took over. The healthcare 
professionals who worked in Intermediate Care were the ones who complained most 
bitterly about the people they visited who had a device which they couldn't use. They 
were also the most likely to check over a period of time that the older person could 
manage. 
Healthcare professionals from both Secondary and Intermediate Care spoke of the 
problems they had in finding a community pharmacy which would fill a MCA for an 
older person. The hospital pharmacists stated that often they had to ask a different 
pharmacy than the one that the older person usually used, which could cause problems 
with accessibility or delivery as well as asking the older person to use an unfamiliar 
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pharmacy. A number of the non-phannacists interviewed observed that it was time 
consuming and costly to dispense medication in a MCA. It was interesting to note that 
interviewee HCP9 (a GP from a dispensing practice) sent the prescriptions for the 
patients who required a MCA to the local phannacy for dispensing because he said it 
took too long to fill a MCA. 
Research studies have looked at the time taken to dispense medication in a MCA. A 
time and motion study carried out in community pharmacies in Northern Ireland found 
that the Dosett® was the quickest to fill with a mean filling time of 1 min 45 sec., while 
the Medidos® took 2 min 52 sec. (McElnay and Thompson 1992). This was for a one 
week supply of three medicines which had already been dispensed into labelled tablet 
bottles for each patient prior to filling the MCA. Clearly it would take longer to 
dispense into a MCA from the blister packs which are the main type of packaging used 
for medication today. Another study (Green, Johnson and Wells 2000) looked at 
dispensing into MCAs, in this case a Nomad® tray, from manufacturers' blister packs 
and compared the time taken with the time taken to dispense from loose tablets. The 
results showed that for certain tablets the time taken to dispense into the Nomad® tray 
from patient packs was twice that from loose tablets. 
Healthcare professionals also discussed the choice of MCA, most community 
pharmacies only supply one type of MCA and other healthcare professionals noted that 
the type offered might not be suitable either for the older person or for the medication 
regimen they were on. Community phannacists who were willing to obtain different 
devices in order to meet a particular need were rated very highly by other health care 
professionals. 
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Dispensing errors were mentioned by a number of health care professionals. The hospital 
consultant felt that it was less likely that a dispensing error would be noticed when the 
medication was all put together in a MCA. Similarly, a number of other staff in the 
Secondary Care Trust stated that they were aware of patients who had been hospitalised 
due to errors in the dispensing of MCAs. Although it did seem as if this might be a 
frequent occurrence, it appears more likely to be a case of a number of different 
healthcare professionals reporting the same problems. The healthcare professionals also 
thought that the older people might be less likely to notice an error than when the 
medicines were dispensed in original packs. A study in Australia identified and 
analysed Dosett®-related incidents reported to the Australian Incident Monitoring 
(AIMS) Study (Levings, Szep and Helps 1999). The study identified 52 Dosett® 
related incidents reported to AIMS from the first 12,000 incidents. The incidents fell 
into three categories: problems with filling (26 problems), problems with use (16 
problems) and problems which were neither related to filling or use (12 problems). 
Fifty percent of the errors identified were therefore due to filling errors, the majority of 
the errors being made by nurses. The paper points out that most filling of Dosett®s is 
done by nurses in Australia. The UKCC issued guidance for nurses (United Kingdom 
Central Council for Nursing 1992) and instructed nurses in the UK not to fill MCAs for 
patients. Only 3 of the 26 errors, in the Australian study, were made by pharmacists. 
Around a third of the errors involved the incorrect use of a correctly filled Dosett® with 
patients responsible for the majority of the errors. The errors were mostly due to poor 
communication, haste and distraction, or patient confusion and dementia. The 
researchers concluded that errors made during filling can cause serious problems for 
patients. They advised that strict protocols for filling MCAs should be designed and 
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adhered to. They also recommended that patients and carers should be educated about 
potential errors in filling and using MCAs. 
Just one non-pharmacist stated that not all medicines can be put in a MCA. Interviewee 
HCP 16 was well informed about problems of stability and stated that some drugs could 
not be put in to the MCA because they had to be in the dark or airtight. The two 
community pharmacists were both concerned about the problems of stability and felt 
that on some occasions it could be considered an ethical dilemma trying to decide 
whether it was possible to include certain drugs in a MCA. Studies have looked at the 
stability of drugs in MCAs (Church and Smith 2006;Walker 1992a) In both these 
studies the researchers obtained information on a number of different medicinal 
products from the manufacturers and presented the advice in table form. 
In the study by Church and Smith, the pharmaceutical companies gave permission for 
the information to be published provided the following disclaimer was printed 
"it is important to note that the individual manufacturers do not endorse this 
practice of transferring medicines from the original packs to compliance aids as 
it may be outside the terms of their product licence. For the majority of 
manufacturers any information they provide is based on anecdotal evidence or 
in-house studies as no formal studies would have been carried out. " 
Therefore although information on stability is available the various manufacturers are 
careful to remove themselves from giving any responsibility. The pharmacist therefore 
still has to make his or her own decision. 
As well as the problem of stability, there were other reasons why individual medicines 
were not put into the older person's MCA. PRN medicines (that is, those taken by the 
patient when required) were mentioned by a number of healthcare professionals as 
presenting a dilemma. Usually these are analgesics and the older person may only wish 
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to take them when the pain is severe. Should these drugs be packaged separately or put 
in the MCA encouraging the older person to take them regularly? Taking the analgesics 
regularly may improve the effect in some circumstances. However, if the older person 
has decided that they do not wish to take their pain relief regularly, they may try to miss 
out the dose or move the tablet from the MCA and errors may result. 
Other medicines with non-standard doses and specific instructions were also identified 
as potential problems, for example, medicines taken only weekly or at more frequent 
times during the day. 
Finally, medicines which may require frequent dose changes were also seen as causing 
problems. Warfarin was a particular problem as the older person may have their dose 
changed just after a new MCA has been delivered. When any dose change is 
communicated to the community pharmacy, either the change is not implemented until 
the following week or the MCA has to be collected and a new dose dispensed. 
However, there may not be a new prescription at this point only a faxed message from 
the clinic. Once again the pharmacist is presented with a dilemma. One of the 
community pharmacists stated that this had become more of a problem in recent years 
now that the guidance on the treatment of AF includes use of anti-coagulants (National 
Institute for Health and Clinical Excellence 2006). The National Patient Safety Agency 
has recently issued a patient safety alert entitled "Actions that can make anticoagulant 
therapy safer." (National Patient Safety Agency 2007) Step nine of this statement 
advises that a risk assessment should be carried out on the use of Monitored Dosage 
Systems for anticoagulants for individual patients. The statement goes on to say that the 
general use of MDS for anticoagulants should be minimised as dosage changes are more 
difficult to enact when using these systems. 
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7.7.3 What are the beliefs and attitudes about the use of MCAs 
I wished to discover if healthcare professionals believed that giving an older person a 
MCA would lead to better health and quality of life. I also wanted to discover if 
healthcare professionals had specific beliefs and attitudes towards older people and 
whether these drove the decision to issue a MCA. 
A minority of the healthcare professionals believed that the MCA would help maintain 
the older person's independence but one GP thought that issuing a MCA might reduce 
an older person's independence. However more healthcare professionals stated that 
older people wished to remain in control and to continue to follow their own routines. 
These observations agree with the findings of a research study undertaken in Australia 
(Thompson and Stewart 2001). In the Australian study 94% of respondents reported a 
method for remembering to take their medication. These methods included taking with 
a meal, take immediately on rising, keep where likely to be seen and use of a chart or 
calendar. This use of external reminders or cues agrees with the work done on 
medication adherence and memory discussed in section 7.7.4. (Branin 2001; Gould, 
McDonald-Miszczak and King 1997) Not all the healthcare professionals were happy 
with their older patients using their own routines and strategies for reminding 
themselves. Comments were made about the more unusual and bizarre systems. Other 
healthcare professionals were happy to let the older people use their own systems, 
feeling that trying to introduce another system might be counterproductive. 
The interviewees were asked if they were aware of older people who intentionally chose 
not to take their medication. I used this area of questioning to try to deternline the 
healthcare professionals' beliefs and attitudes concerning older people and their 
medication. 
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Non-compliance has been described as being divided into intentional and non-
intentional as discussed in Section 1.4.2. A study of people aged over 60 in the USA 
found that 73% of the non-adherence identified was intentional. The authors went on to 
conclude that "traditional efforts aimed at reducing the incidence of forgetting to take 
medicines would not seem to be helpful in cases of intentional non-adherence" (Cooper. 
Love and Raffoul 1982). If this is the case, providing an older person with a MCA 
would seem to be of little value. Another paper hypothesised that intentional and non-
intentional non-compliance were two separate behaviours which have different factors 
associated with them (Wroe 2002) 
To look at this issue further, I asked the healthcare professionals if they were aware of 
older people who made a decision not to take their medication. This was followed up 
with prompts to try to elicit their feelings and to find out what action they would take. 
All of the healthcare professionals with the exception of HCPl stated that they were 
aware of intentional non-compliance in some older people. Side effects of medicines 
and the older people's own beliefs about medicine taking were the reasons most 
interviewees gave for intentional non-compliance. When asked how they felt about 
older people deliberately deciding not to take their medication there were a number of 
different points of view. One nurse felt that she would respect the older person's 
decision whereas others thought that the older people were not honest about their 
medicine taking behaviour. The use of the word 'honest' implied that the healthcare 
professional did view intentional non-compliance as a form of deviant behaviour. This 
is discussed by Donovan and Blake who pose the question "Patient Non-compliance: 
Deviance or Reasoned Decision making?"(Donovan and Blake 1992). Donovan and 
Blake suggest that patients perceive medicine taking in a different way from healthcare 
professionals and in particular do not 'follow doctor's orders'. Patients weigh up the 
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costs and benefits of taking the medication, by taking into consideration their own 
circumstances. Thus, whilst the behaviour may be seen as 'deviant' by the doctor (or 
other healthcare professional), from the patient's point of view it is perfectly reasonable. 
The findings from my study appear to agree with this hypothesis, the healthcare 
professionals stating that they understood that the older people had their own reasons 
for not taking their medication but this behaviour was seen as deviant or not honest. 
I tried to discover if there was a feeling of resentment on the part of the healthcare 
professionals when they saw older people whose worsened condition could be attributed 
to non-compliance with their medication. The healthcare professionals were reluctant to 
admit to any resentment although interviewee HCP8 said that the reason for re-
admission would be discussed and that staff would be more saddened than resentful. 
Older people's own beliefs about medicine taking were seen as a reason for non-
compliance by about half of the interviewees. The healthcare professionals noted that 
sometimes the older people's beliefs were incorrect. For example, not taking medication 
regularly for fear of addiction or 'getting to used to it'. 
Communication was the best solution for the majority of the healthcare professionals. 
They felt that the older person had not received sufficient information about their 
medication and therefore did not understand why compliance was important. This 
opinion is supported by a study which investigated acutely hospitalised older patients 
(Shabbir, Han and Naglie 1999). The researchers found that approximately half of the 
patients investigated had not received any medical education prior to discharge despite 
changes to their medication regimes. The solution, according to the healthcare 
professionals interviewed in my study, was obvious; talk to the older person about their 
medication. Explain what each medicine was for, why it was important to take it and, if 
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necessary, inform them about possible side effects. Research supports the use of such 
interventions (Rich et al. 1996) A telephone call from a suitably trained pharmacist to 
provide information about newly prescribed medication was also found to improve 
compliance (Clifford et al. 2006). Some of the healthcare professionals in the main 
study stated that they would consider other courses of action. For example if side 
effects were causing the problem the pharmacists would discuss with the prescriber a 
change of drug and other healthcare professionals would also consider this. Reporting 
non-compliance back to the prescriber was seen as a 'duty' by a number of the nurses, 
whereas the prescribers stated that they would discuss the issue but would be happy for 
the older person to make the decision. 
Did the number of years post registration affect the healthcare professionals' 
attitudes and beliefs? 
I tried as far as possible to recruit both recently registered and more experienced 
healthcare professionals within my purposive sample. I aimed to compare the 
interviews across the different professions and across the level of experience. The 
length of time on the register for the healthcare professionals ranged from one year to 
thirty years. The young staff nurse who stated that she did not recommend the use of 
MCAs for patients in her care (Section 7.3) had been on the register for one year. The 
junior hospital doctor (3 years post registration) stated that patient problems (poor 
memory, physical disabilities, home circumstances) were most likely to trigger the issue 
of a MCA. Only one other interview produced more themes around patient problems 
and that was given by a nurse (23 years post registration). The junior hospital 
pharmacist had the best knowledge of intentional non-compliance among the recently 
registered group and was also aware of the meaning of the term concordance. 
241 
Communicating with the older people about their medication was only discussed by the 
junior hospital pharmacist and the junior hospital doctor. 
A study which measured the attitudes to concordance m newly qualified medical, 
nursing and pharmacy graduates (Raynor et al. 2001) concluded that newly qualified 
doctors, nurses and pharmacists hold favourable attitudes to concordance but a 
significant minority, mainly pharmacists, held negative views. The differences in the 
understanding of concordance may reflect the different training in medicines 
management undertaken by the different professions. The pharmacy undergraduate will 
have studied compliance and concordance but this may not be so for the other groups. 
7.7.4 Did the healthcare professionals think ageism existed? 
The older people whom I interviewed had introduced this theme in the first interviews. 
I included a question about age and age discrimination in the topic guide for the 
healthcare professionals, by using the statements made by the older people to introduce 
the topic. The majority of the interviewees stated that, although this type of behaviour 
might occur elsewhere, they did not act in this way. 
The National Service Framework (NSF) for older people (Department of Health 2001) 
Standard One states that "NHS services will be provided, regardless of age, on the basis 
of clinical need alone. Social care services will not use age in their eligibility criteria or 
policies, to restrict access to available services." Standard Two-Patient-centred care: 
states that "older people should be treated as individuals and enabled to make choices 
about their own care". The King's Fund commissioned research to look at age 
discrimination (Roberts, Robinson and Seymour 2002) This report concluded that the 
objectives of the NSF to eradicate ageist practices from the NHS would not be met 
unless more help was given to local managers to implement the policy. 
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The health care professionals thought there was a danger in appearing to patronise the 
older person and a minority of the interviewees said that they might on occasion treat 
the older person like a child, albeit with the best of intentions. A study in Belgium 
explored a number of issues concerned with the inappropriate use of medicines for 
elderly patients admitted for acute care (Spinewine et al. 2005) A number of categories 
were identified as underlying inappropriate use of medicines including 'Paternalistic 
decision making'. The researchers stated that ageism could be viewed as a form of 
paternalism and they concluded that this may contribute to the inappropriate use of 
medicines in elderly patients. Another qualitative study investigated the diagnosis and 
management of heart failure in primary care using focus group interviews with GPs 
(Fuat, Hungin and Murphy 2003). Ageism was highlighted in all the focus groups with 
GPs stating that they would be more likely to 'aggressively treat' a younger patient 
rather than an older one. 
Some interviewees stated that this was not 'an age thing' but sometimes older people 
might be treated in a certain way because they couldn't understand or couldn't manage 
because of a physical disability. One interviewee said she thought she shouted at all the 
older people automatically because so many were deaf but realised that this might be 
offensive to someone whose hearing was perfect. These statements highlight a 
stereotypical way of thinking about older people. Age stereotypes have been defined as 
knowledge structures which people use to process information concerning age 
(Hummert 1999). Age stereotypes can influence both our perceptions of and behaviour 
towards others. The healthcare professionals exhibited stereotypical opinions regarding 
older people, in particular concerning memory and ability to understand. 
The healthcare professionals interviewed held the belief that older people were more 
forgetful despite the fact that this has not been conclusively proved by research. This 
243 
negative stereotype of the forgetful older person is common in our society and there is 
evidence to suggest that older adults respond to these attitudes by behaving as the 
stereotype (Hess 2006). 
Communication or lack of communication was again linked to problems in this area 
with some interviewees stating that often misunderstandings can happen when the right 
explanations are not given. 
Are Multi-compartment Compliance Aids ageist? 
This point was raised in the older people's interviews when one or two interviewees 
questioned why they had received a MCA; 'is it to do with my age?' they had asked. 
Those interviewees who were self-filling when asked about a pharmacy filled MCA 
replied that they didn't need that help yet, implying that MCAs were for people less able 
to manage than themselves. 
The healthcare professionals thought that MCAs might look rather child-like and 
insulting. 
MCAs are rarely gIVen to groups other than the elderly. People suffering with 
HIV / Aids sometimes use them because the regImens are very complex, and 
occasionally MCAs are given to people with learning difficulties who are taking a 
number of medications. It could be said, therefore, that the use of MCAs is ageist as 
they are primarily issued to older people. However this would depend on the indications 
for their use. Provided that the recipient is happy to use the device and is capable of 
using it then this should not be a problem. The difficulty arises when the MCA is issued 
without consultation or assessment and the reasons for the issue are unclear. 
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7.8 Summary 
In summary this chapter has looked at the findings from the interviews with healthcarc 
professionals and identified the following issues. 
The Trigger for use of multi-compartment compliance aids was most frequently 
hospital discharge. 
Use of MeAs. The main advantage identified by the healthcare professionals was ease 
of use and convenience. However the interviewees identified more disadvantages than 
advantages. There was some difference of opinion among the professions about the use 
of MCAs. In particular there was a tendency to lay the blame for problems at another 
professional's door. 
Health Beliefs. The healthcare professionals discussed not only their own attitudes and 
beliefs about older people managing their medication but also the beliefs of other 
professionals and older people. There were differences between the professional groups 
in their attitude to intentional non-compliance, with some interviewees taking a more 
paternalistic point of view. 
Age / ageism. The majority of the healthcare professionals stated that ageism might 
occur but not in their particular area of practice. Some interviewees did state that the 
issuing of an MeA could be seen as insulting to some people. There was understanding 
of the older person's point of view but there was also a feeling that older people should 
follow the 'doctor's orders'. 
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Chapter Eight: 
Further discussion of the findings and implications 
for practice and further research 
8.1 Introduction. 
This chapter draws together the [mdings from all the parts of the study previously 
described, commencing with a review of the aim of the programme of work. 
Chapters six and seven contained the findings obtained from the interviews both with 
older people and healthcare professionals and a discussion of these findings supported 
by references from the literature was presented. In this chapter I compare and contrast 
the findings from both sets of interviews and the comparisons are then used to explore 
the level of agreement between the two parts of the main study and the preliminary 
study. Also included are explanations for the findings, using the underpinning 
theoretical approaches which were described in chapter 4. Finally, I put forward the 
implications of this research for policy, practice and for further research. 
8.2 What was the aim of the study? 
The aim of the study was to discover how the attitudes and beliefs of older people and 
healthcare professionals affect the use of multi-compartment compliance aids (MCAs) 
by older people living in the community. Firstly, to consider the older people, their 
beliefs would concern: 
The seriousness of their illness. 
The likelihood that the illness was treatable 
The safety and efficacy of the medication. 
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These are all aspects of the Health Belief Model (Becker and Maiman 1975). The 
beliefs of the older people are usually based on evidence. However that evidence rna\' 
not always be reliable when viewed by a healthcare professional, but seem genuine to a 
lay person. This is supported by research undertaken with 100 patients with Type 2 
diabetes and 104 healthcare professionals (Clark and Hampson 2003). The study 
revealed several differences in beliefs and attitudes between patients and health care 
professionals with the patients believing that type 2 diabetes was a less serious 
condition compared to the healthcare professionals. The patients, therefore, were less 
likely to see the value of maintaining tight blood sugar control than the healthcare 
professionals. 
Attitudes, on the other hand, are often based on the person's own feelings or opinions 
and may have little to do with evidence; the attitude of a patient to their doctor may rely 
on any number of factors which have little to do with medical expertise. Older people 
may not only have beliefs about medication but also attitudes concerning how they take 
their medication. Some people will take their medication exactly as instructed whilst 
others will maintain a much more relaxed attitude not worrying too much if they miss a 
dose or take an extra dose. It may be easier to change a person's attitude to medicine 
taking but harder to change a deeply held belief. 
The healthcare professionals, because of their medical training, hold evidence-based 
beliefs about the treatments they prescribe for patients. However, at times these beliefs 
may be challenged by new research or government guidelines. Attitudes on the other 
hand can influence the behaviour of healthcare professionals both in the way they relate 
to older people and their medication problems. A study of the prescribing behaviour of 
doctors in the USA (Epstein, Read and Winickoff 1984). investigated the relationship 
between physician beliefs and attitudes when prescribing anti-inflammatory drugs. The 
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physicians were asked both "belief' and "attitude" questions concerning commonly 
prescribed anti-inflammatory drugs. The researchers concluded that, while there was no 
relationship between physician's beliefs and prescribing behaviour, there was a 
relationship between certain attitudes and the physician's behaviour. The researchers 
concluded that attitudes are based on more complicated patterns of information 
including personal biases, and may be more difficult to alter. 
In order to ascertain if these attitudes and beliefs, held by both groups, affected the use 
of MCAs by older people living in the community I considered four areas of interest. 
The four areas of interest, 'Trigger for use', 'Use of MCA', 'Health beliefs' and 'Age 
and ageism' were investigated from both the older person's and the health care 
professional's point of view. The intention by doing this was that I would be able to 
compare the data obtained from the two groups and use the two sets of data to 
corroborate one another. 
8.3 Comparison of the findings from the older peoples' and healthcare 
professionals' interviews. 
In order to understand how the attitudes and beliefs of both groups might influence the 
use of MCAs, it was necessary to find out from the older people what lead to the issue 
of the MCA. I also needed to explore this from the 'other side' and so the healthcare 
professionals were asked to describe the characteristics of an older person for whom 
they would request the issue of a MCA. 
8.3.1 What triggered the supply of the MCA and what are the characteristics of 
older people receiving a MCA? 
Hospital admission and discharge were highlighted as triggers for MCA use in both the 
preliminary study and the main studies. In the preliminary study the patients cited 
hospital discharge as the occurrence most likely to lead to the issue of a MeA. This 
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supports the findings from the older peoples' interviews in the main study. A majority 
of older people interviewed in the main study stated that they had managed their 
medication perfectly satisfactorily until either they had gone into hospital or had 
experienced a worsening of their illness. The healthcare professionals in the main study 
characterised the older people who would be issued with a MCA on hospital discharge 
as forgetful, having a large number of different medicines and as at risk of "bouncing 
back" into hospital. These were the main influences for issuing a MCA, supported by 
the professionals' beliefs that the device would improve compliance and that patients 
should take their medication as directed. 
There was a belief among many of the older people that hospital admission or failure to 
cope at home would lead to residential care. A research study in Australia (Quine and 
MOffel 2007) interviewed older people about the hopes and fears that they held for their 
future. The fear of nursing home admission was ranked third in the list of fears by the 
respondents, with loss of independence in general ranked second. In another study 
undertaken in Australia, interviewees stated that they would rather die than have a hip 
fracture treated and have to be admitted to nursing home care.(Salkeld et al. 2000). 
This belief was supported by the Care of the Elderly consultant who stated 
" ... it is quite a horrific thought really you know people don't want to come into 
hospital because they perceive that they will never be allowed to come back 
home again. " HCP 13 
The need to remain in their own home and look after themselves was uppermost in 
many of the older peoples' thoughts. Therefore, this would lead to acceptance of any 
medication or device on discharge, with only the most determined and independent 
questioning any decision. Thus MCAs and medication changes were accepted, and only 
once they were established back home did they begin to question their medication 
regimen or the use of the MCA. This finding is directly consistent with the symbolic 
249 
interactionist theory, which I described in Chapter 4 and which will be discussed later in 
this chapter. 
Research studies have investigated discharge from hospital and the problems that can 
occur with medication, as discussed in Section 6.7.l. The most widely held opinion of 
the healthcare professionals was that older people who 'bounced back' repeatedly did so 
because of non-compliance with medication. This was then a main driver in the issue of 
a MCA when discharging the patient. 
However, is there evidence that repeated re-admissions to hospital in the older age 
group are due to non-compliance? Several research studies have looked at drug related 
admissions to hospital. Some studies have looked at adverse drug reactions (Mannesse 
et ai. 1997; Pirmohamed et ai. 2004) and other studies have looked at a range of drug 
related incidents (Bhalla, Duggan and Dhillon 2003; Mc Donnell and Jacobs 2002; 
Chan, Nicklason and Vial 2001). The studies which looked at admissions resulting 
from adverse drug reactions considered only those admissions which could be directly 
linked to a serious adverse reaction to the patients' prescribed drug therapy and 
excluded overdosing, under-dosing and non-compliance. The studies which looked at 
drug related incidents also considered non-compliance and omission of indicated 
treatment. 
A study undertaken m Tasmania (Chan, Nicklason and Vial 2001) considered 240 
patients aged 75 and over who had unplanned admission to hospital over an 8-week 
period, of these 240 admissions 4% were considered to be caused by non-compliance. 
A similar study in Cambridge (Bhalla, Duggan and Dhillon 2003) considered acute 
adult admissions over a 9-week period. These admissions were reyiewed by a clinical 
pharmacist and a review panel made the final decision on which admissions \\ere dmg-
250 
related. 840 admissions were screened and 85 (10%) patients were identified as having 
a drug-related admission. Eighteen percent of these admissions were considered to 
relate to drug therapy failure, the most implicated category of which was non- or poor 
compliance. A third study, carried out in the USA (McDonnell and Jacobs 2002), 
comprised a retrospective chart review of 158 adverse drug reactions linked to hospital 
admission. The researchers linked a third of these admissions to non-compliance with 
medication. In all the studies, the main cause of drug-related hospital admission was an 
adverse drug reaction; however each study concluded that compliance issues were also a 
cause of a significant number of hospital admissions. 
Further investigation reveals that non-compliance in each study was defmed differently. 
Chan (op.cit.) included both patient non-compliance with prescribed medication and 
non-compliance due to failure on the part of the physician to prescribe. McDonnell 
(op.cit.)included problems with OTC medication in their patient compliance issues. 
Bhalla (op.cit.) included non-compliance in the therapeutic failure category, which also 
contained changes to medication, e.g. dose reduction and dose discontinuation. 
Therefore, although non-compliance appears to play a significant part in hospital 
admissions in these studies, the cause may not lie completely with the patient. 
8.3.2 Perceived advantages and disadvantages of MCAs 
Both the older people and the healthcare professionals had very clear views on the 
advantages and disadvantages to the older person of using a MCA. Figure 17 below 
compares the advantages and disadvantages as seen by the two groups. 
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Figure 17: Comparison of themes relating to advantages and disad t f 
MCA 
van ages 0 
use. 
Older People Healthcare Professionals 
I Easy to use Easy to use I 
Acts as reminder Memory aid I 
Continuous supply I I No need to think 
Aids independence I 
Medicines always available For benefit of others I 
I Well looked after. I -------'-----. ___ -------.Jr , /' ~ • Not a memory aid 
I~I No use if cognitively impaired I Older person unable to use Change of MCA 
~~ Change of medication 
~ Prefers own system ~ I Identification of medicines ~ I 
~ I Loss of choice I I Inflexib Ie dispensing 
~ I 
~ t--------
Stability of medicines 
~ Practicalities of supply 
Six o'clock warfarin 
I Difficult to use 
I Needs to identify medicines 
I Lack of communication 
~I _St_il_lm __ ak_e_s_m_i_st_a_ke_s_· __________ ~I~~ 
~L ______________ M_e_d_ic_~_io_n_e_r_ro_rs~i 
A majority of the older people took a practical attitude to the use of the MeA seeing 
ease of use as the most important advantage. Ease of use was also cited as an advantage 
by users in the preliminary study. The healthcare professionals also stated ease of use 
as an advantage and also suggested that the MeA was a memory aid. The older people 
used the term ' reminder' rather than saying that the MeA aided their memory and ther 
is a subtle distinction here, with ' reminder ' being suggestive of a g ntle prompt about 
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something which has just slipped the memory whereas a memory aid suggests 
something which helps the failing memory. Both groups noted that having a MCA 
ensured that there was always medication available. For the healthcare professionals 
this referred to the prescription ordering and delivery by the pharmacist and for those 
older people supplied by the pharmacy this was also an advantage. The self-filler group 
also thought that filling a MCA ensured a regular supply because when the MCA was 
filled for one week the older person could calculate if there was sufficient for the next 
week's fill or whether a new prescription was needed. Medication was therefore always 
on hand. For the carers who filled MCAs this was also an advantage. 
Those older people who fitted into the "uninterested in medicines" category liked their 
MCA because it removed the need to think about their medicines. About a third of the 
healthcare professionals thought that giving an older person a MCA helped the 
healthcare professional. The help that the healthcare professional referred to was 
defined as the ability to monitor the older person's medicine usage, by looking at the 
MCA and observing what had been removed. It is important to remember that the fact 
that a medicine is not in the MCA does not conclusively indicate that the medicine has 
been taken. The older people interviewed did not seem to be aware of this practice and 
did not state that any healthcare professionals asked to view their MCA. 
It is easy to see from Figure 17, that numerically the perceived disadvantages of MCAs 
outweighed the perceived advantages. The older people did not identify as many 
disadvantages as the healthcare professionals. In fact, for the healthcare professionaL 
disadvantages cited outweighed advantages by almost two to one. 
The difficulty of removing the medication from the MCA was discussed both by older 
people and healthcare professionals and is also a finding from the preliminary study. 
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The older people discussed problems experienced by themselves and also indicated how 
others might have problems using the devices. Some healthcare professionals held very 
strong views about the difficulty of using a MCA; these views usually concerned the 
lack of assessment carried out by colleagues in another sector. 
Despite some healthcare professionals stating that MCAs did act as a memory aid, the 
majority thought that MCAs did not act as in this way and that this was a disadvantage. 
The healthcare professionals also stated that MCAs are not suitable for those older 
people with cognitive impairment; these statements were all anecdotal, that is based on 
clinical experience, as little research appears to have been carried out in this area. 
Research with cognitively impaired older people presents problems because Research 
Ethics approval usually requires the study subjects to be able to give informed consent. 
Therefore subjects who cannot provide this consent will not be included in the study. A 
study of older people discharged from hospital into the community investigated the 
relationship between cognitive impairment and medication adherence (Conn, Taylor and 
Miller 1994) This study is rare in seeking to investigate the abilities of the cognitively 
impaired, however the authors do state that the participants had only moderate 
impairment. It appears that both groups managed their medication well although twice 
as many of the cognitively impaired group received help from a third party than did the 
cognitively intact. In another study (Botello and Dudrak II 1992), adherence to long 
term medication was not associated with impaired cognitive abilities although, as the 
authors indicate, the study was limited by the small number of participants. In contrast 
several of the self-filler group stated that a characteristic of someone who received a 
MCA filled by the pharmacy might be confusion or dementia. Similarly one of the 
pharmacy-filled group wondered if she might have been issued with a MeA because 
someone thought she was confused. 
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The pharmacists were the only professional group to discuss the problems which might 
occur post-discharge if the community pharmacy provides a different MCA to the one 
issued by the hospital. Presumably other healthcare professionals are unaware that this 
might happen. Approximately a quarter of the older people interviewed had 
experienced a change in the MCA. The reasons for this were either a change on 
hospital discharge or a change of device by the community pharmacy. This change was 
met with very different opinions; some older people coped very well whilst others were 
unhappy with the change. This change of device for whatever reason appears to be an 
important issue and should only be undertaken with clear counselling by a suitable 
professional. One of the youngest healthcare professionals interviewed observed that 
not all MCAs are set up in the same way and the days and dosage times can be in 
different positions. Careful instruction is required to make sure that errors do not occur. 
The underlying issue here is that the older person should be assessed and if a MCA is 
deemed to be necessary then the most suitable one for that older person should be 
chosen and continued. Further assessments would then be necessary at intervals to 
check that the MCA is still suitable. 
We have seen that the inability to identify the medication in the MCA was highlighted 
as a disadvantage both by older people and the healthcare professionals. The older 
people felt the need to be able to identify the tablets in the MCA for a number of 
reasons. These included to check the right medicine had been dispensed and to 
correctly identify a medicine they didn't want to take. Healthcare professionals also 
acknowledged this problem particularly relating to generic medicines which might have 
a different colour, shape or markings. This means that the older person may become 
unsure about the medication in the MCA and may be more likely to become confused 
by the changes, effective counselling led to a decrease in confusion and a lessening of 
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fears. We have seen that the older people who receive a MCA are sometimes less likely 
to receive any face-to-face counselling about their medication. 
So the removal of the medication from the original packaging removes a point of 
reference and means that the older person cannot check if the correct drug has been 
dispensed. Those older people categorised as "expert patients" are most likely to be the 
ones who notice changes to the medication or who adjust doses of medication according 
to symptoms or health beliefs. This behaviour is unlikely to change because a MeA has 
been issued and therefore more problems may occur. 
The older people categorised as "uninterested in medicines" are not likely to be 
concerned about identifying medicines and therefore not be aware of changes to their 
medication or dispensing errors. 
Only three healthcare professionals observed that not all medication can be put into a 
MCA - two of these were pharmacists and one was a nurse. The pharmacists were 
concerned about stability and while the nurse was aware of this, she also mentioned 
'when required' medicines, which also can cause a problem. Research carried out with 
community nurses in Scotland (Stewart et al. 2001) discovered that 51 % of those 
interviewed stated that they did not know of any drugs which should not be dispensed in 
a MeA. The majority of the older people interviewed in the main study had other 
medication which was not in the MeA; and, in contrast to the healthcare professionals, 
none said that this was a particular disadvantage, although having to remember to take 
weekly medication was remarked upon. Approximately half of the interviewees in the 
preliminary study had medication which was not in their MeA and the majority stated 
that this presented no problem. This particular aspect of MeA use does not appear to 
have been studied. 
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The healthcare professionals discussed another aspect of the use of MCAs, which was 
'practicalities of supply'. The themes in this section all related to problems which the 
healthcare professional might experience when arranging or dispensing in a MCA. 
Although these problems might constitute disadvantages for the older person these were 
not themes discussed by the older people. 
The fact that not all community pharmacies will dispense in MCAs was discussed by a 
third of the healthcare professionals. This might mean that the older person would get 
their prescription dispensed by a different pharmacy to the one they had used regularly 
before. This raises the prospect of older people obtaining dispensed medication from 
two different sources resulting in incorrect patient medication records (PMRs) and the 
possibility of some medication being dispensed twice and some medication not being 
dispensed at all. 
Although the older people were worried when different medicines appeared in the 
MCA, no mention was made of the problems which could occur if a new medicine was 
prescribed or a dose changed which required alteration to the drugs in an already filled 
MCA. Just one older person mentioned the changes to dosage which might occur with 
her warfarin. However she explained that the pharmacy would receive instructions 
from the hospital and would then arrange to make any changes to the medication in the 
MCA. The interviewee was full of praise for the system. This is in complete contrast to 
statements made by a number of healthcare professionals regarding the problems they 
now face because of the increased use of warfarin by older people. Both community 
and hospital pharmacists discussed the need to change the dose of the warfarin and 
explained that if a new MCA had just been delivered there could be a delay in the new 
dose being implemented. The junior nurse working in primary care pointed out that 
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dose changes and new medication often meant that she had to visit the phannacy to 
obtain a new MCA for the patient. 
Errors were discussed by both older people and healthcare professionals. The older 
people were worried that the pharmacist might make a mistake when dispensing the 
medication and this was the reason why the self-fillers were happy to fill the MCA 
themselves. The self-fillers stated that they liked to be in control and that they had no 
problems filling the device, and the healthcare professionals were happy to suggest that 
older people did this for themselves. However there could be a danger that the older 
person could make a mistake. The ability of a group of arthritis patients to correctly 
load their medications into three types of over-the counter medication organisers was 
investigated in the USA (Park et al. 1991). This small study showed that patients do 
make errors filling these devices and that these errors are related to the number of 
medications the participants are taking. The healthcare professionals in my study who 
suggested that older people could be provided with a device to fill themselves did not 
express any concerns about accuracy and did not state that they would check the older 
person's ability to carry out this task. Among the health care professionals there was 
some enthusiasm for devices being filled by an informal carer and again there is the 
concern about accuracy. The Intermediate Care pharmacist stated that she had 'trained' 
some family members to fill a MCA and the Primary Care nurse discussed a 
'responsible' family member filling the device. One of the older people interviewed 
whose MCA was filled by a family member described how this family member refused 
to allow anyone else to fill the MCA despite this causing problems when she went 
away. The relative who filled the MCA was said not to trust anyone else to fill the 
MCA correctly. 
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8.3.3 The health beliefs of the older people and the health care professionals. 
The main focus of this study was to determine whether beliefs and attitudes of both sets 
of interviewees affected the use of MCAs. The topic guides for both sets of 
interviewees was designed to ascertain what health beliefs the interviewees might hold. 
In Section 6.7.3, I discussed the health beliefs and attitudes held by the older people and 
in Section 7.7.5, I explored the health beliefs and attitudes of the healthcare 
professionals. 
Figure 18 below illustrates the health beliefs of the older people and the healthcare 
professionals and shows how these health beliefs affect the use of a MeA. 
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Figure 18: Compariso?s o~ the themes relating to beliefs and attitudes re ardin 
use of MCAs and medicatIOn. g g 
Older People 
Medicines are important 
Knowledgeable about medicines 
Independence and being in control 
Doctor are the experts I follow their 
orders 
I Medicines are a way of life 
Relationship with healthcare 
professionals 
Medicines are harmful 
Take too many medicines 
Changes to medication 
Healthcare Professionals 
Remain in control 
Maintain independence 
Education & counselling 
Negotiation 
Important for older people to trust 
healthcare professionals 
Poor knowledge about medicines 
Patient 's must take medication as 
prescribed 
Lack of communication 
Loss of independence 
The companson of the beliefs and attitudes of the older people and the healtbcare 
professionals shows both similarities and differences. 
Both older people and healthcare professionals identified independence as being 
important. For the older people independence meant being in control and therefore thi 
belief was unlikely to lead to use of an MeA with the exception of those who were elf-
fillers. The health care professionals saw independence as both a hindrance and an 
encouragement for use. This means the healthcare professionals mu t id ntify the old r 
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person's opinions about their independence. Providing a MeA to someone who sees 
this as indicating a loss of their independence could result in failure to use the device 
and a breakdown in the healthcare professional/patient relationship. 
A large majority of the older people thought that medicines were important and a 
similar number were very knowledgeable about their medication. However for some 
older people, accepting that doctors were the experts and following doctors' orders was 
an important belief. The healthcare professionals identified that trust in a healthcare 
professionals was important for older people and noted that difficulties could arise when 
medication prescribed by a trusted doctor was changed by someone they did not know 
and for reasons which weren't explained. 
Healthcare professionals believed that older people (and probably people of all ages) 
should take their medication as directed and therefore methods to improve compliance 
with medication were important. The healthcare professionals were aware that older 
people might intentionally decide not to take their medication; the reasons given were 
side effects and the older people's beliefs. 
A minority of the older people took the view that medicines were harmful, side effects 
were a worry, and they needed to be certain that any prescribed medicine was really 
necessary. One of the older people interviewed was of the opinion that doctors were too 
keen to write prescriptions at the "drop of a hat". 
The healthcare professionals were asked specifically if they recognised intentional non-
compliance among their patients. The majority stated that they did and their views on 
the causes agree with the views of the older people. Side effects were seen as an 
important cause of intentional non-compliance as were poor understanding among older 
people of how their medicine worked and the best way to take it. Howc\er the 
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healthcare professionals thought that a good deal of intentional non-compliance was due 
to the patient's own beliefs about medicines, i.e. that they were taking too many, they 
are fed up with taking the tablets, or they think their illness has improved and they don't 
need to take the medicine any more. The healthcare professionals attitude to this varied , 
some respected the older peoples' decisions, but some took a different approach as 
discussed in Section 7.7.5. 
The healthcare professionals had many solutions to the problem of non-compliance 
including issuing a MeA. However if the non-compliance is intentional it is unlikely 
that the MeA will have any effect. Many healthcare professionals discussed 
communication as a good means of improving the older person's compliance and many 
studies have been carried out looking at such ideas (Opdycke et al. 1992, Lowe et al. 
2000a). Both these studies found that education programmes improved medication 
compliance and knowledge. This idea of communication is supported by the older 
people who often expressed a wish that they were better informed about their 
medication. 
Both the interviews with the older people and the healthcare professionals produced 
themes which were categorised as "6pm warfarin" and this category gives an insight 
into the health beliefs of both groups. Five older people had been prescribed warfarin, 
four were still taking it at the time of interview and one had had the prescription 
changed after a fall led to bleeding and hospitalisation. This particular interviewee was 
very articulate about her medication and knew that the bleeding in her knee joint was 
due to her warfarin treatment. She was adamant that she had taken her medication 
correctly prior to the accident although the unannounced arrival of the Dosett® box 
immediately after discharge may indicate that there was a level of non-compliance. Thc 
problems arose because the first MeA contained neither warfarin nor clopidogrol 
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leaving her for a week without treatment and the next MCA contained both. It is hardly 
surprising that this lady was reluctant to use her MCA. 
The other participants also reported excellent compliance with their warfarin and stated 
that "warfarin was speciaf' and they never forgot to take it. Research studies have 
investigated the influence of compliance on anti-coagulation control with warfarin 
(Kimmel et al. 2007, Engova, Duggan and MacCallum 2002). Kimmel et al monitored 
patients from anticoagulation clinics in the USA for a mean of 32 weeks. Compliance 
with the medication was measured using a Medication Event Monitoring System 
(MEMS). The MEMS device records the removal of the bottle top and thus gives an 
indication of compliance. The results showed that poor compliance with warfarin 
medication does lead to poor anticoagulant control and that even small variations in 
compliance can lead to clinically significant changes in anticoagulation. The older 
people in this study indicated that they did take their warfarin exactly as directed and 
rarely if ever forgot a dose. The older people interviewed shared a belief that warfarin 
was important to maintaining their health and showed some understanding of the side 
effects. 
In a preliminary study undertaken by Engova (2002), a survey of patients attending a 
hospital based anticoagulant clinic identified compliance from total plasma levels of 
warfarin. Subjects were also questioned about their levels of compliance, health beliefs 
and knowledge of medication. Sixty percent of the patients recruited had INRs within 
the standard therapeutic range on two or all three occasions; 93% knew the indication 
for warfarin and all the patients knew their current dose. Three quarters of the patients 
took their warfarin in the evening and the researchers explored the reasons for this, 
noting that 92% of the patients whose warfarin was started in hospital took their dose in 
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the evening. Engova and colleagues concluded that lack of compliance was not the 
main cause of instability in warfarin controlled anticoagulation. 
The two studies quoted above have reached different conclusions with one study 
identifying non-compliance among the patients taking warfarin and the second study 
reporting a degree of compliance. The two studies investigated a similar number of 
patients attending anti-coagulant clinics, the mean age of the patients in the Kimmel 
study was 58.5 yrs and in the Engova study was 67 years, there were more men in the 
Kimmel study. The Engova study findings are very similar to those in this study with 
interviewees reporting high compliance in conjunction with a 6pm dose. 
The senior secondary care nurse interviewed also supported the view that older people 
were meticulous in taking their warfarin at 6pm and she remarked on the fact that some 
older people became quite distressed if the dose was not given on time. The 
pharmacists interviewed were aware of the 6pm dose regimen and the reasons for it and 
reported some level of resistance among other staff if the dose was changed to the 
morning. For some older people, changing the warfarin dose time to breakfast time 
would be better especially if all other medication is taken at this time. Provided the 
medication is always taken at the same time and the anticoagulant clinic knows when 
the dose has been taken there is no clinical problem. 
A bigger problem may be caused by the time lag which may occur between the INR test 
being carried out and any change of dose being actioned. One of the community 
pharmacists spoke at length about the difficulties encountered because of the large 
number of older people taking warfarin ( the number of has increased in recent years 
due to the guidelines on the treatment of AF). A time lag may occur if the dose change 
was implemented on the days following the issue of a new MeA. If another box is not 
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sent out then the patient may wait a week for the new dose to be included. This may 
have implications for subsequent INR results as research (Kimmel et al. 2007) has 
shown that even small numbers of missed tablets can affect the anticoagulant range. A 
patient safety alert in relation to anticoagulant therapy has recently been published 
(National Patient Safety Agency 2007). This safety alert suggests that the use of MCAs 
for anti-coagulants should be minimised. 
The majority of the older people interviewed stated that they did take their medication 
as directed; however there was some indication of intentional non-compliance. Some 
interviewees were also worried about taking too many medicines and they were also 
concerned about side effects. These feelings are supported by various qualitative 
research studies which have looked at patient's beliefs about medicines. Home (2004) 
discussed two factors which appeared to influence patients when making decisions 
about medicine taking. These two factors were the extent to which the medication was 
needed and the risks involved in taking it. The older people interviewed have also 
discussed these issues. 
The healthcare professionals also had very strong attitudes towards other health care 
professionals often pointing a finger of blame at someone else. So the community 
pharmacist states that it is the hospital staff that drive the issue of MCAs in order to 
discharge older people more quickly. The secondary care staff state that, if the older 
person is receiving home care, then a MeA must be issued. The staff in Intermediate 
Care seemed the happiest to make their own decisions based on assessing the patient. 
Finally one General Practitioner accused the community pharmacists of initiating MCA 
use in order to gain more dispensing fees. This comment highlights the lack of 
understanding among other healthcare professionals regarding the funding of 
dispensing. The community pharmacists' concern oyer the lack of funding for \1CAs. 
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was discussed in Section 2.5.5. This culture of blame and accusation does not 
encourage co-operative working among the different professions. There is a great deal 
of misinformation circulating concerning the use of MCAs within all sectors of 
healthcare and this attitude does not assist the appropriate use of these devices. 
Research has been undertaken into inter-professional team-working (Molyneux 2001; 
Snelgrove and Hughes 2000) however this has concentrated on those healthcare 
professionals working in multi-disciplinary teams. The healthcare professionals 
interviewed in my study were not referring to other healthcare professionals on the same 
team but someone working in another place and often in another sector of the NHS. 
Frequently the complaints could have been resolved if communication between the 
different professions and sectors had been better. One interviewee who received a 
complaint from a healthcare professional in another sector concerning older people 
discharged with a MeA they could not use, took steps to ensure that a more rigorous 
assessment was undertaken in future. 
The healthcare professionals expressed strong beliefs about compliance with 
medication. This was despite apparently accepting that older people should make their 
own decisions about their medication and that these decisions be respected. There was 
an underlying belief that medication should be taken as prescribed. During the course 
of the interviews the pharmacists did discuss the issue of concordance, but for the other 
healthcare professionals this was an unfamiliar expression, a minority were able to 
define what concordance meant and others did explain that they would talk to the older 
person about their medication. Healthcare professionals' attitudes to concordance are 
discussed later in this chapter. 
Changing a person's beliefs or behaviour can be complex and this process plays an 
important part in health promotion. This suggests we should look to the strategies used 
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in such activities as smoking cessation. We know that, in order to give up smoking, a 
patient has to have reached a certain point on the transtheoretical model of behayiour 
change as described by Prochaska and DiClemente (1982). Only then can the various 
smoking cessation methods be discussed and the most appropriate method decided on. 
In the same way, it is of little value to issue a MCA to a person who has decided not to 
take their medication unless this process has been preceded by counselling or an 
education programme. Research into non-compliance with post-transplant medication 
has looked at exploring the use of behaviour change for improving compliance with 
medication (Robbins 1999). The cycle of change consists of five stages: 
precontemplation, contemplation, preparation, action and maintenance. Patients who 
are in the first stage are not ready to take action even if the action is lifesaving or life 
enhancing. Patients in the contemplation stage are more aware of the benefits but are 
easily discouraged by side effects or inconvenience. Those patients in the preparation 
phase are poised for action; they see the benefits and are keen to continue with 
treatment. Those patients in the action phase have begun to take the medication but 
only for a short period of time. However they see the advantage and believe they have 
the ability to continue. Finally, those patients in the maintenance phase have adjusted 
their life to include taking their medication and feel they are able to continue. Older 
people who intentionally do not take their medication as directed will therefore need 
more support than simply issuing a MCA. Although some studies investigate the use of 
educational strategies, there appears to be little work done on changing the behaviour of 
older people in this context. 
8.3.4 Age and Ageism 
A third of the older people interviewed in this study complained of some form of ageist 
treatment. Being treated like a child or being 'talked down to' were two commonly 
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occurring themes. Other interviewees related occasions when healthcare professionals 
assumed that they could not understand the instructions or the diagnosis which \\"as 
being given. This assumption of a lack of understanding was then made worse by 
giving the information to a relative or carer. The older people felt ignored and belittled. 
The provision of a MCA was not seen as ageist although three interviewees thought that 
other people might be insulted by being given this type of help. There was also the 
thought, expressed by the self-fillers and by one of the pharmacy-filled group, that 
receiving a pharmacy-filled MCA indicated a decline in mental faculties. The majority 
of the interviewees were anxious to point out that they still had their mental faculties, 
describing completing crosswords, describing their hobbies and just simply remarking 
that they were 'all there". Clearly losing ones mental faculties is a fear that many older 
people will have, we are reminded frequently in the press of the increasing incidence of 
Alzheimer's disease and other forms of dementia and that the incidence of dementia in 
the over 80s is 1 in 5. Receiving a MCA may suggest to some older people that they are 
thought to be losing their faculties and this may cause distress. 
The healthcare professionals were all well aware of the requirements of the NSF for 
older people (Department of Health 200 I) regarding ageism. Approximately a third of 
the interviewees agreed with views expressed by the older people concerning treating 
older people like children and being patronising. The majority of interviewees stated 
that they knew this occurred but it was others not themselves. A minority of the 
healthcare professionals admitted that their own behaviour might occasionally be 
regarded as patronising, although they stated that this was not intentional. 
In contrast to the older people, who expressed a fear that healthcare professionals might 
consider that they were cognitively impaired, the healthcare professionals felt that many 
older people are in denial about their cognitive state. The healthcare professionals 
268 
supported this idea by stating that the families of older people would often report 
instances of mental confusion. 
It is important to consider whether the issuing of a MCA is done mainly on age grounds, 
i.e. the person is over 65 and has a complex medication regime and there is a suspicion 
of non-compliance. It is well known that other groups of patients are at risk of non-
compliance and have very complex medication regimes; however these patients are 
commonly in the under 65 age range. These groups include post-transplant patients and 
patients with end stage renal disease. The report "A question of choice - compliance in 
medicine taking." produced for the Medicines Partnership (Carter, Taylor and Levenson 
2004), looked at compliance in different groups of people including those mentioned 
above. The report consisted of a literature review supported by the views of individual 
patients and patients groups. The post-transplant patients exhibited high levels of non-
compliance despite knowing that failure to take the medication as directed can lead to 
transplant failure and possible death. The strategies used to improve compliance in 
these patients and which were described by the report included oral and written 
information, videotapes, computer-based decision aids and the internet with no mention 
ofMCAs. The post-transplant patients resemble older people in all criteria (i.e. possible 
life threatening effect of non-compliance, complex medication regime, side effects of 
drugs) with the exception of age, as very few transplant patients are over 65years. The 
question could therefore be asked: "Are older people missing out on more rigorous 
strategies to assist them with taking their medication?" 
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8.4 Exploration of key findings. 
The aim of the thesis is to determine how the attitudes and beliefs of older people and 
healthcare professionals affect the use of multi-compartment compliance aids by older 
people living in the community. The key [mdings are described below and summarised 
in figures 19. and 20. 
The thesis begins with a preliminary study which provided background information for 
the main study. This preliminary study raised a number of questions concerning the use 
of MCAs by older people living independently in the community. Part one of the 
preliminary study indicated that the number of MCAs in use in primary care was much 
higher than had been initially thought. A prior literature review had indicated that the 
evidence for the use of MCAs was sparse and this raised the question "why were so 
many MCAs in use when there was no solid evidence that the use improved compliance 
with medication?" 
The literature review as described in Chapter 3 was undertaken in order to obtain a more 
definitive view on the efficacy of MCAs. The studies reviewed were divided in their 
opinion on the value of MCAs and suggested that more rigorous studies needed to be 
undertaken. 
The main study investigated the use of MCAs by older people and sought to discover 
their attitudes and beliefs concerning not only the use of a MCA but also medicines 
management and their health. Healthcare professionals were interviewed to discover 
their attitudes to MCA use and their beliefs about older people and their medication. 
Reviewing the data obtained from all sections of the thesis leads, in the first instance, to 
enquire what triggered the issue of the MCA. The interviews with patients in the 
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preliminary study and the older peoples' interviews in the main study indicated that 
hospitalisation and subsequent discharge was the most frequent trigger. However a 
majority of all interviewees were uncertain about the reason for the issue. Data from 
both the preliminary study and the main study indicated that many older people found 
their MCA both convenient and easy to use. However there was little indication that the 
users thought that using the MCA improved their compliance with medication. 
Delivery of the MCA and organisation of repeat prescriptions by the pharmacy were 
seen as advantages, however there was evidence in both the preliminary and the main 
study that this may disadvantage the recipient because contact with the healthcare 
professional is lost. The MCA user also becomes distanced from their medication 
receiving just an anonymous collection of multicoloured tablets and capsules with no 
means of identification. 
Those people who made this decision to use and fill a MeA themselves, i.e. the self-
fillers, saw themselves as independent and in control. They were responsible for their 
own medication supplies and retained contact with healthcare professionals. However 
using a MCA removed the need to think about their medication for the majority of the 
week. 
The problems encountered by the older people using the MCA were initially discovered 
during the preliminary study and were similar in the main study. Interviewees found it 
difficult to remove medication from the MCA and often resorted to their own methods 
to resolve the problem. The healthcare professionals were well aware of these 
difficulties but never-the-Iess there was little indication of an assessment of the patient 
prior to issue. The review of the literature on MCAs revealed very few studies on the 
ability of patients to use these devices; studies were mainly concerned with discovering 
whether using a MeA improved a person's medication compliance. 
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One of the key findings of the main study was the importance of independence and 
remaining in control for the older people interviewed. The importance of independence 
and control to the older people was also recognised by the healthcare professionals. The 
importance of independence and control to some of the older people can indicate their 
personal beliefs concerning their health. These beliefs have been interpreted using 
various social control models. Wallston (1982) discusses the degree to which 
individuals believe they are responsible for their health. Those individuals who believe 
they are directly responsible are described as exhibiting "internal" control. While those 
who believe that other people are responsible are said to exhibit "external" control. 
Therefore those older people who state that they are independent and in control may be 
unhappy receiving their medication in a MCA which removes an element of personal 
control. For those older people who were happy to "follow doctors orders", that is they 
exhibited "external" locus of control, then accepting a MCA would be in keeping with 
their beliefs. 
The majority of the older people interviewed gave details of their lives and how this had 
affected their current state of health and quality of life. I realised, as I listened to their 
stories that taking their medication as directed was, for many of them, not high on their 
list of priorities. Conrad, writing on the experience of illness (Conrad 1987), states 
people who are sick spend only part of their time in a patient role and that this role may 
not be the most important thing in their lives. Therefore the older person may welcome 
the issue of a MCA because it allows them to take less time managing their medicines 
and enables them to get on with their everyday lives. In a similar vein Charmaz( 1987) 
states that people with chronic illnesses do not want to be seen as patients first and 
people second, they wish to be seen as individuals living a life outside of their illness. 
This agrees with the symbolic interactionist theory as described by Mead (193'+) who 
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describes the role of self as looking back at oneself from the other's perspecti\'e. The 
older people whom I interviewed did not wish to be seen as patients who used a MCA 
but as individuals who were trying to accommodate their illness within the context of 
their everyday lives. 
Another key finding which emerged from the study is the belief of the healthcare 
professionals that medication should be taken exactly as prescribed. Despite some of 
the healthcare professionals stating that they would respect the older person's decisions 
not to take a particular medicine, the underlying feeling is always that the doctor 
prescribes and the patient responds by taking what is prescribed; if this were not the 
case MCAs would not be issued. This type of belief is much more in line with the 
functionalist approach as described by Talcott Parsons (1951). There was little 
indication that the healthcare professionals would discuss medication management with 
the older people and identify any problems and listen to the older person's point of 
view. Considering that the healthcare professionals were, in the main, aware of the 
limitations of these devices their actions seem open to question. However the 
healthcare professionals' actions in supplying a MCA routinely to patients who fit a 
certain criteria can be interpreted as "being seen to do something" or, as one pharmacist 
interviewee put it, "to tick a box". These actions therefore can also be interpreted by 
interactionist theory, with the healthcare professional needing to be seen by other 
healthcare professionals as addressing a problem. In addition to this need, healthcare 
professionals are also under pressure from NHS management to follow treatment 
guidelines and once again the healthcare professional needs to be seen to be adhering to 
these guidelines despite the fact that this may not be in the best interest of the patient. 
This aspect was discussed by the doctors interviewed, in particular the Care of the 
Elderly consultant and the pharmacist working with the Intermediate Care Team. 
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The question which I have to ask is 'is compliance really necessaryT Although the 
earliest reference to compliance with medication is often stated to have been made by 
Hippocrates the literature starts in earnest in the 1950s with the introduction of new and 
powerful drugs, for example antibiotics. A study in the Lancet in 1957 (Dixon, 
Stradling and Wootton 1957) investigated compliance with the anti-tuberculosis 
treatment P.A.S. The study tested the urine of outpatients with tuberculosis who were 
being treated with P.A.S. (a combination of isoniazid and p-aminosalicylic acid). The 
results showed that only 50% of the patents tested had been taking the medication 
despite professing to the contrary. The authors concluded that the non-compliance was 
due to the unpleasant side effects of the drug. However their attitude to the patients is 
interesting, the article starts with a quotation from Hilaire Belloc's Cautionary Tales: 
"Matilda told such Dreadful Lies, 
It made one Gasp and Stretch one's eyes" 
Further on in the article, patients are described as 'untrustworthy' and the article goes 
on to describe how 'many tablets can be found scattered in flowerbeds surrounding 
some of our hospitals'. The authors draw the conclusion that this drug is unsuitable for 
outpatient use, in other words, the patients must be supervised strictly while taking this 
treatment. It is easy to understand the worries and frustrations of these authors, 
effective treatments for tuberculosis was relatively new and they were already aware 
that resistance to treatment might develop. Studies into non-compliance with 
medication continued to increase and by the year 2007 the number of studies identified 
by a MEDLINE search using the Mesh term Patient Compliance was 11913. This 
interest in compliance with medication indicates the importance placed on the subject 
by the healthcare profession, however not everyone see compliance in the same light. 
James Trostle (a medical anthropologist) argues that compliance with medication is 
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itself the problem,(Trostle 1988) Trostle goes on to state that many articles have been 
written about the causes of non-compliance and the methods used to address the 
problem, but few have asked why this subject came to be so important. In the 
introduction to his article, he states that rather than being concerned with improYing 
medical treatment it is, albeit covertly, about power and control. Another article, 
written ten years later, also discusses non-compliance and professional power (Playle 
and Keeley 1998). Playle and Keeley discuss the history of research into non-
compliance with medication and again pose the question "why has the issue of non-
compliance in healthcare become such a major focus of interest and research?" The 
article concludes that this increase in interest in non-compliance while appearing to 
research strategies and interventions to improve compliance actually seeks to justify and 
reinforce professional authority and power. The article goes on to say that healthcare 
professionals should re-think the professional - patient role and consider patients as 
active participants rather than passive recipients in their own healthcare. 
This theory leads on to the introduction of concordance as discussed in the report by the 
Royal Pharmaceutical Society (1997). This report described concordance as a 
negotiation between prescriber and patient. During the healthcare professionals' 
interviews the pharmacists did discuss the issue of concordance, but for the other 
healthcare professionals this was an unfamiliar expression and only a minority were 
able to define what concordance meant. Others did explain that they would talk to the 
older person about their medication. A study investigated whether it was possible, by 
using extended consultations, to achieve concordance with 'non-adherent' patients 
(Dowell, Jones and Snadden 2002). This study was unusual because the researchers 
combined a qualitative study of extended consultations with "Balint" style clinical 
meetings (Balint 1969). These "Balint" style meetings, enabled the clinicians to discuss 
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the transcripts of the consultations allowing development of the consultation strategy. 
As a result of the qualitative study the researchers developed a model for undertaking 
this type of consultation. The researchers noted the limitations of their study but stated 
a belief that this type of consultation was likely to improve clinical outcomes. 
The lack of understanding of the term concordance among the majority of the health care 
professionals suggests that more education needs to be undertaken possibly at 
undergraduate level. A training plan for healthcare professionals has been suggested 
(Weiss 2004) which focuses not only on developing communication skills but also 
requires the professional to reflect on the influence of personal values on patient 
relationships. 
The subject of concordance has been discussed in a number of articles and editorials in 
the medical press, often with a less than favourable tone (White 2003;Ferner 2003). In 
an education and debate article (Heath 2003), the author argues that although 
compliance can be seen as embodying the belief that' doctor knows best', concordance, 
while paying lip service to mutual respect between the prescriber and the patient, 
actually conceals a level of coercion. Therefore there is still resistance and a lack of 
understanding of the nature of concordance. 
The final key finding relates to age and ageism. I have previously discussed the fact 
that relying on chronological age as a marker for "being old" is unreliable. We are 
frequently told both by government organisations and the press that we live in an aging 
society and that this will cause financial problems in years to come. In Sections 1.6.1 
and 1.6.2. I have described the increase in the elderly population and the level of 
medication use by older people. These figures can lead to the assumption that as we age 
we will succumb to poor health and increased medication use, leading to concerns 
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regarding the cost to the NHS of an ageing population. However this picture of a large 
population of chronically sick older people may be a misconception. Tallis in his book 
(2004) states: 
the vast majority of people in later life enjoy excellent health or have health 
problems that are sufficiently under control not to be a barrier to the enjoyment 
of a reasonably full life. P. 226 
Linked to this discussion concerning the health of older people is the concept of the 
"medicalisation of old age". Medicalisation is a term used to describe a process through 
which a largely social problem is re-defined as a medical one. Therefore ageing is seen 
as a problem which needs to be solved by medical intervention rather than a natural 
process which occurs throughout the lifespan. It has been suggested that this 
biomedical approach is responsible for a construct of ageing as a time of decay and 
decline (Koch and Webb 1996). Healthcare professionals who concur with this model 
may succumb to negative stereotyping of old age. However the opposite opinion is held 
by others within the medical professions who see medicalisation of old age as 
something to be encouraged (Ebrahim 2002). Ebrahim states that although 
medicalisation should be encouraged it can also be dangerous. He continues that there 
are legitimate concerns concerning over-prescribing, hospital acquired infections and 
the use of tranquillisers for restraint, but concludes that: "Attempts to ration such care 
on the grounds of the fair innings argument or by chronological age are flawed" p863. 
How do these arguments impact on the issue ofMCAs? From Koch's (op. cit.) point of 
view biomedicalisation leads to negative stereotyping and this may well lead to the 
inappropriate issue of a MCA. In contrast, Ebrahim (op. cit.) would argue that older 
people are entitled to all medical interventions irrespective of chronological age or age 
stereotyping and therefore the issue of a MCA may assist an older person to organise 
what may inevitably become a complex regime. 
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The healthcare professionals interviewed held the belief that older people were more 
forgetful despite the fact that this has not been conclusively proved by research. This 
negative stereotype of the forgetful older person is common in our society and there is 
evidence to suggest that older adults respond to these attitudes by altering their 
behaviour (Hess 2006). Therefore the older person may expect to become more 
forgetful and accept the MCA despite being capable of managing without it. The 
underlying belief of healthcare professionals when a MCA is issued is that the deyice 
will assist the older person to take their medication exactly as intended by the 
prescriber. All the research undertaken attempts to discover if the compliance rate 
improves when a MCA is supplied. This suggests that the underlying reason for issuing 
an older person with an MCA is to ensure that medication is taken as directed. 
What seems clear is that healthcare professionals should not base the treatment of older 
people purely on the grounds of chronological age but on the assessment of their 
individual risk (Grimley-Evans 1997). A concordant or shared decision making 
approach should be taken with all possibilities discussed, this should lead not only to 
better and more appropriate treatment but the more appropriate use of MCAs. 
Key messages for staff and policy makers. 
Figure 19: What was known about this subject prior to this work being 
undertaken 
MCAs assumed to be the ideal solution for older people having problems managing 
medication. 
There was very little evidence to support this view. 
The numbers of MCAs issued was unknown. 
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Figure 20: What information has this work added to what was already known 
The preliminary study indicated that large number of MCAs were being issued to 
patients despite little evidence for their use. 
The literature review in the main study revealed a lack of robust studies on the use of 
MCAs and little evidence of effectiveness 
The main study has provided the following information: 
For older people the need to remain in control of their lives and maintain their 
independence is of great importance. The effect of this is often under estimated by 
healthcare professionals 
There was evidence of ageism within the NHS despite all health care professionals being 
aware of the problem. The issue of a MCA could be seen as ageist by some older 
people and there was little evidence to show that people were consulted about the issue 
ofa device. 
Paternalistic ways of working were much in evidence and this was admitted by the 
health care professionals. In particular as pharmacists we must learn to look beyond the 
medication and our desire to ensure that all medication is taken exactly as prescribed 
and consider the older person in a more holistic way. 
Healthcare professionals must question their own beliefs about compliance with 
medication. Do we allow older people to make their own decisions about taking their 
medication? Are MCAs used to ensure that older people follow our instructions? Are 
they in fact a means of social control? 
MCAs are too often seen as a quick and relatively easy method of hastening hospital 
discharge and providing evidence for other healthcare professionals that the older 
person's ability to manage their medication has been addressed. 
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8.S Limitations of the thesis findings. 
The preliminary study aimed to provide a picture of the supply and use of MCAs in one 
health authority area at one moment in time. The response rate from part one of the 
study was sufficiently high to provide an indication of the numbers of MCAs which 
might be in use in the country as a whole. The randomly selected sample of community 
pharmacists was small but representative of the pharmacies providing this service across 
the health authority area. The structured nature of the questionnaire limited the 
information provided by the pharmacists. Although the final question asked the 
pharmacists if they would like to provide any additional information about the use of 
MCAs this did not allow for an in-depth discussion. Therefore the information obtained 
from the pharmacists concerned who requested the issue of a MCA to a patient, and the 
procedures that followed such a request. This information highlighted further areas for 
research. The results from part three of the preliminary study were limited by the very 
low recruitment rate which has been discussed in Section 2.6.3. In addition the 
structured nature of the questionnaire meant that the data obtained was limited to a 
narrow field mostly concerning the interviewees' ability to use the MCA and their 
knowledge of the medication regime. However the results from this study did suggest 
further areas for research. 
Chapter 3 comprises a detailed review of the literature concerning the use of MCAs. 
This review was undertaken in order to determine the depth of evidence concerning the 
efficacy of MCA use. The review of the literature undertaken before the start of the 
preliminary study had indicated that the evidence was limited but it was necessary to 
establish, as far as possible, the full extent of the evidence. The literature review was 
limited to studies which had MCAs as the main focus. The main study in this thesis 
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was undertaken using Grounded Theory methodology and followed the methodology' of 
Strauss and Corbin (Strauss and Corbin 1998) which allows for a limited re\'iew of the 
literature to be undertaken prior to the start of the research. However, as recommended 
by Strauss and Corbin, I did not review all the literature in the field of compliance prior 
to starting the main study. Instead, as each interview was undertaken and analysed and 
new themes emerged, I searched for literature in these areas. The research studies were 
then woven into the discussion of the analysis. Carrying out the main review of the 
literature in this way allows for flexibility in literature searching, but does not provide a 
formal description and discussion of the search methods and results. 
The main study was undertaken using Grounded Theory methodology which allowed 
for much more flexibility in the interviews. The number of older people interviewed 
was small, however according to grounded theory methodology it is only necessary to 
continue sampling until theoretical saturation is reached and no new themes developed. 
This had occurred in these interviews and therefore a sample of fifteen was considered 
sufficient. Only two male patients were interviewed and this is not representative of the 
proportion of men in the over 65 population. Therefore it is not possible to detect from 
the data if gender has any influence on older people's attitudes and beliefs. The 
percentage of male interviewees in the preliminary study was 32% however the age 
range in that study was wider. 
The sampling of healthcare professionals was theoretical, based on information obtained 
in the older peoples' interviews. Interviewees represented the three healthcare 
professions most likely to be involved in the issue of MCAs to older people and were 
working in primary, intermediate and secondary care. Any problem \\ith these 
interviews may be due to the difficulties of interviewing fellow healthcare professionals 
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especially those from the same profession as the interviewer. There is a possibility for 
bias and this was discussed in Section 5.4.1. 
8.6 Implications for policy and practice. 
The findings of this body of work have some important implications for policy and 
practice. 
8.6.1 The evidence for the use of MCAs by older people living in the community 
The literature review described in chapter 3 concluded that the evidence for the use of 
MCAs by older people living in the community was inconclusive. This finding agreed 
with that of other systematic reviews which had investigated the same topic (Haynes et 
al. 2005;Heneghan, Glasziou and Perera 2006). It would appear, therefore, that a large 
number of older people are being issued with devices which have no evidence base for 
their use. In a short article a pharmacist posed the question "Is it ethical to use 
monitored dosage systems when efficacy is questionable?"(Gartside 2005) 
This must surely be of concern to all healthcare professionals. The evidence for the use 
of these devices is very tenuous and it would be foolish to place too much reliance on 
their ability to improve compliance with medication. 
On the practical side however, there is no doubt that these devices are popular with 
older people who find them convenient and easy to use and because of this factor 
medication compliance may improve. Equally, other older people do not like the 
devices or find them difficult to use and therefore, in these cases the use of a MeA 
provides a barrier to the appropriate use of medication. 
8.6.2 Assessing the medicines management abilities of older people 
The older people interviewed in this study gave no indication that their abilities to 
manage their medication had at anytime been assessed. The healthcare professionals 
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did indicate that some form of assessment took place under certain circumstances, with 
the staff working in Intermediate Care appearing to have the most robust systems. 
There were complaints from half of the healthcare professionals interviewed that they 
had observed older people who were unable to use the MeA which had been issued to 
them. The healthcare professionals concluded that in these cases no assessment had 
been carried out. However the data which emerged from the main study indicated that 
the assessment should not only include the physical abilities of the older person to 
manage the packaging, there must also be assessment of their understanding of the 
medication regime including names of drugs, therapeutic actions and possible side 
effects. Equally important are the older person's beliefs about their medication because, 
as has already been discussed, these beliefs can influence the older person's medicines 
management. Finally any assessment needs to be undertaken within the older person's 
own home, where the healthcare professional can place medicines management within 
the older person's daily routines. 
Figure 21 shows diagrammatically the situation regarding the assessment of older 
people as discovered during both the preliminary and main studies. When a holistic 
assessment took place which covered not only the older persons' medication regime and 
their medical condition but also their lifestyle, social circumstances and concerns, then 
this contributed to more appropriate MCA use. If alongside this holistic assessment the 
older person was given the opportunity to have a major input into discussing their care 
then this lead to even more appropriate use. The interviews with the healthcare 
professionals indicated that this type of approach was most likely to be taken by the 
Intermediate Care Team nurses. When a more medically orientated assessment took 
place by a doctor then the assessment was likely to be less holistic and the older person 
was likely to have less opportunity to express their own point of view. The least holistic 
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assessment appeared to be undertaken by pharmacists who focused on medication 
review, and in some cases but not all, to assessing the ability of the older person to use 
the device. The older person had least opportunity to put their point of view forward 
with the pharmacist. 
This suggests that there needs to be a much more multi-disciplinary approach to 
assessment with more opportunity for the older person to express their own attitudes 
and beliefs. 
Figure 21: Diagrammatic representation of the assessment carried out by the 
different healthcare professional groups 
Holistic assessment 
including home, social Medical assessment. 
support, aids and Includes some social 
medication Assessment. 
I D Pharmacy assessment 
N I 0 Focus on medicines \ U C 
Attitudes and / R 
> 
T 
S 0 beliefs of 
older people \ E R Phal ,,"2 cists S ! s L V' V \2 
Appropriate and successful MeA use 
Key: the wider the arrow the more lik.ely to lead to appropriate and successful use. 
Although within secondary care the healthcare professionals discussed that the decision 
to issue a MeA would be taken by the multi-disciplinary team there seemed to be little 
opportunity for the older person to put their point ofyiew. The older person would then 
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be discharged from secondary care and the provision of the MCA would pass to the 
community pharmacist. The MCA provided might be the same as the one provided on 
discharge or a different type. There was little evidence of further assessment or 
discussion with the older person. Therefore the community pharmacist needs to be 
included within the multi-disciplinary holistic assessment, which might also need to 
include the GP and primary care nurse. At all steps on the way the older person needs 
to be involved. 
The Intermediate Care Team staff who were interviewed, described their assessment 
process, and this did approach the ideal format. However there still needed to be more 
multi-disciplinary discussion. One ICT where staff were interviewed had a pharmacist 
on the team as part of a research project. This provided the opportunity for medication 
reviews and pharmacist input but still left a gap regarding the provision of the MCA by 
the community pharmacy. 
The interviews with the older people provided little evidence of a patient-centred 
approach when assessing their medicines management abilities. It has to be 
remembered that the issue of a MCA may not be the best solution for a particular person 
for a great many reasons and healthcare professionals should be prepared to consider 
alternative strategies. 
Figure 22 below represents a method of approaching older people's medicines 
management issues, derived from the data obtained from both preliminary and main 
studies, and suggested as a way forward. 
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Figure 22: Diagram detailing a proposed method of approaching old I ' 
d
' , er peop e s 
me lcmes management. 
Multi-disciplinary 
discussions 
Patient-centred discussion and assessment of medicines management issues 
All assistance refused older person 
to continue as before 
Education, counselling, 
Behavioural change 
Reminder charts 
Memory prompts e.g. pagers, 
Alarms, text messa in 
MeA 
Supervised assistance with 
medication 
Older person to manage 
medication as before 
The implications for both policy and practice can therefore be seen from Figure 21 
above: 
The beliefs and attitudes of both older people and healthcare professionals need to be 
taken into consideration. For the healthcare professionals this may mean more 
education and training around the issues of concordance, shared decision making or 
patient-centred approaches. Further training may also be needed to address 
stereotypical images of older people. For the older people more education on their 
illnesses and the place of medication. 
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Policies need to be put into place to allow more multi-disciplinary discussion of older 
people's medicines management within all sectors of the NHS. In particular these 
discussions should include the community pharmacist irrespective of which sector the 
discussions are held in. The community pharmacist has in the past been mainly seen as 
the provider of these devices and has had little input into the more holistic approach to 
an older person's medicines management. However the community pharmacist needs 
to be included in the discussion as he or she will be responsible for the ongomg 
provision of the device and will be the point of contact for the older person. 
The assessment of older people needs to become much more patient-centred with the 
older person's point of view welcomed and valued. There needs to be acceptance of the 
fact that some older people can manage perfectly well and wish to continue with their 
own medicines management routine. Assessment also needs to identify the reasons for 
non-compliance (if it exists) as the strategies which can be used are different depending 
on the type of non-compliance, with a key difference being between intentional and 
non-intentional non-compliance. 
Finally it should be recognised that some older people will resist any offer of help and 
advice and if this occurs after careful assessment and discussion then their wishes 
should be respected. 
The assessment process I have described above is complex and will require changes in 
both policy and in practice. It should also be remembered that healthcare provision is a 
dynamic situation and the older people will not remain in the same condition after an 
initial assessment. Therefore arrangements must be put in place to revisit the 
assessment at regular intervals. 
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8.7 Implications for future research 
Various implications for changes to policy and practice have been made in Section 8.6 
and although these suggestions have been made based on the findings of this thesis it 
will be necessary to under take further research to ascertain if these changes are 
effective. 
The more holistic, multi-disciplinary assessment which I suggest will provide better 
medicines management for older people needs to be investigated thoroughly. 
During the course of this thesis I have indicated that there is a lack of robust research 
into various aspects of the use of MCAs. The literature review in chapter 3 concluded 
that the standard of the few RCTs which looked at the ability of MCAs to improve 
medication compliance was poor. Therefore further studies, which are well constructed 
and conducted, are needed. 
There are also other areas ofMCA use which are under researched: 
New studies are needed to assess the abilities of older people to remove the medication 
from the newer sealed disposable devices. The two studies identified which looked at 
ability to use (Atkin et al. 1994;Nikolaus et al. 1996) only investigated refillable MCAs. 
The safety of MCAs has not been investigated in this country despite there being 
anecdotal evidence that serious problems do occur. The only study identified in the 
literature review (Levings, Szep and Helps 1999) was undertaken in Australia and 
therefore the level of errors is not directly applicable to the UK. 
All the studies which investigate the use of MCAs do so in the short term, there is a 
need for a longitudinal study to investigate how a patient's ability to use the device may 
deteriorate over time. 
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8.8 Conclusion 
This thesis has provided further insight into the use of MCAs by older people living 
independently in the community. The preliminary study highlighted the increased use 
of these devices in primary care. The interviews with both the pharmacists and the 
MCA users in the preliminary study indicated that little assessment was undertaken to 
determine the patients' medicines management requirements, few alternative strategies 
were suggested and there was little evidence of matching the MCA to the need of the 
patient. 
The majority of previous research in this field has attempted to determine the ability of 
MCA use to improve compliance with medication and this research has been discussed 
in detail in Chapter 3. The literature review, however, highlighted that very little 
research had been undertaken to determine the attitudes and beliefs of both the older 
people who use these devices and the healthcare professionals who recommend the use 
of MCAs. This thesis aimed to rectify this situation. 
The findings from the main study reveal that the beliefs and attitudes of the older people 
can influence not only their use of MCAs but also the role of medication within their 
daily lives. 
The healthcare professionals were revealed, in some cases, to possess stereotypical 
views concerning older people and their ability to manage their medication. Despite 
having reservations concerning the use of MCAs, the healthcare professionals still 
recommended the use of these devices by older people. 
This study challenges the view that what is required is more rigorously conducted RCT s 
ofMCA use, which will provide a definitive answer to the question "do MCAs improve 
compliance?" The reality is much more complex with healthcare professionals and 
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policy makers alike needing to think beyond the simple action of issuing a MeA to 
providing more detailed assessment of older people's medicines management skills. In 
addition there needs to be a more concordant or Shared Decision Making approach with 
older people having the right to choose not to take their medication if that is their wish. 
Further research is therefore required to test out this new method of assessment and to 
develop a framework for assisting older people with their medicines management. 
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Appendix 1. Preliminary Study 
Self-administered pharmacist questionnaire 
Administered pharmacist questionnaire 
Administered patient questionnaire. 
Patient leaflet and consent form 
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Community Pharmacists Questionnaire 
Use of Multicompartment Compliance Aids (MCAs) in 
Primary Care 
Question 1. 
Do you dispense medicines in MCAs to any patients living in their own homes? 
If YES - about how many patients do you have at p resent? 
If NO - Give reasons if possible 
Question 2. 
Approximately how many patients living independently 
at home do you have using each system? 
Question 3. 
Yes 
No 
Dosett 
Medidos 
Nomad 
Other 
(specify) 
Would you be prepared to be involved further in the research? 
Yes 
No 
Name and Address 
----------------------------------------------
----------------------------------------------
-----------------------------------------------
Please return in the SAE provided 
Thank you for your time. 
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Use of Multicompartment Compliance Aids (MCAs) in 
Primary Care 
Pharmacist's follow up questionnaire 
1. In your experience who is the person who usually requests the dispensing of 
medicines in MCAs for patients living in their own homes? 
doctor 
carer 
patient 
social services 
district nurse 
hospital 
yourself 
Please rank the above answers 1 - 7 (1 is most often 7 is least often) 
2. Once a request to dispense medication in an MCA has been received what procedure 
do you follow? 
subsidiary questions to be asked if not found out above. 
2a Is the patient assessed for ability to open the aid and remove medication? 
YES D NO D 
If YES - how? 
2b Is the patient assessed for reading ability i.e. can the patient read the days of the 
week and the times? 
YES D NO D 
If YES - how? 
--'"' 
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2c. Do you counsel the patient about using the aid or is the aid delivered by the driver in 
the usual way? 
ALWAYS D 
SOMETIMESD 
NEVER D 
2d. Do you first try to simplify the regime? 
YES D 
2e. Do you check the drugs for stability in the aid? 
YES D 
If YES - what information do you use? 
2f. Does the pharmacy have a written procedure? 
YES D 
NO D 
NO D 
NO D 
3. Have you ever been pressured by other healthcare professionals to dispense 
medication in an MCA even when you know that the use is inappropriate; or has this 
not happened? 
If yes: 
how often does this happen? 
what action would you normally take? 
4. Have you ever been pressured by the patients family to dispense medication in an 
MCA? 
if yes: 
how often? 
what action would you normally take? 
5. Who fills the MCAs? 
pharmacist D 
qualified dispenser D 
unqualified dispenser D 
counter assistant D 
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6. Who checks the dispensing if this is not carried out by the pharmacist? 
7. Do you have any problems or concerns about the checking procedure? 
8. How much time approximately is taken up with dispensing drugs in MCAs for 
patients at living independently at home? 
a. on the first occasion 
b. on subsequent occasions 
9. Who delivers or collects the MCA. 
pharmacist D 
driver D 
other (specify) D 
10. Do you obtain weekly scripts from the GP for these patients? 
always D 
when GP agrees D 
never D 
9. Do you usually order the repeat prescriptions from the GP. or does the patient make 
the request? 
pharmacist D 
patient D 
other ( specify) D 
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11. What procedure do you follow if the MCA is returned with tablets still in it? 
12. Who decides which make of MCA to use? 
pharmacist D 
depends on patients needs D 
other (specify) D 
13. Do you have a preferred MCA? 
YES D NO D 
if YES a. which make? 
--------------------
b. why? 
14. Who pays for the MCA? 
patient D 
pharmacy D 
other D 
15. Is there anything else you would like to say about MCAs for patients in their own 
homes? 
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GALEN STUDY 
PATIENT QUESTIONNAIRE 
Patient Details 
Patients name 
Address 
Telephone 
Date of birth 
Gender 
Type of accommodation 
own home 
sheltered housing 
Living arrangements 
Male D 
D 
D 
alone D 
with partner D 
with son / daughter D 
with other relative / friend D 
with paid carer D 
Support Services 
Home help D 
District nurse D 
Relative / friend who visits D 
Warden D 
FemaleD 
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General Practitioner 
Name 
Address 
Telephone 
Additional Information 
For example name and address of carer, access to home, preferred time for visit. 
Agreement to Visit 
Date consent form supplied 
Date consent form signed 
Date & time for visit 
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Hello, I'm Jacky Nunney from the University of Leeds. Do you remember I spoke to 
you about some research we are doing into the use of special containers for medicines? 
Are you still willing to answer some questions for me? Can I come in? 
Have you got all your medicines here for me to see? 
Have you got the patient information leaflet which I gave you? 
Have you signed the agreement at the back of the leaflet? 
This is what I am going to do 
• Ask you about your medicines 
• Talk about any problems you might have 
So first of all a few questions about your medicines 
Section A Review of medication. 
1. Can you show me which medicines you take? 
(Patient can look at MCA and any bottles if necessary.) 
• What is the name of the medicine? 
• How much do you take? 
• How often do you take it? 
• What is it for? 
Do you take it every day or just when you need it? 
Fill in answers on chart. 
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Current medication on PMR 
Drug Dose Frequency in MeA comments 
(yes/no) 
314 
Patient reported medication 
Drug dose frequency what for MeA (yes/no) 
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Section B: Review of medicines by other professionals 
Obtaining repeat prescriptions 
Has anyone talked to you about your medicines recently? 
e.g. GP. Hospital Doctor, Practice Nurse 
YES D 
If YES give further details if possible including when. 
3. Does anyone help you with your medicines at home? 
Nobody 
Relative 
Nurse 
Home care 
Other (specify) 
What do they do to help? 
Comes into home & puts tablets out 
Gives medicine to patient 
Fills monitored dosage system 
Writes a chart 
Other (specify) _________ _ 
D 
D 
D 
D 
D 
D 
D 
D 
NO D 
4. Who orders your repeat prescription from the Doctor's surgery? 
Myself D 
Relative D 
Home care D 
Other (specify) _________ _ 
5. When do you order your repeat prescription? 
When medicine has run out 0 
When a few days supply left 0 
When a weeks supply is left 0 
Every 4 weeks 
Pharmacy does it 
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Other (specify) __________ _ 
Who collects your medicines from the pharmacy? 
D 
D 
Myself D 
Relative D 
Home care D 
Other (specify) ________ _ 
Section C Assessment of physical abilities / disabilities 
Now I would like to ask you about how you manage your medicines 
7. Do you have a problem using the (type of MCA) 
YES (has a problem) D 
NO (no problem) D 
State problem if there is one 
------------------------
8. Ask patient to demonstrate opening and removing a tablet from the MCA 
YES D NO D 
9. Show patient card with days of week and times written on and ask patient to 
read it. 
YES D NO D 
10. Do you have any problems swallowing your tablets? 
YES D NO D 
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11. If you are going to be out of the house when you need to take a medicine what 
do you do? 
Section D 
12. How well do you think you would be able to remember to take your medicines 
if you had your medicines in bottles? 
very well D 
quite well D 
not well D 
not at all D 
13. Do you have any ways of reminding yourself to your medicines? 
14. Do you remember who first suggested that you had your medicines put in a 
(type of MeA)? 
15. There are a few different types of special container, did the pharmacy let you 
choose which type? 
YES D 
NO D 
16. Is it a problem that some of your medicines are in the box and some are not? 
NOT APPLICABLE D 
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17. How does the (type of MCA) compare with ordinary bottles for you 
Is it ---------------------much better D 
a little better D 
no different D 
a little worse D 
much worse D 
19. Is there anything else you would like to tell me about how you get on with 
your (type of MCA)? 
Research pharmacist's personal assessment of patient's ability. 
My assessment of the patient's ability to manage their medication is -
Patient could manage very well with medication in bottles D 
Patient could manage reasonably well with medication in bottles D 
Patient could manage with difficulty with medication in bottles D 
Patient could not manage at all with medication in bottles D 
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University of Leeds 
Division of Academic Pharmacy Practice 
0113 3926737 
Patients managing their medicines at home project 
We would like to invite you to take part in the above research project 
What is the project about? 
• In this research project phannacists (chemists) have been asked to find 
patients who have their medicines dispensed in special containers 
(compliance aids.) 
• These patients are being asked if they would like to take part in the 
project. 
• If you agree a research phannacist will visit to talk to you about your 
medicines. 
The phannacist will ask you about your medicines and the compliance aid. 
What will I have to do? 
The research phannacist will ask you for a good time to visit you at home. 
She will: 
• talk to you about everything to do with your medicines. 
• ask you some questions about how you manage your medicines. 
All the information which you give to the pharmacist will be 
confidential and only used for the research project. 
What is the project for? 
• We will be visiting about 100 patients like you across Leeds. At the 
end, we will look to see how people cope with their medicines in special 
containers (compliance aids) 
• This will help us find the best way to help people manage their 
medicines at home. 
Do I have to take part? 
• No, you do not have to take part. If you do not, it will not affect the way 
your doctor or chemist treats you in any way. 
Can I change my mind? 
• Yes, you can change your mind at any time. Just call in at the phannacy 
or you can phone and tell us. 
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What do I do now? 
If you want to take part in the project, please read the consent form below 
and sign at the bottom. 
Consent Form 
I have read and understood the patient leaflet about the managing medicines at home 
project. 
I agree 
• to have a visit from the Research Phannacist. 
• I understand that the infonnation which I give the phannacist will be used in the 
research proj ect 
Patient's signature 
Patient's name 
(block capitals) 
Date 
Mrs J Nunney (Research phannacist) 
Division of Academic Phannacy Practice 
University of Leeds 
0113 3926737 
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Appendix 2. Literature review 
Literature search details 
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Literature Search details 
All searches limited to Human, English language and years 1982 - 2003 
Medline 
Keyword or phrase Number of references No retained Number 
identified by search for further retained in 
scrutiny review 
Patient compliance and 15 10 1 
compliance aids 
Patient compliance and 33 6 1 
reminder systems limit to 
all over 65 
Patient compliance and 29 27 8 
drug packaging limit to all 
over 65 
Embase 
Keyword or phrase Number of references No retained Number 
identified by search for further retained in 
scrutiny review 
Compliance aid$ 10 7 3 
Patient compliance AND 11 11 2 
drug packaging 
Patient compliance & 4 4 0 
reminder systems 
CINHAL 
Keyword or phrase Number of references No retained Number 
identified by search for further retained in 
scrutiny review 
Compliance aid$ 19 0 
Patient compliance & 14 0 
reminder systems 
Patient compliance & drug 1 1 1 
packaging 
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PsycINFO 
Keyword or phrase Number of references No retained ~umber 
identified by search for further retained in 
scrutiny review 
Compliance aid$ 1 1 
Patient compliance & drug 0 
packaging 
Patient compliance & 0 
reminder systems 
International Pharmacy Abstracts (IP A) 
Keyword or phrase Number of references No retained Number 
identified by search for further retained in 
scrutiny review 
Compliance aids & elderly 10 4 
Drug packaging and 55 
patient compliance 
Reminder systems and 6 
patient compliance 
Pharm-line 
Keyword or phrase Number of references No retained Number 
identified by search for further retained in 
scrutiny review 
Compliance aids & elderly 45 12 7 
Drug packaging and 34 4 3 
patient compliance 
Reminder systems and 
patient compliance 
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Appendix 3. Older people's interviews 
Pharmacist introduction letter 
Older person information leaflet and consent form 
Topic guide 
Please reply to: 
Phannacy Practice & Medicines Management Group 
Room 2.23 
Tel: Direct Line: 0113-3431232 or 3431340 
E-Mail: J.M.Nunney(a)leeds.ac.uk 
To Community Pharmacists 
X Primary Care Trust 
Dear Colleague 
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Our Ref: IN 
10 June 2004 
Research into the use of Multicompartment Compliance Aids in Primary Care 
Some of you will know me from my previous research in this field supported by Galen 
Awards from the Royal Pharmaceutical Society and from my time as c.P.P .E. tutor for 
Leeds. I am now working as a part-time lecturer in the School of Healthcare Studies 
and also studying for a PhD. The aim of the research for my PhD is to study the use of 
Multicompartment Compliance Aids (Dosett, Medidos, Nomad, Venalink and similar) 
by older people living in the community and to try to find if the attitudes and beliefs of 
healthcare professionals and older people influence the decisions to use these devices. 
I intend to carry out interviews with a number of different healthcare professionals both 
in Primary and Secondary Care. I also want to discover what the older people 
themselves think of the devices and I intend to interview older people who have their 
medicines dispensed in this way. I have ethical and research governance approval for 
this study however because of tighter controls put in place by ethics committees I am 
not allowed to approach patients directly and this is the reason for my letter to you. I 
am looking for a number of community pharmacists who regularly dispense medicines 
to patients in MCAs who would be willing to approach their patients on my behalf The 
patients must be able to read, understand and sign a consent form (which does exclude 
many of the patients) 
I am enclosing a sheet which gives more details of the procedure for obtaining consent 
from patients, if you feel able to help, please sign the enclosed slip and return to me in 
the freepost envelope provided. I will provide consent forms and further details to those 
pharmacists who offer to help. 
Thanking you in anticipation. 
Best wishes 
MRS JACKY NUNNEY 
PHARMACY LECTURER and PhD STUDENT. 
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Older People Managing their Medicines at Home 
What is it all about? 
My name is Jacky Nunney and I am a researcher and associate lecturer 
at the University of Leeds. 
I have been researching into the use of Multi-compartment Compliance 
aids by older people living in their own homes for a number of years. 
The current research project will form part of my PhD thesis. 
I am inviting healthcare professionals to discuss their views on the use 
of Multi-compartment compliance aids by older people, how effective 
these aids are and what problems older people experience when 
managing their medicines. 
I am inviting you to take part in the study. 
What will be involved? 
• The discussion will take the form of an interview, which will last 
between 30 and 45minutes 
• You will be asked before the interview if you agree to being tape-
recorded. This will help me to remember the main points of the 
discussion. I will listen to the tape myself, the recording will be 
transcribed and then destroyed. You may decline to answer a 
question at any time during the interview. 
• The discussion will take place at a time and venue convenient for 
you. 
Confidentiality 
All recordings will be kept in a secure place, transcribed notes will be 
kept in a secure filing cabinet or on a password protected computer. I 
will not discuss your views with anyone else and it will not be possible 
to identify any participant in any publications or presentations. 
Do I have to take part? 
Taking part in this research project is entirely voluntary. You do not 
have to participate if you do not want to. 
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What do I need to do now? 
• If you would like to take part please complete the attached consent form 
and return it to me in the envelope provided. I will contact you to 
arrange an appointment. 
• If you do not wish to take part there is no need to take any further 
action. 
• If you would like further information you can contact me, 
Jacky Nunney tel: 0113 3431232 or e-mail:J.M.Nunney@leeds.ac.uk 
You can also write to me at: 
Pharmacy Practice and Medicines Management Group 
School of Healthcare Studies 
Baines Wing 
University of Leeds 
PO Box 214 
Leeds LS2 9UT 
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Patient Identification Number for this Study: 
CONSENT FORM FOR RESEARCH STUDY 
Title of Project: Managing your medicines at home 
Name of Researcher: Jacqueline Nunney, University of Leeds 
• 
• 
• 
• 
• 
• 
I have read the information sheet for the above study. 
I have had the opportunity to ask questions about the study, and to discuss it with 
family and friends. 
I understand the purpose of the study, and how I will be involved. 
I understand, and accept, that if I take part in the study I will not gain any direct, 
personal benefit from it. 
I understand that all information collected in the study will be held in confidence and 
that, if it is presented or published, all my personal details will be removed. 
I confirm that I will be taking part in this study of my own free will, and I understand 
that I may withdraw from it, at any time and for any reason, without my medical care 
or my legal rights being affected. 
• I agree to take part in the above study. 
Signed Date 
Person taking consent Date 
Researcher Jacqueline Nunney 
Researcher (if different Date 
from above) 
Please 
tick to 
say yes 
o 
o 
o 
o 
o 
o 
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Multi-compartment compliance aids study 
Individual interviews with Older People who have their 
medicines dispensed in or use a Multi-compartment 
compliance aid 
Topic guide 
Can you think back to the time before you had your medicines put into a 
special box? 
1. Can you tell me how you managed your medicines? 
2. Did you ever have a special way of reminding yourself to take your 
medicines? 
• Prompt Some people put the containers in special places 
• Prompt Some people make charts 
• Prompt Some people put the medicines in other containers. 
3. Does anyone help you with your medicines at home? 
• What do they do? 
4. Do you remember who first suggested that you had your medicines in 
this type of box? 
• Prompt Can you tell me who it was? 
• Prompt Do you know why they suggested it 
5. Were you asked if you wanted your medicines dispensed in this way? 
• Prompt Would you have said no if asked? 
• Prompt Were you offered a choice of box? 
6. How do you manage with your box? 
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• Prompt Can you describe how you remove the medicines from the 
box. 
7. What benefits are there in having a box? 
8 I would now like to talk to you about taking medicines in general 
• Prompt Is taking medicines correctly important 
• Prompt Do you think you take too many 
• Prompt Do you hold any personal beliefs about medicines 
9 Can I ask you now about being independent, is that important 
10. Finally can I ask about the relationship you have with healthcare 
professionals for example your GP or hospital doctor, your pharmacist 
and any nurses. 
• As an older person do you think your age affects this relationship? 
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Appendix 4. Healthcare professional Interviews. 
Healthcare professional introductory letter. 
Healthcare professionals information sheet and consent form 
Topic guide 
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Please reply to: Pharmacy Practice & Medicines Management Group Room 2.23 
Tel: Direct Line: 0113-3431232 or 3431340 
E-Mail: J.M.Nunney@leeds.ac.uk 
Our Ref: JN i HCP2 
26 January 2006 
Dear 
Research into the use of Multi-compartment Compliance aids by older people 
living independently at home. 
I am a pharmacy lecturer at the University of Leeds and I am currently undertaking 
research into the above topic for a Doctor of Philosophy degree. I have interviewed a 
number of older people who regularly have their medicines dispensed in Multi-
compartment compliance aids (Nomad®, Venalink® or similar) and would now like to 
interview healthcare professionals who may request the provision of this type of device 
for older people in their care. The research study has full ethical approval from X East 
and X West Ethics Committees and I hold an Honorary NHS contract with all five X 
Primary Care Trusts. I have informed X Local Medical and Pharmaceutical 
Committees of my research and have been given their support. 
I would like to interview General Practitioners and Practice Nurses about the use of 
Multi-compartment compliance aids, the benefits to older people and the possible 
disadvantages. Interviews can take place at a venue and a time to suit the interviewee 
and should last no longer than 30 minutes, interviews will be tape recorded for ease of 
transcription. 
I am enclosing a number of copies of the Information Leaflet, which gives more details 
about the research, and copies of the formal consent form. Anyone who is willing to 
participate should complete the consent form and lor reply slip enclosed with this letter 
and return it to me in the freepost envelope provided. I will then make contact directly 
to arrange an interview. Please ask if you would like a copy of the research protocol 
that includes some details of the work completed so far. I will telephone in a few days 
time to answer any queries. 
Thank you for your time and consideration. 
Yours sincerely 
MRS JACKY NUNNEY 
PHARMACY LECTURER 
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Older People Managing their Medicines at Home 
What is it all about? 
• My name is Jacky Nunney and I am a researcher and associate lecturer 
at the University of Leeds. 
• I have been researching into the use of Multi-compartment Compliance 
aids by older people living in their own homes for a number of years. 
The current research project will form part of my PhD thesis. 
• I am inviting healthcare professionals to discuss their views on the use 
of Multi-compartment compliance aids by older people, how effective 
these aids are and what problems older people experience when 
managing their medicines. 
• I am inviting you to take part in the study. 
What will be involved? 
• The discussion will take the form of an interview, which will last 
between 30 and 45minutes 
• You will be asked before the interview if you agree to being tape-
recorded. This will help me to remember the main points of the 
discussion. I will listen to the tape myself, the recording will be 
transcribed and then destroyed. You may decline to answer a question 
at any time during the interview. 
• The discussion will take place at a time and venue convenient for you. 
Confidentiality 
• All recordings will be kept in a secure place, transcribed notes will be 
kept in a secure filing cabinet or on a password protected computer. I 
will not discuss your views with anyone else and it will not be possible 
to identify any participant in any publications or presentations. 
Do I have to take part? 
• Taking part in this research project is entirely voluntary. You do not 
have to participate if you do not want to. 
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What do I need to do now? 
• If you would like to take part please complete the attached consent fonn 
and return it to me in the envelope provided. I will contact you to 
arrange an appointment. 
• If you do not wish to take part there is no need to take any further 
action. 
• If you would like further information you can contact me, 
Jacky Nunney tel: 0113 3431232 or e-mail:J.M.Nunney@leeds.ac.uk 
You can also write to me at: 
Pharmacy Practice and Medicines Management Group 
School of Healthcare Studies 
Baines Wing 
University of Leeds 
PO Box 214 
Leeds LS2 9UT 
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Healthcare professional Identification Number for this Study: 
CONSENT FORM FOR RESEARCH STUDY 
Title of Project: Older people Managing your medicines at home 
Name of Researcher: Jacqueline Nunney, University of Leeds 
• 
• 
• 
• 
• 
• 
I have read the information sheet for the above study. 
I have had the opportunity to ask questions about the study. 
I understand the purpose of the study, and how I will be involved. 
I understand, and accept, that if I take part in the study I will not gain any direct, 
personal benefit from it. 
I understand that all information collected in the study will be held in confidence and 
that, if it is presented or published, all my personal details will be removed. 
I confirm that I will be taking part in this study of my own free will, and I understand 
that I may withdraw from it, at any time and for any reason. 
• I agree to take part in the above study. 
Signed Date 
Person taking consent Date 
Researcher Jacqueline Nunney 
Please 
tick to 
say yes 
o 
o 
o 
o 
o 
o 
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Appendix 5. Original Paper. The Pharmaceutical Journal 
December 2001 
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How are multi-comparUllent 
compliance aids used in primary care? 
By Jacky M. Nu1Jney, DipConnltPharllt, MRPbarlltS, a:lld D. K. Theo IWYllOr, PhD, MRPbarlllS 
A1M • To detemline the scale of dis~nsing in compli-
ance aids t() patients athOltlC, how community pharma-
cists pro\'ide tlUs servia: and the c;\ctent to which 
patie.nts' needs are met. 
DESIGN . Self-completion questionnaire to c.onrrac(-
cd pharmacies, administered qucstionnair<l to 10 
nnd.omly selected commiJ.nity phamucists and admi-
nistered questionnaire to patients us.ing a compliance 
aid at home. 
SUBJECT'S A.ND SETTING • The study was conducted 
in the Leeds Bea.lch AuthorilY llrea. Phllrtrulcists were 
interviewed in theircommunityphann.acics and patients 
in their homes. 
RESULTS • Responses were recei\·e.d from 123 phar-
macies (80%), of whom 95 (77%) supplied 1,328 
patient'S with 11 multi-compartment complhlnce gjd 
(MCA). Most commonly used we.re the Nom3d (694; 
52%). Dosett (363; 27%) and Medidos (116; 9%). 7 of 
the 10 ph3rmacists interviewed required 7 d3)' pre-
scriptions and S paid for the a.id themselves. S would 
make an initial visit to aSSC$$ pgtiCllts and 8 supplied 
their preferred device without refere.nce to the p:atient. 
1 had a written procedure and in 2. an unqualified 
assistant filled the de\·ices. In 4 pharmacies delivery 
Was by a non-qualified ~rson. Of the 169 eligible 
p2tients, 56 Jl:AtientS wert intcn-tewed (33%). In IOml 
48 (86%) had.no i.nput into ordering their prescription 
and had their device delivered by the phamtaq·. The 
names of their medicines were not known by 38 (68%) 
and 10 (18%) said they had difficulty using the de\ice; 
22 patieptS (39%) thought they would be able to 
remember fO take their medicines if still in con\'en-
tion.'tI conrai.ners. 
CO, 'CLUSION • Large numbers of patientS living at 
home have their medicines in an MCA, but initia tion 
and supply appeJirs not to be focused on cheir needs_ 
M,CAs can take away a key link between the patient 
and their health professional. They can abo cause 
patientS to lose some responsibility for their own 
medjci.nes. Before supply, an gssessment should deter-
mine iodivi.dual needs and the appropriate interven-
tion - supply of lU1 MCA is only one optiOI1. Lack of 01 
parmt-nt mechani.sm makes the need for 2ppropri:)[C 
targeting u rgent; pharmacists are expected to provide 
the sen.jce ~;thout suppOrt or resources, placing :I 
strain on inter-professional relationships. An evi-
dence-based mechanism (or use, urgeting those who 
really need an MCA should be s\lstaiollble through 
implement2tion of medicines mlmagement, as :I re \lIt 
of the 1\~S National Plan. 
MUlti-compuuncm rumpli-. ancc aid s (MCAs) 3rc widely used for p;1tic:ntS pc~i"c:d 'l~ having problems wi th medi-
cine t"Jl-ing lit home. The 3ids hold se'-cn 
days of 2 patient's medicines ill 28 inner 
c,;mp'irtllientS. (am for cllcb day- They 
appe<lr ro be accepted by m:,")' health L~rc 
professionllls as a solution for p1ticnts h"v-
il1g' Pt()hleJll5 man:j!,-ing their U\cdidjl':'~ 2( 
home_ This is despite tht:.re being litde c,; -
dcnce for their ·t:ffcctiycncss. l .! A recent 
dc\'d l)l)lllenr is Uul tT2ditional A-leAs (rueh 
u Dosen :md Mcdidos) b~"e been o\'C.r-
shadowed by monitored d0S2ge sysrcms 
(MDSs) whkh, alrho'lgh initially di;$igrtcd 
for institulional usc. ue: .Iro p.rofTWlcd for 
u.~e by patients in their own bome.J The: 
ST:Iostial significnncc~ and one 31.1lhor 
concluded that it was onl), of limited 
' 'lllue.l Somc worL:ers }"",e found th'l the 
Dosert is rarely swt-'lblc for the "!derly" nnd 
Atkin' found that H per cellI of elderly 
patients could nO! open 2 D n ett box. 
Cr-ome cf at" found no significant imprm'c-
menr in the compli2nce of elderly pHi..,nts 
" 'ho used the D osCtl dC\~CI:. There h1"<: 
beell more rigorous tri .. !s or MCAs when 
used 3 put of 3 multiple in.ter ... cntion in 
the US.-,IY Howe\-er it i difficult to assess 
the indhi.du.i roles of the vllrious intervc.n-
tions employed. In Ihe latter srudy. o nly 
half of the patients were still using the 
D oserl .fter six months, 
all. I:-H although in one study 35 per enl 
of patients could nOI remOVe the ublets 
"quickly. ""';rh e~$C· , l1 A rri~1 of the Do ell 
and Mcdidos de:';c"", in a self-mcdk:lllon 
scheme " '\15 unsuccessful because of the 
difficulry patients had in opt'ning the 
dc\·iccs." Sweeney (/ al found the Med.dos 
-"xtremely useful" in seleeted patients 
(althougb il Iud been incorrectly relilled 
by rwo {la.t.ients)." A 8'''1] revieW" of com-
pliance aids for the elde rly included no 
critical analysis of their role or effecti ... ,-
ness . 
There arc few published conlrolled 
studies of the USc of MOSs. compliance 
aids. A sn:dv in 1 2 of a sysrem WI[h me 
simiiarities ' (O an MOS.h 'cd the arne 
b ·d of compliance :IS ,,-ilh patients using 
o rd inary bottles,l H owevCf. ini".u .... 
bave been undert:u':Cll 1<>Ca1l)· in the UK 
" i th sysrcms scI in place by hc:llt:h .uthon-
nes to usc .\10S,:IS compliance .ids in UI1 
w.y, 19,!O Ryan -Woollc ' re ntly reea-
relled the use of.n ,\IDS 10 m nllor medI-
cines warolge and f.cilit:lle concord~nce.: 1 
Tablet a>1.1n l~ in !\o o srudlc 10 the lq 
appeared 10 sbow imp ro\'cd comphance 
rates in ddcrl ' paocnts, 1(0" ",'cr, tbc 
authOr> CO llCCrlc thu ",",0' I of J 
b~forc repear prcJmlOged \-is! Ill. h.\'I: 
I'n:! ;n adnmC:lgcs )lnd d,i:Md'1Inages thal 
have been '3.ssociueJ wi th I.he u.se of MCAs 
"re described in Pu.nel 1. 
Wbn;f it tb~ evidcnul The Olostcommnnlv 
used ~nd studied ,\1C-,\ i.s the Dosett 
(kno,,'n 3$ Mcdisel in the: United States) 
~nd it hu bee:n th~ subjcc( of ~ number of 
tri~ls ,,;th confliCting n:rults. Some h3\'C 
been reported "5 being little morc than ~ 
collceli n (If l1ncctlow reports, I o thcrs 
I13Ve iI, Illdo:d to') few p<lti.;nlS 10 defect 
Some work h". t:omp:.red "3r;OU$ 
MCAs. mostly usi ng 0 cri lerion of patienl 
~c .. :~p[.biliIY, \-'1u::d-ba:$cd devices lppe:ar 
lust populOlrll ~nd WaU;"r',. series of stud -
ies found rhe: Medidns most popular o"a-
11 IE PI i:\R.\l>\CEUTICALjOURJ'AL (yOLl67) IO=bcr! I 
occu.rr~d (rhe viSl)llI rl$ture Qr all MDS or 
MCA nmkes such adjustments more lik.ly 
tnan with tonvenrioo:u container.5).ll.1) 
There are no published comparisons of 
patient 3cccpt2bility between MCAs and 
MDSs. 
Wbot O~ the aJU77ulriv~sf There ate :i 
number of alternative St~I.egie.~ for tack.Jing 
uruntentiona.l non-compliance, some of 
which h2\'1: a wider evidence b:asc. Patients 
with unintentional non-wmplianct: UStr .. Uy 
need help with: 
1 Knowing when to take doses 
1 Remembering to raJa: dost.>s 
1. Coping with ~ complex regimen 
The key .ppr01I1;:he$ He simplifiC2tion 
an.d ution;.lhation of dle m.edicine regi-
mcn, cueing of doses and t.ailoriog regi-
men:s,H medicine reminder chuts,H.16 and 
''1I.riOIlS m.ernoty aids.17 These life 
described in l'ancl2. 
IVbyJo this sttuIy?Tht- sca.le of \lse ofMC.A.~ 
is nOl!:nown and methods of providing a ser-
vice through community ph:iMludsts have 
nOt been des<.Tibed in detail. MCA.~ may be 
useful for some p' .. rienu, hut the appropriate 
metb<Xl fQt u rgeting is not; !.::nown. 
The report "From ool:npl .... "rx W oonCQf-
dance" cnn6m.lw !he need for n:s<-'2rch inm 
inren'entlons ",-hlch ~ddTcss unintentional 
non-compliancc, including compliance aids.l~ 
Th.is sfudy investigated the role of these 
aids in t111~ wider pictutt: of complia.nce sup-
pQrt imetVcnu.Qlls ~nd how their usc CUI b~ 
tafbrettd. The objectives were W : 
1 Ascertain the current scale of dispens-
ingaf medicines in MCAs to patients 
livillg in their own home. in the Leeds 
He1l1tb Authority:lr(:1l 
Dl:terminc how c:.ommunjty phanna-
cists provide this service 
1 Assess the nee.ds of p:ltients feed,·jng 
medicines in MCt\$ ;lna whether thc:sc: 
were bc.ing met through fheir current 
medicaJ and pharml!ceutical cue 
\Ve have :ldoptcd the term "multi-com-
p~nent compliance aid" w differentiate 
between devices designed to oontain tablets 
~nd apsules frolll those which ~ssisr in the 
:administNtion pf nOft-ol1l1 dose {omu. ego 
cye-drops >lnd inhalers. Botb t)' \lCS of 
devke b;wc be,en referred to as "compli-
ance aids", \,v" chose (0 continue to usc the 
term *compliance" in this repQrt, father 
th~o "adherence". dUI: to the historical use 
of the former in rcl~(ion to such a.ids. 
METllODS 
There were three phases to the ~rudy: 
ScJf-<:tnnplttion pbllnnDo/ qun-tio,,,,ain A 
'df-completion qucstiono2ire ,,".oS $Cnt 1'0 ~U 
15! ronO'licteo pnartn>leies in l..ecds und 
asked: 
1 Did tit.:)' d;"pc.l\~ mcdjdnf:S in MCAs 
to \)<,:oplc living in their own homes? 
1 D=OO2ool 
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Panel l :,Proposed advantages and 
disadvantages of multi-compartment 
, compliance aids 
Adwilri~ fii~, , , 
. 1 Some At.ris1c p1tieJits on multiple 
me&c:ation nu)' be 2ble to be a:red 
!or~hbmc 
1 PatientS ~ 1I.1"e: genenlly ltlen but 
on.mmp1ex:r~,giImJ)$ ~y be helped 
M non of medi· 
, almal or inforinaI) 
otherwise' prepared (or allowed) to 
$ivo medicioes 
I Al:e lIS " ,rcmmdcr to ~tknt$ wbo 
i' " frequen~ forget to take dOSd of 
medicin¢$ 
.~. jfkt 
'Dbadvanuam 
1 The: p!lli~t loses $Orne :upansi-
hility lort'h(:jt mcd~ 
). The MeA Ullly be filled inrom:ctly 
by 4 non-professional 
o 1 M:my dose farms ate unsu.ble oue-
;5ide thelt ~na1 packaging , 
1 Ml~ ~ !onm cannot,go into an 
MCA,eg, inh2Jen,liquick,.dropa 
1 No ~(:<>gi)*4 {Xiyment .system for 
suppl)' or tilling 
1 Colt (ofdevi~ 'lI1d for profeS$lo.nal 
~Iilling') 
CoItlD1Cnt 
1 Could prevent the need for admis-
sion to hospital (or nursing or resi-
dential home) 
1 Such pncticaJ assmancc lIlay be 
dTeetivdy provided by a reminder 
wrt 
1 Can result in .. prO<:e:s$ focused on 
the n«ds of the arers, l1uher tb:an 
thOSt! of the p2tienu 
1 There ~ other simpler methods 
such as remindetdlltTtS 
Comment 
1 May be inevit2ble in some patientS 
with poonllCn121 11:11,0) 
1 AImtdy happens ,,~th tranSfer 
betwtm boWe1 in the home 
1 Undear whether of real significance 
in short teml 
1 Such dose (orms often OOI~rote a 
$igniJicant part of a patienl'$ regimen 
1 Can I~ ro inll:.r--pror-ional dis-
pull:. and misundem:a.oding in all 
uea when: a multidisc:iplilW)' 
approach is essetltnl 
1 Cost-efi'C(.'Uvc analyses ne-ed apply-
ingto dmnninc optimum UK 
P~el ~: Interventions to support patients 
having problems with unintentional 
non-compliance 
4 llegimcn.m.ionalisationlsimp1ification 
Defore other intervcntions, make the: regimen as $lrople as possible. 
.Reduoe ~Jlumber ofn:JeciiQnes to a lnininlum aDd dose: frequencies to once or twice 
, dally,.·ht3poss.lble. 
Tailoring regimem and cueing doses 
, TlI.iloringdose-taldng rimes to 6.tln with a p2tient's daily routine can be helpful. 
Doses can also be lin1ced to events in J»tients' dally routint, ego meal times :and bedtime. 
Thi. helps the: patient to rcmc:mber ro take thUr doses.. 
Medic:iJicrcmindcr mans 
\ £ssentMllytwo-dimensiom.l MC.'\s which show wbat medicines to take *t eadl dose t:ak:-
. ing time, but with the medicines remaining in their se~te ~Ot2inCl'$. Studies have 
shown mat st!cll charts an improve knowledge and C()mpJi~nce. Th¢)' both help in gen-
eral understanding of a complex regimen and act as * .. emindcc or cue. 
lfiemol}' aids . • • • •. I These jndude telephone remln_ timed :ahrms, tefrig~tOt sbcbrs, etc . 
. 'if!' 
1 How many p.1tiems reteived their medi-
cines in MCAs? 
1 Wh.ich device(s) did Ihc)' use? 
Adtninintnd pbantlildsr f{Uemolmllin An 
.<Wioonal q\lc:monnaire W:IS sent to ! 0 !";In-
THE PHAR1>,lACEtmCAL)OlJ""R.'1AL (VOL 266) 
domly ~ected conununllY pMnn2cIsts who 
n.'SflOru:!cd to the ",l(-a:>mpletion qut,stion-
Mire ~nd said that they provided media "", 
in ... tCAs. Befon: randomiS>loon, the pnar-
m~cisrs were divided into groups dc:pcndtng 
on the number of p4ticnu rect:lytng ",cdl-
; S 
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' \1111 I: \"110 \I~"I' 1111 Utl 1\, H\ 
()f 111f \\t 'ITl-f.O\lI'\1r1 'IF,"T 
• T\IlU .l: ~l' \11II HOI I>AIII "'. S l '~I'<'; 
r \f'1I T\ PI' or \It'I 11-f:41\lP\RT\1I 'T 
(,O.\lPIH'Cf All) (x,,56) 
I 
I 
( o\n'll\ '( I \II) 
wi .. ) r:ruJa,,$ 
dclive:t)· 
Driver 
I'hATUUrut 
Ph~"rtacisl ~ d.i.'U 
Ph~TU\aclSI or ,dative 
Ph.nn'1ciu Or pn.no"y aSSistl1nl 
Ph~ .. nac)' asmt:Ult 
N,un!;¢TQr 
pharmacies 
l 
2 
I 
I 
I 
Dose« 
Nomad 
Metlidt>< 
Venalinli: 
A-hnrex Sun & M<>Ofl 
Number of 
patie>'lts 
20 
19 
Ii 
i 
'* 
Sex 
Agcin)~ 
BUllsing 
fw",k/m.lc 
MCi1n ("'''te) 
Owllholl'\¢ 
Sh(.ller¢ti 
W 18(W.l1%) 
78,5 (4<>-93 ) 
43 
II 
W~rtkn rontrolled 
Alone 
\Vllh roMe,T 
Woth rd.th-clfriend 
HOln.~~N 
District:n~ 
Rdati .. elfri.nd '"ho "i$its 
Nc:,tl(IV 
ciru.."S i.n MCAs from \he phllnmcy. ie. 1-10, 
11-20,21-30, over 30, Four wcre randomly 
~k'«.ed from the U"[ f,'TO\'P, lilrc:c from rhe 
J<:Ci.md, IWQ from the third Gnd one from Ule 
founh group (to bdp get a balanced picmre 
across the spectrum of cnnununii)' pluonna-
ck;;), 'DIe ph~rm;1dc:~wl'fC: fl."'c:n $In;U inue-
pcn<lenu (up to thr(,~ shops). one from ~ 
small independent multiple and twO from 
laf!,'e multiples. The population S<.'1Ycd by 
these phllrnt:lcies \\'\tS vliriea. ~nging (t()ll} 
inn.er etty II) the tuNI $ub-urbs. Of dw phar-
ITI3cists involvt.-d, six were proprietors and 
roUf .... ere employees. 
The qu~stionn3irc w~s de~i!,'1lcd 10 
all!,wcr the following \1\H.~tions : 
1 Who requestS the dispensing of fIledi-
,iIlCS in MeAs for patic.1l1S living in 
\heir own homes? 
l. \I,"har method of assl!-'\l;lnent of the 
p1Itic:nt does the phannadstuse? 
\\"h~i \'c:rh:ll advice 1I.nd inf{)rmatiM 
does the parient receiver 
1 VVt.:.t procedures are in pl~ce ill tbe 
pn;u;macy f(l( di:spcming in MCA!< lind is 
(here 3 14'T1 ttenprotoco.1? 
1 Did the phannacists have an)' COIlCCrns 
• hOllt disj>ensing in MC>\s? 
Administere4 putimt quffliomUlin All 
palicnr with \1CAs supplied and filled by 
\he 10 selectlld phllrmndes werc cont"u:u:d 
b), lettcr to !iCek con.~cnt Ulld. dlcn hy tele-
phone to arr-lOge ~ home ,'ish, 
A qw:stionnllire, b~scd on .~ previousl), 
\",-liducd qllcsponna'n:,N \\'0\$ \l~jgfled fO 
be u;;cd by the research ph~rm2cjM when 
intl!n -iewing patients in their own homes. 
The: qu~tion.nairt: WliS desigm:d to 1I.nswer 
the following questions: 
1 Did the patient l:now the nllIDCS of, and 
indk-:ltions for, \heir medicines? 
1 Could the pniellf man,,!;e to usc \he 
MCA t:OtTectiy and did tIle), ",cd,'" any 
assil>'Ulllcc:? 
1 How did the patient obtain repeat pre-
scriptions front the: GP and fllMer sup-
plies of medicines? 
1 How did the p-atient feel they would be 
a hie to lIlan ab'C if thi:Y d ill not haw the 
medicines in an M CA? 
1 How did the: patient fed the MeA com-
pared with medicines in ordinary bottles 
~Ild packs; 
ApproVOIl WItS olmlined from Lt.-eds 
HCi1lth Au\horitylUniU!d Leeds TC2ching 
HO$pi13ls Rt.~3rt:h Ethics C(lm.uiuce. A 
copy of the questionn~ire is 3vaihble on 
request from the authof$. 
R£sUL1'S 
SCIf-#ntlpICWI pbnrouuy qllcnitm"J1,i~ 
We rec<.-ived cotnplemd questionn:lirc;; from 
123 of the 152 oonlnlcted pharffilldcs (80 
per c"m), Oi these, 95 (77 per cent) dis-
peme-d medicines in MCA.s to patients in 
their Qwn homcs, The tOul nll.rober oJ 
patients receiving their medicines i.n MC~~ 
was I,ns (avef'2ge of I t per pharmacy, 
Tall!,'" 1-70) . 
Most C('mUlon w~.s the N()m~d (an 
MDS) which was used hy 694 parien.ts (51 
per cent), followed by the I)Q$Ctl with 363 
(27 per cent) ;.nd ;\lcdidos I 16 (9 per cent). 
(h'e-nlll, 819 patiltots (62 per cent) we.rc 
using an M'DS,r2ther than a conv"ntional 
MeA, Preliminary results for this question-
mire h~"c previouslr been reportcd) o 
Then: were 28 ph'lntlllcies (23 per cent) 
which did nor dispense in MCA.s ro padents 
Ihing i.lldcpcndcntly in duo t:Olnl11unity. -n.c 
rt:~$().tl$ mted 'nclud~-d; flO demand ( It ); no 
rClllWlerntion (6); would dispen~ if gi"co 
se\'eIl-day prescriptions (l); !)harm<lCY nOt 
suilllble (insuffideJ)t Sl)'-lL"C) (1); no reason 
gi"cn(9), 
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Administtrui pbarn"uin If"rsti,mTUlTrr 
The 1 0 n.ndol1lly selected ph:.rm3cists 
nnked gellL'r.I1 pr:actitioners (CPs) :rnd has-
pir.al StllfT 1$ lhe main inirinors of requcsts 
for ~. n MeA, closely followed b c:m:~ 3nd 
socia! s.:n;ces' Sf>lJf. The phmn:tcistS rJted 
thelll$C!ves as ix:ing \he I~t likdy to inie-
ate use of m MC'A 
Seven ph:trmQcim always rcquo'ted 
sevcn dQ)' prescripoons from the GP and 
would Dot prcx:ec<l if the CP reru~d . O n 
would ask, but if n:fused would dispen e in 
thc ,\-IC-\ :tllyW:!y. Two pharmacists 
requested 2S-d~y pl'CScripoon ind d is-
()cnsed fOIlT by seven <by to the )nlient I t 
onl! nme. Six ph:tt0l2cisL'! stared fhal rhey 
would order the repeat prc;;cription them-
sdycs (with the patjt!nrs apP'(W.I!) ltut \'wo 
pn,fcrn.-d the patient to order their O"T1 
repeat prescriptions. In eight c;t cs lhe 
phllMllacy paid for lhc MC ... , T .... o pharnu-
am 5tal-W rh3t they did, on ocCllsion, 
recei ,'c p~ymCnt for the MCA from the 
padent. 
Five phamucins said they ,,'ould make 
2,11 initial "isit III llSSe5S \he patient befo re 
setting up the scn~ce ~od St."'"n s:aid they 
would chec!.: the patient's ability (0 ~ thc 
M<.;A, tight .."id that Ihey \\-'Quld provide 
infonnation 3nd advice to the patient on 
first supply, but only one .... ould suggest sim-
plifiClltion of the regimen and >SSl'S:S 
p~.tjents' prol,'TCSS in conventional t'OlIt:lin-
e<s fim, Eight of the phllmlllcins cl<:cidcd on 
the type of device without reference to Ihe 
p_~lient 311d C'Jch had a prefcm:.d MC ... (six 
"",,rcMDS), 
Sevcn ph3rmaci (S mte<i that lhey 
would check the subility of drub'S in 3n 
MC>\, Sources. quoted for information w<;re: 
1 Pharmacist's own \mow ledge 
1 M~1,l4crurcr's lifl:rmuc or D~m Sheet 
Compendium 
1 British N~tioml Forrnuhry 
1 Roy ... l Pharmaceutic-Jl Society infoml~­
rion 
Three $:lid that they did nor think there 
was a problem. considering the short kn!,'th 
of time tht: drug$ were in the .\1CA, 
One pharillacy hau a written prOCt:dll¥C: 
in pl3ce, although most kept a file with the 
nOlmes of the patients receiving \heir meili-
cincs in MCA$, Two ph~rn\.,cisl-$ lilways 
filled the: M CAs thclnJ<:lvc$ v>-ith Ii"" ,h.'lr-
ing the CIS!.:. wi\h either 1 qualified dispenser 
or .. o un(jllalifie.d assi$uflt- 11\ olle ph2nnllcy 
dispensing WlIS ~1,,'lIYS Clrried out hy ~ (IUll-
i.fied dispenser and in two b)' an unq ualj lied 
assisumt- The pharmacists who all''3)'$ filled 
the MCA$ {hcm~d\"e ' dId not get .. nyane to 
check them; in the other eases the ph,rm~­
cislchccl:cd the dispcnse~' work. However, 
half of the ph2rmllcists h~d conCcMlS on th~ 
:Ibility [0 check dispensing into ,\1CA.s 
proper/yo The ;l\'cnge ~tim"rcd time t:1Kcn 
for dispL'1lsing 2 seven-dOl}' suppl)' was 15 
minutcs ,ll! the firsr (ICC:l,i,m, 2nd ,i l' n in -
utes on subscqucnt occ:lSions. In four af the 
ph2mlllcies, \he MC\ "'3S deli\'cred by 1 
non-qualified person (Table I ), 
Four phamuciSL'< ~id (here "-ere: 0C(lI -
sions when th . h2d be:t:n pressured by other 
ID=bu!OOI 
health an: professionals to supply dru~ In 
MCAs, when they fdt this was in~ppropriate, 
but that this was not 2 frequent OCClIITt!J\cc. 
Administlm'4 pJlriml '1"cnitmflJlfrv Of the 
169 patients being supplied with II MCA 
from the above: phannllcies,61 (36 per cent) 
parie:nu cOO$cmed to being int.crviewed and 
56 imcrviews w<ore completed. They h.:td iI 
mean of six medicines in the MCA (range 
1-12) and 52 per cent h.:td oth.er medicines 
nm in tht lvtCA Table 2 shnws demograph-
ic deuils of these patients. 
\-Vhc:n asked who had suggested the 
use of 2n MCA. p3tients' rna" common 
respon~ W'aS that it '\'2 .$ hospiul s I.aff (22; 
39 per cent) and GPs (9; 16 per cent). Only 
one p:nicn! sa.id that they ha.d be';;/l given a 
choice of MCA. For 48 p~tients (S6 per 
cent), the pharmacy ordered their pre-
~'tTiptiotl "nd $0 the p"tient had no input.. 
~'3in 49 patients (S6 per cent) had the: 
device delivered by the ph.:trmacy. Most 
puients were usillg a Doseu (2(}; 36 peT 
cent) or Nomad (19; 34 per cent) device 
(Table 3). All hospitlll initialed MCAs were 
the Doset! device. 
The nllmes of the mt.'t!icines in the 
;\1CA were nO[ .known hy 38 {llItients {6S 
per cent) and I (} (18 per cent) reported dif-
ficulty in using the d(:vice; 22 $<lid they 
though t tbe}' would he ~hl.e to reJl1l!mber to 
ta.I .. : their medIcines jf dispensed in wnven-
oon21 conrainers. A quarter of comments 
voluntc.cred by p:tti~nts rehle.d to the fact 
that the MCA 2l1owe~ fhem to sec i( they 
h •. d forgonen to tau a doS<!. Over 90 per 
<'>ent (52) $<lid thar the MCA was much bet-
ter thl1n ordinary bottJcs. However. :I ~'ll>­
jcctive 3s~"Ssment by the research 
pharmacist suggested that three could m. n-
O1gc very well,. :U1d }(I rc*~m",bly well. ,,';th 
conventiorul containers. 
DISCUSSION 
This work suggestll that (through extrapola-
rion to Ilrirain 15 II " 'hole) tht.'1'c are ovcr 
[00,000 patienlS living in their own home 
whose: medicines 3re di~penS(.-d in MCAs. 
The most widdv used de,;ce was an 
MDS (NQlnllrl) rather than II eom'enlional 
"'lCA. This may rd,m: to the MDS which 
indh~duat pharmacies U$e for supply 1.0 resi-
dential and nursing homes. The most (.x)m-
mo:nlv used MC'!" was the Dosen, ",i th 
Sign ificantly less use of the Medidos, despite 
some e\;dence th.at patients prefer it.lll-ll 
Pour-fifth.s of the phannadsts had 3 pre· 
fcrrt't! MCA, rho\l),oh this was nOf an "';-
dence-based decision. Only one pacicSit said 
thl:)' h~d been ~ble fO chO()Si! the type of 
"ICA. The use of Dmen devin'S for aU 
those discharged from hospiul sometimes 
Jed ro 3 cha.nge (0 their phannllcis{'s pre-
ferred de\~ce once ~[ home. It appears 
pariCnl ' needs are no! the prime criterion 
for the cnoicc.ofMe."," 
Ltuk of JX1Y1tJmf as " bmrit'/" The m>lin rea-
son given by pl"'ml:lcist.~ who did no! dis-
pense in M e.o\s \\'35 the l:l4:k of p:I} l1lCOt, liSld 
this was the most common source of com-
m~-nt during intt:n;ews. Seven of the JO phar-
macists would not di~lXn.sc in an MCA unless 
I Decc:mbe:r 100 1 
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the GP provided seven-da ' prescriptions. It is 
clear that the use of such surrog;ate paymems 
to m~puhte the remuner.tion ~1'Ste1ll is 
irutPl'ropri>lte aod c;an h.rl'll Gp.ph.:tnu;ocist 
relationships. Problems also arise: when the 
patient's local pharmacy will not dispt.-nse In 
MCAs, learling to tWo pharn12t;i>'t$\x.'ing\lli\d 
(one far medicines in the MCA ~nd the other, 
more local pharmacy, for incldenul needs), 
neither wirh complete records. 
Triggen for mpp/y mul patitnl assemnnu 
It is of nOfe thal ph.:tmucls:tS named the GP 
~s th.e perron most likely to requo't the usc 
of an MCA, along with hospiul suff, and 
$<lW thel1lsci\'<:$ as least likely to initi~tc use. 
This may be: II n;sult Q( ph.rlll2cislS hAving 2 
better apprccilluoo of the lld,,:1nCl.gcs and 
d~ad~'3tlta~'S of ,\1C\s. Tnl in ing of health 
care profl!SSian.2ls appt:ars (o be needed in 
l<Upporti.hJt p-.>dcnts h~\>jng problems with 
man2ging their mc:&dn<:$ at home. This 
should include hospiul and social serviC'CS 
$t')(f. 
On.1)' half of the pharmacists inter-
viewed would visit the raticor to assess 
their $tJitability for an MeA and only one 
would try out a simplified regim<."fl first in 
conventional containers. ] Iowcver, the first 
ques tion should be: "Is an MCA appropri-
ate or woult! another option be ulore 
appropriate?")1 Patients' individual needs 
depend on their mou\'3(ion, type of n:gi-
men, and phYliic~1 and cOgDiuve ~bility. As 
shown in Pmell . the fi.rst 1;03.1 is to ensure 
that rhe patitnt's regimen is as simple as 
possible, in tradition. I conaincrs with 
.. pptopri.trc labdling, along with 2ppropri-
ate advice and. rc:min.der chut where nec-
essary. If it is found thaI such a dc,;ce is 
appropriate, the.n the: next question s hould 
be: "Which MCA?". In nuny OlSCS. this 
process would need a domiciliary assess-
ment. 
ProaJuru and protocolt Only one pharma-
cy had a wrirten protocol in Pu.cc (Ropl 
Pharmaecuut'3l Society guidclinc hll''''' lim-
ited use as they onl)' appl~' to MC.>\s sup-
plied to rcsidl'1ltial or nursing homcsJr). 
Clinieal gov"'rn~nee requires th.t,. protocol 
should be 2V2ibble and it should consist of 
twa parts: p~ticnt n-sessment ~ nd dispeosing 
~nd wpply of rhe MeA. 
Drug stability needs darifiotion, \\~th 
pncrical guidance needed for pha.rmacistS 
on the sh.ort-term transfer of medicines into 
MeA&. There is c()nc<:>nl over tht; .biliry to 
chedt di.~pc:nsing imo MC.1\s and the use of 
unqu~Jjfit:d assistants for Me.1\s is open to 
question. PhUlllacistli need to Qullit their 
dispensing "fit! checking procedures and 
ha\'c dear protocols and docmnenta!ion in 
place. 
Ur'" ronsrnt rate The low consent nte for 
the patient int.e.n~ews (around one third) 
limits {he: wider appHClbility of these find-
ings. The low nte could h."c been predict-
ed in this group of elderly patients due to 
significant numhers of Iy~tients tOO ronfulied 
to be able to gin' informed cons .. -nt ,and 
patients who were reluctant to :tilow a 
stranger in to tbcir homcs. 
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However, rhe comments of some 
patients suggested that they h.:td dctl'CtL-d an 
ulterior InOU"e ant! lhat 501IleonC 
·going 10 tr), lO akc their Me." ''''l\'". This 
needs to be borne in mind if prorocois whIch 
promote options other than .\1CAs 2fc 
br.ought into use. 
Palinrt u::mcnbip of nudUVu$ mu1 
pmicnl-profc:s:riDtlId t'Ontlut "Cf NO-
thirds of patients did nOl know th n:ames of 
any of thor medicines in the ,\ Ie.-\. These 
d~'1ces rem()\"C the ownership by some 
patients of their treatment; their medicin 
become an an.onymous collection of \-:m-
oosly coloured and sized t:Iblets and eap ;ules 
which rhey s....,.lIow in one SO. at predeter-
mined timeS. S<''P3I'l1lC t2blett in different 
bottles help to maintain a lin!.: bc:twcc:n th.e 
p~ tiem lInd their medicines, tho: Jl2uenr 
rt:lilining some responsibility for their own 
mediation. 
Mo., patients Iud their repe:.ll prescrip· 
tion ordered by the ph2rm~C}' 2nd then Ih~ 
dc\,;cl: w'.s delivered. frequendy by 2n 
unqualified person. Thus the porient 
becomes not only dh"OT'C<'<I from their Illcd-
iotion, b\ll .!.w from the dOCtor ~nd ph.,. 
1Il2clSt who prescribe 2nd dispense it. In 
particular the \"atu2btc link between the 
putielll 2nd phanll2cisl is lost. Ther<: is nu 
opporrunity for the patient to ask question 
or opportunity for rhe: phannacist 10 asses 
p~ticnt:$' changing needs "~ lh TCSp"et to 
their medicincs. Almost on~-fifth of pallen! 
Sllid thl!)' h.d some: difficulty getting mL-di-
cines out of the :aid. P<.UL"flt:$' medicin"", 
man:a{(cmcnt needs may have changed .fter 
rhe MCA .... as initiated - hence the need for 
continu21 moniloring, Pre<;ous reSC2rch h:l.. 
shown thu housebound patients who rardy 
Sec 2 ph.:tnnacist oft.,," h.:t\·c a number of 
medication problem.< which n«d rcso!.--
ing.)) 
PatinllS' infOT71farUm "uds There w .. .s 
2nectloul evidence of patient :lIlt! carer mis-
understanding of the systJ!m for supply. Th,s 
cmph~ises the need for precise lind d~-t:lilcd 
information ro bc: given al the beginning. 
Puiems ",.-cd the following '-.:rtr.J and wril-
ten infon1l2u.on when .n .\1CA is lirst up-
plied : 
1 How 10 U$C the aid 
\.Vh:Jt to do if .. do e is missed 
1 Arrangements if .'ny from the house 
1 How 10 get further suppl ies 
h~.nmml prol(KO/S for MCAr Over 90 pcr 
cent of p.ticnts .id they prderred the 
MCA to con\'entiorW bonle . For "1:Inr, the 
m2in benefit apP"'lred to be tha[ Ihey could 
see if they h~d forgottt:n [0 akc • dose; 
~Plr.lrctJtly ;t n12ior C'onccm. Howc\'er. 
almost 70 per cent still relied on Other 
methods to remind themseh-es to al.:c their 
medicines 31ld it ""a. ~pp~renl 2t home visi ts 
rh'lt some p.ocnrs o r carers 1<:2\-': OUI tllblecs 
on rhe: able for patients ro CI!.:e ",ith their 
nexl meal. Other5 were bking tht'11l au! t 
put in other conl>1incrs. Perhaps for many 
potients - those who need to cheel., 
whether rhey ha\'~ uken 2 d e - "hat is 
8 
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nc.ca~"t:I 1$ lin aid with jll"t {our comp.a.rt-
ment$ in.U) which the f)arient or c:lrC:r could 
set out the d~ily doses each morning. This 
intervention (;ould be: pan of II wide.r proto· 
col to address the Ileeds of patienlll with 
prohlems with untntcnuunal mm-compli-
~nce. 
The research phUII1:lclsr'S subjective 
~ssessment lmggesled that 29 o{ the 61 
patienlll would be 3blll (0 cope w/:ll or re~­
ron3bl)' wdJ withou;! 2.n MCA. Review of a 
patient'S medicine regimen :md considen-
tion or other interventions (as dl'SCribe.d in 
Panel 2) needs to be pm of 1I prot.ocol for 
lneedng the tv,,~d$ of pnjents with prob.-
lems with unim:enrion~l non-compli. 
:lOce.l" This a.ssessmenr suggests t~t the 
number of pgtiellts using MCAs could be 
$ign ifi(;antiy reduced through such ~ 
process, 
Rnnll,umtJ()n A fundamem .. 1 problem at 
the he-~.rr of the use of MCAs is the hdt of 
n!mUflefll.don. For this: to be resol,,,,,<I. fun-
den: will need to be reassured th~t MCAs life 
being properly t2Tgeted. Th.e b ·d of remu· 
nc.ration will need to reflect the U'Uc time 
and res<IUf<:e commitment of .~ properly 
constitulcxi wrvi<:c, ie, inc.luding recom-
mendations made herereg2rding docutnen-
ettion, pltl.ienr as!>essment, and the provis:ion 
of i,,(cmlt~lioll lind advice, The publklltion 
of tilt" N:oti"n1l1 Plan for the NH.5, wilh 
Ulllicit support for medicinL'S management 
2nd nLOW me.thod$ of remuneration for phu-
m!1Clsts, is an opponunity w ~ddreSli this 
issu<:,H 
Limifllti01ls The questionnaires to the 
phamlacists dcpendf.."t:I on :lCCUflHe self· 
reporting of dll:ir bdlllviour. It i~ IXl$$iblt 
thu thert: \V'~ some o".~r-rcponing of the 
ertent to which ml.""su.res we.re in place to 
ensure appropr.iatt usc of MCAs. The 
resuJts should dlcrcfoTe be etL:.cn as the most 
optimistic p.ierurc of the currem situation. 
The kl\~ t:Osl:;<:1ll rJtel:O the p''Iticnt 
i nte,,~ews needs to be t2ken infO 2Cl:OUnt 
when looking .It thest responses. Some of 
the non-responders would undoubtedly be 
am()ng Ule 111(l5t vulncnlble and must in 
need of moniiodng and Sltppon for t.hcir 
medicine taking. 
Future work This mId)' ~s laid the (lunda-
tiOM for further ~rch into MCAs, Key 
q uc.<t1ons 'u~ 
1 How acceptable arc MDSs ~$ devices for 
\1$<: by paticnCli inlheir own hom .. '!i~ 
1 Which ;\-teA {including MOSs} do 
pltlients prefer? 
1 Could :I ·singk.d"y~ Me:-\. (filled by the 
pati~m or arer) be sufficient for those 
p~dcnt$ who JUSt ne<!d reminding 
wheth!!r they ~\'C taken iI. dose? 
1 HOI<' do MCAs. ,'vlDSs and other imer-
vcmions. eg, fCb';men £ilnplifienion, 
remindcr chll!1:S .nd $ingle day MC.>\s 
compMe (through nwdomised con-
trolled trials)? 
h is important rh~t ~nr suehsrudies arc 
independent of the 1l11IllUfJcmfcrs of the 
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a.ids, Devc]0pIIICntal work thar necds to he 
done indude.~: 
1 Testing of a protocol for inlen'cning 
when patients have problc:ms with wltn -
nmtiorull non-colllpl ilnc<: (The fuJI 
range of non-MCA intcrvc:ncions 
should be considered and it should 
include a role for :Ill sukt:holders, 
[indudin.g h05pital and social scrvices).} 
1 Guide1i.ne$ for di'1)Cllsing ::!nJ supplying 
MCAs ro patiems ~ l home (Th.,,;e 
should preferably be 2n exlension of 
currcllt ROYJJ Phartn2ctutical Society 
guidelines far rc.siaenti~1 and nursing 
h()mcs. Thq- should do,'e·tail with the 
above assessment protocol. once a deci-
sion has been m~dc to supply all. !>'tCA 
~nd l'hould ,,(wer personnel. prcmis.es 
and equipment, production and proce-
dures, method of liUpply and advice to 
the patient.) 
1 A pracric:ll guide w "'hich medidnes 
e;m he placed in lin MCA for up w four 
weeks 
1 Development of a written b'Uidc for 
p3tients using an MCA 
CONCLUSION 
HClI.lth professionals need to know the 
l)laC'c or MCAs in th" wider C'Ontexl of 
medicines m:an~gcment {Qr pltticnts llt 
home. The pl~ce of e2ch intervention 
(induding "tCAs) needs determining. so 
t~t C'lch e:Jn be etrgcu,d to those who 
would m(m benefit, Phmullcisl$ net:d cri-
U,-n3 to ensure Ihn MCAs 3rt: onJ\' used 
wben appropriate, and thc), need didence 
on which to base their recommend:a tion. If 
an Me:" j~ the appropriate intel'\'l!nrion, 
then e,i dencc-based protocols ire needed 
for the choice of MCA :lnd the dispensing 
and supply of the device. The cost of filling 
~nd suppl}~ng MCAs, I~ck of a payment 
mechanism and the compliotions that 
Ilr.ise from th·eir usc in practice iU".\re. tit($C 
need more pre sing. 
It is of concern lh'll o,'er .100.000 
p:nients living independently in the commu· 
nity in Brilain ~re using MCAs, despite the 
bd: of good evidence that such dc\';ces :He 
effective, 
Patients ue receiving the dc\;ces large-
ly without aDY llSSl:ssment or whether their 
use is QPpropriste in their CtS", There is nQ 
prope.r re(ert'~ 1 ()f asse\>.~mcnt mechanism 
between prinlllry and secondary CI.rc. It 
lW:ElI£NCES 
$et;rtl$ thloll the process I.S focused on the 
needs of professiomls :lOd carers and 001 on 
the patients' needs. This is in direct ronflict 
with the concept of concordanc-c in medi· 
cine.r.alcing.!J " 'hich is ooscd on 1)40CntS 
playing a full role in decisions about their 
medic.ines, An as.>l!SSmenl of the p3t .. :.ms 
new.s should be the starting point.11 
PoItients must nOI be issucxi "1th :tn 
MCA withour fim being l\lo1ieS!!<:d. The 
2SSL'SS.ment should follow st:lnd~rd guide-
lines which 3rt: needed to ensure Ihal :111 
patienl$ receive the imen-ention :IJld C1In: 
most suited 10 their needs. 1f the assessl1lent 
indk;ues thlll all MCA is the most 'I)Propri· 
afe option, then (he fi rsl ddivery should 
always be mllde b)' 11 pn2nUJlost or suitllbl), 
trained technician , erbal:lJld ",rilten infor-
mation should include bow to use. Ihe gid, 
how IJ) gc't further $1I11pli~~ ~"d wlto U) ~sk 
(or (\lrther infornarion. 
The medicine managcment problems 
of many patients currently using :\1CAs 012)' 
be able to be man,,(,!cd in ~nother "11>'. $il1\' 
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Multicompartment compliance aids in primary care: building 
an evidence base. 
J.M. Nunney, D.K. Raynor, Division of Academic Pharmacy Practice, 
University of Leeds 
Introduction 
The profile of medication compliance in the 1990s has been increased by the "From 
Compliance to Concordance" reportl , which confirmed: 
• the distinction between intentional & unintentional non-compliance2. 
• that compliance aids are often used for unintentional non-compliance i.e. by 
patients who wish to comply but have problems remembering and understanding 
complex regimes. 
The report said that such aids must be carefully targeted to be effective. 
There is little research associated with the use of compliance aids3 and so such targeting 
cannot at present be undertaken accurately. 
Objectives 
This work forms part of a larger study and aimed to answer the basic questions: 
• How many patients living in their own homes are receiving their medicines in 
compliance aids from pharmacies in one Health Authority? 
• What types of aids are used? 
• We have used the term 'Multicompartment Compliance Aids' (MCAs) to 
distinguish these aids from mechanical administration aids. 
Method 
A questionnaire was sent to all 152 contracted pharmacies in Leeds. This included the 
questions: 
Q 1. Does your pharmacy dispense in MCAs to patients in their own 
homes? 
(a) If so; how many patients? 
(b) If not; why do you not use MCAs? 
Q 2. Which type(s) ofMCA do you use? 
Results 
119 replies (78%) were received 
92 (77%) pharmacies used MCAs for a total of 1327 patients at home. 
The median number of patients with an MCA per pharmacy was 10 (range 2-70). See 
Table 1. 
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The most frequently used MCA was Nomad, followed by Dosett and Medidos. See 
Table 2 
The most common reason for not dispensing in MCAs was lack of funding. 
Table 1: Numbers of patients with MCAs per pharmacy 
No. of patients with No. of 
MCAs pharmacies 
1-10 50 
11-20 22 
21-30 13 
31-40 3 
41-50 2 
51-70 2 
Table 2: Types of MCA used for all pharmacies 
Type ofMCA No. of patients 
Dosett 416 
Medidos 116 
Nomad 694 
Manrex 40 
Venalink 85 
Other 30 
Discussion 
There is little data on the number of patients using MCAs at home. 
Unpublished data suggest that the number of MCAs in use in Leeds was 5-10 per 
pharmacy 
This survey shows that the actual range is 2 to 70, with a median of 10. 
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The dispensing of medicines in MCAs for over 1300 patients in one Health Authority 
represents a considerable investment in terms of both time and money for the 
community pharmacist. 
These large numbers are a cause for concern because of the limited evidence for the 
benefits of MCAs. 
Strategies for tackling unintentional non-compliance with a greater evidence base 
should be used first e.g. regime simplification & medicine reminder charts. 
The place of each intervention (including MCAs) needs determining, so each can be 
targeted to those who would benefit most. 
More work is needed so that MCAs can be effectively targeted. Only then is appropriate 
remuneration likely to become available. 
Future Work 
The next stage of this work involves undertaking a needs assessment of a random 
sample of patients using MCAs. 
Who recommended the use of an MCA? 
What was the basis for the choice ofMCA? 
Do they actually need an MCA or could other strategies be used? 
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WHAT IS THE EVIDENCE FOR THE USE OF MULT-COMPARTME.'\T 
COMPLIANCE AIDS BY OLDER PEOPLE LIVING IN THE COMMUl\'ITY? 
Authors: Nunney J, Raynor DK, Knapp PRo 
Pharmacy Practice & Medicines Management Group, School of Healthcare 
Studies, University of Leeds, Leeds LS2 9UT 
J .M.N unney@leeds.ac.uk 
Aim: A structured literature review was undertaken to investigate the evidence to 
support the use of Multi-compartment Compliance Aids by older people, living in the 
community. 
Method: Systematic searches of Medline, CINHAL, EMBASE, PsychINFO, 
International Pharmaceutical Abstracts and Cochrane were carried out for the period 
1982 to present. Both UK and international, English language literature were searched. 
Hand searches were undertaken within the same parameters, as were bibliographies of 
identified articles and colleagues' personal collections. The keywords used were patient 
compliance, compliance aids, drug packaging, reminder systems and searches were 
limited to age over 65 were possible. Key words were combined and not all keywords 
produced results in each database. Identified articles were reviewed and those in which 
Multicompartment Compliance Aids (MCAs) were the main or a major focus of the 
article were obtained for further review and analysis. 
Results: Twenty eight articles were identified by the above method, these articles could 
be divided into a number of classifications as described in table!. 
Tablel. 
Type of article Number 
Randomised 7 
controlled trial 
Controlled trials 2 
Trials without 2 
control 
Descriptive articles 8 
Experimental studies 9 
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The articles were critically evaluated and the result of the trial determined. Seven 
Randomised controlled Trials were identified and of these three found that the use of an 
MCA improved compliance and four found no improvement. All of the non 
randomised controlled trials and the non controlled trials stated that patient compliance 
was improved. Critical analysis of the trials revealed a number of problems which 
would have a bearing on the trial result. The method of randomisation was described in 
only two of the randomised controlled trials. Outcome measures varied from 
measurement of blood pressure and plasma drug levels to self reported compliance and 
pill counts. The number of patients enrolled in the studies varied from 12 to 297. The 
interventions described all included a MCA but often included counselling, charts or 
other instruction leaflets, therefore making it difficult to determine if the improvement 
was due to the MCA alone or the combination of interventions. 
Discussion. A randomised controlled trial is often seen as the gold standard of research 
into a particular intervention. The randomised controlled trials investigated were 
divided in the conclusions obtained and because some of the trials were flawed it is 
impossible to draw a valid conclusion. The other trials although indicating that 
multicompartment compliance aids improved compliance suffered from small numbers 
of patients or from multiple interventions which made it impossible to determine which 
intervention had caused the improvement. 
Conclusion: The available literature describing trials of the use of Multicompartment 
compliance aids does not provide sufficient evidence for the use of these devices in 
primary care. 
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Multi-compartment compliance aids: Who gets the benefit? 
Who takes the risk? 
Authors: Mrs 1. Nunney. Prof. D.K. Raynor, Dr P. Knapp. Prof. SJ. Closs 
Focal Points. 
• 
• 
• 
Multi-compartment Compliance Aids (MCAs) are often seen by healthcare 
professionals as providing benefits to older people 
Older people and healthcare professionals agree on some of the benefits but recognise 
different risks. 
Healthcare professionals need to consider the older person's concerns if they use these 
devices. 
Introduction: Multi-compartment compliance aids (MCAs) are issued to large numbers of 
older people despite little evidence for their effectiveness 1. This study aims to discover whether 
the attitudes and beliefs of older people and healthcare professionals influence the use of multi-
compartment compliance aids. The findings discussed here focus on the risks and benefits 
which the interviewees identified. 
Method: Semi-structured qualitative interviews were undertaken with a purposive sample of 15 
older people aged over 65, taking more than 4 regular medicines and using a MCA and 17 
healthcare professionals (doctors, nurses and pharmacists) from primary, intermediate and 
secondary care. Research ethics and governance approval was obtained for all stages of the 
research. All the interviews were taped, and transcribed. Preliminary analysis of the data has 
been undertaken using the grounded theory approach as described by Strauss and Corbin2• 
Verbatim transcripts were analysed and emerging themes coded. As further transcripts were 
analysed the themes were constantly compared and similar themes were then grouped into 
categories. 
Results. Convenience and ease of use was the benefit most frequently cited by the older 
people; although a minority of interviewees thought the MCA did help them take their 
medicines correctly. The main benefit identified by the healthcare professionals was also ease 
of use although some stated that the MCA could aid memory. Both groups agreed that it was 
easier to remove all the medication to be taken at one dosage time, at once from a MCA, rather 
than have to open a large number of original packs. 
The biggest risk identified by the older people was receiving the wrong medication in the \1CA 
or receiving a medicine which they could not identify. Taking a whole day's or week's supply 
of medication at one time was the most serious risk the healthcare professionals identified. 
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Healthcare professionals also discussed dispensing errors stating these posed a risk to older 
people and that dispensing medicines in a MCA might lead more frequently to these errors. 
Non-compliance itself was considered a risk by the healthcare professionals leading, in their 
opinion, to repeat hospital admissions. MCAs are seen by some healthcare professionals as the 
answer to the problem of non-compliance and therefore could be viewed as a benefit. 
Discussion. This study has shown that MCAs may make the process of medication easier for 
some older people. It is possible that medication compliance may be improved through the use 
of MCAs especially if the regimen is complex and the older person is at risk of taking the 
medication incorrectly. The link between medication compliance and memory is complex 
involving both retrospective and prospective memory3. Therefore the MCA may help by 
removing the need to remember the medication regimen but may not help with the prospective 
component. Non-compliance may lead to an increase in hospital adrnissions4 and therefore 
issuing a MCA could be seen as providing a benefit, but healthcare professionals must not 
ignore the risks involved. 
References 
1. Nunney, J. Raynor, DK. Knapp, P. What is the evidence for the use of multi-compartment compliance aids by 
older people living in the community. In Health Services Research & Pharmacy Practice Kings College London & 
University of London 2004 
2. Strauss, A. Corbin, J. Basics of qualitative research: techniques and procedures for developing grounded theory. 
2nd ed. Thousand Oaks: Sage Publications. 1998. 
3.Branin, J. The Role of Memory Strategies in Medication Adherence among the Elderly. Home Health Care Services 
Quarterly. 2001 Vol. 20(2) 1-15 
4 H d RL Avery AJ Howard PD. Partridge M. Investigation into the reasons for preventable drug related . owar,. ,., , 
admissions to a medical admissions unit: observational study. Quality and Safety in Health Care. 2001 Vol. 12 280 -
285. 
